High-Value Investment Insights
Discover articles with exceptional investment signals and actionable insights from earnings calls
Exceptional Signals (19-20)
Articles with the strongest investment signals, representing significant opportunities or risks
LSCC Q1 2026: Compute and Communications Revenue Surges 86% as AMI Deal Doubles TAM
LSCC is exhibiting exceptional signal: long reinvestment runway, disruptive business model, accelerating growth (86% YoY in core segment), backlog visibility into 2027, margin expansion, and a doubling of TAM via AMI. The business is clearly transitioning to a higher-value platform model with compounding economics and high optionality.
ONC Q1 2026: Brukinza Drives 38% Growth, Pipeline Advances Signal Multi-Asset Inflection
ONC demonstrates a long reinvestment runway, disruptive business model, and accelerating growth across multiple metrics. Unit economics, customer value, and cash flow are all improving. The business is transitioning to a multi-asset growth leader with clear valuation upside, supported by backlog, guidance, and pipeline momentum.
Core Scientific (CORZ) Q1 2026: $3.3B Capital Raise Unlocks 1.5GW Expansion, Shifts Model Beyond Bitcoin
Core Scientific is undergoing a significant business model reset with a multi-gigawatt, high-return reinvestment runway, confirmed margin expansion, and strong forward indicators. The capital raise, rapid capacity ramp, and business evolution signal a rare, high-upside inflection—well above the threshold for maximum signal.
Hidemar (HMR) Q1 2026: Fee Revenue Surges 216% as Asset-Light Model Scales with Tanker Volatility
Hidemar demonstrates a long reinvestment runway, with rapid fleet and revenue growth, exceptional operating leverage, and high returns on capital. The business model is disruptive, self-reinforcing, and cash flow generative. Growth rates and backlog inflection are well above 40%, with strong guidance and clear evidence of a compounding platform.
ASM (ASM) Q2 2026: Logic Foundry Drives 24% Growth as 1.4nm, DRAM, and China Tailwinds Build
ASM demonstrates a long reinvestment runway at high returns, recent significant growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, backlog and guidance are strong, and the business is highly disruptive with accelerating cash flow. Revenue and EPS growth are well above 20%, and ASM is positioned as a growth business.
VNET (VNET) Q1 2026: Wholesale Revenue Surges 58% as AI Orders Fuel 519MW Pipeline
VNET demonstrates a long reinvestment runway, a massive uptick in wholesale backlog, improving unit economics, a self-reinforcing business model, rising customer value, exceptional future growth based on backlog, a disruptive model, accelerating cash flow, and is projected to grow well above 40% annually. It is clearly a growth business at a key inflection.
Jabil (JBL) Q3 2026: AI-Driven Infrastructure Surges 50% as Third Hyperscaler Win Expands Growth Base
Jabil is demonstrating a clear long runway with high returns, substantial AI-driven growth, margin expansion, and strong cash generation. The business model is increasingly self-reinforcing with new hyperscaler wins and global capacity ramps, and guidance signals sustained high growth on a larger base. The article provides strong evidence for each signal criterion, supporting a top score.
Mobilicom (MOB) Q1 2026: Backlog Surges 151% as Tier 1 Design Wins Expand U.S. Defense Pipeline
Mobilicom demonstrates a long reinvestment runway, exceptional backlog growth, improving unit economics, and a self-reinforcing, regulatory-driven business model. Customers are becoming more valuable, with a shift to recurring software revenue. The outlook is for accelerating growth and margin expansion, with evidence of a disruptive model and multi-year structural demand. The business is clearly in a high-growth phase with strong forward signals.
Arista Networks (ANET) Q4 2025: AI Networking Revenue Target Raised 18% to $3.25B as Demand Surges
Arista Networks is demonstrating a long reinvestment runway with high ROIC, significant AI-driven growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, guidance is exceptional, and the business is clearly disruptive. Cash flow is accelerating, and revenue/EPS growth is above 20%. The company is transitioning from a growth to a dominant AI infrastructure player, making this a high-signal, thesis-relevant story.
XNCR Q1 2026: XF819 Dose Expansion Sets Up Multiple Late-Stage Oncology Catalysts
Zencore is at a pivotal inflection with multiple late-stage catalysts, a broad pipeline, and clear optionality for high returns on capital. Clinical data and backlog are set to accelerate, with disruptive platform potential and rapidly improving unit economics. The business is positioned for exceptional growth, with a runway for commercial and partnership expansion.
EOS Energy (EOSE) Q1 2026: Backlog Jumps with 2 GWh Frontier Deal, Unlocking Project Finance Flywheel
EOS Energy is demonstrating a long reinvestment runway with high returns, evidenced by a transformative project finance platform, significant backlog expansion, and accelerating manufacturing scale. Unit economics are improving, the business model is self-reinforcing, and customer value is deepening. Growth rates are exceptional, the business is disruptive, and cash flow inflection is imminent. The company is at a critical inflection point, and the signal for future value creation is very high.
Shopify (SHOP) Q4 2025: GMV Surges 31% as AI Commerce Rails Drive New Merchant Adoption
Shopify demonstrates a long reinvestment runway, accelerating growth, improving unit economics, and a self-reinforcing business model with expanding global and enterprise adoption. Recent developments (AI rails, UCP, agentic commerce) are highly significant, with clear evidence of accelerating revenue, cash flow, and merchant value. The business is disruptive, with strong forward guidance and compounding optionality.
Baidu (BIDU) Q1 2026: AI Cloud Infra Jumps 79% as GPU Mix Lifts Margin Trajectory
Baidu demonstrates a long reinvestment runway, with exceptional growth in AI Cloud Infra (79%) and GPU cloud (184%), improving unit economics, and a disruptive, self-reinforcing business model. Customer value is increasing, cash flow is accelerating, and the business is clearly in a high-growth phase with global expansion, making it highly relevant for investors seeking upside.
AMG (AMG) Q4 2025: Alternatives AUM Jumps 35% as Fee-Driven Growth Accelerates
AMG is undergoing a major business model shift with a long reinvestment runway, exceptional recent growth (35% alt AUM, 60% YoY EPS guide), improving unit economics, and a self-reinforcing affiliate model. Customer value is rising, the outlook is robust, and the business is now positioned as a growth compounder in a secularly expanding segment. Signal is very high for investors.
XEO (XEO) Q3 2025: Managed Premium Surges 140% to $1.2B, Margin Expansion Drives IPO Momentum
XEO demonstrates a long reinvestment runway, a disruptive insurance-as-a-service business model, exceptional recent growth (140% managed premium, 90% revenue), expanding margins, deepening customer value, accelerating cash flow, and a strong forward outlook. The business is at an inflection point with high signal for investors.
Modine (MOD) Q3 2026: Data Center Sales Surge 78% as Segment Spin Unlocks Climate Pure Play
Modine is undergoing a structural transformation with a long reinvestment runway and high ROIC opportunities in climate solutions. The business exhibits exceptional growth in data center sales, improving unit economics, deepening customer value, and a disruptive pivot to a pure-play model. Recent results and guidance signal accelerating growth, margin expansion, and robust cash flow potential, making it highly investable.
Robinhood (HOOD) Q4 2025: Platform Assets Surge 70% as Product Velocity Unlocks Multi-Segment Growth
Robinhood demonstrates a long reinvestment runway, disruptive model, clear acceleration in growth, improving unit economics, and deepening customer value. The business is transitioning into a multi-segment fintech with strong growth signals, compounding advantages, and high cash flow potential.
Hippo (HIPO) Q2 2026: Casualty Premiums Jump 61% as Diversification Accelerates Beyond Homeowners
Hippo demonstrates a long reinvestment runway, disruptive business model evolution, and accelerating growth across multiple lines. Unit economics and margins are improving, customers are becoming more valuable, and the business is transitioning from a legacy homeowners focus to a diversified, technology-driven platform. Guidance revisions and backlog/partner expansion suggest exceptional future prospects.
Tower Semiconductor (TSEM) Q4 2025: Silicon Photonics Surges 75%, Unlocking $920M CapEx Expansion
Tower Semiconductor demonstrates a long reinvestment runway, exceptional growth in new platforms, improving unit economics, and a self-reinforcing business model. Customer value is deepening, guidance is exceptional, and the CapEx-backed model is disruptive for the foundry sector. Revenue and EPS growth are well above 40%, and the business is positioned as a growth leader rather than a legacy or transition story.
Tempus AI (TEM) Q1 2026: Data Business Jumps 41% as Pharma Demand Deepens
Tempus AI demonstrates a long reinvestment runway, disruptive and self-reinforcing business model, accelerating growth (data business up 41%, pharma contracts scaling), improving unit economics and cash flow, and strong customer deepening. The outlook is exceptional, with raised guidance and backlog expansion. The business is clearly in a high-growth phase with significant optionality and margin leverage, making the signal extremely high.
Lumentum (LITE) Q2 2026: OCS Backlog Surges Past $400M, Unlocking Multi-Customer AI Upside
Lumentum demonstrates a long reinvestment runway, disruptive business model, and accelerating growth (backlog >$400M, 60-68% YoY segment growth, margin expansion, customer diversification). Unit economics are improving, pricing power is evident, and the business is transitioning into a high-growth, supply-constrained inflection. The signal is exceptionally strong for investors seeking high-upside, thesis-driven opportunities.
Aeva Technologies (AEVA) Q1 2026: Revenue Jumps 90% as Multi-Segment Deployments Accelerate
Aeva is demonstrating a long reinvestment runway with a disruptive, high-ROIC business model. The article evidences a significant inflection in growth (90% YoY revenue jump), commercial wins, improving unit economics, and diversified, accelerating revenue streams. The business is moving from R&D to commercial scale with strong backlog, pipeline, and operational leverage, all of which are hallmarks of a high-signal, high-upside growth story.
Lantronix (LTRX) Q3 2026: Embedded IoT Jumps 22% as Drone Revenue Outlook Doubles for 2027
Lantronix demonstrates a long reinvestment runway, disruptive business model, rapidly growing drone revenue, improving unit economics, and increasing recurring revenue mix. The business is transitioning to high-margin, high-growth verticals with strong backlog and regulatory tailwinds, making it highly investable and thesis-relevant.
Axon (AXON) Q1 2026: AI Product Revenue Surges 700% as System Adoption Accelerates
Axon demonstrates a long reinvestment runway, exceptional growth in AI and counter-drone, improving unit economics, and a self-reinforcing business model. Customer value is deepening, guidance is accelerating, and the business is disruptive with cash flow ramping. Revenue and EPS are growing at a high rate, and the company is firmly in growth mode.
ICHR Q1 2026: Q2 Revenue Guide Surges 17%, Margin Expansion Signals Structural Shift
Ichor demonstrates a long reinvestment runway, clear evidence of accelerating growth (guidance up 17% sequentially, over 30% in two quarters), improving unit economics, and deepening vertical integration. The business model is becoming more self-reinforcing, with proprietary content and customer stickiness rising. Guidance and backlog signal exceptional near-term growth, and the company is transitioning into a structurally higher-margin, higher-growth phase with strong cash flow potential. The business is clearly in a high-growth, non-legacy phase with multiple avenues for further upside.
TVTX Q1 2026: Filspari Revenue Jumps 88% as FSGS Approval Unlocks $3B Peak Sales Path
TVTX demonstrates a rare disease platform with a long reinvestment runway, high returns, and disruptive business model. The FSGS approval is a significant business evolution, with rapid growth and expanding addressable market. Unit economics are improving, the business model is self-reinforcing, customers are becoming more valuable, and cash flow is accelerating. The company is positioned for sustained high growth, with all signal questions strongly supported by the call's facts and guidance.
BWXT (BWXT) Q1 2026: Backlog Surges 77% as U.S. Nuclear Capacity Expansion Accelerates
BWXT demonstrates an extraordinary signal profile: a long reinvestment runway, disruptive model, accelerating backlog (+77%), improving unit economics, and strong cash flow growth. The business is at a sector inflection with high growth visibility, diversified revenue streams, and clear competitive advantages. All key signal questions score at the highest level based on the provided evidence.
Advanced Energy (AEIS) Q1 2026: Data Center Revenue Surges 102%, Capacity Expansion Accelerates
AEIS demonstrates a long reinvestment runway, disruptive growth in data center and semiconductor, expanding margins, and accelerating cash flow. Recent developments include a 102% YoY surge in data center revenue and raised guidance for both revenue and margins. The business model is self-reinforcing, with clear evidence of compounding advantages, and the company is transitioning into a high-growth, high-ROIC phase. All signal criteria are met at the highest level.
Palantir (PLTR) Q1 2026: U.S. Revenue Soars 104% as AIP Drives Institutional Adoption
Palantir is exhibiting a rare combination of hyper-growth, expanding margins, and deepening customer value, with a disruptive AI-native platform driving institutional adoption. The business model is self-reinforcing, unit economics are improving, and the runway for reinvestment is long given current capacity constraints. Backlog and guidance revisions signal exceptional future prospects, and the company is transitioning from pilot to core infrastructure status in critical sectors.
Paladine AI (PDYN) Q1 2026: Backlog Jumps $3.5M as Defense SwarmOS Demand Accelerates
Paladine AI demonstrates a long reinvestment runway, major backlog and revenue growth, improving unit economics, and a disruptive business model with strong optionality. The business is transitioning to a high-growth phase, with accelerating revenue and margin inflection, supported by recent contract wins and operational validation. The signal is exceptionally high for investors seeking early-stage, high-growth opportunities.
Eaton (ETN) Q1 2026: Data Center Orders Soar 240%, Powering Record Backlog and Guidance Boost
Eaton is at the center of a secular growth inflection, with a 240% surge in data center orders, 12-year backlog, and accelerating organic growth. The business model is self-reinforcing, with improving unit economics, pricing power, and high returns on capital. The company is transitioning into a disruptive, high-growth platform with accelerating cash flow and broad-based end market strength. All signals point to exceptional future growth and valuation upside.
DigitalOcean (DOCN) Q1 2026: AI Customer ARR Jumps 221% as Inference Cloud Capacity Scales
DigitalOcean is demonstrating a long reinvestment runway with high returns, a massive uptick in AI-native ARR, improving unit economics, and a self-reinforcing business model. Customer value, growth rates, and future guidance all point to a high-growth, disruptive business with accelerating cash flow and exceptional forward prospects.
Atlas Energy Solutions (AESI) Q1 2026: Logistics Margins Surge to Mid-Teens as Power Pipeline Doubles
Atlas Energy Solutions is at a rare dual inflection, with both logistics and power segments showing accelerating growth, contracted cash flow, and strong pricing leverage. The article demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and exceptional future growth prospects—all supported by recent developments and management guidance. The business is positioned as a growth leader with substantial upside.
Sterling Infrastructure (STRL) Q1 2026: Backlog Surges 131% as E-Infrastructure Drives Multi-Year Visibility
Sterling Infrastructure is displaying a rare, high-signal inflection: a 131% surge in backlog, 174% segment revenue growth, and raised guidance for over 50% top-line and 72% EPS growth. The business model is vertically integrated, self-reinforcing, and benefiting from secular tailwinds in data centers/semiconductors. Unit economics, margin profile, and cash flow are all accelerating, with clear evidence of compounding value and long reinvestment runway. The article captures these signals with precision, making it highly actionable for investors.
Astera Labs (ALAB) Q1 2026: Scorpio X Ramps to 320 Lanes, Doubling AI Fabric Dollar Content
Astera Labs demonstrates a long reinvestment runway, disruptive business model, accelerating growth and cash flow, and clear expansion into high-value, high-ASP markets. The article evidences double-digit revenue growth, backlog expansion, improving unit economics, and deepening customer value, all supported by transcript data. The business is positioned as a growth leader in a rapidly expanding, high-return segment with substantial optionality and clear avenues for future outperformance.
Jacobs (J) Q2 2026: Data Center Pipeline Up 400%, Rewiring Growth and Margin Outlook
Jacobs demonstrates a rare combination of accelerating growth, margin expansion, and strategic repositioning toward AI infrastructure and digital consulting. The 400% increase in data center pipeline, double-digit organic growth, and clear reinvestment opportunities signal a business with exceptional upside and high investor relevance.
AMD (AMD) Q1 2026: Data Center Revenue Surges 57%, CPU TAM Outlook Doubles to $120B
AMD is demonstrating a long reinvestment runway at high returns, with a doubled TAM and multi-year customer commitments. Growth rates are exceptional, backlog and guidance are accelerating, and the business model is self-reinforcing with deepening customer value. The company is positioned as a growth leader, not a legacy or transitional business.
CARLS-Med (CARL) Q1 2026: Surgeon Base Expands 60%, Unlocking Platform Scale and Margin Leverage
CARLS-Med demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, a self-reinforcing business model, deepening customer value, and strong forward guidance. The capital-light, disruptive model and accelerating cash flow potential position it as a high-growth, high-signal business.
Lumentum (LITE) Q3 2026: Operating Margin Expands 2,140bps as Supply Constraints Tighten
Lumentum demonstrates a long reinvestment runway at high returns (massive capacity expansion, multi-billion dollar agreements), with significant recent growth and backlog increases. Unit economics and margins are improving rapidly with scale and product mix. The business model is self-reinforcing, with clear customer lock-in and vertical integration. Customers are becoming more valuable, and the future outlook is exceptional based on guidance and backlog. The model is disruptive, cash flow is accelerating, and revenue/EPS growth is above 40%. The company is a clear growth business, not legacy or stalled.
Sea Limited (SE) Q1 2026: Shopee VIP Subscribers Jump 40%, Expanding Member-Driven GMV Flywheel
Sea Limited demonstrates a long reinvestment runway, exceptional recent growth (47% revenue, 40%+ VIP subs), improving unit economics, a self-reinforcing business model, increasing customer value, and strong guidance. The business is disruptive, cash flow is accelerating, and revenue/earnings growth is well above 20%. This is a growth business with significant upside and multiple compounding levers.
Onto Innovation (ONTO) Q1 2026: Dragonfly G5 Pipeline Drives 50% Advanced Packaging Growth Outlook
ONTO is demonstrating a long reinvestment runway, exceptional growth (30%+ guide, 50%+ in advanced packaging), improving unit economics, and multiple self-reinforcing business model elements (software leverage, hybrid metrology, product breadth). The business is not mature, has disruptive characteristics, and is showing accelerating cash flow and margin expansion, all well supported by call evidence.
Energy Vault (NRGV) Q1 2026: Backlog Surges 108% as IPP Model Drives Margin Expansion
Energy Vault is demonstrating rare and exceptional signal: backlog up 108% with over 80% recurring/owned, margin inflection underway, and AI infrastructure demand driving a multi-year growth runway. The business model is shifting to a high-ROIC, recurring cash flow platform with global optionality and accelerating EBITDA. Unit economics, customer value, and global expansion are all improving, with clear evidence of a disruptive, high-growth business model.
Ouster (OUST) Q1 2026: Rev8 Launch and 44% LiDAR Growth Signal Paradigm Shift in Physical AI
Ouster demonstrates a long reinvestment runway with high returns, a disruptive business model, and clear evidence of accelerating growth (44% LiDAR revenue growth, strong guidance, and platform adoption). The business is self-reinforcing, with improving unit economics, increasing customer value, and a transition to a platform model. The outlook and recent developments suggest exceptional future growth and industry leadership.
Uber (UBER) Q1 2026: Uber One Membership Surges 50%, Anchoring Ecosystem Expansion
Uber is demonstrating a long reinvestment runway, rapid membership and AV growth, improving unit economics, and self-reinforcing business model dynamics. Customer value and engagement are deepening, guidance is strong, and the business is transitioning to a high-growth, cash-generative model with clear disruptive potential. Revenue and EPS growth are robust, and the business is not stalling. The signal is exceptional for investors seeking compounding platform models.
HUT 8 (HUT) Q1 2026: $9.8B BeaconPoint Contract Anchors Power-First Data Center Expansion
HUD-8 demonstrates a long reinvestment runway, recent step-change in backlog, improving unit economics, and a self-reinforcing, disruptive business model. Contracted revenue growth is exceptional, cash flow is set to accelerate, and the company is firmly in growth mode with substantial upside potential. All signals point to a business with high strategic value and valuation upside.
FLEX (FLEX) Q4 2026: CPI Segment Set for 65% Growth as Spin Unlocks AI Infrastructure Upside
Flex demonstrates a long reinvestment runway with high ROIC, a major business evolution (CPI spin-off, 65% growth in segment), improving unit economics, and a self-reinforcing business model. Customer value is deepening, guidance is exceptional, and the business model is disruptive with accelerating cash flow. Growth is projected well above 20% annually, and the company is firmly in a growth phase.
United Therapeutics (UTHR) Q1 2026: Relenopeg Data Signals Path to $8B+ Revenue Run Rate
United Therapeutics demonstrates a long reinvestment runway, a disruptive pipeline with large market expansion potential, and recent clinical results that signal a step-change in growth. Unit economics, customer value, and cash flow are all improving, with the business poised for high double-digit growth. The model is self-reinforcing, and the company is transitioning into a high-growth phase.
TG Therapeutics (TGTX) Q1 2026: BrionV Rx Base Climbs Past 25,000, Doubling Addressable Market with SubQ Path
The business demonstrates a long reinvestment runway, a step-function in growth, improving unit economics, and a self-reinforcing model. The subcutaneous launch and pipeline expansion are highly disruptive, and revenue/earnings growth is exceptional. The business is transitioning into a compounding, growth-phase model with clear investor upside.
Taysha (TSHA) Q1 2026: R&D Spend Climbs 116% as BLA Submission Nears for Rett Gene Therapy
Taysha demonstrates a long reinvestment runway, recent significant developments, improving unit economics, and a self-reinforcing business model. Customer value is deepening, guidance and backlog are exceptional, and the business model is disruptive. Cash flow is accelerating, growth is likely to exceed 40% annually, and the company is clearly in a growth phase.
Flowtech (FTK) Q1 2026: Data Analytics Jumps to 50% of Gross Profit, Accelerating Recurring Revenue Transformation
Flowtech demonstrates a rare, high-signal business inflection: a recurring, high-margin analytics segment now dominates gross profit. The company shows accelerating backlog, improving unit economics, a disruptive DaaS model, and strong growth guidance. The business is not mature or capped, but rather at the start of a new high-return cycle with clear reinvestment opportunities, making it highly actionable for investors.
Arm (ARM) Q4 2026: AGI CPU Demand Doubles to $2B, Signaling Platform Inflection
Arm is demonstrating a rare, high-signal business model shift: doubling AGI CPU demand, surging data center royalties, and a disruptive move into finished silicon with a long reinvestment runway. Unit economics are improving, customer value is deepening, and the business is transitioning from IP licensing to a platform-centric growth engine. The future outlook is exceptional, with 20%+ growth, accelerating cash flow, and a clear industry read-through for investors.
PCT Q1 2026: 95% Production Growth Unlocks Branded Sales Ramp and Macro Tailwinds
PCT demonstrates a long reinvestment runway with high returns, as evidenced by the 95% production growth on minimal cost increase. There is a significant business inflection, with branded sales and backlog growth, and clear improvement in unit economics. The business model is self-reinforcing, with regulatory and customer qualification moats. Customers are becoming more valuable, and guidance points to exceptional growth in the near term. The business is disruptive, cash flow is accelerating, and revenue/EPS growth will likely exceed 40%. This is a growth business at a major inflection.
Coherent (COHR) Q3 2026: Data Center and Comms Surge to 75% of Revenue as Indium Phosphide Capacity Doubles
Coherent demonstrates a rare combination of long reinvestment runway, accelerating backlog, improving unit economics, and disruptive business model (AI photonics, CPO, thermal). Growth is well above 40%, margins are expanding, and the business is transitioning into a cash flow machine with multiple new revenue vectors. The signal is extremely high for future valuation upside and strategic investor interest.
Kratos (KTOS) Q1 2026: Backlog Hits $2B as Hypersonics, Engines, and Space Drive Multi-Year Growth Visibility
Kratos is demonstrating a long reinvestment runway with high returns on capital, disruptive business model evolution, accelerating revenue, and margin expansion. Backlog and pipeline growth is exceptional, and the business is transitioning into a clear growth phase with strong evidence for continued outperformance. All signal questions are strongly supported by call evidence and outlook.
IBEX (IBEX) Q3 2026: Health Tech Grows 54% as AI Partnership Lifts Margin Trajectory
IBEX is demonstrating a long reinvestment runway in high-ROIC verticals (health tech, AI CX), with significant growth in health tech (54%) and technology, clear improvement in unit economics, and a self-reinforcing business model through digital/AI integration. Customer value is increasing, guidance is raised with accelerating growth, and the business is transitioning from legacy BPO to a disruptive, tech-enabled model. Cash flow is accelerating, and IBEX is now a growth business with strong forward indicators.
Revolution Medicines (RVMD) Q1 2026: $2.1B Capital Raise Fuels RAS Inhibitor Pipeline Acceleration
The business demonstrates a long reinvestment runway, disruptive model, and exceptional growth potential. The RASLUTE-302 trial results and $2.1B capital raise mark a step-change in development and commercial trajectory. Unit economics are poised to improve, and the business is transitioning from clinical to commercial with strong backlog and operational momentum. All signal questions are met at the highest level based on the evidence.
AppLovin (APP) Q1 2026: Consumer Vertical Accelerates 25% in March, Unlocking Platform Expansion
AppLovin demonstrates exceptional signal: a long reinvestment runway, disruptive AI-driven business model, accelerating growth (over 50% YoY), and margin expansion. Unit economics and customer value are improving, and the opening of the platform is a meaningful inflection. The business is not mature or capped, and the outlook/guidance supports sustained high growth and cash flow generation.
SITM Q1 2026: CED Revenue Soars 158% as Precision Timing Penetration Accelerates
SITM demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, self-reinforcing business model, increasing customer value, and accelerating cash flow. Guidance and backlog signal exceptional future growth, and the business is both disruptive and in high-growth mode. Revenue and EPS are growing at rates well above 40% annually.
Coherent (COHR) Q2 2026: 4X Book-to-Bill Signals Prolonged AI Data Center Demand Surge
Coherent demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, self-reinforcing business model, increasing customer value, and a disruptive, high-growth trajectory. Guidance and backlog are exceptional, with clear signals of accelerating revenue, EPS, and cash flow. The business is at the center of a structural AI infrastructure buildout, with order visibility and financials supporting a top-tier signal score.
EDAP (EDAP) Q1 2026: HIFU Revenue Surges 78% as Multi-Specialty Adoption Accelerates
EDAP is demonstrating a long reinvestment runway, with HIFU revenue up 78% and multi-specialty adoption accelerating. Unit economics are improving, the business model is increasingly self-reinforcing, and recurring revenue is scaling. The outlook is for 34-45% YoY growth in the core segment, with clear catalysts from regulatory and clinical milestones. This is a high-signal, high-upside growth story.
Amprius Technologies (AMPX) Q1 2026: Sitecore Drives 153% Growth as Defense and Mobility Orders Build
Amprius demonstrates a long reinvestment runway, disruptive technology, and strong growth signals with 153% YoY revenue increase and major customer wins. Margins are poised to recover as scale improves, and guidance upgrades reflect accelerating demand. The business model is self-reinforcing, with increasing customer value and robust backlog, positioning the company as a high-growth, high-signal investment opportunity.
Ligand (LGND) Q1 2026: Zoma Acquisition to Add 120+ Assets, Lifting Royalty Growth Trajectory
Ligand demonstrates a long reinvestment runway with high ROIC, a transformative acquisition (Zoma) that significantly increases growth trajectory and backlog, improving unit economics and a self-reinforcing business model. Customer value is increasing, and the business is positioned for accelerated cash flow and earnings growth. The model is disruptive within its niche, and guidance implies strong forward growth, making this a high-signal, high-upside story for investors.
MACOM (MTSI) Q2 2026: Data Center Revenue Surges 60% as Backlog Hits Record High
MACOM demonstrates a long reinvestment runway with high returns on capital, exceptional recent growth, and improving unit economics. The business model is self-reinforcing, customers are becoming more valuable, and the outlook is for exceptional growth. Cash flow is accelerating, and the company is transitioning into a high-growth phase with strong industry tailwinds. All signal criteria are strongly met.
AAON (AAON) Q1 2026: Data Center Segment Surges 104%, Driving Capacity Expansion and Margin Volatility
AAON demonstrates a long reinvestment runway, disruptive business model shift, and exceptional recent growth (Basics up 104%, company guidance for 40-45% sales growth). Unit economics and cash flow are improving with scale, and backlog/forward guidance reflect accelerating growth. The business is clearly in a high-growth phase with emerging competitive advantages and strong future optionality.
Praxis Precision Medicines (PRAX) Q1 2026: $474M Cash Infusion Extends Runway as Dual Launches Near
Praxis demonstrates an exceptional growth profile: long reinvestment runway, disruptive model, accelerating cash flow needs, and multiple late-stage catalysts. Backlog and guidance revisions point to a transformative period with multiple high-value launches and broadening addressable markets. The business is clearly in a high-growth, inflection phase with strong evidence from the call supporting each signal criterion.
Unity (U) Q1 2026: Vector-Powered Ad Revenue Jumps 80%, AI Roadmap Drives Strategic Inflection
Unity is demonstrating a long reinvestment runway, disruptive business model evolution, accelerating growth (Vector ad revenue up 80%), improving unit economics, and margin expansion. Guidance and commentary point to exceptional growth and profitability inflection, with clear evidence of a compounding, self-reinforcing business model.
Xometry (XMTR) Q1 2026: Marketplace Revenue Jumps 40% as Siemens Partnership Expands Platform Reach
Xometry demonstrates a long reinvestment runway, disruptive business model, accelerating growth, improving unit economics, and a major strategic partnership that meaningfully alters its trajectory. The company is moving into a new S-curve, with evidence of compounding network effects, exceptional future growth, and superior cash flow potential.
PVLA Q1 2026: $230M Financing Extends Runway, Accelerates Rare Disease Launch Ambitions
PVLA demonstrates a long reinvestment runway, multiple high-growth catalysts, improving unit economics, a self-reinforcing business model, increasing customer value, and a disruptive, scalable platform. The business is transitioning to commercial execution with accelerating growth, supported by a strong balance sheet and pipeline.
Innodata (INOD) Q1 2026: 54% Revenue Surge Anchors 40%+ Growth Guidance Lift
Innodata is demonstrating a long reinvestment runway, disruptive business model, and accelerating growth with high margin expansion. The business is transitioning to recurring, platform-driven revenue with improving unit economics, deepening customer relationships, and strong forward guidance. All major signal factors are present at the highest level.
IREN (IREN) Q3 2026: AI Cloud Revenue Doubles, $3.7B ARR Target Anchors Platform Shift
IREN demonstrates a long reinvestment runway at high ROIC, with a decisive pivot to high-growth AI cloud. There are clear, recent significant developments (AI cloud revenue doubling, large backlog), improving unit economics, self-reinforcing business model, increasing customer value, and exceptional future prospects based on backlog and guidance. The business model is disruptive, cash flow is accelerating, and the company is positioned as a growth business.
Datadog (DDOG) Q1 2026: RPO Surges 51% as AI and Platform Expansion Accelerate Adoption
Datadog demonstrates an unusually strong signal profile: long reinvestment runway, major growth inflection (51% RPO surge, record bookings), improving unit economics, compounding platform effects, deepening customer value, and accelerating growth across both AI and non-AI segments. The business model is disruptive, cash flow is robust and accelerating, and revenue/EPS growth is well above 20% annually. The company is clearly a growth leader, not a legacy or merely transitioning business.
Arrowhead Pharmaceuticals (ARWR) Q2 2026: Redemplo Scripts Surge 40% as Cardiometabolic Pipeline Nears Data Catalyst
Arrowhead demonstrates a long reinvestment runway, disruptive RNAi platform, accelerating script growth, improving unit economics, and a robust pipeline with multiple near-term catalysts. Exceptional growth and capital discipline are evidenced by the 40%+ script surge, $1.8B cash balance, and major data catalysts ahead. The business model is self-reinforcing, customer value is deepening, and the outlook is for continued high growth.
CoreWeave (CRWV) Q1 2026: $40B Bookings Surge Drives Backlog to $99B, Margin Expansion in Sight
CoreWeave demonstrates every attribute of an exceptional, high-signal business: enormous reinvestment runway, explosive backlog and growth, improving unit economics, deepening customer value, disruptive business model, and accelerating cash flow potential. The business is not only in hypergrowth but is also becoming foundational to the AI infrastructure ecosystem, with a capital structure that de-risks future scale. The signal is extremely high for investors seeking outsized returns from AI infrastructure.
Synaptics (SYNA) Q3 2026: Core IoT Surges 31%, Robotics Pipeline Hits 35 OEMs
Synaptics is demonstrating a long reinvestment runway with high returns, a major uptick in IoT and backlog, improving unit economics, and a self-reinforcing business model. Customer value is deepening, future guidance is exceptional, and the business is disruptive with accelerating cash flow. Revenue and EPS growth are projected well above 40%, and the company is firmly in growth mode.
McEwen Mining (MUX) Q1 2026: Net Income Swings $39.7M as Copper and Gold Optionality Accelerates Growth Path
MUX demonstrates a long reinvestment runway, clear double-digit growth, improving unit economics, and a self-reinforcing business model with copper and royalty leverage. Customers (shareholders) are seeing value accretion, and guidance/outlook is exceptional. The business is disruptive in the mining space, with accelerating cash generation and growth well above 40%. This is a clear growth business with high investor relevance.
Insmed (INSM) Q1 2026: Brinsupri Delivers 44% Sequential Growth, Underpinning Long-Term Expansion
Insmed demonstrates a long reinvestment runway, disruptive business model, rapidly improving unit economics, and accelerating growth with a strong pipeline. The 44% sequential growth, cash flow inflection, and expanding addressable markets signal exceptional business evolution and upside.
Keras Life Sciences (CAI) Q1 2026: Molecular Profiling Revenue Surges 85%, Expanding Clinical Margin Leverage
Keras Life Sciences demonstrates a long reinvestment runway with high returns on capital, exceptional recent growth in molecular profiling revenue, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, future guidance is exceptional, and the company’s disruptive platform and accelerating cash flow signal robust growth. The business is clearly positioned as a high-growth, innovative leader in its segment.
Cloudflare (NET) Q1 2026: Developer Platform Adds 1M Users, Accelerating AI-Driven Monetization
Cloudflare demonstrates a long reinvestment runway, disruptive business model evolution, and accelerating developer and AI workload growth. The business is transitioning rapidly with improving unit economics, high customer stickiness, and expanding partner leverage. Guidance and backlog imply exceptional forward growth, and the company is at the forefront of industry transformation, providing high signal for valuation upside.
Applied Optoelectronics (AAOI) Q1 2026: Data Center Revenue Surges 154% as AI Infrastructure Demand Outstrips Capacity
AOI is experiencing a supply-constrained inflection in a secular growth market (AI data center optics). The article details a long reinvestment runway, massive recent growth, improving unit economics and margins, self-reinforcing business model via vertical integration, deepening customer relationships, and accelerating cash flow. Revenue and EPS are set to grow well above 40%, and the business is clearly in a high-growth phase with disruptive potential.
Natera (NTRA) Q1 2026: Oncology Volumes Surge 55% as ASP Momentum Unlocks Margin Upside
Natera demonstrates a long reinvestment runway, rapid growth in oncology and women’s health, improving unit economics, and a self-reinforcing business model with payer and evidence moats. Customers are becoming more valuable, guidance is being raised, and the business is highly disruptive with global and lateral opportunity. Cash flow and profitability are accelerating, and the company is firmly in high-growth mode. All major signal criteria are met or exceeded.
LightPath Technologies (LPTH) Q3 2026: Backlog Triples to $111M as Vertically Integrated Infrared Demand Surges
LightPath has a long reinvestment runway, a tripling of backlog, improving unit economics, a self-reinforcing vertically integrated model, rising customer value, and an exceptional growth outlook. The business model is disruptive (proprietary U.S. glass, vertical integration), cash flow is accelerating, and revenue/earnings growth is poised to exceed 40% annually. This is a growth business at a major inflection.
Akamai (AKAM) Q1 2026: $1.8B AI Infrastructure Deal Signals Double-Digit Growth Inflection
Akamai is undergoing a business model transformation with a long reinvestment runway, massive new deals, accelerating high-margin growth, and disruptive positioning in distributed AI compute. The pipeline, backlog, and guidance all point to exceptional future growth, with clear evidence of improving unit economics, cash flow potential, and customer value expansion.
Microchip (MCHP) Q4 2026: Data Center Design Wins Propel 35% Revenue Surge Amid Tight Capacity
Microchip demonstrates a long reinvestment runway, disruptive growth in data center and FPGA, rapidly improving unit economics, and a self-reinforcing business model. Recent developments include a 35% YoY revenue surge and record backlog, with guidance and commentary pointing to exceptional future growth, margin expansion, and secular tailwinds. The business is in a clear growth phase with accelerating cash flow and high investor relevance.
Century Aluminum (CENX) Q1 2026: Mount Holly Expansion Adds Nearly 10% to U.S. Output, Positioning for $400M Run-Rate EBITDA
Century Aluminum is at a major inflection: nearly 10% U.S. capacity expansion, a structurally higher EBITDA run-rate, and a significant new project (Oklahoma) with disruptive potential. Unit economics, pricing power, and cash flow are all improving, with clear evidence of a growth business and high reinvestment runway. The article details double-digit growth, backlog, and a transition to strong free cash flow, aligning with all signal criteria.
Reddit (RDDT) Q3 2025: Advertiser Count Up 75%, Automation and App Focus Drive Margin Surge
Reddit is showing rare hypergrowth (68% revenue, 74% ad growth), massive advertiser expansion (75%), clear margin acceleration, and a disruptive, self-reinforcing business model with significant international optionality. Unit economics and ARPU are improving, and management is guiding to further growth and margin expansion. The business is not mature or capped, and the inflection is both recent and material, with upside remaining.
Micron (MU) Q3 2026: $22B Customer Deposits Signal Durable AI Memory Demand
Micron demonstrates a long reinvestment runway, exceptional backlog and growth acceleration, improving unit economics, and a self-reinforcing business model. Customer value is increasing, guidance and backlog are exceptional, and the business is transitioning to a disruptive, high-growth, cash-generative model. All signal criteria for a thesis-grade, high-upside investment are met.
Calumet (CLMT) Q1 2026: MaxSAF 150 Expansion Unlocks 4x SAF Output, Positioning for Renewable Margin Upside
Calumet demonstrates a long reinvestment runway with the renewables expansion, a major business evolution (4-5x SAF output), improving unit economics, and a self-reinforcing model via integration and contract structure. Customer value is increasing, the guidance is exceptional, the model is disruptive, cash flow is accelerating, and growth rates are well above 40%. This is a clear growth business with substantial upside.
LQDA Q1 2026: Utrepia Drives 44% Sequential Sales Growth, Anchoring Category Leadership
LQDA demonstrates a long reinvestment runway, exceptional growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, future guidance is exceptional, and the disruptive, cash-generative model supports high growth. The business is clearly in a high-growth phase with substantial upside.
ASTS Q1 2026: $3.5B Cash Secures 45-Satellite Launch Cadence Amid Direct-to-Device Race
ASTS demonstrates clear signs of a long reinvestment runway, disruptive business model, accelerating growth, improving unit economics, and a strong pipeline in both commercial and government segments. The company is transitioning into high-growth commercialization, with guidance and backlog pointing to exceptional future growth. All signals point to a business with significant upside and strategic inflection.
Venture Global (VG) Q1 2026: Contracted Portfolio Jumps to 84%, Accelerating Expansion Path
Venture Global displays multiple signals of exceptional business evolution: a long reinvestment runway, accelerating growth, rapidly improving unit economics, a self-reinforcing business model, and expanding customer value. The company is transitioning into a market leader with accelerating cash flow, high growth rates, and strong backlog visibility, all of which are thoroughly evidenced in the article.
Applied Materials (AMAT) Q2 2026: Semiconductor Systems Revenue Up 16% as AI-Driven Demand Extends Multi-Year Growth Visibility
Applied Materials demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, future guidance is robust, and the business is both disruptive and rapidly scaling. Revenue and EPS growth are expected to exceed 30%, and the company is firmly in growth mode. The signals are clear, strong, and directly relevant to investors seeking upside.
Camtek (CAMT) Q1 2026: AI-Driven Orders to Lift H2 Revenue Over 25%
Camtek demonstrates a long reinvestment runway with high returns on capital, a disruptive AI-enabled business model, and accelerating growth in both hardware and software. Unit economics are improving, backlog and order flow are at record levels, and the company is transitioning to higher-margin recurring software revenue. All indicators point to an exceptional growth trajectory with clear valuation upside.
KRMN Q1 2026: Backlog Surges 61% as Multi-Year Defense Commitments Expand Visibility
Karman Space and Defense is at a major inflection: backlog up 61%, multi-year contracts, double-digit segment growth, expanding margins, and high visibility. The business model is self-reinforcing with deepening customer ties and segment diversification. Growth is split between organic and inorganic, with accelerating cash generation and a disruptive mix of defense/space exposure. Guidance and backlog suggest exceptional near-term and long-term growth, with clear reinvestment runway and optionality.
WeRide (WRD) Q1 2026: International Revenue Surges to One-Third of Total, Accelerating Global Robotaxi Scale
WeRide demonstrates a long reinvestment runway, rapid revenue growth, improving unit economics, and a disruptive, scalable business model with accelerating international profitability. Backlog and guidance point to exceptional growth. The business is clearly transitioning from early-stage to global scale, with all signal criteria strongly met.
AmpliTech Group (AMPG) Q1 2026: Gross Margin Jumps 1500bps as 5G Orders Drive Backlog Above $20M
AmpliTech presents clear evidence of a long reinvestment runway, disruptive business model, accelerating growth, and improving unit economics. The backlog surge, margin expansion, and guidance all point to a business at a major inflection with high investor signal.
YPF (YPF) Q1 2026: Shale Oil Jumps 39% as Margin and Cash Flow Hit Records
YPF is undergoing a structural transformation with a long reinvestment runway in high-return shale assets, exceptional recent growth, rapidly improving unit economics, and a self-reinforcing business model. Customer value, guidance, and backlog are all accelerating. The business is disruptive for the region, with cash flow and growth metrics that position it as a high-upside, thesis-changing story.
Nebious (NBIS) Q1 2026: Pipeline Expands 3.5x as Full-Stack AI Cloud Demand Surges
Nebious demonstrates a rare combination of hypergrowth, expanding margins, disruptive business model, and long reinvestment runway, with clear evidence of accelerating backlog, pricing power, and customer value. The strategic partnerships and capital discipline further reinforce exceptional future prospects and investment signal.
Compass Pathways (CMPS) Q1 2026: 90% State Rescheduling Readiness Accelerates Comp360 Launch Path
Compass Pathways is at a major inflection, with regulatory acceleration, a long reinvestment runway, and disruptive business model characteristics. There is clear evidence of improving unit economics, self-reinforcing business model, increasing customer value, and exceptional growth prospects. The business is transitioning into a high-growth, first-mover position in a new therapeutic category with substantial optionality and accelerating cash flow potential.
Omeros (OMER) Q1 2026: Yartemlia Launch Reaches 30 Sites, Accelerating Standard of Care Ambitions
Omeros demonstrates a long reinvestment runway with high returns, rapid launch velocity, improving unit economics, and a disruptive, self-reinforcing business model. Customer value is increasing, backlog and guidance are exceptional, and the business is transitioning to a high-growth, cash flow-positive profile. All signal criteria are strongly met.
USA Rare Earth (USAR) Q1 2026: $1.75B Cash Position Fuels Global Mine-to-Magnet Integration
USAR demonstrates a rare combination of long reinvestment runway, disruptive vertical integration, government-backed demand, and accelerating scale. The business model is self-reinforcing, customer value is deepening, and the company is transitioning rapidly into a growth platform with strong cash flow potential. All signal criteria are met at the highest level.
Ondas (ONDS) Q1 2026: Backlog Surges to $457M, Unlocking Multi-Domain Defense Scale
Ondas demonstrates a long reinvestment runway, exceptional backlog growth, improving unit economics, a self-reinforcing business model, deepening customer value, and a disruptive shift to software-driven revenue. The business is transitioning to high-margin, high-growth territory with accelerating cash flow potential and robust revenue/EPS growth. This is a clear growth business with strong signal for investors.
Prenetics (PRE) Q1 2026: IM8 Revenue Surges 6x, Subscription Model Drives 64% Gross Margins
Prenetics demonstrates a long reinvestment runway with high returns, a major business inflection (6x growth in IM8 revenue), improving unit economics, a self-reinforcing model through subscriptions and athlete partnerships, deepening customer value, and accelerating future guidance. The business is disruptive, cash flow is accelerating, guidance implies >40% growth, and it is clearly a growth company.
Unusual Machines (UMAC) Q1 2026: 296% Revenue Surge Signals Relentless Drone Demand Outpacing Supply
UMAC demonstrates a rare high-growth, high-margin, and capital-efficient profile with a long reinvestment runway, disruptive vertical integration, and accelerating demand. The business model is self-reinforcing, customer value is increasing, and the company is positioned for exceptional future growth with regulatory and market tailwinds. All signal criteria are strongly met.
Eton Pharmaceuticals (ETON) Q1 2026: Guidance Raised 9% as Hemangiol Launch Bolsters Rare Disease Runway
Eton demonstrates a rare disease platform with a long reinvestment runway, accelerating growth (73% YoY, guidance raised 9%), and new product launches with high incremental margins. The business model is self-reinforcing, unit economics are improving, and the company is transitioning into a diversified, high-growth specialty pharma. Guidance and backlog point to exceptional growth, and the business is not mature or capped. All signal criteria are met for a high-growth, high-ROIC opportunity.
InVenture (INV) Q1 2026: Bookings Hit $50M as Excelsius Targets $100M Run Rate Amid Data Center Inflection
InVenture demonstrates a rare and compelling setup: long reinvestment runway, recent step-function growth in bookings, improving unit economics, and a self-reinforcing model across multiple high-growth verticals. Customer value is deepening, backlog and guidance point to exceptional near-term growth, and the business model is disruptive with lateral opportunities. Cash flow and revenue are both accelerating, and the company is transitioning from validation to high-growth, with high investor signal throughout.
Salcuity (CELC) Q1 2026: $2.5B Peak Revenue Target as Getatelicib Launch Nears Approval
Salcuity is at a major inflection point with a disruptive therapy near approval, a large addressable market, and multiple growth avenues. Unit economics, customer value, and business model are all improving, with strong evidence of a long reinvestment runway and clear signals of future high growth and cash flow potential. The article identifies and substantiates these signals directly from management commentary and company data.
TTMI Q4 2025: Book-to-Bill Hits 1.35 as AI and Defense Fuel 19% Growth Trajectory
TTMI demonstrates a long reinvestment runway in high-return segments (AI, defense), with significant recent growth (19% YoY, backlog up, book-to-bill 1.35+). Unit economics and margins are improving, the business model is self-reinforcing, and customer value is rising. Guidance and backlog point to exceptional future growth. The business model is disruptive within its niche, cash flow is accelerating, and both revenue and EPS are set for strong growth. This is a clear growth business with high investor relevance.
Agilysys (AGYS) Q4 2026: Subscription Revenue Jumps 30%, AI Ecosystem Drives Margin Expansion
Agilysys demonstrates a long reinvestment runway, significant growth inflection, and improving unit economics. The business model is self-reinforcing, with deepening customer value and exceptional future growth visibility. The company is disruptive within its vertical, with accelerating cash flow, high double-digit revenue and EPS growth, and a clear status as a growth business. All signal criteria are strongly met.
Duos Technologies (DUOT) Q1 2026: $14M Tech Solutions Backlog Marks Inflection in Edge Data Center Pivot
Duos Technologies is at a clear inflection point with a long reinvestment runway, large new contracts, and a disruptive, asset-light business model. Backlog and contracted revenue are surging, margins are drastically improving, and the business is transitioning from legacy to high-growth, high-margin AI infrastructure. The article provides strong evidence of exceptional future growth, high returns, and strategic relevance.
Aurora (AUR) Q4 2025: 400% Revenue Surge Forecast as 200+ Driverless Trucks Targeted for 2026 Exit
Aurora is at a major inflection, with a massive revenue ramp, full capacity commitment, and a disruptive business model shift. Hardware cost reduction, contracted demand, and the transition to a high-margin, subscription-like model all point to exceptional growth and reinvestment potential. Customer value, margins, and scale are all improving, with clear evidence from guidance and backlog. This is a rare, high-signal business evolution.
GOLAR LNG (GLNG) Q1 2026: $17B Backlog and 19% GIMI Outperformance Accelerate Fourth FLNG Order
GOLAR LNG demonstrates a long reinvestment runway with high returns, recent double-digit growth and backlog acceleration, improving unit economics, a self-reinforcing business model, rising customer value, and exceptional future prospects based on guidance. The business is disruptive, cash flow is accelerating, and both revenue and EPS growth are well above 40%. The company is a clear growth business with multiple levers for further value creation.
GDS (GDS) Q1 2026: New Bookings Surge Past 340MW, Locking in Multi-Year AI Upside
GDS demonstrates a long reinvestment runway, disruptive business model, accelerating growth, and strong unit economics. The business is at an inflection point with exceptional backlog and bookings growth, improving returns, and is positioned as a growth leader in a structurally shifting market.
Hesai (HSAI) Q1 2026: LiDAR Backlog Surges Past 6 Million Units as Physical AI Expansion Accelerates
Hesai demonstrates a long reinvestment runway, disruptive business model, and high growth rates with robust backlog and accelerating recurring revenue models. Unit economics, customer value, and cash flow are all improving, with clear signs of business model compounding and global expansion. Guidance and backlog signal exceptional future growth.
Keysight (KEYS) Q2 2026: Orders Surge 56% as AI and Defense Fuel Record Backlog
Keysight demonstrates a long reinvestment runway, exceptional recent growth (orders up 56%, revenue up 31%), improving unit economics, self-reinforcing business model, deepening customer value, and accelerating cash flow. The business is highly disruptive in its markets, with multi-year visibility, and is growing well above 20% annually. The article highlights all these factors with clear evidence from the earnings call.
Roivant (ROIV) Q4 2026: $2.25B Moderna Settlement and 73% ACR20 Response in Refractory RA Signal Pipeline Inflection
Roivant demonstrates a long reinvestment runway, transformative capital infusion, and accelerating late-stage pipeline with multiple high-growth opportunities. Clinical and financial metrics point to improving unit economics, deepening customer value, and a disruptive, scalable business model. The outlook and execution signals are exceptional, with clear potential for rapid revenue and EPS growth, making this a high-signal, high-upside opportunity.
Nvidia (NVDA) Q1 2027: Data Center Revenue Soars 92% as Blackwell Drives AI Infrastructure Surge
Nvidia demonstrates a long reinvestment runway, exceptional growth, improving economics, self-reinforcing platform advantages, and disruptive expansion into new TAMs. The business is not only accelerating but also broadening its moat, with clear evidence of continued high growth and cash generation. The article supports these points with specific metrics and management commentary.
SoYoung (SY) Q1 2026: Aesthetic Center Revenue Surges 186% as Chain Expansion Drives Scale Advantage
SoYoung demonstrates a long reinvestment runway with high ROIC, exceptional growth in core segments, improving unit economics, and a self-reinforcing, disruptive business model. The company is transitioning into a high-growth, cash flow-accretive chain, with accelerating revenue and margin expansion, strong customer retention, and clear industry leadership, all supported by transcript evidence.
MINISO (MNSO) Q2 2025: Overseas Sales Surge 29% as Large-Store Model Drives Channel Upgrade
MINISO is demonstrating clear evidence of a long reinvestment runway, disruptive business model evolution, accelerating growth, improving margins, and strong capital returns. The business is in a high-growth phase with significant optionality and execution levers, offering high signal for investors.
Elemental Royalty (ELE) Q4 2025: Pro Forma Revenue Jumps to $87M as Merger Leverage Unlocks Cash Flow
Elemental Royalty demonstrates a long reinvestment runway, major structural growth (merger, Tether investment), improving unit economics, and a self-reinforcing business model. Customer value and cash flow are accelerating, with multi-year growth visibility and disruptive digital payout innovation. The business is firmly in a high-growth phase with substantial upside.
Pony AI (PONY) Q1 2026: RoboTaxi Revenue Jumps 395% as Fleet Expansion Targets 3,500 Vehicles
Pony AI demonstrates a long reinvestment runway, exceptional revenue and backlog growth, improving unit economics, and a disruptive, self-reinforcing business model. The company is transitioning into a high-growth phase with accelerating cash flow and is positioned as a leader in a rapidly expanding market. All signal criteria are met at the highest level.
ALX Oncology (ALXO) Q1 2026: 100% Response in CD47-High HER2+ Breast Cancer Underscores Biomarker Strategy
ALXO is demonstrating a potentially disruptive, biomarker-driven oncology platform with high response rates, long durability, and major clinical inflection. The business is in a high-growth, high-optional, early-stage phase with accelerating data catalysts, strong unit economics (if validated), and a long reinvestment runway. The article clearly signals a business with significant valuation upside if execution continues.
Semtech (SMTC) Q1 2027: Data Center Revenue Jumps 39% as 1.6T Pipeline Accelerates
Semtech demonstrates a long reinvestment runway with high ROIC, a major inflection in data center demand (backlog, bookings, and guidance all sharply up), improving unit economics, and a self-reinforcing business model. Customer value is rising, the outlook is exceptional, and the business is highly disruptive with accelerating cash flow and growth. All evidence points to a structural transition to high growth and margin leverage, making this a high-signal, thesis-rich story.
Modine (MOD) Q4 2026: $4B Data Center LTA Locks in Multi-Year Growth Visibility
Modine demonstrates a long reinvestment runway with a disruptive pivot to data center cooling, underpinned by a $4B multi-year LTA. Growth rates are exceptional (data center up 158%, company guidance for 20-80% segment growth), with strong unit economics, margin expansion, and cash flow acceleration. The business model is self-reinforcing, customer value is rising, and the transition to a pure-play climate solutions provider marks a high-signal inflection. This is a rare, high-upside, actionable growth story.
Marvell (MRVL) Q1 2027: Interconnect Growth Surges 70%, Accelerating AI Infrastructure Tailwind
Marvell is showing an exceptional inflection in growth, with a long reinvestment runway, accelerating backlog, improving unit economics, and a disruptive, self-reinforcing business model. Customer value is deepening, cash flow is accelerating, and guidance revisions point to exceptional future growth. The business is a clear growth story with industry-wide read-through.
Guerrilla Technology Group (GRRR) Q1 2026: Cash Surges 373% as AI Infrastructure Build Accelerates
Guerrilla Technology is demonstrating a long reinvestment runway, rapid growth, improving unit economics, and a disruptive, self-reinforcing business model. Backlog and guidance revisions indicate exceptional future growth, with accelerating cash flow and a transition to a growth business. The article highlights all relevant signal for a high-growth, high-upside opportunity.
Kingsoft Cloud (KC) Q1 2026: AI Cloud Revenue Jumps 90% as Token Demand Explodes
KC is undergoing a structural pivot with clear evidence of a long reinvestment runway, disruptive model, accelerating growth, and improving unit economics. The business is showing exceptional backlog and guidance, with a high likelihood of continued high growth and margin expansion. The signal is strong, actionable, and relevant for investors seeking upside.
Glue Holdings (GLOO) Q4 2025: Revenue Quadruples as AI-Driven Platform Accelerates Margin Path
Glue Holdings demonstrates a long reinvestment runway, disruptive business model, and accelerating growth. The company is showing a quadrupling of revenue, margin expansion, and a shift to recurring, high-value contracts. Recent acquisitions, AI-driven workflow automation, and cross-segment replication provide self-reinforcing growth and improving unit economics. Guidance signals exceptional future growth (over 30%), with the business transitioning to profitability, strong cash flow prospects, and high retention. All signal criteria are fully met, making this a high-signal, actionable opportunity.
Snowflake (SNOW) Q1 2027: COCO Adoption Drives 400bp Acceleration, Reshaping Platform Demand
Snowflake demonstrates a long reinvestment runway, clear disruptive business model, accelerating growth, improving unit economics, and deepening customer value. The quarter marks a structural inflection with AI-native products driving exceptional growth, margin expansion, and platform adoption. The signal is extremely high, with strong evidence of durable competitive advantages and a significant step-change in business fundamentals.
Genius Group (GNS) Q1 2026: Pro Forma Revenue Jumps 80% as Premium Model Drives 10x Student Monetization
Genius Group demonstrates a long reinvestment runway, disruptive model, and clear acceleration in both revenue and profitability. Unit economics, customer value, and business model self-reinforcement are all improving rapidly, with exceptional growth guidance and strategic inflection clearly evidenced in the transcript and commentary.
Credo (CRDO) Q4 2026: Optical Revenue to Top $600M as AI Interconnect Demand Surges
Credo is demonstrating a dramatic inflection point with an optical revenue ramp, exceptional growth (over 80% YoY), improving margins and free cash flow, and diversification of its customer base. The business model is disruptive, self-reinforcing, and benefits from vertical integration. Backlog and guidance revisions are strong, and the company is positioned as a core enabler for AI infrastructure, with clear evidence of high growth and reinvestment runway.
Broadcom (AVGO) Q2 2026: AI Semiconductor Bookings Top $30B, Extending Demand Visibility Through 2028
Broadcom is demonstrating an extraordinary growth inflection with long-term revenue visibility, exceptional AI bookings and backlog, and accelerating financials. The business model is disruptive, self-reinforcing, and poised for continued high growth. All signal criteria are met at the highest level.
CIENA (CIEN) Q2 2026: Backlog Surges $600M, HyperRail Orders Signal Multi-Year AI Network Tailwind
CIENA demonstrates a long reinvestment runway, exceptional backlog growth, improving unit economics, and a disruptive, self-reinforcing business model. The business is growing revenue and EPS at high rates, with clear evidence of accelerating cash flow and a transition into a multi-year, high-growth cycle driven by AI infrastructure demand.
ServiceTitan (TTAN) Q1 2027: MAX Locations Double, Driving 25% Revenue Growth and AI Monetization Momentum
ServiceTitan demonstrates a long reinvestment runway, rapid AI-driven growth, improving unit economics, and a self-reinforcing business model with deepening customer value. Growth is accelerating, margins are expanding, and the business is transitioning into a high-growth, cash-generative vertical SaaS leader with disruptive potential and strong forward guidance.
Planet Labs (PL) Q1 2027: Backlog Surges 72%, Locking in Multi-Year Demand Visibility
Planet Labs demonstrates a long reinvestment runway, disruptive business model, and accelerating growth (backlog +72%, guidance raised, 40%+ revenue growth). Unit economics are improving, customers are becoming more valuable, and the business is transitioning into a high-growth, cash-generative model. The signal is exceptional and thesis-relevant.
Oracle (ORCL) Q4 2026: RPO Surges 363% as $67B AI Infrastructure Contracts Redefine Growth Visibility
Oracle's business is undergoing a structural transformation with a massive, visible reinvestment runway, exceptional growth metrics (RPO up 363%, cloud revenue up 93%, multi-cloud up 404%), improving unit economics, and disruptive commercial/pricing models. The evidence points to a business with rare, multi-year growth visibility, accelerating cash flow, and a transition from legacy to high-growth AI infrastructure leader. All signal criteria are strongly met.
Glue (GLOO) Q1 2026: Revenue Triples, Platform Synergies Drive 238% Growth and Margin Upside
Glue demonstrates exceptional signal: a long reinvestment runway, compounding platform synergies, and disruptive business model with accelerating growth and improving unit economics. Recent revenue growth is well above 40%, with backlog and guidance revisions upward. The business is transitioning from acquisition to integrated platform, with clear evidence of margin expansion, ARPU growth, and expansion into new verticals, all supported by transcript-based data.
Navan (NAVN) Q1 2027: AI-Driven Bookings Jump 50% as Platform Penetration Accelerates
Navan is demonstrating a rare combination of hyper-growth (50% bookings, 40% revenue), clear margin expansion, and strong evidence of a disruptive, AI-driven business model with a long reinvestment runway. Unit economics are improving, customer value is deepening, and the business is transitioning from legacy to growth leadership. Guidance and backlog signal exceptional forward momentum and the article makes a strong case for continued upside.
QT Imaging (QTI) Q4 2025: Scanner Shipments Triple, Locking in $24M Gulf Distribution Backlog
QT Imaging demonstrates a long reinvestment runway, disruptive business model, and clear transition to recurring revenue. The article highlights a transformative quarter with significant backlog, accelerating growth, improving unit economics, and a platform shift that positions the company for exceptional future performance.
NEBIUS (NBIS) Q4 2025: Capacity Commitments Surpass 2GW, Driving $16–20B CapEx Acceleration
NEBIUS demonstrates an exceptional growth runway, with sold-out capacity, accelerating revenue, and robust cash flow. The business model is disruptive, vertically integrated, and self-reinforcing with deepening customer value. All leading indicators—ARR, margin, backlog, and guidance—signal a high-growth, high-ROIC business with substantial upside and industry read-through.
Hinge Health (HNGE) Q4 2025: Free Cash Flow Margin Hits 36% as AI Drives Operating Leverage
Hinge Health demonstrates a rare combination of high growth (51% YoY, with 39%+ guidance), expanding margins, and clear operating leverage. The business model is self-reinforcing with strong network effects (Hinge Select), high retention, and improving unit economics. The company is moving toward cash flow machine status, with accelerating free cash flow and clear optionality for reinvestment. The future outlook is exceptional, with significant white space, disruptive business model, and a long reinvestment runway. All signal criteria are fully met.
Kodiak (KDK) Q1 2026: Driverless Hours Surge 120% as Platform-Agnostic Autonomy Scales
Kodiak presents a rare combination of rapid revenue and operational growth, expanding backlog, improving unit economics, and a disruptive, platform-agnostic business model. The company is transitioning to scaled commercialization with strong capital backing, high customer value growth, and clear evidence of compounding business advantages. The signal for investors is exceptionally high.
MPWR Q4 2025: Enterprise Data Growth Floor Raised to 50% Amid Supply Chain and Module Expansion
MPWR demonstrates a long reinvestment runway with high returns, recent significant growth inflection (50%+), improving unit economics, self-reinforcing business model, deepening customer value, and strong backlog/guidance. The business is disruptive, cash flow is accelerating, and both revenue and EPS are set to grow well above 20%. This is a clear growth business with exceptional near-term and long-term prospects.
Bloom Energy (BE) Q4 2025: Product Backlog Soars 140% as AI and CNI Demand Redefine Onsite Power
Bloom Energy demonstrates a long reinvestment runway, exceptional backlog growth, improving unit economics, a self-reinforcing business model, increasing customer value, and a disruptive approach to power generation. Guidance and backlog indicate accelerating growth, and the business is transitioning to a high-margin, recurring revenue model with strong cash flow. All signal criteria are met or exceeded, supporting a high score.
ARM (ARM) Q3 2026: Data Center Royalties Double, Positioning for 50% Hyperscaler Share
ARM displays a long reinvestment runway, accelerating growth, improving unit economics, and a self-reinforcing business model. The article details rapid data center royalty expansion, exceptional backlog/guidance, disruptive business model evolution, and robust cash flow prospects. The business is clearly in a high-growth phase with strong evidence of future upside.
Immunovant (IMVT) Q3 2025: BREPO 45mg Delivers 100% Responder Rate, Accelerating Pipeline Momentum
Immunovant demonstrates a long reinvestment runway with multiple late-stage pipeline catalysts, a disruptive and differentiated business model, and accelerating growth prospects (100% responder rate, multiple pivotal readouts, $4.5B cash). Unit economics, customer value, and cash flow trajectory are all improving or poised to inflect. The business is transitioning from development to growth with exceptional near-term catalysts, making the signal extremely high for investors.
Figma (FIG) Q1 2026: AI Credit Monetization Lifts Net Dollar Retention to 139%, Driving Guidance Raise
Figma is exhibiting multiple hallmarks of a high-signal, high-upside business: accelerating growth, strong unit economics, a disruptive and self-reinforcing business model, and clear evidence of long runway with high returns on capital. The transition to AI credit monetization is a major inflection, and all key signal questions are met at the highest standard.
Kyivstar (KYIV) Q1 2026: Digital Revenue Jumps 257%, Multiplay Penetration Hits 40% of Mobile Base
Kyivstar demonstrates a long reinvestment runway, major digital revenue inflection, improving unit economics, a self-reinforcing multiplay model, deepening customer value, and exceptional near-term growth. The business is disruptive, cash flow is accelerating, and growth rates are well above 40%. The business is clearly in the high-growth category, with thesis-relevant signal throughout.
Ethos Technologies (LIFE) Q1 2026: Direct Channel Rockets 136%, Powering Platform Scale and Product Expansion
Ethos demonstrates a long reinvestment runway, disruptive business model, rapid growth (well above 40%), and improving unit economics at scale. Backlog, product launches, and partnerships support future growth. The business model is self-reinforcing and cash flow is accelerating, with clear evidence of a growth company.
Applied Materials (AMAT) Q1 2026: Semiconductor Equipment Set to Grow 20%+ on AI-Driven Demand Surge
AMAT demonstrates a long reinvestment runway, significant recent growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, and the future outlook is exceptional, with guidance for 20%+ growth and industry-leading positioning in disruptive, high-growth segments. Cash flow is accelerating, and the business is solidly in a growth phase with high revenue and EPS growth potential.
Better Home & Finance (BETR) Q3 2025: Tin Man AI Platform Drives 64% QoQ Margin Expansion as Partnerships Scale
The business demonstrates a long reinvestment runway, disruptive platform model, rapidly improving unit economics, accelerating growth, and strong customer value expansion. Backlog and guidance are exceptional, the business is transitioning to a high-growth, SaaS-like margin profile, and the AI platform model is both self-reinforcing and cash generative. The signal is unusually high and relevant for investors.
Amazon (AMZN) Q4 2025: AWS Backlog Jumps 40%, Securing Multi-Year AI Growth Visibility
Amazon demonstrates a long reinvestment runway with high ROIC, a massive and accelerating AWS backlog, and clear improvements in unit economics and business model self-reinforcement. Customer value is deepening, future growth is exceptional (with 40%+ backlog growth), and the business is disruptive with accelerating cash flow. The company is positioned as a growth leader rather than a mature or transitioning business.
LightPath Technologies (LPTH) Q2 2026: Assemblies and Modules Drive 44% of Revenue, Accelerating Vertical Integration
LightPath demonstrates a long reinvestment runway, accelerating backlog, improving unit economics, a self-reinforcing business model, deepening customer value, exceptional guidance, a disruptive model, accelerating cash flow, and strong growth—all supported by transcript evidence.
Alphabet (GOOG) Q4 2025: Cloud Backlog Jumps 55% QoQ, AI Demand Drives $240B Pipeline
Alphabet demonstrates an exceptional growth profile with a massive and accelerating cloud backlog, strong reinvestment at scale, clear improvements in unit economics, disruptive business model, and accelerating cash flow. The business is not mature or capped, and all signal criteria are met or exceeded based on the call.
Q2 Holdings (QTWO) Q3 2025: Backlog Jumps $485M as Tier 1 Wins and AI Strategy Drive Momentum
Q2 Holdings demonstrates a long reinvestment runway, disruptive model, accelerating backlog and revenue, improving margins, deepening customer value, and clear growth inflection. The business is not mature or capped, and the article supports the signal with concrete numbers and developments.
Firefly Aerospace (FLY) Q1 2026: Spacecraft Revenue Hits $67.6M on Artemis and Defense Tailwinds
Firefly Aerospace demonstrates a rare combination of long reinvestment runway, step-function growth (revenue and backlog), improving unit economics, and a self-reinforcing business model (AI/data/software + vertical integration). Customer value is deepening, guidance is exceptional, and the business is disruptive with accelerating cash flow. Revenue and EPS growth prospects are well above 40% annually, and the business is clearly in a growth phase with significant upside.
Lucid Diagnostics (PAVM) Q2 2025: Revenue Climbs 40% as Medicare Milestone Nears
Lucid Diagnostics is at a genuine inflection point, with a long reinvestment runway, disruptive business model, and accelerating growth potential pending Medicare coverage. The 40% sequential revenue jump, margin structure, and backlog dynamics provide high signal. The business is transitioning from pre-coverage to potential high-growth, high-margin scaling, offering exceptional upside if reimbursement milestones are met.
Klaviyo (KVYO) Q4 2025: Enterprise ARR Doubles as Autonomous CRM Drives 32% Growth
Klaviyo demonstrates a long reinvestment runway, rapid growth, improving unit economics, self-reinforcing business model, increasing customer value, exceptional guidance, disruptive potential, accelerating cash flow, strong growth metrics, and is positioned as a growth business. The article captures all these high-signal elements.
Better Home & Finance (BETR) Q4 2025: Tin Man AI Platform Hits 44% of Volume, Driving Structural Shift
The business demonstrates a long reinvestment runway, disruptive model, accelerating growth, improving unit economics, and compounding data advantages. Recent developments (Tin Man AI at 44% of volume, 77% YoY revenue growth, guidance for 70%+ YoY loan growth) signal a major business evolution with strong forward momentum and significant upside potential.
EquipmentShare (EQPT) Q1 2026: Rental Revenue Jumps 37% as T3 Platform Drives Share Gains
EquipmentShare demonstrates a long reinvestment runway, disruptive technology, accelerating growth, and improving margins. The business model is self-reinforcing, with strong customer economics and capital efficiency. Guidance and backlog signal exceptional future growth, and the company is positioned as a high-growth, technology-enabled disruptor in a legacy industry.
Velo3D (VELO) Q1 2026: RPS Drives 48% Revenue Surge, Defense Backlog Hits $30M
Velo3D is transitioning to a recurring revenue model with strong backlog growth, margin expansion, and large defense contracts. The business shows a long reinvestment runway, improving unit economics, disruptive model, and accelerating cash flow, with clear evidence of growth and transition from pilot to scale.
Firefly Aerospace (FLY) Q4 2025: Backlog Climbs 22% as SciTech Integration Accelerates Defense Upside
Firefly demonstrates a long runway with high returns (backlog, national security tailwinds), recent step-change in growth (163% revenue, 22% backlog increase), improving unit economics, and a compounding business model through integration and recurring revenue. Customer value is increasing, guidance is exceptional, and the business is highly disruptive with accelerating cash flow potential and strong growth outlook.
Solve Energy (MWH) Q1 2026: Backlog Jumps 82%, Locking in Multi-Year Revenue Visibility
Solve Energy demonstrates a long reinvestment runway, disruptive business model evolution, and accelerating growth with exceptional backlog expansion. Unit economics, recurring revenue, and margin profile are improving, with evidence of compounding advantages and strong future outlook. The business is clearly a growth story with high investor relevance.
Aurora (AUR) Q4 2025: 400% Revenue Surge Forecast as Driverless Fleet Scales to 200 Trucks
Aurora is at a major inflection, with a 400% revenue ramp, visible backlog, improving unit economics, and a disruptive business model. The path to breakeven gross margins, a long reinvestment runway, and a shift from pilot to scaled commercial operations all signal outsized upside and high investor relevance.
Forgent Power Solutions (FPS) Q3 2026: Bookings Surge 308% as Backlog Hits $2B, Margin Expansion in Sight
FPS is experiencing a business inflection with triple-digit bookings growth, a swelling backlog, accelerating margin expansion, and a clear shift to cash generation. The business model is disruptive, self-reinforcing, and shows improving unit economics and customer value. Revenue and EPS are set to grow at exceptional rates, and the company is transitioning into a high-growth, high-cash-flow phase with a long reinvestment runway. The signal is extremely high for investors seeking upside.
Apollo Global Management (APO) Q4 2025: Origination Surges 40% to $305B, Unlocking Multi-Segment Expansion
Apollo is demonstrating an exceptional growth trajectory: 40% origination surge, multi-segment expansion, improving unit economics, and clear evidence of a self-reinforcing, diversified business model. The runway for reinvestment is long, with high returns and compounding opportunities, and the outlook/guidance supports continued growth above 20%. The business is not mature or capped, and the article presents convincing evidence for strong future compounding.
Figure (FIGR) Q1 2026: Consumer Loan Marketplace Volume Doubles, Unlocking Rule of 140 Margin Leverage
Figure demonstrates a long reinvestment runway, disruptive business model, and accelerating growth with clear improvements in unit economics and operational leverage. The business is rapidly onboarding partners, expanding into large new markets, and showing exceptional growth rates in both revenue and margins. The model is self-reinforcing with strong customer value expansion and clear signals of future outperformance.
Solve Energy (MWH) Q4 2025: Backlog Soars 87% to $8B, Locking in Multi-Year Demand Visibility
Solve Energy is demonstrating a structural inflection with an 87% backlog increase, high recurring revenue, improving unit economics, and a disruptive integrated model. Guidance and backlog signal exceptional forward growth (over 50% YoY), with expanding addressable market and cash flow. The business is positioned as a growth compounder with high barriers and strategic optionality.
Klarna (KLAR) Q1 2026: Transaction Margin Surges 44% as Fair Financing Scales
Klarna is showing all hallmarks of a high-signal, high-upside business: long reinvestment runway, accelerating growth (44%+), improving unit economics, clear network effects, deepening customer value, and disruptive business model. Guidance and backlog imply further acceleration. The business is not mature or capped, and the narrative is supported by both financials and qualitative commentary. This is a rare, exceptional signal profile.
White Fiber (WYFI) Q1 2026: Data Center Revenue Jumps 200% as Retrofit Model Accelerates AI Demand Capture
White Fiber exhibits a long reinvestment runway with high ROIC, a step-change in growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, guidance and backlog signal exceptional future growth, and the model is both disruptive and cash generative. Revenue and EPS growth rates are well above 40%, and the business is clearly in growth mode with substantial pipeline optionality.
KLIC Q1 2026: General Semiconductor Surges 90% YoY, Advanced Packaging Growth Accelerates
KLIC demonstrates a long reinvestment runway, a significant YoY growth inflection, improving unit economics, and a self-reinforcing business model (advanced packaging, memory, data center tailwinds). Customers are becoming more valuable, guidance is for accelerating growth, and the business model is disruptive with clear lateral opportunities. Cash flow and revenue/EPS are accelerating, and KLIC is positioned as a growth business with strong forward signals.
Ethos Technologies (LIFE) Q4 2025: Direct Channel Revenue Soars 93% as Platform Scale Drives Margin Leverage
Ethos demonstrates a long reinvestment runway, disruptive digital model, and accelerating growth metrics. Backlog and revenue/EPS growth are exceptional. Margins, unit economics, and customer value are all improving at scale. The business is self-reinforcing with clear network effects and AI/data advantages. Cash flow is rapidly expanding. The company is firmly in the high-growth, high-optional category with strong signals for further upside.
Datadog (DDOG) Q4 2025: $1.63B Bookings Surge Signals AI-Driven Platform Expansion
Datadog demonstrates a long reinvestment runway, accelerating growth, improving unit economics, and a self-reinforcing platform. The business is clearly disruptive, with strong future guidance, accelerating cash flow, and exceptional customer metrics. All signals point to Datadog being a high-growth, high-ROIC business with durable competitive advantages and significant upside.
PATRON (PTRN) Q1 2026: Net Revenue Retention Hits 127% as Non-Amazon Channels Surge 119%
PATRON demonstrates a long reinvestment runway with high returns, recent breakout growth, improving unit economics, and a self-reinforcing model. Customer value is deepening, guidance is raised with accelerating growth, and the business model is disruptive and cash generative. Revenue and EPS are growing at high rates, and the company is clearly a growth business with significant upside.
Viant Technologies (DSP) Q1 2026: CTV Contribution Surges 40% as Advertiser Shift Accelerates
Viant demonstrates a long reinvestment runway with strong ROIC, a disruptive business model, and accelerating growth in CTV and proprietary data. Exceptional financial and operational metrics (e.g., 40%+ CTV growth, margin expansion, and record pipeline) indicate a high-growth, self-reinforcing platform with clear investor upside. All signal criteria are strongly met.
Viant Technologies (DSP) Q1 2026: CTV Contribution Surges 40% as Advertiser Shift Accelerates
Viant demonstrates a long reinvestment runway, disruptive business model, and accelerating growth in CTV and data-driven products. Backlog, pipeline, and guidance all point to exceptional future growth. Unit economics and customer value are improving, and the business is transitioning into a high-growth, cash-generative model with clear competitive moats.
Monolithic Power Systems (MPWR) Q4 2025: Enterprise Data Growth Floor Raised to 50% as Backlog Visibility Expands
MPWR demonstrates a long reinvestment runway, a disruptive business model, accelerating growth (notably a 50%+ growth floor in enterprise data), and improving unit economics. The backlog extension, module/system migration, and strong free cash flow conversion all signal a business with exceptional future prospects and high investor relevance. All signal criteria are strongly met.
AXTI Q1 2026: Indium Phosphide Backlog Surges Past $100M, Triggering Aggressive Capacity Doubling
AXTI demonstrates a long reinvestment runway, disruptive model, and accelerating growth with a $100M+ backlog and plans to double (then double again) capacity. Unit economics are improving, margins recovering, and customer value deepening. The business model is vertically integrated and self-reinforcing. Guidance and backlog imply exceptional growth, and the company is positioned as a pivotal supplier in a rapidly expanding market.
AppLovin (APP) Q4 2025: 66% Revenue Surge Extends AI-Powered Margin Expansion
AppLovin demonstrates a rare combination of hyper-growth, margin expansion, and compounding business model advantages. The article details a long reinvestment runway, disruptive self-reinforcing platform economics, accelerating cash flow, and exceptional growth rates. All key signal criteria are met or exceeded based on the reported numbers and commentary.
AXTI Q1 2026: Indium Phosphide Backlog Surges Past $100M, Triggering Aggressive Capacity Doubling
AXTI demonstrates a long reinvestment runway (multiple years of capacity doubling), a backlog surge over $100M, improving unit economics, and a vertically integrated, self-reinforcing model. Customer value and ARPU are rising, the business is positioned for exceptional growth, and the model is disruptive within the substrate supply chain. Cash flow and profitability are inflecting, and the business is transitioning from recovery to high-growth mode, with revenue and EPS likely to grow above 40% annually. All signals indicate a high-growth, high-ROIC business at a key inflection.
RadNet (RDNT) Q4 2025: Digital Health ARR Set to Surge 86% with Gleamer Acquisition
RadNet demonstrates a long reinvestment runway, disruptive SaaS/AI business model, accelerating ARR and FCF, improving unit economics, and a clear transition to a global digital health leader. The article highlights exceptional growth, margin expansion, and industry leadership, making the signal highly actionable and relevant for investors.
Madison Air (MAIR) Q1 2026: Backlog Doubles to $2.5B, Powering Commercial Momentum
Madison Air demonstrates a long reinvestment runway, disruptive business model, and accelerating growth. Backlog and order growth are exceptional, unit economics and cash flow are improving, and recurring revenue is expanding. Guidance and business evolution signal high future growth, with clear lateral opportunities. The company is not a legacy or stalling business but a growth platform with strong valuation upside.
RadNet (RDNT) Q4 2025: Digital Health ARR Set to Surge 86% with Gleamer Acquisition
RadNet demonstrates a long reinvestment runway, disruptive SaaS/AI model, rapidly accelerating ARR, improving margins, and a strong growth outlook. The business is transitioning to high-quality, recurring revenue with global expansion optionality and clear operational leverage. Signal is exceptionally high given the scale of digital health transformation and strategic positioning.
Red Cat (RCAT) Q4 2025: Cash Surges to $168M as USV and Drone Output Scales for Global Demand
Red Cat is at an inflection point, with a long reinvestment runway, disruptive business model, and clear operational and financial signals of accelerating growth. The article details a transformative increase in cash, rapid manufacturing scale, and substantial contract pipeline, with evidence of improving unit economics and a self-reinforcing business model. The company is positioned for significant revenue and EPS growth, and the strategic context supports a high signal score.
Roblox (RBLX) Q3 2025: Bookings Surge 70% as DAUs Top 151 Million, Margin Compression Ahead
Roblox demonstrates a long reinvestment runway, exceptional growth rates, improving unit economics, and a self-reinforcing business model with strong network effects. Customer value is deepening, and future guidance signals continued acceleration. The business is disruptive, cash flow is accelerating, and both revenue and EPS are likely to grow over 40% annually. Roblox is firmly positioned as a high-growth business with significant valuation upside.
Supermicro (SMCI) Q1 2026: $13B GB300 Orders Signal AI Data Center Surge Despite Margin Compression
SMCI displays a long reinvestment runway with high ROIC opportunities, driven by the AI data center surge and $13B in new orders. There is a significant business evolution with record backlog, and unit economics are set to improve as DCPBS scales. The business model is becoming more self-reinforcing through platform leadership and customer lock-in. Customers are becoming more valuable, and future guidance is exceptional with raised full-year revenue outlook and accelerating growth. The business is disruptive, cash flow is poised to accelerate, and revenue/EPS growth is expected to exceed 40%. This is a growth business at a major inflection.
Astera Labs (ALAB) Q4 2025: Opex Jumps $16M as AI Connectivity Demand Expands TAM 10x
Astera Labs is pursuing a 10x TAM expansion with clear reinvestment at scale, rapid growth in backlog and revenue, improving unit economics, and deepening customer value. The business model is disruptive and self-reinforcing, with accelerating cash flow and a multi-year growth runway. The company is not mature or capped and is positioned for exceptional growth, as evidenced by management's commentary and financial results.
ALXO Q2 2025: CD47 Biomarker Drives 65% ORR in HER2+ Gastric, Reshaping Breast Cancer Strategy
ALXO demonstrates a long reinvestment runway, a major inflection in clinical data (65% ORR in biomarker-selected patients), improving unit economics via focused pipeline, a self-reinforcing biomarker-driven model, increasing customer value, exceptional future growth potential, a disruptive approach in IO, accelerating cash flow runway, very high growth prospects, and is positioned as a growth business. All signal criteria are met at the highest level.
ASX Q4 2025: LEAP Services Double to $3.2B, Driving Margin Upside and Capacity Race
ASX demonstrates a long reinvestment runway with high returns, recent doubling in LEAP growth, improving unit economics, self-reinforcing business model, and deepening customer value. Guidance and backlog point to exceptional forward growth. The business is disruptive, cash flow is accelerating, and revenue/EPS growth is robust, making it a clear growth business with high signal.
EOS Energy (EOSE) Q3 2025: Commercial Pipeline Jumps 21% as Data Center Demand Drives 22% of Volume
EOS shows a long reinvestment runway, significant acceleration in pipeline and backlog, improving unit economics, a self-reinforcing business model through automation and strategic partnerships, increasing customer value (data center and long-duration focus), exceptional future outlook with accelerating growth, disruptive business model in a rapidly scaling market, accelerating cash flow trajectory, revenue and EPS growth likely to exceed 40%, and is a clear growth business. All answers are strongly evidenced by the call data.
Hyperion DeFi (HYPD) Q1 2026: DeFi Monetization Surges 140% as Triple-Dip Strategy Scales
Hyperion DeFi demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, a self-reinforcing model, and deepening customer value. The business model is disruptive, cash flow is accelerating, and the company is clearly transitioning into a high-growth operator with significant upside potential, as evidenced by financials, backlog, and strategic positioning.
QuickLogic (QUIK) Q1 2026: New Product Revenue Jumps 51% as RadPro and Intel 18A Initiatives Accelerate
QuickLogic demonstrates a long reinvestment runway (RadPro, Intel 18A, chiplet model), with significant recent growth (new product revenue up 51% sequentially). Unit economics are improving, the business model is becoming self-reinforcing, and customer value is increasing. Guidance and backlog point to exceptional future growth, and the company is transitioning toward a disruptive, high-growth model with accelerating cash flow. The business is likely to grow revenue and EPS well above 40%, and is positioned as a growth business with strong optionality.
BlackSky (BKSY) Q1 2026: Gen 3 Contracts Drive $160M Backlog Surge, International Mix Expands
BlackSky is at a clear inflection: contract wins, backlog surge, and raised guidance all reflect a transition to high-growth, high-margin SaaS-like economics with international expansion. The business model is disruptive with a long reinvestment runway, compounding advantages, and accelerating cash flow. All signal criteria for upside and investor relevance are met or exceeded.
Roivant (ROIV) Q3 2025: Brepo 45mg Delivers 100% Response in CS, Unlocking Orphan Inflammatory Expansion
Roivant demonstrates a long reinvestment runway with high returns, transformative clinical results, improving unit economics, a self-reinforcing business model, and deepening customer value. The future outlook is exceptional, with accelerating growth, disruptive potential, and strong cash flow prospects. All signal questions are met at the highest level based on the evidence presented.
BGC (BGC) Q4 2025: FMX UST Market Share Hits 40% as Revenue Surges on Energy and Electronic Expansion
BGC demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, a compounding self-reinforcing model, and increasing customer value. The business is at an inflection, with guidance and backlog supporting further acceleration. The model is disruptive, with cash flow and EPS growth exceeding 20%+ and a clear trajectory as a growth business.
Strata Critical Medical (SRTA) Q3 2025: 80% EBITDA Growth Signals Medical Platform Inflection
SRTA demonstrates a long reinvestment runway with high returns on capital, a transformative business evolution, improving unit economics, and a self-reinforcing, disruptive platform model. Growth rates, margin expansion, and cash flow inflection are exceptional, with strong evidence of a structural inflection and significant upside.
SITM Q4 2025: CED Revenue Surges 160% as Renesas Timing Acquisition Doubles Scale
SITM demonstrates a long reinvestment runway, exceptional growth (160% in CED, 66% overall), improved margins and unit economics, and a business model with clear network effects and self-reinforcement through the Renesas acquisition. Customer value is increasing, future guidance is strong, and the business is disruptive with clear lateral opportunities. Cash flow and EPS are accelerating, and the company is transitioning into a high-growth, industry-leading model.
Osprey Health (OSCR) Q4 2025: Membership Surges 58%, Margin Expansion Anchors 2026 Profitability Pivot
Osprey demonstrates a long reinvestment runway with high returns, disruptive business model, accelerating growth, improving unit economics, and strong customer value expansion. Backlog/guidance revisions are exceptional, with the business clearly transitioning to high-growth and profitability. The article signals a major inflection for investors.
Unity (U) Q4 2025: Vector Surges 72% YoY, Accelerating Shift to High-Margin AI Platform
Unity demonstrates a long reinvestment runway with high returns, a significant business inflection via Vector's explosive growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, future guidance is exceptional, and the business is both disruptive and accelerating in cash flow. Growth rates are well above 40%, and the business is in a clear growth phase.
Hyperfine (HYPR) Q3 2025: Gross Margin Jumps 450bps as Next-Gen MRI Launches Drive Pipeline Expansion
Hyperfine demonstrates a long reinvestment runway, clear business model evolution, improving unit economics, and a disruptive approach to medical imaging. The business is transitioning to high growth with accelerating revenue and margin expansion, supported by robust backlog, a multi-vertical pipeline, and significant guidance revisions. All signal questions are fully met with strong evidence.
IREN (IREN) Q2 2026: $3.6B GPU Financing Secures 95% of Microsoft AI CapEx, Unlocking Platform Scale
IREN demonstrates an exceptional growth runway, disruptive business model, and significant backlog and revenue acceleration. The transition to AI cloud, compounded by large contracts and secured power, signals an inflection to high-margin, high-growth operations. All signal criteria are clearly met or exceeded.
Hyperion DeFi (HYPD) Q3 2025: Validator Stake Surges 60% as DeFi Monetization Flywheel Accelerates
Hyperion DeFi demonstrates a long reinvestment runway, disruptive and compounding business model, rapidly accelerating validator growth (+60% MoM), expanding recurring revenue, and strong guidance for further growth. Unit economics are improving, customer value is deepening, and the business is transitioning into a high-growth, cash-generative model. All signal questions are met at the highest standard.
Strata (SRTA) Q4 2025: Organic Growth Surges 35%, M&A and Regulatory Tailwinds Expand Platform
Strata demonstrates a long reinvestment runway, disruptive model, and accelerating growth (35% organic, robust M&A pipeline, margin expansion, and regulatory tailwinds). Unit economics are improving, customers are becoming more valuable, and the business is transitioning into a clear growth phase with upside optionality. Guidance and backlog signal exceptional near-term and multi-year prospects.
Klarna (KLAR) Q3 2025: Fair Financing Merchants Double, Fueling 139% Product Surge
Klarna demonstrates a long reinvestment runway, disruptive business model, and clear compounding effects from network and product expansion. There is strong evidence of exceptional growth, improving unit economics, and a transition to a higher-margin, multi-product fintech platform. The company is not a legacy business and is showing accelerating revenue, margin, and cash flow potential.
XEO (XEO) Q4 2025: Managed Premium Surges 140% as AI-Driven Platform Onboards $100M in New Clients
XEO shows an exceptional growth inflection: managed premium up 140%, ARR +55%, rapid third-party onboarding, and >100% free cash flow conversion. The business model is disruptive, self-reinforcing, and highly scalable, with accelerating growth, improving unit economics, and a long reinvestment runway. The company is transitioning from single-client risk to a diversified, high-growth platform, with clear signals of compounding value and industry disruption.
Red Cat (RCAT) Q1 2026: Revenue Surges 849% as Black Widow Pipeline Hits $700M
Red Cat demonstrates a unique inflection: massive revenue growth, a $700M+ pipeline, improving margins, and operational leverage. The business is disruptive, has a long reinvestment runway, and is transitioning into a high-growth, cash-generating model with accelerating guidance and sector tailwinds. All signal factors are strongly supported.
Enlight Renewable Energy (ENLT) Q1 2026: U.S. Revenue Share Hits 37% as Portfolio Surges Past 41GW
Enlight demonstrates a long reinvestment runway, clear inflections in U.S. and storage growth, improving unit economics, and self-reinforcing advantages. Customer value is rising, future guidance is exceptional, and the business model is disruptive with accelerating cash flow. The company is transitioning into a high-growth, high-return platform with strong optionality and industry leadership.
Figma (FIG) Q3 2025: Paid Teams Surge by 90,000 as AI-Native Platform Drives 38% Growth
Figma demonstrates a rare combination of rapid growth, expanding TAM, strong unit economics, and a disruptive, self-reinforcing business model. All key signals—runway, product adoption, customer value, margin trajectory, and market positioning—are exceptional and well-supported by the earnings call.
Innodata (INOD) Q1 2025: Revenue Soars 120% as Generative AI Pipeline Expands Across Big Tech
Innodata demonstrates a long reinvestment runway, disruptive business model, and exceptional growth rates (120% YoY). Margins are expanding, recurring revenue is growing rapidly, and the business is transitioning toward platformization with high-value, sticky customers. The company is not mature or capped, and the business model is compounding with scale and customer value deepening. The signal for future growth and valuation upside is very high.
D-Wave Quantum (QBTS) Q4 2025: Sales Pipeline Expands 1500% as Dual Platform Strategy Accelerates
D-Wave demonstrates a rare combination of explosive pipeline growth (1500%), clear commercial inflection, and unique dual-platform technical leadership. The business model is disruptive, with recurring revenue and system sales both accelerating. Bookings and backlog are at record levels, and the company is transitioning from R&D to commercial adoption with Fortune 100 and government validation. The quantum computing sector is early but D-Wave shows exceptional growth, optionality, and potential for compounding returns.
AST SpaceMobile (ASTS) Q2 2025: CapEx Jumps to $323M as Satellite Manufacturing Scales for Direct-to-Device Launch
ASTS demonstrates a long reinvestment runway, a disruptive and self-reinforcing business model, and is at a major inflection with significant operational and financial developments. Unit economics and customer value are set to improve with scale, the business is transitioning to a growth phase, and the outlook is for rapid expansion. The article captures these signals directly from the call and management commentary, justifying a top score.
Beta Technologies (BETA) Q4 2025: Backlog Surges by $2B as Regulatory Tailwinds Accelerate Commercialization
Beta Technologies displays a long reinvestment runway, disruptive business model, rapidly expanding backlog, improving unit economics, and accelerating defense and commercial opportunities. The business is moving from validation to commercialization, with clear signals of high growth, margin potential, and durable competitive advantages.
Enlight Renewable Energy (ENLT) Q3 2025: Storage Portfolio Soars 6x in Three Years, Powering $2B Revenue Runway
Enlight demonstrates a long reinvestment runway at high returns, a massive recent uptick in storage-driven growth, improving unit economics, and a self-reinforcing business model. Customers (utilities) are becoming more valuable with storage/renewables integration, and guidance is revised upward with strong backlog. The business is highly disruptive, cash flow is accelerating, and revenue/EPS growth is robust. This is a top-tier, high-signal growth story with sector leadership potential.
Oracle (ORCL) Q1 2026: RPO Surges 359%, Unlocking Multi-Year AI Cloud Revenue Visibility
Oracle demonstrates a rare and exceptional inflection: a 359% surge in RPO, multi-year backlog, accelerating cloud and database revenue, and a disruptive AI-driven business model with a long reinvestment runway. Unit economics, customer value, and cash flow potential are all improving at scale. The business is clearly transitioning into a high-growth, high-visibility phase with industry-wide implications, warranting the highest signal score.
InVivid (IVVD) Q3 2025: $87M Capital Infusion Powers Pivotal Antibody Launch Path
InVivid demonstrates a long reinvestment runway, a disruptive business model, and clear evidence of accelerating growth (41% YoY revenue, major capital infusion, pivotal trial catalyst). The business is transitioning from niche to broad market, with improving unit economics, robust commercial expansion, and high-value pipeline optionality. The risk/reward is highly asymmetric given the clinical and regulatory inflection ahead.
York Space Systems (YSS) Q4 2025: Revenue Surges 52% as Backlog Hits 107 Satellites for Launch
York Space Systems demonstrates a long reinvestment runway, disruptive business model, accelerating growth, and exceptional backlog visibility. Margins are expanding, unit economics are improving, and the company is transitioning to a scaled, high-growth incumbent with clear competitive advantages. All factors point to a business with very high signal and material valuation upside.
Enovix (ENVX) Q1 2026: Korea Pipeline Surges to $130M as Drone and Eyewear Markets Accelerate
Enovix demonstrates a long reinvestment runway, disruptive technology, and accelerating growth across multiple verticals. Backlog and pipeline expansion, improving unit economics, and a shift from validation to commercial scaling all signal an exceptional business inflection. The business model is self-reinforcing and cash flow is poised to accelerate, with strong evidence of future revenue and EPS growth.
Kodiak (KDK) Q4 2025: Driverless Truck Fleet Doubles to 20, Accelerating Physical AI Scale-Up
Kodiak demonstrates a long reinvestment runway, disruptive business model, rapid growth, improving unit economics, and a clear path to recurring cash flow. The company is at an inflection point with accelerating revenue, expanding backlog, and significant optionality across verticals. All signal questions are strongly evidenced by the call and company commentary.
RedCat (RCAT) Q3 2025: Revenue Surges 200% on Defense Drone Ramp, Blue Ops Maritime Launch Expands TAM
RedCat shows a long reinvestment runway with new contracts and manufacturing scale. The 200% sequential revenue growth and large backlog expansion are clear signals of business evolution. Unit economics and margins are improving with scale, and the business model is becoming self-reinforcing via manufacturing and software integration. Customers (defense/government) are increasing in value, and future growth is exceptional based on backlog and guidance. The model is disruptive with lateral moves (maritime), and cash flow is set to accelerate. The business is transitioning into a high-growth phase with revenue and EPS likely to grow far above 20% annually.
Vertiv (VRT) Q4 2025: Backlog Doubles to $15B as Americas Orders Surge, Extending AI Data Center Tailwind
Vertiv is demonstrating a rare combination of explosive order growth, expanding backlog, and accelerating margins/cash flow, all underpinned by secular AI data center demand. The business model is self-reinforcing, with services and system integration deepening customer value. Guidance and backlog signal exceptional forward growth, and the company is positioned as a disruptive, high-growth, high-ROIC leader in its segment.
17 Education & Technology (YQ) Q1 2026: Yiqi Aixue Lifts Revenue 359%, AI Ecosystem Drives Margin Expansion
YQ demonstrates a long reinvestment runway, disruptive business model, accelerating growth, expanding margins, and clear evidence of improving unit economics and customer value. The company is in a strong growth phase with a self-reinforcing AI/data flywheel, making the signal both high and actionable.
Cerebras (CBRS) Q1 2026: Core Revenue Doubles as Wafer-Scale AI Demand Accelerates
Cerebras demonstrates a long reinvestment runway, disruptive business model, and rapidly accelerating growth (core revenue up 92%, cloud/services up 167%). Backlog and guidance signal exceptional future growth. Unit economics and margins are improving with scale, despite temporary rental headwinds. Major partnerships (OpenAI, AWS) validate product-market fit and reinforce the self-reinforcing business model. The company is clearly in the high-growth, high-ROIC phase with strong cash flow prospects as scale is achieved.
Penguin Solutions (PENG) Q3 2026: AI-Driven Memory Sales Surge 111% as Backlog Builds for Inference Era
Penguin Solutions demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, and clear self-reinforcing business model attributes. Customer value is rising, backlog and growth guidance are exceptional, and the business model is disruptive with accelerating cash flow and revenue. The article substantiates these points with transcript-based facts.
EquipmentShare (EQPT) Q2 2026: Rental Revenue Up 37% as T3 Drives Share in Mega Projects
EquipmentShare exhibits a long reinvestment runway, disruptive business model, accelerating growth and margins, and deepening customer value. Recent results and guidance revisions signal exceptional forward prospects, with the business model compounding and clear evidence of technology-driven share gains.
Palo Alto Networks (PANW) Q3 2026: NGS ARR Soars 60% as AI-Driven Demand Redefines Security Landscape
PANW demonstrates a long reinvestment runway, disruptive business model, accelerating growth, improving unit economics, and strong customer retention. The business is benefiting from structural AI tailwinds, with significant recent developments and clear margin expansion. Guidance and backlog support the case for continued outperformance, making it highly actionable for investors.
PUBM Q1 2026: Emerging Revenue Surges 80%, AI-Driven Model Sets Up Double-Digit Growth
PubMatic demonstrates a long reinvestment runway, disruptive AI-driven business model, accelerating emerging revenue, and expanding margins. Unit economics are improving, the business is self-reinforcing, and customer value is increasing. Backlog/guidance signals exceptional future growth, and the model is highly scalable with cash flow acceleration. All signal criteria are strongly met.
AEHR (AEHR) Q4 2026: Backlog Surges 430% to $80.6M as AI and Photonics Burn-In Demand Accelerates
AEHR demonstrates a long reinvestment runway with high returns, a massive surge in backlog, and a business model pivoting to high-growth AI and photonics markets. Unit economics and margins are improving, the model is self-reinforcing, and customer value is increasing. The outlook is exceptional, with disruptive potential and accelerating cash flow. The business is in a clear growth phase with significant optionality.
Kestra Medical Technologies (KMTS) Q4 2026: Gross Margin Expands 1,100bps, Accelerating Market Penetration
Kestra displays all the hallmarks of a high-signal, high-upside business: a long reinvestment runway, disruptive model, accelerating growth (44%+ guided), expanding margins, improving unit economics, and strong customer value trends. The business is transitioning to cash generation, with clear evidence of compounding advantages and sector read-through.
Frequency Electronics (FEIM) Q4 2026: Backlog Hits $111M, Catalyzing Multi-Year Growth Trajectory
FEIM demonstrates a rare combination of record backlog (multi-year revenue visibility), margin inflection, high-barrier market entry, and a clear transition to a scalable, high-ROIC business model. The business is exiting legacy drag, has accelerating growth (34% CAGR target, book-to-bill near 3.0), and is positioned for high incremental returns. The article details a disruptive, high-optional business at a key inflection, with evidence of accelerating earnings power and long runway.
ASML (ASML) Q2 2026: DRAM Demand Drives 75% Memory Growth, Order Visibility Extends Through 2028
ASML is demonstrating a rare multi-year growth inflection with long reinvestment runway, accelerating demand, improving unit economics, and compounding business model advantages. The order book, margin trajectory, and technology leadership all point to exceptional future growth and cash flow. The business is disruptive with high strategic optionality, and guidance/backlog supports sustained >20% growth. Signal is extremely high for investors seeking upside.
Tesla (TSLA) Q2 2026: CapEx Surges 100% as FSD and Robotaxi Drive New Backlog Records
Tesla is executing on a rare, high-velocity inflection with long reinvestment runway, disruptive business model, accelerating growth, and substantial backlog/guidance revision. The business model is self-reinforcing, customer value is deepening, and the future outlook is exceptional with clear, thesis-relevant signals throughout.
TE Connectivity (TEL) Q3 2026: Record $5.7B Orders Signal AI-Driven Backlog Surge Into FY27
TE Connectivity is exhibiting all the hallmarks of a high-signal, compounding business: long reinvestment runway, record-breaking order growth (27% YoY overall, 36% in industrial, 70% YTD in DDN), clear margin expansion, and a business model reinforced by secular AI, electrification, and grid modernization trends. Unit economics are improving, backlog is swelling, and the business is transitioning into a higher-growth, cash-generative phase. The model is self-reinforcing with content growth and strategic M&A, and guidance signals continued acceleration.
Alphabet (GOOG) Q2 2026: Cloud Revenue Soars 82% as AI Drives Record $514B Backlog
Alphabet’s results and positioning clearly indicate a long reinvestment runway, disruptive business model, accelerating growth, and exceptional backlog visibility. All signal criteria are met at the highest level, with evidence of compounding economics, deepening customer value, and a transformative growth profile.
Digital Realty (DLR) Q2 2026: Backlog Hits $1.9B, Securing Multi-Year Double-Digit Growth Path
Digital Realty demonstrates a long reinvestment runway, accelerating backlog, improving unit economics, and disruptive business model characteristics. The business is growing rapidly with high visibility into future earnings and margin expansion, supported by a robust pipeline and strategic capital initiatives.
Freeport-McMoRan (FCX) Q2 2026: U.S. Mine Operating Income Surges 2.4x, Accelerating Copper Growth Pipeline
Freeport-McMoRan is showing a long reinvestment runway, major growth inflections (2.4x US operating income, 65% net income growth), improving unit economics, self-reinforcing model with brownfield/technology, rising customer value, exceptional guidance, disruptive leach innovation, accelerating cash flows, >20% growth, and clear growth trajectory.
Aurora (AUR) Q2 2026: Gen 2 Hardware Cuts Costs by 50%, Accelerates Path to Profitability
Aurora demonstrates a long reinvestment runway with high returns as it transitions to a scalable, asset-light business model. There are significant recent developments (hardware cost halving, rapid fleet expansion, 400%+ revenue growth guidance). Unit economics are improving, the business model is self-reinforcing, and customer value is deepening. Guidance and backlog are exceptional. The business is disruptive with clear lateral opportunities, accelerating cash flow, and projected high growth rates. Aurora is clearly a growth business entering industrial scale.
MaxLinear (MXL) Q2 2026: Infrastructure Revenue Jumps 145% as Optical Demand Rewrites Growth Trajectory
MaxLinear is undergoing a major business model transformation with a long reinvestment runway, significant growth inflection in optical infrastructure, improving unit economics, and expanding margins. The business model is self-reinforcing with increasing customer value, backlog visibility, and disruptive potential in data center connectivity. Guidance and reported results support exceptional growth, and the business qualifies as a high-growth, thesis-relevant opportunity.
Prague Holdings (PRG) Q2 2026: Consolidated GMV Surges 60% as Ecosystem Model Unlocks Margin Expansion
PRG demonstrates a long reinvestment runway, exceptional recent growth (GMV +60%), improving unit economics, and a self-reinforcing model driven by ecosystem and AI. Customers are becoming more valuable, guidance is raised, and all segments are compounding. The business is disruptive in consumer finance, cash flow is accelerating, and revenue/EPS growth outlook is well above 20%. This is a clear growth business with high signal for investors.
Sensient Technologies (SXT) Q2 2026: Natural Color Conversion Revenue Hits $25M, Signaling Acceleration Toward $1B Goal
Sensient is in the midst of a major secular shift with a long reinvestment runway, clear regulatory and consumer tailwinds, and double-digit growth. Unit economics are improving, the business model is self-reinforcing, and customer value is increasing. Backlog and guidance are exceptional, the model is disruptive, and cash flow is ramping. Revenue and EPS growth are high, and the business is firmly in a growth phase.
Sanmina (SANM) Q3 2026: Core Revenue Up 17%, AI and Cloud Demand Accelerate Next Leg
Sanmina is demonstrating a long reinvestment runway, disruptive business model pivot, and exceptional growth (nearly 70% YoY, $16B+ target). Unit economics and customer value are improving. Cash flow and margin dynamics are strong. The business is now a scale growth platform in a secularly advantaged sector.
Applied Digital (APLD) Q4 2026: Contracted Lease Value Doubles to $36B, Unlocking Multi-Gigawatt Expansion
The business demonstrates a long reinvestment runway, massive recent growth in contracted value, improving and scalable unit economics, a self-reinforcing business model, deepening customer value, and accelerating growth outlook. The transition to a platform operator with direct hyperscaler commitments and a power pipeline is highly disruptive and signals exceptional future prospects.
Cadence (CDNS) Q2 2026: $8.1B Backlog and Agentic AI Adoption Propel 19% Growth Outlook
Cadence demonstrates a long reinvestment runway, disruptive AI-driven business model, and accelerating growth across all segments. Backlog, recurring revenue, and customer value are all rising materially. The company is showing exceptional growth and guidance revision, with clear evidence of self-reinforcing economics and a multi-year growth trajectory.
Baker Hughes (BKR) Q2 2026: IET Orders Double to $7.1B, Unlocking Multi-Year Power Systems Ramp
Baker Hughes exhibits a long reinvestment runway (multi-year power systems ramp), recent step-change in growth (IET orders doubled), improving unit economics and margins, and a self-reinforcing business model with growing recurring revenue. Customers are becoming more valuable (higher ARPU, recurring services), and backlog/guidance is exceptional. The business model is disruptive within energy infrastructure, cash flow is accelerating, and growth rates are robust, with the company clearly in a growth phase.
Celestica (CLS) Q2 2026: CCS Revenue Soars 84% as AI Infrastructure Demand Drives Record Margins
Celestica is demonstrating a long reinvestment runway with high ROIC, exceptional growth rates, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, the business is in a structural acceleration, and there are clear disruptive dynamics with strong future guidance. All signal criteria for a high-growth, high-upside business are met.
Bloom Energy (BE) Q2 2026: Brookfield Financing Grows 5x to $25B, Locking In AI Power Demand Surge
Bloom Energy is at a major inflection: institutional capital, accelerating AI/data center demand, margin and cash flow inflection, and a disruptive business model with a long runway. Backlog and revenue growth are exceptional, and the company is positioned as a growth compounder with strong investor signal.
Core Scientific (CORZ) Q2 2026: $14B AMD Deal Locks In 530MW, Shifts Model to Long-Term AI Infrastructure
Core Scientific demonstrates a long reinvestment runway with a disruptive business model shift, exceptional backlog growth, and clear evidence of improving unit economics and customer value. The AMD deal and execution cadence underpin accelerating revenue and cash flow, with the business positioned as a growth platform in a supply-constrained, high-demand sector. All signal criteria for upside and business evolution are satisfied.
Connexa Pharmaceuticals (KNSA) Q2 2026: ARCLIS Revenue Jumps 55% as Penetration Hits 21%
Connexa demonstrates a long reinvestment runway with only 21% market penetration and clear avenues for redeployment at high returns. There is a significant uptick in growth (55% YoY revenue gain), improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable over time, and the future outlook is exceptional with raised guidance. The business is disruptive in rare disease pharma, cash flow is accelerating, and revenue/EPS growth is well above 40% annually. This is a high-growth, innovative business with strong signal for investors.
Ecolab (ECL) Q2 2026: Global High Tech Surges 29% as Portfolio Shifts Toward High-Margin Engines
Ecolab is demonstrating a strong inflection with high-growth, high-margin segments (global high tech, digital, life sciences) now central to its business. There is clear evidence of a long reinvestment runway, disruptive model, accelerating growth, improving unit economics, and exceptional future guidance. The business is not mature or capped and shows all hallmarks of a high-signal, compounding opportunity.
Corning (GLW) Q2 2026: Optical Sales Jump 32% as AI and Data Center Demand Accelerates
Corning shows a long reinvestment runway with high returns, major double-digit growth in optical and solar, improving unit economics and margins, and a self-reinforcing business model through long-term agreements. Customer value is deepening, backlog and guidance are exceptional, and the business is shifting to a disruptive, platform-led model. Cash flow is accelerating, and revenue/EPS growth is expected to be well above 20%. This is a clear growth business, not a legacy or transitioning story.
Bandwidth (BAND) Q2 2026: Five $1M+ AI-Driven Wins Signal 22% Growth Inflection
Bandwidth is showing a clear inflection with accelerating growth, strong unit economics, and a disruptive, usage-based AI business model. Guidance and backlog support high growth, margins are expanding, and the business is not mature or capped. The article evidences all major signal criteria.
NXP Semiconductors (NXPI) Q2 2026: Physical AI Pipeline Expands to $1.5B, Accelerating Edge Growth
NXPI is demonstrating a long reinvestment runway with high ROIC, double-digit and accelerating growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, backlog and guidance are exceptional, and the business is both disruptive and a cash flow machine. Revenue and EPS growth are robust, and the business is firmly in growth mode.
LAM Research (LRCX) Q4 2026: NAND Revenue Doubles, Driving 20% Sequential Growth Outlook
LAM Research is demonstrating exceptional growth and business model evolution: doubling NAND revenue, record service growth, expanding margins, and a clear multi-year runway driven by AI and memory transitions. All signal questions are strongly evidenced by the call, supporting a top score.
Vertiv (VRT) Q2 2026: Operating Margin Expands 410bps as Data Center Demand Accelerates
Vertiv demonstrates a long reinvestment runway, exceptional growth (net sales up 24%, guidance for 37% YoY, EPS up 60%, backlog acceleration), improving unit economics (margin expansion), and a self-reinforcing business model with increasing customer value. The business is clearly in a high-growth phase, with disruptive elements in AI/data center infrastructure, strong cash flow growth, and is not a legacy or transitioning business.
Impinj (PI) Q2 2026: Endpoint IC Revenue Jumps 53% as Food and Logistics Demand Accelerate
Impinj exhibits all hallmarks of a high-signal, inflecting business: expanding reinvestment runway, accelerating growth, improving unit economics, deepening competitive moat, and clear customer value expansion. The business is transitioning from cyclical recovery to structural growth, with industry read-throughs and strategic pivots that are highly relevant for investors seeking upside.
SoFi (SOFI) Q2 2026: Cross-Buy Rate Jumps 16 Points, Accelerating “Everything App” Flywheel
SoFi demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, and a self-reinforcing platform model. Customers are becoming more valuable, and the business is shifting to recurring, high-margin revenue. The business model is disruptive, cash flow is accelerating, and guidance/metrics indicate >40% growth, classifying it as a high-growth company with significant upside.
CBRE (CBRE) Q2 2026: Infrastructure Services Revenue Surges 45%, Anchoring Multi-Year Growth Outlook
CBRE demonstrates a long reinvestment runway in high-ROIC infrastructure/data center services, with exceptional growth rates, improving unit economics, and strong compounding business model characteristics. The business is disruptive within its space, cash flow is accelerating, and management guides to >20% EPS growth. This is a clear growth business with secular and cyclical tailwinds, and the article surfaces these signals well.
L3Harris (LHX) Q2 2026: Missile Solutions Revenue Jumps 14% as Backlog Hits $42B
L3Harris demonstrates a long reinvestment runway with high ROIC, exceptional recent growth (Missile Solutions up 14%, international up 20%+), and a record $42B backlog. Unit economics and margins are improving with automation and scale, and the business model is self-reinforcing with high switching costs and network effects in defense contracting. Customer value is rising (international mix, recurring revenue), and the future outlook is exceptional based on backlog and guidance. The business is highly disruptive in defense, cash flow is accelerating, and revenue/EPS growth is above 20%. This is a clear growth business with substantial optionality and valuation upside.
Teradyne (TER) Q2 2026: AI Drives 100%+ Revenue Surge as Wafer-to-Data Center Strategy Accelerates
Teradyne is exhibiting exceptional growth, business model leverage, and strategic positioning in a secularly expanding market. The article details a 100%+ revenue surge, accelerating AI-driven mix, margin expansion, and clear evidence of a long reinvestment runway, all supported by management commentary and guidance.
Corset Therapeutics (CORT) Q2 2026: Lithioly Launch Adds $47.6M, Accelerating Oncology Expansion
Corset Therapeutics is demonstrating a long reinvestment runway with high returns, a transformative product launch (Lithioly) driving a step-change in growth, and improving unit economics. The business model is self-reinforcing with expanding network effects (guideline inclusion, payer coverage), and customers (physicians, patients) are becoming more valuable. Future growth is exceptional based on guidance and pipeline catalysts, with disruptive potential in both oncology and endocrinology. Cash flow is accelerating, and the company is transitioning into a high-growth phase.
FormFactor (FORM) Q2 2026: Gross Margin Surges to 53.3% as Advanced Packaging Demand Accelerates
FormFactor demonstrates a long reinvestment runway with high returns, significant recent growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, guidance is exceptional, and the business is disruptive with accelerating cash flow. Revenue and EPS growth are strong and sustained, and the business is clearly in growth mode.
Amphenol (APH) Q2 2026: IT Datacom Surges 89% as AI Demand Drives Record Bookings
Amphenol is experiencing explosive growth (IT Datacom up 89%, bookings up 94%), with clear evidence of a long reinvestment runway, improving unit economics, and a self-reinforcing business model. The business is highly cash generative, guidance is accelerating, and the company is positioned at the center of a secular AI/datacenter buildout. All signal criteria are strongly met.
Expand Energy (EXE) Q2 2026: Twin Eagle Deal Adds $200M EBITDA, Unlocks Integrated Gas Platform
EXE is pivoting to an integrated gas platform with a long reinvestment runway, clear disruptive business model, accelerating cash flow, and strong growth signals (e.g., Twin Eagle EBITDA, raised FCF guidance, and expanding customer base). The business is compounding, with improving unit economics and growing customer value. The strategic shift and sector implications provide high signal for investors.
Flex (FLEX) Q1 2027: Cloud & Power Infrastructure Surges 35% as Spin-Off Nears
Flex demonstrates a long reinvestment runway (AI infrastructure), recent significant segment growth (35%+), improving unit economics, a self-reinforcing business model (integration with hyperscalers), increasing customer value, exceptional guidance, disruptive positioning, accelerating cash flow, and strong growth prospects. The business is clearly in a high-growth, transformative phase with substantial upside.
Lemonade (LMND) Q2 2026: LAE Ratio Falls to 5%, Driving Operating Leverage and AI Edge
Lemonade demonstrates a long reinvestment runway with high ROIC potential, a disruptive AI-driven model, and accelerating growth in both top-line and key business segments. The LAE ratio and margin improvements are exceptional, with clear evidence of compounding advantages and cash flow inflection. The business is in a high-growth phase with expanding opportunities and clear signals of sustained outperformance.
ASX Q2 2026: ATM Operating Margin Jumps 6.2pts as AI Packaging Demand Stretches Capacity
ASX demonstrates a rare combination of long reinvestment runway, disruptive business model, and accelerating growth. The article substantiates margin expansion, backlog/guidance inflection, and a clear path to sustained high returns on capital. All signal questions are fully supported by the call details and outlook, justifying top marks.
Integrity (ASIC) Q2 2026: Brokerage Channel Mix Lifts Premiums 23%, Drives Margin Outperformance
Integrity demonstrates a long reinvestment runway, disruptive technology integration, and accelerating growth metrics. Premiums, margins, and cash flow are all improving at high rates, and the business model is clearly self-reinforcing. The outlook, guidance, and risk factors are all well supported by transcript evidence.
META (META) Q2 2026: AI-Driven Ads Push 27% Revenue Growth, CapEx Commitment Signals Multi-Year Compute Bet
Meta demonstrates a long reinvestment runway, clear disruptive business model, and accelerating growth in both core and emerging segments. There are significant recent developments (AI-driven ad growth, enterprise monetization), improving unit economics, and a self-reinforcing model with network effects. The future outlook is exceptional, with CapEx signaling a multi-year growth and infrastructure bet. All signal questions are strongly supported by transcript evidence.
Monolithic Power Systems (MPWR) Q2 2026: Enterprise Data Surges 45%, Capacity Expansion Targets $6B+
MPWR demonstrates a long reinvestment runway with high returns, exceptional recent growth (45%+ in enterprise data), improving unit economics, a self-reinforcing business model, increasing customer value, and exceptional forward growth guidance. The business is disruptive, cash flow is accelerating, and the company is clearly a growth business with revenue and EPS likely to grow over 40% annually. The signal is very high for investors.
AXTI (AXTI) Q2 2026: Indium Phosphide Revenue Surges 164%, Backlog Exceeds $100M as AI Demand Outpaces Capacity
AXTI demonstrates a transformational inflection: explosive revenue and margin growth, a massive backlog, and clear avenues for reinvestment at high returns. The business is transitioning into a dominant AI infrastructure supplier with disruptive potential, compounding network effects, and accelerating cash flow. Guidance, backlog, and customer prepayments all signal exceptional future growth, with industry-leading economics and runway.
Allegro MicroSystems (ALGM) Q1 2027: Data Center Revenue Jumps 32%, Accelerating High-Margin Mix Shift
Allegro MicroSystems demonstrates a long reinvestment runway, disruptive business model, and accelerating growth in high-value verticals. All signal questions are strongly supported by earnings data: gross margin expansion, content growth, and robust backlog/bookings trends. The business is clearly in a high-growth phase with multiple secular tailwinds and visible catalysts.
Gardent Health (GH) Q2 2026: Oncology Test Volume Jumps 63% as SHIELD Coverage Expands
Gardent Health demonstrates a long reinvestment runway, disruptive and self-reinforcing business model, and exceptional growth signals: 63% oncology volume growth, SHIELD quadrupling, and accelerating coverage. Unit economics and margins are improving, with clear levers for future cash flow. The article highlights a business transitioning to high-growth, with strong operational and commercial inflections, making it highly relevant for investors seeking upside.
SPX Technologies (SPXC) Q2 2026: Data Center Capacity Boosts to $1.1B, Driving 27% EBITDA Growth Outlook
SPX Technologies demonstrates a long reinvestment runway with high ROIC opportunities in data center infrastructure, a major recent capacity expansion, improving unit economics, and a self-reinforcing business model via M&A and integration. Customer value is increasing, guidance is being revised upward, and the business model is both disruptive and cash-generative. Revenue and EPS growth rates are accelerating, and the company is clearly in a high-growth phase with actionable upside.
Silicon Motion (SIMO) Q2 2026: Farai and Boot Drive Solutions Reach 30% of Revenue, Diversification Accelerates
SIMO demonstrates a very strong signal profile: a long reinvestment runway, dramatic revenue mix shift, improving unit economics, self-reinforcing model (NAND access and solutions), deepening customer value, and accelerating growth outlook. The business is clearly transitioning into a high-growth, less cyclical model with disruptive elements and strong cash flow trajectory. All criteria are met at the highest level.
Madison Air (MAIR) Q2 2026: Backlog Surges 133% as Data Center and Commercial Demand Drive Visibility
Madison Air demonstrates a rare combination of rapid growth (133% backlog increase, 45% order growth), improving unit economics, expanding recurring revenue, and a multi-year runway across secular growth markets. The business model is self-reinforcing, margins are expanding, and the company is positioned as a growth compounder with significant upside. All major signal criteria are met at a high level.
FTAI (FTAI) Q2 2026: Aerospace Module Output Surges 61%, Anchoring Asset-Light Shift
FTAI demonstrates a long reinvestment runway, recent significant growth and backlog uptick, improving unit economics, a self-reinforcing business model, and deepening customer value. The business is showing exceptional future potential based on backlog, is disruptive, cash flow is accelerating, and the company is poised for high annual growth. It is a clear growth business with substantial valuation upside.
Amazon (AMZN) Q2 2026: AWS Revenue Jumps 37% as AI Demand Drives $169B Run Rate
Amazon demonstrates a long reinvestment runway, rapid growth, improving unit economics, and strong self-reinforcing business dynamics. Backlog and guidance signal exceptional future growth, cash flow is accelerating, and the business is disruptive with significant lateral opportunities. The article evidences all these points with specific numbers and management commentary.
Tempus AI (TEM) Q2 2026: FDA Approvals Set Stage for $400M Revenue Uplift by 2028
Tempus AI demonstrates a long reinvestment runway, major FDA-driven inflections, accelerating unit economics, and a self-reinforcing data/diagnostics flywheel. Customer value is deepening, guidance and backlog signal exceptional future growth, and the business model is disruptive with expanding cash flow. Revenue and EPS growth are well above 20%, and the business is firmly in a high-growth phase.
Marta Technologies (MRT) Q1 2026: Gross Margin Soars to 72% as Platform Monetization Scales
Marta Technologies demonstrates a long reinvestment runway, disruptive business model, and accelerating cash flow. Gross margin expansion, cross-service adoption, and network effects signal a compounding, high-growth business. While the growth outlook is strong, guidance is described as conservative, and future growth is volume-driven rather than dependent on new monetization levers—slightly tempering the exceptional signal. Nevertheless, the business is clearly in a transition to profitability with significant upside potential.
Crystal Biotech (KRYS) Q1 2026: Ex-US Revenue Jumps 39% as Global Launch Diversifies Growth
Crystal Biotech demonstrates a long reinvestment runway, disruptive business model, and self-reinforcing platform advantages. There are clear signs of accelerating growth, margin expansion, and pipeline momentum. The only deduction is for revenue/EPS growth not explicitly over 40%, but all other signals point to a high-growth, catalyst-rich business with significant upside.
Digital Turbine (APPS) Q3 2026: EBITDA Margin Expands 900bps as AI and International Drive Outperformance
Digital Turbine demonstrates a long reinvestment runway, clear operating leverage, and self-reinforcing business model with international and brand-driven expansion. The company is transitioning into a high-growth, margin-expanding business with disruptive alternative distribution models and accelerating cash flow. The only deduction is for revenue and EPS growth not definitively exceeding 40% annually, but all other signals are strong and investment-relevant.
CLEAR (YOU) Q1 2026: ClearOne Bookings Surge 5x, Unlocking Enterprise and GovTech Tailwind
Clear exhibits a long reinvestment runway, disruptive business model, and exceptional recent growth in enterprise bookings (5x), with improving unit economics and margin expansion. The business is self-reinforcing, with deepening customer value and strong cash generation. While revenue growth is strong (near 20%), it does not exceed the 40% threshold for a full score on that metric. The business is clearly in a high-growth transition phase.
BAM Q4 2025: Fee-Bearing Capital Surges $64B as AI and Credit Platforms Scale
BAM demonstrates a long reinvestment runway, clear business model evolution, and strong growth in fee-bearing capital and earnings. AI infrastructure and private wealth channels provide disruptive, high-ROIC opportunities. Unit economics, customer value, and cash flow are all improving. The only deduction is on question 9, as guidance is for mid-to-high teens FRE growth rather than 40%+ revenue/EPS growth, but all other signals are strong for a compounding, growth business.
Steel Dynamics (STLD) Q2 2026: Aluminum Shipments Jump 135%, Setting Up Second-Half Ramp
STLD is showing a major step-change in growth with the aluminum platform ramping rapidly, backlog surging, and clear margin/cash flow inflection. The business model is not fully disruptive (score 1 for Q7), but otherwise, the signals are strong: high reinvestment runway, accelerating growth, improving unit economics, and clear multi-year visibility. This is a high-signal, thesis-rich quarter.
ESCO Technologies (ESE) Q1 2026: Orders Surge 143% as Backlog Sets Multi-Year Growth Runway
ESCO Technologies demonstrates a long reinvestment runway, exceptional recent growth (orders +143%), and strong unit economics with operating leverage. The model benefits from some self-reinforcing elements (backlog, defense contracts) and improving customer value. The business is not fundamentally disruptive but is showing strong growth and cash flow acceleration, with revenue and EPS growth guided well above 20%. The signal is very high, though the business is not a category-defining disruptor.
Park Aerospace (PKE) Q4 2026: Missile Material Demand Quadruples as Defense Juggernaut Arrives
Park Aerospace is experiencing a major, government-mandated surge in missile material demand, indicating a long reinvestment runway and disruptive, defense-driven growth. Unit economics are poised to improve with scale, the business model is self-reinforcing due to sole-source positions, and customer value is deepening. Backlog and quoting activity suggest exceptional near-term growth, and the company is transitioning into a high-growth phase. However, commercial aerospace remains a drag, capping the revenue growth score at 1.
Roblox (RBLX) Q3 2025: Bookings Surge 70% as DAUs Top 151 Million, Margin Compression Ahead
Roblox demonstrates a long reinvestment runway, disruptive business model, and exceptional growth rates across core metrics. Recent developments (bookings and DAU surges) signal a significant inflection. Unit economics and customer value are improving, and the business model is compounding. However, near-term cash flow is not yet accelerating due to margin compression from investment cycles, warranting a slightly lower score on that dimension.
California Resources (CRC) Q1 2026: EBITDAX Outlook Raised 42% as Capital Efficiency Drives Margin Expansion
CRC demonstrates a long reinvestment runway with high estimated IRR and capital multiples, significant positive guidance revisions, and clear margin and productivity improvements. The business model is evolving toward self-reinforcing with CCS and power/data center integration. Customer value and optionality are increasing, and the company is becoming a strong cash flow generator. The only minor deduction is for revenue/EPS growth, which is strong but not clearly above 40% annually.
Pharming (PHAR) Q2 2026: Joenja Grows 40% as Pipeline Readouts Set Up Multi-Billion Opportunity
Pharming demonstrates a long reinvestment runway, significant recent developments (Joenja up 40%), improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, and future growth is exceptional with major pipeline catalysts. The business is disruptive within rare disease, cash flow is accelerating, and it is a clear growth business. Revenue/EPS growth is likely to be in the 20-40% range, justifying a 1 for question 9. Overall, signal is very high.
IonQ (IONQ) Q1 2026: RPO Surges 554% as Multi-Product Quantum Platform Gains Commercial Traction
IonQ demonstrates a long reinvestment runway, disruptive business model, clear commercial inflection, and accelerating backlog and revenue growth above 40%. Unit economics are improving, customer value is deepening, and the business is positioned for high growth. Only cash flow is not yet accelerating, but otherwise, signal is extremely high and relevant for investors.
Porch Group (PRCH) Q2 2026: Insurance Services Margin Hits 48% as Policy Growth Accelerates
Porch Group displays a long reinvestment runway with high returns on capital, exceptional margin expansion, and clear evidence of business model scalability. Recent growth is robust (but not quite 40%+ at consolidated level), and the business is self-reinforcing with data/AI advantages and distribution expansion. Unit economics and customer value are improving, with accelerating cash flow and a clear transition to a high-growth, high-margin model. The only minor deduction is for revenue/EPS growth not exceeding 40% at the consolidated level.
Intuitive Machines (LUNR) Q1 2026: $1.1B Backlog and 3x Revenue Surge Signal Infrastructure Flywheel
Intuitive Machines is showing a step-change in scale, backlog, and business model evolution. The company has a long reinvestment runway, disruptive infrastructure model, and is shifting to recurring revenue with accelerating backlog and growth. Some cash flow risk remains, but the signal for investors is very high due to the magnitude of recent developments and the transformation underway.
LSCC Q4 2025: Attach Rate Surges Past 3 FPGAs Per Server, Unlocking Multi-Year Growth Path
Lattice demonstrates a long reinvestment runway, accelerating attach rates, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, backlog visibility is strong, and the business is transitioning to a high-growth, cash-generative model. The only deduction is for revenue/EPS growth, which, while strong, is guided at 20%+ but not 40%+ for the full year.
Payoneer (PAYO) Q1 2026: B2B Volume Surges 44%, Powering Core Profitability Expansion
Payoneer demonstrates a long reinvestment runway, disruptive business model, and self-reinforcing network effects. B2B volume growth and ARPU expansion are exceptional, with clear evidence of operating leverage and optionality from AI and stablecoin. Revenue growth is strong but not consistently above 40%, warranting a slightly lower score on that dimension. Overall, the business is positioned for durable, high-quality growth.
Americas Gold and Silver (USAS) Q1 2026: Silver Revenue Soars 189% on High-Grade Output and Antimony Upside
USAS demonstrates a long reinvestment runway, transformative growth, improving unit economics, and strong operational leverage. The business model is not fully disruptive (antimony optionality is emerging, not proven), but most dimensions signal high upside and strategic evolution.
Gold Royalty Corp (GROY) Q1 2026: Adjusted EBITDA Surges 312% Amid 250+ Asset Portfolio Expansion
GROY demonstrates a long reinvestment runway, explosive organic growth potential, improving unit economics, and a self-reinforcing business model with high customer value. The business is transitioning to a cash flow machine with accelerating growth, though its royalty model is not fully disruptive (hence a 1 on question 7). Overall, the signal for future value creation is very high.
Glue (GLOO) Q3 2025: Platform Revenue Jumps 127% as M&A Flywheel Accelerates
Glue demonstrates a long reinvestment runway, disruptive business model, rapidly accelerating growth (432% YoY), improving unit economics, and deepening network effects. The business is transitioning to a higher-margin, recurring revenue model with expanding enterprise customer base. The only slight deduction is for cash flow, as EBITDA is still negative though improving.
AppLovin (APP) Q4 2025: 66% Revenue Surge Extends AI-Powered Margin Expansion
AppLovin shows exceptional signal: long reinvestment runway, disruptive AI-driven business model, accelerating growth, improving unit economics, and high cash generation. The only deduction is for question 6, as the forward guidance, while strong, does not indicate an exceptional (30%+) acceleration for the next quarter, but otherwise the business is a clear standout for growth and compounding.
Equinix (EQIX) Q4 2025: AI-Driven Bookings Surge 42%, Fueling Capacity and Margin Expansion
Equinix demonstrates a long reinvestment runway, clear disruptive business model, and accelerating AI-driven demand with improving unit economics and margin expansion. Most signal criteria are strongly met, though top-line growth is under 20% so question 9 is scored conservatively. The business is not unknown but the inflection is substantial and well-supported.
GoodRx (GDRX) Q1 2026: PharmaDirect Surges 82% as Prescription Model Shifts to Durable Revenue
GoodRx is executing a clear business model shift with a long reinvestment runway, high growth in PharmaDirect, improving unit economics, and a self-reinforcing platform. Customer value is increasing, guidance is raised, and the business is disruptive. The only deduction is on annual growth rate, which is strong but not clearly over 40% for the entire business.
Gold.com (GOLD) Q3 2026: Revenue Surges 244% as Volatility and M&A Unlock Record Scale
Gold.com shows a long reinvestment runway, major business evolution, improving unit economics, and a self-reinforcing model with strong customer value trends. Current growth is exceptional, with digital and international expansion providing further optionality, though the business model is only semi-disruptive versus legacy finance. Cash flow and earnings are accelerating, and the business is clearly in a high-growth phase.
Blackstone (BX) Q2 2026: AI-Driven Data Center Platform Surges 42%, Unlocking New Fee Engines
Blackstone is showing a rare combination of secular growth drivers, business model transformation, and embedded realization upside. The AI/data center platform surge, fee engine diversification, and perpetual capital expansion signal a long reinvestment runway and self-reinforcing model. The only deduction is on annualized growth, which while strong, is not consistently above 40% across all metrics.
ASUR Q2 2026: Recurring Revenue Rises 19% as AI and Cross-Sell Drive Margin Expansion
ASUR demonstrates a long reinvestment runway with high returns, clear inflection in recurring revenue and margins, improving unit economics, and a self-reinforcing business model with AI and cross-sell. Customer value is deepening, and the business is in clear growth mode. The only slight deduction is on the revenue/EPS growth rate, which is strong but not definitively above 40% annually.
Frontline (FRO) Q1 2026: Spot Rates Double to $181K, Unprecedented Tanker Tightness Drives Cash Surge
Frontline is experiencing an exceptional inflection with spot rates at record highs, cash flow surging, and visible backlog. The business model is not disruptive in a tech sense, but the current market structure and operational leverage make this a rare, high-signal setup for investors.
Babcock & Wilcox (BW) Q1 2026: Pipeline Surges 17% to $14B as AI Data Center Demand Transforms Backlog
BW demonstrates a strong growth runway with a massive pipeline and backlog surge, clear improvements in unit economics, and a self-reinforcing business model as it becomes a critical supplier to AI data centers. Customer value is increasing, and guidance/backlog point to exceptional growth. The business is semi-disruptive (not fully disruptive), but is rapidly transitioning to a growth model with accelerating cash flow and high expected revenue/EPS growth, justifying a very high signal score.
Littlefuse (LFUS) Q2 2026: Industrial Segment Jumps 52% as Bookings Hit Record High
Littlefuse demonstrates a long reinvestment runway with accelerating growth, record bookings, and expanding margins. The business is not fully disruptive but is transitioning toward higher-value, high-growth segments. Backlog, design win momentum, and segment growth rates signal exceptional near-term and long-term prospects. Unit economics, customer value, and cash flow are all improving, but the model is not entirely disruptive, warranting a slightly conservative signal score.
Allegiance (LGN) Q4 2025: Backlog Surges 49%, Locking in Multi-Year Data Center Demand
Allegiance demonstrates a long reinvestment runway, a 49% backlog surge, improving unit economics, self-reinforcing labor/capabilities, and growing customer value. The business is transitioning to growth with accelerating cash flow, revenue, and EPS, with clear evidence of compounding scale. The only deduction is for business model disruption, as it is semi-disruptive rather than fully disruptive.
BlackSky (BKSY) Q4 2025: International Revenue Surges 50% as Gen 3 Satellites Drive Backlog to $345M
BlackSky demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and a self-reinforcing platform. The company is experiencing significant international growth, with a 50% YoY surge and record backlog. Cash flow and margins are improving, and the business is transitioning into a high-growth, globalized intelligence provider. The only deduction is for revenue growth, which, while strong (24% guide), does not exceed the 40% threshold for maximum points.
Hinge Health (HNGE) Q1 2026: Billings Surge 52% as Platform Expansion Unlocks New Growth Vectors
Hinge Health demonstrates a long reinvestment runway, significant growth inflection (52% billings), improving unit economics, a self-reinforcing model, and deepening customer value. The business is disruptive, cash flow is accelerating, and the company is transitioning from single-product to platform. The only deduction is for revenue/EPS growth, which is guided at 36% YoY (not over 40%), otherwise all other signals are strong.
BitGo (BTGO) Q1 2026: Derivatives Launch Drives 32bps Margin as Institutional Platform Expands
BitGo demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong customer value deepening. There are significant recent developments, especially in derivatives and stablecoin infrastructure, and the business is positioned for growth. The only deduction is for revenue/EPS growth, which is over 20% but not clearly over 40%.
Happen (HAPN) Q2 2026: Loan Originations Surge 29% as Brand Transition and AI Drive Margin Highs
Happen demonstrates a long reinvestment runway with strong ROIC, double-digit growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, the business is disruptive, and cash flow is accelerating. Guidance and backlog signal exceptional future growth, though annualized revenue/EPS growth is just below the 40% threshold for maximum scoring. The business is clearly in a high-growth phase.
Comfort Systems USA (FIX) Q2 2026: Backlog Soars 73% to $14.1B, Modular Capacity Expansion Accelerates
FIX demonstrates a rare combination of long reinvestment runway (modular/tech buildout), massive backlog growth, improving unit economics, and a disruptive, compounding business model. The only deduction is for future growth rates moderating somewhat per management, but the overall signal is very high and actionable.
VECO (VECO) Q1 2026: $250M Indium Phosphide Orders Signal Multi-Year AI Optical Ramp
VECO demonstrates a long reinvestment runway with a record $250M order book and clear avenues for high-return capital deployment. There is a significant business evolution with the AI optical ramp, improving unit economics, and a self-reinforcing business model in photonics and advanced packaging. Customer value is increasing, and backlog/guidance point to exceptional future growth. The business is disruptive and transitioning to a cash flow engine. Revenue/EPS growth is strong but not quite at the 40%+ level, hence a 1 for Q9. VECO is a growth business with secular tailwinds.
KLIC Q2 2026: Thermal Compression Capacity Expands 300% as Demand Surges Across Logic, Memory, and Automotive
KLIC demonstrates a long reinvestment runway, transformative capacity expansion, improving unit economics, self-reinforcing business model, and deepening customer value. The business is not quite growing revenue/EPS at 40%+ annually based on guidance, but all other signals are strong, with exceptional growth prospects and disruptive positioning.
Cellebrite (CLBT) Q1 2026: AI-Driven Portfolio Fuels 21% ARR Growth, Doubling TAM Ambition
Cellebrite demonstrates a long reinvestment runway, major AI-driven inflection, improving unit economics, and a self-reinforcing, disruptive business model. Customer value and cash flow are increasing, and the business is clearly in a growth phase. The only deduction is for revenue/EPS growth likely being under 40% annually based on guidance, but all other signals are strong and actionable for investors.
Alnylam (ALNY) Q4 2025: TTR Franchise Soars 151%, Anchoring 2030 Growth Ambitions
Alnylam is showing a long reinvestment runway, disruptive RNAi modality, and a massive TTR growth inflection, with strong unit economics and margin expansion potential. The only deduction is for future guidance not being exceptional (>30% acceleration) beyond the current year, but otherwise the business is high-signal and thesis-relevant for investors seeking scalable, compounding biotech models.
Ocular Therapeutix (OCUL) Q1 2026: SOL1 Superiority Data Drives NDA Momentum and 12-Month Disease Control Narrative
OCUL demonstrates a long reinvestment runway, disruptive business model, and exceptional recent clinical results that reset the competitive landscape. Unit economics, customer value, and business model self-reinforcement are all improving or strong. The only slight deduction is on cash flow, which is not yet accelerating given the business is still pre-commercial. All other indicators point to a high-signal, high-upside growth story.
Figure (FIGR) Q4 2025: Marketplace Volume Surges 131% as Capital-Light Model Gains Scale
Figure demonstrates a long reinvestment runway, compounding business model, improving unit economics, and disruptive potential. Growth is strong but not quite at the most exceptional/accelerating level for future guidance, thus a slight deduction. Otherwise, signal is very high with clear valuation upside.
Madrigal Pharmaceuticals (MDGL) Q2 2026: ResDifera Patient Base Doubles, Underpinning $1.3B Trailing Sales Run-Rate
Madrigal demonstrates a long reinvestment runway, significant recent growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, and the business is disruptive with accelerating cash flow and strong growth. The only slight deduction is for future guidance not being 'exceptional' (over 30% acceleration) but still robust. Overall, this is a high-signal, high-upside specialty pharma story.
Johnson Controls (JCI) Q3 2026: Backlog Surges 32% to $21B, Anchoring AI-Driven Growth Trajectory
JCI demonstrates a long reinvestment runway (AI/data center infrastructure), record backlog growth, improving unit economics, self-reinforcing business model, and deepening customer value. The business is transitioning into a high-growth, margin-expanding, cash-generative model with clear disruptive potential. Guidance and backlog suggest exceptional outlook, though growth rates are just under the 40% threshold for a perfect signal score.
LSAK Q3 2026: Consumer Lending Originations Surge 88% as Platform Margins Expand
Lusaka Technologies demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing platform model. Customer value and business model disruption are evident, as is accelerating cash flow. While revenue and EPS growth guidance is strong, it is just below the 40% threshold for maximum scoring. Overall, the business is in a growth phase with high investor relevance.
Bilibili (BILI) Q2 2025: Games Revenue Jumps 60% as AI-Driven Ads Expand Margin Path
Bilibili demonstrates a long reinvestment runway, strong recent growth in games (60%) and advertising (20%), improving unit economics, and a self-reinforcing business model via community and AI. Customer value is deepening, and guidance is for further margin and profit expansion. The business model is disruptive and cash flow is accelerating. However, revenue/EPS growth is likely just below the 40% threshold, so question 9 is scored down. Overall, this is a high-signal, growth business at an inflection point.
NVEC Q1 2027: 81% Revenue Surge Signals Robotics and Medical Sensor Tailwind
NVE demonstrates a long reinvestment runway, disruptive business model, and clear improvements in unit economics and margins. The 81% revenue growth is a major inflection, supported by product innovation and diversified customer growth. While guidance is not explicit, management's optimism and the operational setup suggest ongoing growth, though the lack of formal targets and customer concentration risk slightly temper the score.
Enlight Renewable Energy (ENLT) Q2 2025: Guidance Raised 6% as U.S. Safe Harbor Hits 6GW Milestone
Enlight demonstrates a long reinvestment runway, strong recent growth, improving unit economics, self-reinforcing business model, deepening customer value, and is executing on a disruptive, scaling business model. The only slight deduction is on revenue/EPS growth, which is high but not explicitly over 40% annually in the forward guidance.
BAM Q4 2025: Fee-Bearing Capital Surges $64B as AI and Credit Platforms Scale
BAM demonstrates a long reinvestment runway, disruptive business model evolution (AI infrastructure, private wealth), and improving unit economics. There are significant recent developments (record fundraising, AI platform launch, Oaktree integration). The business is not likely to grow over 40% annually, but otherwise all signal indicators are strong, with clear compounding advantages, expanding customer value, and accelerating cash flow.
PTC (PTC) Q1 2026: Deferred ARR Triples, Locking in Multi-Year Growth Visibility
PTC demonstrates a long reinvestment runway, clear business model transition, and strong deferred ARR signaling multi-year growth. SaaS and AI adoption, competitive wins, and capital allocation all point to a self-reinforcing, high-growth business with exceptional future prospects. The only slight deduction is on near-term revenue/EPS growth, which is strong but not above 40%.
Profound Medical (PROF) Q1 2026: Revenue Doubles as Tulsa Platform Secures Major Payer Adoption
Profound Medical demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and exceptional recent growth (104% YoY). The payer inflection and platform expansion support high future optionality, and the business is transitioning toward profitability. Revenue/EPS growth is strong but not consistently >40%, so question 9 is scored conservatively. Overall, signal is very high for a medtech platform at this stage.
Navan (NAVN) Q1 2027: AI-Driven Platform Lifts Margin 900bps as RFP Volume Surges 200%
Navan demonstrates a long reinvestment runway, disruptive AI-driven model, and clear evidence of accelerating growth and margin expansion. The 200% RFP surge, large enterprise wins, and improving unit economics point to a rapidly scaling platform with compounding advantages. The only deduction is for revenue growth guidance (28-30% YoY), which, while strong, does not exceed the 40% threshold for a perfect score on Q9.
Equinix (EQIX) Q2 2026: CapEx Plan Surges to $7B as AI Demand Drives 23% Bookings Growth
Equinix demonstrates a long reinvestment runway, accelerating growth, improving unit economics, and a self-reinforcing business model. The AI-driven demand surge, record bookings, and robust backlog signal exceptional forward prospects. Only revenue/EPS growth is slightly below the 40%+ threshold, otherwise the business is a clear compounder with high signal for investors.
Workday (WDAY) Q1 2027: Agentic AI ARR Nears $500M, Accelerating Platform Monetization
Workday exhibits a long reinvestment runway, disruptive business model, and accelerating AI-driven growth with material ARR and margin expansion. Unit economics, customer value, and operating leverage are all improving. Only one point is deducted for revenue/EPS growth not being above 40%, but all other signals are extremely strong and thesis-relevant.
Strong Signals (16-18)
Articles with valuable investment signals that merit attention
Duolingo (DUOL) Q1 2026: AI Content Output Surges 10x, Setting Up Durable User Growth
Duolingo demonstrates a long reinvestment runway, disruptive AI-driven business model, and improving unit economics. User and revenue growth are strong but not at the highest possible level (>40%), and future guidance is good but not exceptional. The business is clearly in growth mode with accelerating cash flow and increasing customer value, but the growth rates and outlook are just short of the most extreme signal.
Datadog (DDOG) Q4 2025: $1.63B Bookings Surge Signals AI-Driven Platform Expansion
Datadog demonstrates a long reinvestment runway, disruptive and self-reinforcing business model, improving unit economics, and deepening customer value. Bookings and backlog are surging, and large deals are accelerating. However, full-year growth guidance moderates to under 20%, which tempers the outlook. The business is still a clear growth story with strong optionality.
MP Materials (MP) Q1 2026: NDPR Oxide Output Surges 63%, Securing Feedstock Moat
MP Materials demonstrates a long reinvestment runway with high returns, a disruptive and self-reinforcing business model, improving unit economics, and exceptional feedstock control. There is a step-function increase in output and backlog, but growth guidance is not above 40% for revenue/EPS, so some scores are capped. Cash flow is accelerating, and the company is positioned for continued high growth and margin expansion, but not all metrics are at the highest possible inflection.
Symbotic (SYM) Q2 2026: Backlog Reaches $22.7B as System Deployments Hit 70
Symbotic demonstrates a long growth runway, high returns on capital, improving unit economics, and a self-reinforcing business model. The backlog is expanding, and the business is shifting toward recurring, high-margin revenue. While growth is strong, it is not consistently above 40% and recent guidance, while positive, is not exceptional, thus a conservative approach is taken for those questions.
Garden Health (GH) Q1 2026: Screening Gross Margin Triples to 56% as Shield Volumes Accelerate
GH demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and compounding self-reinforcing advantages from data and AI. The quarter showed a step-change in screening margins and robust growth, but while growth is strong, it is not (yet) above 40% for all segments. Guidance is positive and there are multiple upcoming catalysts, but the signal is just short of the absolute highest bar for explosive growth.
White Fiber (WYFI) Q3 2025: NC1 Contract Demand Doubles, Anchoring $400M+ Development Path
White Fiber demonstrates a long reinvestment runway, major recent business evolution (NC1 contract), improving unit economics, and self-reinforcing business model. Customer value is deepening and future growth is strong, though not quite at the most exceptional level for all metrics. The business model is disruptive, with cash flow set to accelerate as projects ramp, and the company is clearly in a growth phase. Revenue and EPS growth are likely high but not in the extreme 40%+ category for the next year, and cash flow acceleration is moderate until ramp occurs.
MKS Instruments (MKSI) Q1 2026: AI-Driven Chemistry Lifts Segment 27%, Unlocking Multi-Year Margin Upside
MKSI demonstrates a long reinvestment runway with high returns on capital, clear operating leverage, and accelerating growth tied to secular AI trends. The business model is not fully disruptive but shows strong self-reinforcing characteristics. Revenue and EPS growth rates are robust but not consistently above 40%, tempering the score. Overall, the business is positioned as a growth leader with significant upside potential, though not at the highest possible trajectory.
RLX (RLX) Q1 2026: International Revenue Surges 96%, Cementing Europe as Growth Engine
RLX demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is transitioning to a global growth model with accelerating cash flow and high revenue growth. However, the disruption level and future growth acceleration are strong but not at the absolute highest tier, warranting a slightly conservative signal score.
Upwork (UPWK) Q4 2025: AI Work Surges 50% as SMB and Enterprise Engines Accelerate
Upwork demonstrates a long reinvestment runway, disruptive business model, strengthening unit economics, and clear transition to higher-value segments with AI as a core engine. Backlog and guidance imply good but not exceptional (30%+) growth, hence a 1 on Q6 and Q9. Otherwise, signal is very high with accelerating cash flow, deepening customer value, and a shift to growth business status.
Root (ROOT) Q1 2026: Partnerships Channel Grows 30%, Driving Profitability Surge
Root demonstrates a long reinvestment runway, disruptive model, improving unit economics, and accelerating profitability. Partnership/embedded channel growth is significant, but growth guidance is strong rather than exceptional, and not all metrics point to >40% growth, warranting a conservative deduction.
Oklo (OKLO) Q1 2026: $2.5B War Chest Fuels Multi-Asset Nuclear Deployment Surge
Oklo demonstrates a long reinvestment runway and disruptive business model with multiple growth avenues (power, fuel, isotopes). There are significant, recent, and material business developments: regulatory breakthroughs, large capital raises, and asset deployment. Unit economics are improving as scale increases, and the business model is self-reinforcing with integration and government partnerships. Customers are becoming more valuable (early isotope contracts, Meta partnership), and the future outlook is exceptional given regulatory and fuel milestones. However, cash flow is not yet accelerating (pre-revenue), and annualized revenue/EPS growth is not yet above 40%. Oklo is a growth business, transitioning into execution mode.
Coinbase (COIN) Q1 2026: Derivatives Revenue Surges to $200M as Everything Exchange Strategy Gains Traction
Coinbase demonstrates a long reinvestment runway, rapid growth in new revenue streams (derivatives, prediction markets), improving unit economics, and a self-reinforcing platform model. While not every metric is at hypergrowth levels (revenue/EPS growth is strong but not 40%+), the business is clearly transitioning to a growth platform with high optionality and cash flow leverage.
QuinStreet (QNST) Q3 2026: Home Services Soars 63%, AI Integration Drives Margin Expansion
QuinStreet exhibits a long reinvestment runway with high returns, significant recent growth (notably in home services), and improving unit economics. The business model shows self-reinforcing characteristics via AI and data leverage. Customer value is increasing, and guidance signals strong growth and margin expansion. The business is semi-disruptive due to AI integration, with accelerating cash flow. Revenue/EBITDA growth is strong but not consistently above 40%, and the company is a clear growth business, not a legacy or stalling one.
KMT Q3 2026: Infrastructure Sales Surge 30% as Tungsten Supply Crunch Drives Strategic Gains
Kenna Metals demonstrates a long reinvestment runway, recent significant growth, improving unit economics, and a self-reinforcing business model. Customer value is clearly deepening, and the business is currently exceptional due to commodity-driven disruption. The business model is disruptive in the current context, but cash flow is under pressure, and top-line growth is strong but not consistently above 40%. The company is a growth business, but some risks (cash flow, volatility) temper the signal.
Atlassian (TEAM) Q2 2026: Cloud Revenue Surges 26% as AI Drives Seat Expansion
Atlassian demonstrates a long reinvestment runway, strong unit economics, self-reinforcing business model, deepening customer value, and disruptive potential through AI and cloud migration. While growth is robust, the pace is not quite at the exceptional level for guidance and revenue/EPS (not exceeding 40%), so a couple of areas are scored conservatively. The business is clearly a growth leader but not in a hyper-acceleration phase.
Commerce (CMRC) Q1 2026: GMV Accelerates 14% as B2B and Agentic Commerce Drive Platform Differentiation
Commerce demonstrates multiple high-signal characteristics: long reinvestment runway, accelerating GMV, improving unit economics, self-reinforcing platform, and increasing customer value. The business model is disruptive and cash flow is accelerating. Growth is strong but not consistently above 40%, and while guidance is strong, it is not exceptional. The piece captures a growth business with significant optionality.
Pattern (PTRN) Q4 2025: Non-Amazon Revenue Surges 94% as Platform Diversification Accelerates
Pattern demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong growth in non-core channels. While forward growth moderates (guidance below 30%), the business remains high-signal with accelerating cash flow and platform breadth. The only deduction is due to growth rates moderating from record levels, but the overall signal is robust and actionable.
Robinhood (HOOD) Q2 2026: Net Deposits Surge $22B as Product Ecosystem Drives Record Engagement
Robinhood demonstrates a long reinvestment runway, multiple disruptive business lines, and improving unit economics. There are significant recent developments (record net deposits, new products, international expansion), and the business model is self-reinforcing. Customer value is deepening, and cash flow is accelerating. The growth outlook is strong but not quite exceptional on all fronts, thus a slightly conservative score for growth rate and future guidance.
FlashDX (FLX) Q1 2026: Drone Delivery Orders Surge 157% as AI-Driven Efficiency Recasts Margin Structure
FlashDX exhibits multiple high-signal attributes: a long runway for reinvestment (AI and drone expansion), a disruptive business model, improving unit economics, and deepening customer engagement. The drone segment's 157% sequential order growth is a significant inflection. While growth is strong, full-year guidance is cautious and some metrics (e.g., revenue) are under pressure, which tempers the overall signal. The business is clearly in a growth phase with optionality, but not all metrics are at the highest possible level.
Elowit (ELWT) Q1 2026: Contracted Backlog Climbs 143% as Recurring Revenue Base Expands
Elowit demonstrates a long reinvestment runway, disruptive recurring revenue models, and a 143% YoY backlog surge—clear markers of a business at an inflection point. Unit economics and customer value are improving, and the business model is self-reinforcing. While cash flow is not yet accelerating and annual growth is likely under 40%, the business is firmly in growth mode with exceptional future prospects.
Arm (ARM) Q1 2027: AGI CPU Demand Pipeline Surges Past $2B, Cloud AI Royalties Offset Smartphone Drag
Arm displays a long reinvestment runway, disruptive business model, and accelerating cloud AI/AGI CPU growth, but near-term growth is not above the 40% threshold and some risks around supply chain remain. The business is not entirely unknown, but the shift to AI infrastructure and royalty model deepening provides real signal.
Fastly (FSLY) Q4 2025: RPO Surges 55%, Securing Multi-Year Growth Visibility
Fastly demonstrates a long reinvestment runway with high ROIC, a disruptive business model, and compounding business dynamics (security, AI, contracted revenue). RPO growth and margin expansion signal improving unit economics and customer value. Growth rates are high, though not consistently above 20%+ for all metrics, and guidance is strong but not exceptional (hence 1 on Q6 and Q9). The business is clearly in a growth phase with strong cash flow and strategic flexibility.
Chime (CHYM) Q1 2026: 41% Transaction Profit Surge Anchors Premium Tier and AI Acceleration
Chime demonstrates a long reinvestment runway with high returns, strong recent growth, improving unit economics, and a disruptive, compounding business model. Customer value is increasing, and the company is transitioning to a higher-margin, premium-led model. While growth is strong, it is not accelerating above 40% for the full year, and some guidance is good but not exceptional. The business is clearly a growth story with significant optionality and cash flow potential.
PDF Solutions (PDFS) Q1 2026: Platform Revenue Jumps 36% as AI-Driven Analytics Expand Market Reach
PDFS is transitioning to a platform-centric, high-margin, recurring revenue model with deepening AI integration and strong customer engagement. The business has a long reinvestment runway, improving unit economics, and is disrupting the semiconductor analytics space. However, while growth is strong and the outlook is positive, the 20% annual growth guidance (not over 40%) and some ongoing risks around customer concentration and CapEx temper the signal score slightly.
Rubrik (RBRK) Q3 2026: Identity Resilience Push Lifts Security Expansion Above 40%
Rubrik demonstrates a long reinvestment runway, disruptive platform shift, and high expansion rates, with security add-ons and AI modules driving growth. The business is not yet at hypergrowth (>40% revenue/eps), and monetization of AI is nascent, so a couple points are held back. Still, the signal is very high due to the business model evolution and strong performance indicators.
Rubrik (RBRK) Q4 2026: Net New Subscription ARR Hits $115M as Identity and AI Drive Platform Expansion
Rubrik demonstrates a long reinvestment runway with high returns on capital, clear disruptive potential in cyber resilience and AI operations, and strong unit economics. There is substantial evidence of platform expansion, customer value deepening, and legacy displacement runway. However, while growth is robust, not all guidance points to 40%+ acceleration, and AI contributions are not yet material to near-term financials, warranting a conservative deduction.
Accelerant (ARX) Q1 2026: Third-Party Premium Jumps 150%, Cementing Capital-Light Shift
Accelerant demonstrates a long reinvestment runway, disruptive business model, and compounding economics through capital-light scaling, a growing MGA pipeline, and AI-driven margin improvement. Unit economics, customer value, and platform self-reinforcement are all strengthening. Growth is strong but just under the 40%+ threshold for a perfect score on acceleration. Overall, the signal is very high for a specialty insurance platform.
Sezzle (SEZL) Q1 2026: Subscriber Base Climbs by 44,000 as Platform Flywheel Accelerates
Sezzle demonstrates a long reinvestment runway, a disruptive platform model, improving unit economics, and deepening customer value. While growth is strong and the business is transitioning to a platform with high optionality, the guidance and backlog are not yet exceptional (>40%+). The signal is high due to the business model inflection and compounding flywheel, but not at the very highest tier for explosive near-term growth.
Red Violet (RDVT) Q1 2026: EBITDA Margin Hits 41% as AI-Driven Identity Graph Scales
Red Violet demonstrates a long reinvestment runway, high margins, and a disruptive, scalable business model with compounding effects from AI. Customer onboarding, expanding verticals, and margin expansion signal durable growth. However, revenue growth is strong but not consistently above 40%, and guidance is not formally provided, so some uncertainty remains.
Elemental Royalty (ELE) Q1 2026: Revenue Soars 83% as Portfolio Scale and Optionality Drive Record Cash Flow
Elemental Royalty demonstrates a long reinvestment runway, significant recent growth, improving unit economics, and a self-reinforcing business model. Customers (mine operators) are becoming more valuable as the portfolio matures. While growth is strong and guidance is ahead of plan, it is not yet at an exceptional acceleration (>30%+), and revenue/eps growth is likely in the 20-40% range, not >40%. The business is clearly disruptive and transitioning into a scaled, cash-generative model.
Instacart (CART) Q4 2025: Enterprise Platform Expands to 380 Sites, Unlocking Multi-Year Growth Runway
Instacart demonstrates a long reinvestment runway, rapid enterprise adoption, improving unit economics, and self-reinforcing platform dynamics. Customer value is increasing, and the business model is disruptive with strong cash flow growth. While future guidance is strong, it does not indicate exceptional (30%+) acceleration, and revenue growth is in the 11-13% range, not exceeding 20%, which moderates the score. The business remains a high-growth, multi-engine platform with significant optionality and upside.
Aurora Mobile (JG) Q1 2026: EngageLab ARR Surges 172%, Anchoring Global SaaS Growth Narrative
EngageLab’s ARR surge, international expansion, and SaaS economics point to a long reinvestment runway, disruptive model, and customer value deepening. The business is in hypergrowth with clear compounding advantages. Cash flow is improving but not yet fully accelerating, and revenue/eps growth is strong but not consistently 40%+, supporting an 18/20 signal score.
ALX Oncology (ALXO) Q3 2025: CD47-High Response Rate Hits 65%, Redefining Biomarker-Driven Oncology
ALXO demonstrates a long reinvestment runway, disruptive biomarker-driven strategy, and strong recent clinical advances with high response rates and robust pipeline. While cash flow is not yet accelerating and revenue growth is not imminent, the business is positioned as a high-growth, high-optional business with clear valuation upside if execution continues.
Pagaya (PGY) Q2 2026: Auto Volume Up 33% as Platform Leverage Drives Profit Acceleration
Pagaya demonstrates a long reinvestment runway, disruptive embedded model, improving unit economics, and deepening customer value. There is clear operational leverage and network effect, with accelerating profitability and a strong growth profile. The only slight markdown is on near-term growth guidance (not quite >40%) and backlog exceptionalism, but overall the signal is very high for investors.
Symbotic (SYM) Q1 2026: Paid Development Hits Double Digits as Margin Expansion Accelerates
Symbotic exhibits a long reinvestment runway, disruptive business model, improving unit economics, and recurring revenue growth. Paid development and backlog growth are strong signals, but growth rates, while high, are not at the absolute extreme, and some lumpiness/risks remain. Overall, the business is in a strong growth phase with high investor relevance.
DraftKings (DKNG) Q1 2026: Predictions Investment to Top $300M as Sportsbook Margin Expands 140bps
DraftKings demonstrates a long reinvestment runway, clear disruptive potential, and improving unit economics. Recent developments (predictions ramp, margin expansion, volume surge) are material and signal an important business evolution. However, guidance does not quite reach the 'exceptional' threshold for accelerating growth, and revenue/EPS growth is strong but not above 40%. The business is positioned as a growth leader, but some uncertainty remains around payback and segment transparency.
ESCO Technologies (ESE) Q1 2026: Orders Surge 143% as Backlog Sets Multi-Year Growth Runway
ESCO's order and backlog surge, margin expansion, and segment outperformance provide a clear multi-year growth runway. The business is not fully disruptive and core growth is strong but not at hypergrowth (40%+) levels, so scores are slightly rounded down. Still, the signal is very high given the rare multi-year visibility and new inflection.
NextPower (NXT) Q1 2027: Backlog Climbs to $5.5B as Platform Expansion Accelerates
NextPower demonstrates a long reinvestment runway, disruptive platform expansion, and improving unit economics with a strong backlog and cash flow. However, the guidance revision is positive but not yet at an 'exceptional' acceleration, and revenue growth guidance is strong but not projected to be over 40%. The business is clearly in growth mode with significant strategic upside.
Figure (FIGR) Q3 2025: Marketplace Volume Nearly Doubles as Blockchain Origination Hits 250 Partners
Figure demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and compounding network effects. There is significant partner and volume growth, and the transition to a capital-light, fee-based platform is driving margin expansion. While growth is strong, it is not consistently above 40% in all metrics, and future guidance is positive but not exceptional. Overall, the signal is very high for a business at an important inflection.
Toast (TOST) Q4 2025: Recurring Gross Profit Up 33% as AI-Driven Platform Expands Market Reach
Toast demonstrates a long reinvestment runway, disruptive vertical SaaS model, improving unit economics, and deepening customer value. The business is compounding with scale, expanding into new high-growth verticals and markets, and showing accelerating gross profit and margin expansion. Guidance is strong but not quite at the 'exceptional' acceleration threshold for all metrics, so a couple of questions are scored slightly lower. Overall, the signal is very high and thesis-relevant.
RBC (RBC) Q3 2026: A&D Backlog Surges 230%, Amplifying Multi-Year Growth Visibility
RBC demonstrates a long reinvestment runway, exceptional backlog growth, improved unit economics, and a compounding business model in A&D. Customer value is increasing, and the future outlook is strong with margin and revenue growth. While the industrial segment is less disruptive, the A&D side shows high growth and durability. The revenue growth rate is strong but not consistently above 40%, and the business is a clear growth story.
Neptune Insurance (NP) Q2 2026: AI-Driven Productivity Lifts Revenue Per Employee to $3M, Margin Expands 165bps
Neptune demonstrates a long reinvestment runway with high returns, strong recent growth, improving unit economics, a self-reinforcing model, and increasing customer value. While the business is disruptive and cash flow is accelerating, the forward guidance suggests strong but not hyper-growth, and regulatory upside is not yet realized, slightly tempering the signal score.
Rocket Lab (RKLB) Q1 2026: Backlog Surges 108% as Defense and Space Systems Drive Record $2.2B Pipeline
Rocket Lab demonstrates a long reinvestment runway, major backlog inflection, improving unit economics, and a disruptive, vertically integrated model. While cash flow is not yet accelerating and near-term growth is under 40%, the business is clearly in a high-growth phase with exceptional strategic positioning and investor-relevant upside.
Red Violet (RDVT) Q1 2026: EBITDA Margin Hits 41% as AI-Driven Identity Graph Scales
Red Violet demonstrates a long reinvestment runway, compounding business model, improving unit economics, and strong customer value expansion. There is clear evidence of a disruptive, AI-driven platform with accelerating cash flow and high margins. The only modest deduction is for growth rates not exceeding the 40% threshold and guidance not being exceptional, but the business otherwise shows high signal for investors.
Synopsys (SNPS) Q2 2026: ANSYS Channel Adds $60M Revenue, Margin Expansion Signals Durable AI Tailwind
Synopsys demonstrates a long reinvestment runway, disruptive business model, and self-reinforcing dynamics through the ANSYS integration and AI-driven demand. Backlog and growth are strong but not at the highest acceleration threshold. Unit economics and customer value are improving, with the company positioned as a growth business. Cash flow is accelerating, and business model innovation is evident. However, guidance and growth rates, while robust, are not consistently above 40%, and some risks remain in IP monetization and ANSYS integration.
EOS Energy (EOSE) Q3 2025: Commercial Pipeline Jumps 21% as Data Center Demand Drives 22% of Volume
EOS demonstrates a disruptive model with a long runway, improving unit economics, expanding pipeline, and major operational inflection. The business is not yet showing >40% revenue/EPS growth but is on a strong growth trajectory with high strategic signal for investors.
Toast (TOST) Q1 2026: Recurring Gross Profit Up 27% as AI Agents Drive Platform Expansion
Toast demonstrates a long reinvestment runway, disruptive AI-driven business model, improving unit economics, and strong customer value expansion. Growth is robust but not consistently above 40%, and recent guidance is strong but not exceptional. The business is clearly in a high-growth phase with significant optionality and operating leverage.
Figure (FIGR) Q3 2025: Marketplace Volume Nearly Doubles as Blockchain Origination Hits 250 Partners
Figure is demonstrating a disruptive, capital-light business model with strong network effects, margin expansion, and a rapidly growing partner ecosystem. While growth is high and the business model is self-reinforcing, some forward guidance is tempered by seasonality and not all metrics are above the highest thresholds (e.g., revenue growth not explicitly over 40%). Still, the business is high-signal and positioned for structural upside.
Unity (UNIT) Q2 2026: Fiber Bookings Jump 30% as AI Demand Drives Record Lease-Up
Unity demonstrates a long reinvestment runway, record bookings, improving unit economics, and a disruptive business model. The business is transitioning rapidly to high-growth fiber with strong lease-up, but near-term ARPU softness and legacy drag temper the signal slightly. Overall, the signal is very high and relevant for investors.
ON Semiconductor (ON) Q1 2026: AI Data Center Revenue Doubles, Margin Expansion Signals Recovery
ON Semiconductor is showing clear signs of secular growth with strong reinvestment runway, significant recent growth in AI and energy storage, and improving unit economics. The business model is increasingly self-reinforcing with high-value content gains in automotive and AI. While not fully disruptive, the company is transitioning to a high-growth profile with accelerating cash flow and margin leverage. Some elements (like revenue/EPS growth rate) are strong but not at the highest threshold.
BrainsWay (BWAY) Q1 2026: RPO Backlog Jumps 25% as Deep TMS Adoption Accelerates
BrainsWay demonstrates a long reinvestment runway, disruptive business model, accelerating recurring revenue, and robust margin expansion. Backlog and contract growth are significant, and new protocols are driving adoption. The only slight deduction is for not quite reaching 30%+ growth acceleration in guidance and future outlook, but otherwise the business is clearly in a high-growth, high-visibility phase with strong optionality.
Braze (BRZE) Q1 2027: AI Decisioning Studio Revenue Jumps 27%, Accelerating Enterprise Upsell Cycle
Braze demonstrates a long reinvestment runway, clear business model advantages, improving unit economics, and strong enterprise growth. While revenue growth is strong, it is just above 20% and not at the highest acceleration threshold. The business is disruptive, with accelerating cash flow and a strong growth profile, though not all metrics hit the 40%+ level.
Astrana Health (ASTH) Q1 2026: AI-Driven Platform Delivers 70bp G&A Leverage as Full-Risk Contracts Reach 40%
Astrana demonstrates a long reinvestment runway, disruptive platform, accelerating full-risk adoption, and strong cash flow. While growth is robust, guidance is conservative and not yet at the 40%+ acceleration threshold for some metrics. Most signal factors are strong, but the business is not a complete outlier in growth rate.
Alarm Technologies (ALAR) Q1 2026: AI Data Traffic Surges 10x, Unlocking Operating Leverage
ALAR demonstrates a long reinvestment runway, disruptive model, and compounding network effects, with clear evidence of operating leverage and a 10x surge in data traffic. The business is high-growth and positioned for further expansion, though guidance for the next quarter implies growth moderating below 40%, and near-term volatility tempers the exceptional outlook.
WESCO (WCC) Q2 2026: Backlog Surges 60% as Data Center Momentum Drives Record Visibility
WESCO demonstrates a strong reinvestment runway, record backlog growth, and margin expansion, with clear secular tailwinds. The business model is not fully disruptive but is evolving, and growth is robust but not quite at the highest tier for all metrics. Still, the signal for investors is very high with strong future prospects.
Neptune Insurance (NP) Q1 2026: AI-Driven Premium in Force Surges 32%, Margin Floor Holds Despite Seasonality
Neptune demonstrates a long reinvestment runway with high returns, significant recent growth, improving unit economics, and a self-reinforcing, disruptive business model. Customers are becoming more valuable, and the company is transitioning into a cash flow machine. While growth is strong, it is not consistently above 40% annually, and guidance, while raised, is not exceptional. The business is a clear growth story with high strategic signal.
Hubbell (HUBB) Q2 2026: Data Center Sales Surge 65%, Driving Guidance Raise and Multi-Year Outlook
Hubbell demonstrates a long reinvestment runway (capacity, secular growth), significant recent developments (65% data center sales growth, raised guidance), improving unit economics, self-reinforcing model (installed base, pricing power), and deepening customer value. The business is not disruptive in a platform sense (hence 1 for Q7), and while revenue growth is strong (16-18%), it is not over 40% (Q9). The business is firmly in growth mode with multi-year backlog visibility.
Shopify (SHOP) Q1 2026: Sidekick Drives 4x Active Shops as AI Powers Platform Leverage
Shopify demonstrates a long reinvestment runway, compounding growth, and clear signs of improving unit economics and platform stickiness. The business is disruptive, self-reinforcing, and transitioning to a high-growth, AI-native model. While revenue growth is strong, it is guided in the high 20s percent YoY (not over 40%), so some signal questions are scored conservatively. The outlook and recent developments are highly positive, but not all meet the threshold for the highest possible growth acceleration.
SentinelOne (S) Q1 2027: Non-Endpoint ARR Approaches 50% as Platform Diversification Accelerates
SentinelOne demonstrates a long reinvestment runway, accelerating platform diversification, improving unit economics, and a self-reinforcing business model. AI and non-endpoint ARR are driving growth, but forward guidance (20% YoY) is strong but not exceptional. The business is still a high-growth, disruptive model with improving cash flow and significant industry read-through.
BKV (BKV) Q4 2025: PowerJV EBITDA Jumps 15%, Carbon Capture Target Raised to 1.5M Tons
BKV demonstrates a long runway with high returns on capital, clear business model evolution (CCUS ramp, power/data center exposure), improving unit economics, and self-reinforcing integration. Customer value is rising, and the future outlook is strong but not quite at the 'exceptional' level. The business model is disruptive with lateral optionality, cash flow is accelerating, and the company is in a growth phase. Some metrics (like revenue/EPS growth) are strong but not over 40%, tempering the signal score slightly.
Circle (CRCL) Q1 2026: USDC On-Chain Volume Jumps 263% as ARK Token Presale Raises $222M
Circle exhibits a long reinvestment runway, compounding network effects, and disruptive growth characteristics. Recent ARK developments and surging USDC volumes are highly material. Unit economics and customer value are improving, and the business model is self-reinforcing. While future ARK impacts are not fully quantified, the business is positioned for high growth and cash flow. Revenue and EPS growth are strong but not yet above 40% annually.
NetEase (NTES) Q4 2025: Self-Developed Games Drive 11% Online Revenue Growth, AI Integration Deepens Competitive Moat
NetEase exhibits a long reinvestment runway, significant recent developments (AI, global IP), improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is disruptive with accelerating cash flow. However, while growth is robust, guidance does not indicate >40% growth, and the company is not in hypergrowth mode, warranting a slightly lower score for those questions.
ALXO Q2 2025: CD47 Biomarker Drives 65% ORR in HER2+ Gastric, Reshaping Breast Cancer Strategy
ALXO demonstrates a long reinvestment runway, a disruptive biomarker-driven model, and a clinical inflection with high ORR. Pipeline focus, capital discipline, and partnership expansion support a growth thesis. Revenue and EPS growth are likely strong but not yet at the highest tier, and cash flow is improving but not yet accelerating.
CrowdStrike (CRWD) Q1 2027: Falcon Flex ARR Surges 99%, Cementing AI Security Dominance
CrowdStrike demonstrates high signal on platform leverage, secular AI tailwinds, and exceptional operating metrics. While growth is robust and the business model is disruptive, full-year guidance implies high-20s ARR growth (not 40%+), so some scores are capped. Still, the inflection is clear and the business remains highly investable.
EquipmentShare (EQPT) Q4 2025: 34% Rental Revenue Growth Unlocks Margin Expansion as T3 Tech Drives Share Gains
EQPT exhibits a long reinvestment runway, clear disruptive tech platform, improving unit economics, and a rapidly scaling business model. Growth is strong but not hyperbolic (guidance implies ~27-34%), so not all scores are maxed. The business is clearly in a high-growth phase with multiple self-reinforcing elements, but not every metric is at the absolute top decile.
EME Q2 2026: RPOs Surge 44% to $17.1B, Locking in Multi-Year Demand Visibility
The business demonstrates a long reinvestment runway, accelerating backlog, improving margins, and clear customer value deepening. However, the model is not fully disruptive (score of 1 for Q7), and while growth is substantial, it is not consistently above 40% (Q9). The signal remains very high, with strong forward visibility and compounding advantages.
Prologis (PLD) Q2 2026: Data Center Starts Surge Past $2.1B, Unlocking Multi-Year Growth Runway
Prologis demonstrates a long reinvestment runway, significant growth in data centers, and improving unit economics. The business model is self-reinforcing, customer value is deepening, and guidance is accelerating. While not fully disruptive, the scale and adjacency moves are strategic. Revenue/EPS growth is strong but not above 40%, and the business is clearly in growth mode.
RBC Bearings (RBC) Q4 2026: Aerospace & Defense Surges 41%, Backlog Hits $2.3B as Submarine and Missile Ramps Accelerate
RBC Bearings is exhibiting clear growth signals: a long reinvestment runway, surging backlog, improving unit economics, and self-reinforcing business model with defense/space content expansion. Customer value is rising, and the business is positioned for further growth, though cash flow acceleration and near-term revenue/EPS growth are strong but not yet at hypergrowth levels. The business is not a legacy stall but a full-fledged growth platform.
MicroStrategy (MSTR) Q4 2025: $6.9B Preferred Equity Issuance Anchors Digital Credit Expansion
MicroStrategy demonstrates a long reinvestment runway, major capital raises, improving unit economics, and a disruptive, self-reinforcing business model. Customer value and cash flow are both deepening, and the company is positioned as a growth business. The only areas where the signal is slightly lower are in the exceptional acceleration of future growth (guidance is strong but not over 30%) and annualized revenue/EPS growth (likely under 40%).
Fortinet (FTNT) Q1 2026: Secure Networking Billings Jump 32% as AI Data Center Demand Reshapes Growth Curve
Fortinet demonstrates a long reinvestment runway, disruptive model, and self-reinforcing platform advantages. There are significant growth signals (billings up 32%, OT up 70%, SASE up 31%), but forward guidance for revenue/EPS is in the 15-18% range, justifying a slightly lower score on those questions. The business is clearly in a growth phase with accelerating cash flow and platform leverage, but the absolute growth rate is not hyper-growth (>40%), and service revenue acceleration is still pending.
Klaviyo (KVYO) Q1 2026: Enterprise ARR Customers Up 38% as AI Drives Platform Consolidation
Klaviyo demonstrates a long reinvestment runway, major enterprise and international growth, improving unit economics, and a self-reinforcing SaaS/AI business model. Customer value metrics and margin expansion are strong. Growth is robust but not quite at the highest acceleration tier, and guidance is solid but not exceptional. The business is clearly in a growth phase with high signal for investors.
Red Cat (RCAT) Q4 2025: Cash Surges to $168M as USV and Drone Output Scales for Global Demand
Red Cat demonstrates a long reinvestment runway, disruptive business model, self-reinforcing manufacturing scale, and improving unit economics. There is strong evidence of demand inflection and a robust order pipeline, with accelerating cash flow and a transition to scaled growth. The only deduction is for lack of formal guidance and some uncertainty around the pace of contract conversion, which tempers near-term growth visibility. Nonetheless, the signal for investors is very high.
Redwire (RDW) Q1 2026: Backlog Soars 71% as Book-to-Bill Hits 1.92, Fueling Quality Growth Strategy
Redwire demonstrates a long reinvestment runway with high ROIC potential, a massive backlog uptick, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the future outlook is strong with accelerating growth. The business model is disruptive with lateral opportunities. Cash flow is improving but not yet accelerating, and while growth is strong, revenue/EPS growth is just below the highest tier. Overall, the business is in a clear growth phase with significant upside signals.
AVEX (AVEX) Q1 2026: Tactical Systems Revenue Surges 548% on Deep Strike Ramp, Margin Expansion Signals Durable Demand
AVEX exhibits a long reinvestment runway, disruptive business model, improving unit economics, and strong customer value expansion. Recent results show a massive surge in growth and margin expansion, though future growth is somewhat dependent on pipeline conversion, justifying a slightly conservative score on future guidance and growth rate. The business is not yet at a recurring 40%+ annual growth pace, but it is a clear growth story with significant optionality and upside.
PureCycle (PCT) Q2 2025: $300M Capital Raise Accelerates Global Expansion to 1B Pound Capacity
PureCycle demonstrates a long reinvestment runway, strong recent business evolution, improving unit economics, and a self-reinforcing model with disruptive characteristics. Customer value is increasing, and guidance points to accelerating growth and margin improvement. While not all metrics are at the highest possible level (e.g., cash flow acceleration and revenue/eps growth are strong but not yet over 40%+), the business is clearly in a high-growth, inflecting phase with substantial upside optionality.
Redwire (RDW) Q1 2026: Backlog Soars 71% as Book-to-Bill Hits 1.92, Fueling Quality Growth Strategy
Redwire demonstrates a long reinvestment runway, disruptive business model, and improving unit economics with a record backlog and margin expansion. There are clear signs of accelerated growth and increasing customer value, but cash flow, while improving, is not yet accelerating. Revenue and EPS growth are strong but just below the highest tier, and the business is clearly in a growth phase rather than legacy or transition.
Samsara (IOT) Q1 2027: $101M Net New ARR Accelerates Large-Customer Platform Expansion
Samsara demonstrates a long reinvestment runway, disruptive business model, improving unit economics, self-reinforcing platform, and clear growth orientation. While growth is robust (around 30%), it is not above 40%, so some signal questions are scored conservatively. The business is not entirely unknown or overlooked, but the article surfaces meaningful signals for valuation upside.
JFrog (FROG) Q4 2025: Security Core Hits 16% of RPO as AI Binaries Drive Platform Expansion
JFrog demonstrates a long reinvestment runway, clear disruptive model, and compounding business characteristics. Security and AI-driven binary growth are accelerating platform adoption, with improving unit economics and high retention. While growth is strong, it is not at the highest acceleration tier for all metrics (e.g., overall revenue growth is under 20%). The business is not entirely unknown, but the inflections around AI and security adoption provide strong signal for upside.
Madison Air (MAIR) Q1 2026: Backlog Doubles to $2.5B, Powering Commercial Momentum
Madison Air demonstrates a long reinvestment runway, a doubling of backlog, clear unit economics improvement, self-reinforcing model, and deepening customer value. Guidance is raised and backlog visibility is strong, but the business model, while innovative, is not fully disruptive (score 1 for question 7). Growth is above 20% but not clearly above 40% (score 1 for question 9). The business is solidly in growth mode with accelerating cash flow and margin expansion.
Rubrik (RBRK) Q1 2027: Identity ARR Jumps 38% as Cyber Resilience Platform Outpaces Legacy Rivals
Rubrik demonstrates a long reinvestment runway, clear disruptive model, and compounding business dynamics (identity and AI). There is strong evidence of customer value expansion, platform self-reinforcement, and cash flow leverage. Growth is robust but not explosive (hence some 1s). The business is not yet at hypergrowth (40%+), but is solidly in the high-growth, platform-transitioning camp with clear investor relevance.
MicroStrategy (MSTR) Q4 2025: $6.9B Preferred Equity Issuance Anchors Digital Credit Expansion
MicroStrategy demonstrates a long reinvestment runway, disruptive capital markets innovation, improving unit economics, and self-reinforcing business model. Customer value, cash flow, and growth are all strong. The only area not scoring a full 2 is on guidance acceleration and growth rate, which, while strong, is not at the highest possible level. The business is growth-oriented and not a legacy stalling operation.
Belden (BDC) Q2 2026: Ruckus Acquisition Lifts Solutions Mix Above 20%, Reshaping Margin Profile
Belden is at a structural inflection point with a long reinvestment runway, high-margin mix shift, and strong growth in AI/data center verticals. While not a classic disruptive model (hence a 1 on question 7), the business shows accelerating backlog, improving unit economics, and a clear shift toward higher-value, recurring revenue. The outlook and performance signal above-average upside for investors.
Neptune Insurance (NP) Q3 2025: Written Premium Jumps 33% as Distribution Expansion Drives Record Policy Growth
Neptune Insurance demonstrates a long reinvestment runway, disruptive asset-light model, and strong operating leverage. Premium growth and retention are robust, and margins are exceptional. While not all metrics point to hypergrowth (revenue growth is high but not over 40%), the business is clearly transitioning into a high-quality, compounding, and scalable platform with significant optionality.
Antarex (ATEX) Q3 2026: OPEX Down 20% as Utility Wireless Platform Accelerates Recurring Revenue Shift
Antarex demonstrates a long reinvestment runway, clear business model evolution, and strong recurring revenue growth. There is evidence of improving unit economics, self-reinforcing business model, and increasing customer value. Regulatory and product catalysts are significant, though current growth guidance does not exceed 40% and backlog/guidance inflection is strong but not yet exceptional. The business is highly investable with strong signal for future value creation.
DraftKings (DKNG) Q4 2025: Sportsbook Revenue Jumps 64% as Predictions Pivot Gains Steam
DraftKings demonstrates a long reinvestment runway, disruptive new vertical (predictions), improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the company is transitioning into a diversified growth business. However, while growth is robust, guidance is conservative and the immediate future is not quite at the 'exceptional' level for backlog/guidance revision or revenue/EPS growth over 40%.
Yuanbao (YB) Q1 2026: System Services Surge 39.8% as AI Integration Reshapes Insurance Platform
Yuanbao demonstrates a long reinvestment runway with high ROIC, a disruptive, AI-driven business model, and clear operating leverage. System services are growing rapidly, and the business is transitioning to a high-margin, scalable platform. While growth is strong, it is not above 40% in all metrics, and guidance is for continued double-digit (not hypergrowth) expansion. The business is not entirely exceptional in every metric, but it is highly investable and strategically significant.
Antarex (ATEX) Q4 2026: Spectrum Cash Collections Surge 59%, Unlocking Scarcity Premium
Antarex exhibits a long reinvestment runway with high returns on capital, a disruptive business model, and clear pricing power from spectrum scarcity. There is a step change in cash collections and backlog, improving unit economics, and strong recurring revenue momentum. However, projected revenue growth for next year is not clearly above 20%, so question 9 is conservatively scored. Guidance on future growth is positive but not exceptional (question 6). Overall, signal is very high for a niche but strategically valuable asset.
EXLS Q2 2026: Data and AI Revenue Surges 30%, iMerit Acquisition Expands AI Model Reach
EXL demonstrates a long reinvestment runway, disruptive AI-led business model, and clear compounding effects via recurring revenue and proprietary IP. The iMerit acquisition and rapid AI revenue growth (30%+) are significant developments. Some caution on cash flow acceleration and growth rate (not 40%+), but overall, the signal is very strong for investors seeking growth and transformation in IT services.
NIQ (NIQ) Q1 2026: E-commerce Revenue Soars 33% as AI Monetization Accelerates
NIQ demonstrates a long reinvestment runway, strong compounding advantages, and disruptive business model evolution. The company is showing accelerating e-commerce growth, improving unit economics, and a credible path to margin expansion, with high retention and durable subscription revenue. While overall growth is solid rather than hyperbolic, the business is clearly transitioning to a high-value, high-margin AI infrastructure provider, with multiple levers for future upside. The signal is strong, though not at the absolute apex due to growth rates just under the highest threshold.
Monolithic Power Systems (MPWR) Q4 2025: Enterprise Data Growth Floor Raised to 50% as Backlog Visibility Expands
MPWR demonstrates a long reinvestment runway with high returns, a significant growth inflection in enterprise data, and improving unit economics as scale increases. The business model is self-reinforcing, with customer value deepening and backlog/guidance signaling exceptional future prospects. While the business is highly innovative, it is not fully disruptive in the classic sense—hence a slightly lower score for that dimension. Revenue and EPS growth are strong but not consistently above 40%. The business is clearly in a high-growth phase.
Uber (UBER) Q4 2025: Merchant-Funded Offers Up 50% as Grocery Run Rate Hits $12B
Uber demonstrates a long reinvestment runway, disruptive business model, and improving unit economics, with merchant-funded incentives and grocery growth as major levers. AV commercialization and cross-platform initiatives add further upside, though near-term growth rates are strong but not at the 40%+ threshold. The business is firmly in growth mode, with multiple avenues for further value creation.
Grab (GRAB) Q4 2025: Financial Services Surges, Loan Book Hits $1.3B as Platform Operating Leverage Accelerates
Grab demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and compounding network effects. Financial services and AI-driven efficiency are driving margin expansion and growth. While growth is strong, forward guidance suggests 20-22% revenue growth, not quite at the highest acceleration, and thus some signal points are not maxed.
ACV Auctions (ACVA) Q1 2026: No Reserve Auctions Double, Fueling 20% EBITDA Per Unit Growth
ACV demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and self-reinforcing network effects. No reserve auctions and AI-driven product innovation are driving high conversion and margin expansion. Commercial expansion and new product rollouts provide additional growth levers. While growth is strong, it is not yet at hypergrowth (>40%), and guidance indicates continued but not explosive acceleration. The business is clearly in a growth phase with strong forward indicators.
Rocket Companies (RKT) Q1 2026: AI-Driven Origination Capacity Doubles to $300B, Accelerating Margin Expansion
Rocket demonstrates a long reinvestment runway with high ROIC potential, recurring revenue, and accelerating operating leverage. There are clear, significant developments (origination capacity doubling, margin expansion, synergy realization ahead of schedule). Unit economics are improving, and the business model is self-reinforcing with data and workflow integration. While not a pure disruptor, the platform shift and AI integration are semi-disruptive. Growth is strong but not consistently above 40%, so scoring is conservative. The business is transitioning to a higher-quality, growth-oriented model.
Better Home and Finance (BETR) Q2 2025: Tinman AI Platform Lifts Contribution Margin to 40%, Unlocking B2B Scale
BETR demonstrates a long reinvestment runway, disruptive AI-driven business model, and improving unit economics. Major inflection in B2B margin and volume, but not quite at exceptional (30%+) growth rates for future guidance. The business is transitioning to a high-margin, recurring revenue model with strong optionality and platform effects, though some macro and execution risks remain.
Globant (GLOB) Q1 2026: AI Pods Pipeline Hits $352M, Margin Upside Emerges
Globant demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and self-reinforcing advantages. The AI pods pipeline and margin mix shift are significant, but the overall growth rate is not consistently above 40%, and future guidance is strong but not exceptional. The business is clearly in a growth phase with accelerating cash flow, but not at the very highest growth inflection.
Elbit Systems (ESLT) Q1 2026: Backlog Surges $7B, Unlocking Multi-Year Growth Visibility
Elbit demonstrates a long reinvestment runway, a step-change in backlog growth, improving margins, and evidence of a self-reinforcing business model. Customer value is increasing and the cash flow profile is strengthening. While the business model is not fully disruptive, it is evolving with high R&D intensity. Revenue growth is robust but not consistently above 40%, reflecting a high but not extreme signal score.
Dave (DAVE) Q1 2026: 47% Revenue Growth Unlocks $200M Liquidity Runway for Credit Innovation
Dave demonstrates a long reinvestment runway, disruptive model, improving unit economics, and an emerging moat via proprietary underwriting. There is strong evidence of growth, margin expansion, and capital discipline. However, revenue/EPS growth guidance is under 40%, and while the business is high-growth, it is not yet in the hypergrowth (40%+) category for the coming year. The signal is nonetheless very high, with clear optionality and product innovation.
Block (SQ) Q1 2026: AI-Driven Productivity Lifts Margin to 25% as Cash App Borrow Grows 82%
Block demonstrates a long reinvestment runway, disruptive model, and compounding network effects. AI is driving operational leverage and new product velocity, while lending growth and margin expansion are material. However, lending normalization and the absence of >40% top-line growth cap the score slightly.
Agibank (AGBK) Q4 2025: Active Clients Surge 73% as Hybrid Model Scales, AI Drives Efficiency
Agibank demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and clear operational leverage. Growth is strong but not yet at the highest acceleration (hence 1 on Q6 and Q9). The business is clearly in growth mode with exceptional future prospects, but not all metrics are at the maximum possible signal.
TARS Q1 2026: Xtemvi Drives 85% Growth, Pipeline Expands Beyond Core Eye Care
Tarsus demonstrates a long reinvestment runway, disruptive business model, and strong unit economics, with Xtemvi driving high growth and expanding recurring revenue. Pipeline optionality is significant, though near-term growth rates and future guidance are not at the highest acceleration threshold. Still, the business is clearly a growth story with high investor relevance.
ARGX Q2 2026: VivGuard Drives 60% Revenue Surge as Seronegative GMG Approval Expands Market
ARGX demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong customer value. The business is not showing >40% revenue/eps growth but is still delivering double-digit growth with exceptional pipeline optionality. The risk is that while the current growth is robust, the future hinges on pipeline readouts, so not all signal scores reach the maximum.
Intapp (INTA) Q3 2026: Celeste AI Drives 15% of Net New Bookings, Expanding Beyond IT Budgets
Intapp demonstrates a long reinvestment runway, disruptive business model, and clear improvements in unit economics, customer value, and cash flow. Celeste AI is driving significant new bookings and strategic evolution, but guidance does not indicate hypergrowth (>30%) yet, warranting a conservative approach on those questions. Overall, signal is high given the inflection and market opportunity.
Veracyte (VCYT) Q1 2026: Decipher Volumes Up 24% as Major Launches Set Stage for Next Growth Cycle
Veracyte demonstrates a long reinvestment runway, clear business evolution with new launches, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is disruptive with accelerating cash flow. While growth is strong, guidance still points to sub-40% annualized growth, and future acceleration is possible but not yet exceptional. The business is positioned for growth, but not at the most explosive phase.
HeartFlow (HTFL) Q4 2025: Gross Margin Climbs 400bps as AI-Powered Plaque Revenue Accelerates
HeartFlow demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong self-reinforcing data/AI moat. Revenue growth is over 20% but not consistently over 40% going forward, and while backlog/guidance is strong, it is not 'exceptional' (30%+ acceleration). The business is clearly growth-oriented and non-legacy. Signal is very high, but not the absolute maximum due to the pace of plaque ramp and Q1 guidance.
XZO (XZO) Q1 2026: Non-ACI Premiums Reach $105M, Validating Platform Diversification
XZO demonstrates a long reinvestment runway with high returns, significant business evolution via external premium growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is disruptive with accelerating cash flow. Revenue growth is strong but not above 40%, and the business is firmly in growth mode. However, guidance does not signal exceptional (30%+) future growth, warranting a slightly lower score for questions 6 and 9.
Coincheck (CNCK) Q2 2026: Marketplace Volume Surges 72% as Staking Revenue Doubles
Coincheck demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong customer value expansion. The business is showing operating leverage and moving into high-growth verticals like staking and institutional services. While growth is strong, the outlook does not quite reach exceptional acceleration (>30%) for all metrics, but the signal for continued expansion and optionality is very high.
Sharon AI (SHAZ) Q1 2026: Contracted TCV Surges to $2.2B as Data Center Capacity Expands to 100MW
Sharon AI demonstrates a long reinvestment runway with high returns, major recent contract wins, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is disruptive with accelerating cash flow. While growth is strong, it is not yet at the 40%+ level for revenue/EPS, and backlog/guidance is good but not exceptional, warranting slight conservatism in the signal score.
Navan (NAVN) Q4 2026: New Bookings Up 50% as AI Drives Legacy Displacement
Navan demonstrates a long reinvestment runway, disruptive AI-driven business model, improving unit economics, and increasing customer value. There is clear margin expansion, strong bookings growth, and robust retention. While growth is strong (24-30% YoY), it is not consistently above 40%, and guidance is solid but not exceptional. The business is positioned as a growth leader rather than a legacy or transitioning player.
Pattern (PTRN) Q3 2025: Non-Amazon Revenue Soars 81% as Platform Diversification Accelerates
Pattern demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and compounding customer value. The business is transitioning rapidly to high-growth channels and geographies, but full exceptional acceleration (>30% growth) is not yet fully sustained in all metrics (e.g., next quarter guidance is below 40% growth). Signal is high but not at the absolute maximum due to some moderation in forward growth rates.
DFINIUM Therapeutics (DFTX) Q1 2026: R&D Spend Jumps 77% as Three Phase III Readouts Approach
DFINIUM is on the cusp of a major inflection with three Phase III readouts, a disruptive single-dose psychiatric therapeutic, and a robust cash runway. The business model is highly disruptive with a long reinvestment runway and potential for compounding value. However, growth is not yet proven at the 40%+ level, and cash flow is not yet accelerating, which slightly tempers the signal score.
Soul Strategies (STKE) Q4 2025: Validator Revenue Hits $5.4M as Institutional Solana Adoption Accelerates
STKE demonstrates a disruptive, compounding business model with clear reinvestment runway, improving unit economics, and deepening customer value. The business is transitioning to high-quality, recurring operational revenue with institutional adoption accelerating. While growth is strong, it is not yet at the exceptional >40% level for all metrics, so some questions are conservatively scored. Overall, the signal is very high for investors seeking exposure to blockchain infrastructure.
PodcastOne (PODC) Q3 2026: Adjusted EBITDA Swings $3.5M on AI Monetization and Original IP Leverage
PodcastOne demonstrates a long reinvestment runway, disruptive and self-reinforcing business model, and improving unit economics. The business is transitioning to high-margin, tech-enabled growth with strong cash flow and recurring revenue, but growth guidance is not above 40% and some margin gains are one-off, so scores are capped accordingly.
Bullish (BLSH) Q3 2025: SSNO Revenue Jumps 300% as Tokenization Drives Platform Expansion
Bullish demonstrates a long reinvestment runway, disruptive business model, and clear inflection in its SSNO/tokenization platform. The business is transitioning to recurring revenue and shows strong operating leverage, but near-term growth is somewhat muted by event seasonality and crypto price declines, preventing a perfect score. Still, the signals for future growth and competitive advantage are strong.
Voyager Technologies (VOYG) Q1 2026: Backlog Surges 54% as Defense Pipeline Expands
Voyager shows a long reinvestment runway, disruptive model, and exceptional backlog growth (54% YoY). Unit economics are positioned to improve as production ramps, and the business is transitioning to growth. Guidance suggests strong revenue acceleration (up to 53% YoY), but near-term profitability and cash flow are not yet accelerating, justifying a slightly lower score for questions 8 and 9.
Transocean (RIG) Q1 2026: $1.6B Backlog Surge Signals Deepwater Utilization Approaching 100%
Transocean is demonstrating a long reinvestment runway with high returns, a significant backlog surge, improving unit economics, and self-reinforcing business dynamics. Customer value is increasing, and backlog/guidance revisions are strong. The model is not highly disruptive but is semi-disruptive in the current supply-constrained cycle. Cash flow is accelerating, but revenue growth is likely just under the 40% threshold. The business is firmly in growth mode.
ServiceNow (NOW) Q2 2026: AI ACV Surpasses $1B as Agentic Adoption Drives 9x Uptick
ServiceNow demonstrates a long reinvestment runway, compounding AI/cyber adoption, improving unit economics, and a disruptive, self-reinforcing model. Growth is strong but not hyperbolic; guidance is prudent. The business is clearly in a high-growth phase with strong fundamentals, though not all indicators point to an exceptional (40%+) acceleration.
Advanced Energy (AEIS) Q4 2025: Data Center Revenue Jumps 101% as Capacity Investments Pay Off
AEIS demonstrates a long reinvestment runway with high returns, a recent major uptick in data center revenue, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and backlog/guidance revisions are exceptional. The business is semi-disruptive with strong cash flow acceleration. Revenue/EPS growth is strong but not consistently above 40%. Overall, it is a growth business with high signal for investors.
Affirm (AFRM) Q3 2026: Cardholder Base Hits 4.4 Million as Network Effects Accelerate Repeat Usage
Affirm demonstrates a long reinvestment runway, network effects, improving unit economics, and a disruptive business model. Cardholder growth and repeat usage are accelerating, and funding is stable. However, while growth is strong, it is not consistently above 40% and near-term guidance is constructive but not exceptional, warranting a slightly conservative score.
PURR Q1 2026: Hype Token Holdings Surge 46%, New Validator Deepens Ecosystem Leverage
PURR demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and self-reinforcing advantages. There is a significant uptick in token holdings and value, but future growth rates are not clearly above 40% and guidance is not exceptional. The business is transitioning from pure treasury to ecosystem operator, with strong cash flow growth and multiple avenues for expansion, though some risks and dependencies remain.
ARGX Q1 2026: $400M Cash Build and 90% Gross Margin Underscore Pipeline-Driven Immunology Expansion
ARGX exhibits a long reinvestment runway, improving unit economics, a self-reinforcing business model, and growing customer value. The business is disruptive with high margins and cash flow acceleration. However, while growth is strong, current guidance and backlog do not quite reach the most exceptional tier, and revenue/EPS growth is likely between 20-40% rather than above 40%. The business is clearly in a high-growth, innovation-driven phase.
AXTI (AXTI) Q3 2025: Indium Phosphide Backlog Surges to $49M as AI Data Center Demand Accelerates
AXTI is at a structural inflection with a long reinvestment runway, exceptional backlog growth, improving unit economics, and a self-reinforcing business model. Customer value, business model disruption, and growth signals are all strong. The only moderation is in cash flow and annualized growth (not clearly >40%)—otherwise, signal is high and relevant for investors seeking upside.
Inter & Co (INTR) Q1 2026: Loan Portfolio Surges 33% as AI Banking Push Drives Margin Expansion
The company is showing strong growth, with a long reinvestment runway, disruptive AI-driven model, and improving unit economics. There is a significant shift in business model and margin expansion, though growth is not yet over 40% QoQ and some risks remain in asset quality and fee income diversification.
XPO (XPO) Q2 2026: LTL Margin Hits 79.9% as AI Productivity and Market Share Drive 300bp Gain
XPO demonstrates a long reinvestment runway, major recent margin and productivity inflections, and improving unit economics. The business model is self-reinforcing, customer value is increasing, and cash flow is accelerating. While the model is not fully disruptive, it is semi-disruptive within LTL. The growth outlook is strong but not quite at the extreme upper end for revenue/EPS acceleration, justifying a slightly lower score on those dimensions.
Genius Sports (GENI) Q1 2026: Legend Acquisition Lifts Margin Target to 28%, Accelerates Synergy Playbook
GENI demonstrates a long reinvestment runway, major margin and synergy inflection, improving unit economics, and a self-reinforcing business model. Customer value is deepening, the business is disruptive, and cash flow is accelerating. While guidance is strong, growth rates are not consistently over 40% and future outlook is exceptional but not at the highest threshold for all metrics.
TOYO (TOYO) Q1 2026: Gross Margin Quadruples to 33.5% as U.S. Solar Output Scales
TOYO demonstrates a long reinvestment runway with high returns on capital, a disruptive business model, and clear evidence of structural margin expansion and cash flow acceleration. There is a significant business inflection, but guidance is not yet exceptional (>30% acceleration), so question 6 is scored conservatively. Revenue/EPS growth is strong but not above 40%, warranting a score of 1. The business is clearly a growth business with strong policy and market tailwinds.
Roblox (RBLX) Q4 2025: 69% DAU Growth Fuels Platform Expansion, Margin Leverage in Focus
Roblox demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and deepening customer value. The business is in a high-growth phase with exceptional international expansion and platform leverage. While bookings growth is projected to moderate, the underlying business model remains disruptive with strong cash flow prospects and a clear margin improvement path. The only deduction is for the forward guidance, which, while strong, is not at the highest acceleration.
D-Wave (QBTS) Q1 2026: Bookings Soar 1,994% as Dual-Platform Quantum Bet Accelerates
D-Wave demonstrates a long reinvestment runway with high ROIC potential, and the bookings/backlog surge is a clear inflection. Unit economics and customer value are improving, and the business model is increasingly self-reinforcing. The dual-platform approach is disruptive with significant lateral opportunities. The business is transitioning to recurring, scalable growth, but cash flow is not yet accelerating, and revenue/eps growth is likely in the 20-40% range rather than over 40%. The business is not yet a cash flow machine, but all other signals are strong and point to high strategic upside.
Legion (LGN) Q1 2026: Backlog Doubles to $5.4B as Data Center Demand Drives Expansion
Legion demonstrates a long reinvestment runway, massive backlog growth, improving unit economics, and strong customer value expansion. The business is transitioning to a higher-margin, higher-throughput model with accelerating cash flow and robust growth. While network effects are not fully self-reinforcing, the business is disruptive within its sector. The only slight deduction is for the business model not being a classic platform or network, but otherwise signal is very high.
eToro (ETOR) Q1 2026: Commodities Trading Jumps 4x, Driving Multi-Asset Engagement Surge
eToro demonstrates a long reinvestment runway, disruptive business model, and strong growth drivers (multi-asset, AI, DeFi). Commodities trading and multi-asset engagement are inflecting, with clear evidence of improving unit economics and operational leverage. However, growth is not yet at a hyper-accelerated (40%+) pace, and some cyclicality remains. The business is well-positioned for continued expansion, but the near-term growth outlook is strong rather than exceptional.
XZO (XZO) Q1 2026: Non-ACI Premiums Reach $105M, Validating Platform Diversification
XZO demonstrates a long reinvestment runway, clear platform leverage, and disruptive AI-driven model with improving unit economics and cash flow. The external premium wins and rapid productization are strong signals. The only slight deduction is for the near-term growth guidance not being above 20%+ for both revenue and EPS, and future guidance not being exceptional, but the overall signal is very high.
Klarna (KLAR) Q1 2026: Transaction Margin Surges 44% as Fair Financing Scales
Klarna demonstrates a long reinvestment runway, disruptive model, improving unit economics, and accelerating margin compounding. Most signal criteria are met at the highest level, but revenue/EPS growth guidance is not above 40% and forward outlook, while strong, is not at an 'exceptional' inflection. The business is growth-oriented and investor-relevant, but not at the most extreme end of potential upside.
Grab (GRAB) Q1 2026: On-Demand GMV Jumps 24% as AI and EV Initiatives Deepen Competitive Moat
Grab demonstrates a long reinvestment runway with high returns, significant recent growth (24% GMV, 67% loan disbursal), improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business model is disruptive. Cash flow is accelerating, and the company is a clear growth business. However, revenue/EPS growth is strong but not above 40%, and guidance/growth outlook, while solid, is not at a truly exceptional acceleration level.
PATRON (PTRN) Q1 2026: Net Revenue Retention Hits 127% as Non-Amazon Channels Surge 119%
PATRON demonstrates a long reinvestment runway, disruptive model, and strong unit economics with high NRR and diversified growth. Recent growth is substantial but not quite at the highest acceleration threshold for every metric. Cash flow and margin expansion are evident, and the business is in clear growth mode with multiple avenues for continued value creation.
Life360 (LIF) Q1 2026: Advertising Revenue Jumps 329% as Nativo Integration Unlocks New Scale
Life360 demonstrates a long reinvestment runway with strong ROIC, a major inflection in ad revenue (329% YoY), and improving unit economics. The business model is increasingly self-reinforcing, customers are becoming more valuable, and the AI transition offers further leverage. Growth is strong but not quite at the highest tier for all metrics, and some near-term uncertainties (MAU normalization) temper the outlook slightly.
Cardinal Infrastructure Group (CDNL) Q1 2026: Backlog Climbs 60%, Vertical Integration Drives Margin Expansion
Cardinal demonstrates a long reinvestment runway, significant recent growth (backlog up 60%, organic growth 64%), improving unit economics, and a self-reinforcing model via vertical integration and labor force. Customer value is deepening (80% recurring), and guidance/backlog signals exceptional future growth. The business is not fully disruptive but is semi-disruptive for its sector. Cash flow is accelerating, but YoY revenue/eps growth is high but not consistently >40%. The company is a clear growth business.
Reddit (RDDT) Q1 2026: Ad Revenue Soars 74% as Performance Automation Scales
Reddit demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and exceptional cash generation. Recent growth is strong but not quite at the 40%+ threshold for future quarters, and guidance suggests continued but slightly moderating acceleration. The business is clearly in a high-growth phase, with multiple avenues for value creation, though some future assumptions (e.g., data licensing scale) are not yet fully realized.
Bullish (BLSH) Q4 2025: Options Open Interest Surges Past $4B, Anchoring Institutional Expansion
Bullish demonstrates a long reinvestment runway, disruptive business model, accelerating cash flow, and robust growth in institutional markets. There is strong evidence of improving unit economics, deepening customer value, and self-reinforcing business dynamics. While 2026 guidance is strong, the growth trajectory is not quite at the exceptional/40%+ level for all metrics, warranting a slightly conservative score. Overall, the signal is very high for institutional investors seeking upside.
MNTN Q4 2025: PTV Customer Base Jumps 63%, Fueling Margin Expansion and AI-Led Growth
Mountain shows a long reinvestment runway, disruptive SMB-focused model, and clear margin and customer growth. AI-driven features and strong expansion rates reinforce compounding economics. While growth is strong, guidance for 2026 points to >20% but <40% growth, so not all metrics are at the highest threshold. The business is not yet at hypergrowth (40%+), but the signal is still very strong for a durable, high-quality growth thesis.
Solstrategy (STKE) Q2 2026: HoudiniSwap Acquisition Adds $12M Revenue Run-Rate, Accelerating Infrastructure Expansion
Solstrategy is undergoing a significant business model evolution, adding a large new revenue stream and expanding into higher-margin, disruptive infrastructure. The business model is self-reinforcing, with improving unit economics and increasing customer value. While cash flow is not yet accelerating and growth is not projected above 40%, the strategic runway and optionality are very strong, supporting a high signal score.
Paymentus (PAY) Q1 2026: AI-Driven Bill Wallet Launches as Revenue Jumps 30%
Paymentus demonstrates a long reinvestment runway, disruptive platform launch, and improving economics. The guidance revision is positive but not exceptional (under 30% acceleration), and forward growth is strong but not hyper-growth. Otherwise, the business model, cash flow, and strategic positioning are highly attractive.
CINT (CINT) Q2 2025: 90% of Revenue AI-Influenced as Client Expansion Drives 12% Organic Growth
CINT demonstrates high signal with a long reinvestment runway, rapid AI adoption, improved unit economics, and a disruptive, self-reinforcing business model. Revenue growth is robust but not hyper-growth, and cash flow is accelerating moderately rather than exceptionally. The business is positioned as a growth leader, but sectoral imbalances and the need for further value-based pricing adoption temper the signal slightly.
Instacart (CART) Q4 2025: Enterprise Platform Expands to 380 Sites, Unlocking Multi-Year Growth Runway
Instacart demonstrates a long reinvestment runway, accelerating enterprise adoption, and improving unit economics. The business model is increasingly self-reinforcing, and customer value is deepening. While growth is robust, guidance indicates high but not truly exceptional acceleration, and the business—though disruptive—faces competitive and execution risks, especially in international expansion. The signal is strong but not at the absolute highest tier due to these moderating factors.
GEN (GEN) Q4 2026: Trust-Based Solutions Surge 23% as Financial Wellness Scales to $1B Run Rate
GEN demonstrates a long reinvestment runway, recent double-digit growth in new segments, improving unit economics, and a self-reinforcing platform model. Customers are becoming more valuable, and cash flow is accelerating. However, while growth is strong, guidance implies high single-digit to low double-digit revenue growth (not >20%), and the business, though transitioning, is not yet a breakout disruptor. The business is growth-oriented but not at the very highest signal level.
Webull (BULL) Q1 2026: Institutional Volumes Reach 9.5% of Equity Flow, Accelerating B2B Pivot
Webull demonstrates a long reinvestment runway, disruptive business model, and clear compounding advantages through its infrastructure and AI focus. Institutional and B2B volumes are inflecting, unit economics are improving, and customer retention is exceptional. However, growth is not yet at the 40%+ exceptional level, and cash flow is not yet accelerating, tempering the signal score. Still, this is a high-growth, high-optional business with significant upside potential.
Equinix (EQIX) Q1 2026: Sales Activity Surges 35%, AI Infrastructure Demand Drives Record Backlog
Equinix demonstrates a long reinvestment runway, clear unit economics improvement, self-reinforcing business model, and strong customer value expansion. Growth is robust but not quite at an exceptional acceleration rate, and while the business is highly attractive, it is already well-followed and not a hidden gem, slightly capping the signal score.
BitGo (BTGO) Q1 2026: Derivatives Launch Drives 32bps Margin as Institutional Platform Expands
BitGo shows strong growth signals: high reinvestment runway, recent derivatives launch, improving unit economics, and a disruptive, scalable business model. Margins and client base are expanding. However, growth is not yet at hyper-scale (over 40%), and cash flow is not yet accelerating dramatically, so scores are slightly moderated.
HubSpot (HUBS) Q4 2025: Net New ARR Grows 24%, Signaling Durable AI-Driven Expansion
HubSpot demonstrates a long reinvestment runway, strong growth in net new ARR, improving unit economics, and a self-reinforcing platform model. Customer value is deepening, and the business is clearly in a growth phase, with accelerating cash flow. However, while growth is rapid, it is not at the highest acceleration tier (>40%), and the business model, while innovative, is not fully disruptive in the SaaS landscape. Guidance is for strong but not exceptional acceleration. Overall, the signal is very high but not at the absolute maximum.
Summit Therapeutics (SMMT) Q2 2026: R&D Spend Climbs 24% as Avonisimab Heads Toward FDA Decision
Summit shows a long reinvestment runway with high returns potential via Avonisimab’s platform, recent significant clinical and regulatory developments, improving unit economics, and a disruptive, self-reinforcing business model. Customer value is increasing, but future growth is not yet exceptional (pending FDA approval). Cash flow is not yet accelerating, and revenue/EPS growth is not >40% but is solidly in the growth stage.
Zscaler (ZS) Q3 2026: ZFlex TCV Surges 60% QoQ, Securing Multi-Year Customer Commitment
Zscaler demonstrates a long reinvestment runway, disruptive model, improving unit economics, and deepening customer value. AI Protect and ZFlex growth signal strong business evolution, but near-term guidance is tempered by leadership transition and CapEx inflation. While revenue growth remains robust, it is just below the highest acceleration threshold, and cash flow is healthy but not accelerating at the highest rate. Overall, the business offers high signal for investors but is not at the absolute peak of growth acceleration.
Digital Turbine (APPS) Q4 2026: App Growth Platform Surges 57%, AI-Driven Model Expands Margin
Digital Turbine demonstrates a strong reinvestment runway, clear business model leverage, and a disruptive, AI-driven platform with significant margin expansion and global growth. While growth is robust and the business model is self-reinforcing, some elements—such as future growth rates and the degree of disruption—are significant but not fully exceptional, warranting a slightly conservative signal score.
Veir Biotechnology (VIR) Q1 2026: $1.7B Astellas Deal Accelerates Prostate Cancer Pipeline
Veir demonstrates a long reinvestment runway, disruptive business model, and strong platform leverage via the Astellas deal. There are significant pipeline catalysts and optionality, but growth is not yet at a 40%+ level, and cash flow is not yet accelerating sharply. Still, the business is in a clear growth phase with high investor relevance.
Salesforce (CRM) Q1 2027: AgentForce ARR Surpasses $1B as Slack AWUs Jump 350%
Salesforce demonstrates a long reinvestment runway, compounding network effects, improving unit economics, and a strong pivot to usage-based AI monetization. However, the business is already well-known and large, which tempers the upside signal. Growth is robust but not at the hypergrowth threshold (>40%), and legacy drag is acknowledged. The business remains a growth leader, but not a new or underappreciated story.
nCino (NCNO) Q1 2027: Intelligence Unit Consumption Surges as AI Adoption Drives 38x Usage Uptick
nCino demonstrates a strong reinvestment runway, disruptive AI-driven business model, and accelerating adoption, especially internationally. While growth is robust and unit economics are improving, the signal is just shy of exceptional (e.g., not yet 40%+ topline), and some metrics are still in the early ramp phase.
NOAH (NOAH) Q1 2026: Operating Margin Expands to 37.8% as AI Reshapes Wealth Platform
NOAH demonstrates a long reinvestment runway with high returns on capital, significant recent growth in key metrics, improving unit economics, and a self-reinforcing business model through AI and platform effects. Customer value is deepening, and the business model is transitioning toward disruption, though not fully disruptive yet. Cash flow and margins are accelerating, but overall growth is solid rather than hyper-growth, and the business is not entirely new or unknown, which moderates the signal score.
Once Upon a Farm (OFRM) Q4 2025: Cooler Count to Surpass 5,000, Accelerating Retail Penetration
OFRM demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong customer loyalty. There is clear evidence of rapid growth (30%+), significant retail expansion, and innovation. However, margin expansion is still in the future and growth, while strong, is not yet at a hypergrowth (40%+) level. Cash flow is not yet accelerating, and future guidance is good but not exceptional. Still, the business is solidly in growth mode with meaningful upside if execution continues.
Astera Labs (ALAB) Q4 2025: Opex Jumps $16M as AI Connectivity Demand Expands TAM 10x
Astera Labs demonstrates a long reinvestment runway with high ROIC potential, disruptive business model, and strong growth dynamics. TAM expansion, customer diversification, and product leadership are clear. However, near-term growth guidance is not exceptional (>30%), and margin/cash flow acceleration is moderate due to heavy investment. The signal is high but not at the absolute maximum due to these caveats.
CHA Q1 2026: Overseas GMV Jumps 139%, Franchise Model Shift Unlocks Margin Leverage
CHA demonstrates a long reinvestment runway, clear inflection in overseas growth, and improving unit economics. The franchise model transformation and global expansion are structurally important, with compounding business model attributes and growing customer value. While growth is strong and margins are improving, some areas (guidance, disruptive potential, and growth rate) are just shy of exceptional, warranting a slightly conservative score.
Zephyr (ZVRA) Q1 2026: MyPlypha Reaches 50% Diagnosed U.S. NPC Share, Unlocking Rare Disease Scale
Zephyr demonstrates a long reinvestment runway, disruptive model, and self-reinforcing business attributes, with clear commercial momentum and pipeline expansion. While growth is strong and strategic levers are in place, some metrics (cash flow acceleration, future growth guidance) are not at the most exceptional tier, warranting a slightly conservative score. Still, the business is positioned for multi-year growth and upside.
Baidu (BIDU) Q2 2025: AI Cloud Revenue Jumps 27% as ApolloGo Scales Global Partnerships
Baidu demonstrates a long reinvestment runway with high returns (AI Cloud, ApolloGo), recent significant growth in non-marketing revenue and digital human monetization, and improving unit economics. The business model is self-reinforcing (recurring cloud, digital human, autonomous driving), and customers are becoming more valuable. However, near-term margin pressure and early-stage AI monetization temper the outlook, keeping some scores at 1. The business is clearly in a high-growth, disruptive transition, but not all growth metrics are at the highest acceleration threshold.
AMTX Q1 2026: Revenue Jumps 27% as LCFS Pathways and India Rebound Drive Platform Expansion
AMTX demonstrates a long reinvestment runway with high ROIC potential, significant regulatory-driven growth, and improving unit economics. The business model is disruptive and self-reinforcing, with customers becoming more valuable over time. However, near-term growth is strong but not explosive (under 40%), and cash flow acceleration is moderate, not yet exceptional. The company is clearly in a growth phase, but some upside is still contingent on project execution and regulatory outcomes.
Dell Technologies (DELL) Q1 2027: $51.3B AI Backlog Signals Multi-Year Infrastructure Demand Surge
Dell is a large, well-followed company, so some upside is already priced in, and the business model, while benefiting from a secular AI cycle, is not fully disruptive. However, the scale of backlog, growth, and pipeline is exceptional, with clear evidence of accelerating demand, margin discipline, and strong cash flow. The article demonstrates Dell is in a major growth phase with strong investor signal.
BILL (BILL) Q2 2026: Card Payment Volume Jumps 25% as Platform Monetization Deepens
BILL demonstrates a long reinvestment runway (AI, payments, embedded finance), strong recent growth in card volume and new products, improving unit economics, and a self-reinforcing business model with network effects. Customer value is deepening and the business is transitioning to higher-value segments, but overall growth rates (revenue, EPS) are under 20% with some segments higher. The business is not yet a hypergrowth outlier, but shows strong disruptive and compounding potential.
PodcastOne (PODC) Q4 2026: Programmatic Ad Revenue Doubles, AI Monetization Levers Accelerate
PodcastOne exhibits strong signals of a scalable, tech-driven business with a long reinvestment runway and disruptive potential. Programmatic ad revenue growth, improving unit economics, and a unique equity-based talent model are clear positives. However, while growth is robust, it is not yet at the 'exceptional' level for all metrics (e.g., growth is high but not consistently 40%+), and cash flow, while improving, is not yet accelerating at maximum velocity. Still, the company is positioned as a growth business with considerable upside.
Ascendis Pharma (ASND) Q1 2026: Operating Margin Hits 22% as Diversified Endocrine Portfolio Scales
Ascendis Pharma demonstrates a long reinvestment runway with high returns, recent significant growth inflection, improving unit economics, and a self-reinforcing model. Customer value is increasing, and the business is transitioning into a growth phase with disruptive potential. However, not all signal factors are at maximum: guidance is positive but not exceptionally above 30%, and cash flow acceleration is moderate, not explosive. Revenue growth is strong but not consistently above 40%.
Fastly (FSLY) Q1 2026: Security Revenue Jumps 47% as Platform Diversifies Beyond CDN
Fastly demonstrates a long reinvestment runway with strong ROIC, substantial growth in security and compute, improving unit economics, and a self-reinforcing business model. Customer metrics are trending positively and the business is transitioning to higher-value, higher-growth segments. However, growth outlook is strong but not at hypergrowth levels, and cash flow acceleration is moderate, not explosive. The business is disruptive and positioned for continued growth, but not all metrics signal exceptional acceleration.
HealthEquity (HQY) Q1 2027: Adjusted EBITDA Margin Expands to 46% as AI-Driven Efficiency Reshapes Model
HealthEquity demonstrates a long reinvestment runway with high ROIC, recent margin inflection, and accelerating digital engagement. Unit economics and customer value are improving, and the business is transitioning toward a platform model with emerging disruptive characteristics. Cash flow is robust and accelerating, though revenue growth is strong but not consistently above 40%. The business is solidly growth-oriented, but not at the highest possible signal level for a truly exceptional/transformative company.
Fortinet (FTNT) Q2 2026: SASE Firewall Surges 34%, Unlocking Multi-Pillar Platform Growth
Fortinet demonstrates a long reinvestment runway, strong recent business acceleration, improving unit economics, and a self-reinforcing business model. Customer value and cash flow are increasing. The model is semi-disruptive but not fully, and while growth is strong, guidance and backlog do not indicate >40% acceleration. The business is clearly in a growth phase, but given its scale and sector, the upside signal is slightly capped versus a smaller or newer disruptor.
BILL (BILL) Q2 2026: Card Payment Volume Jumps 25% as Platform Monetization Deepens
BILL demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and deepening customer value. There are clear signals of margin expansion, ARPU growth, and high adoption of new products, but the overall growth rate and cash flow acceleration are strong but not at the highest possible level. The business is not entirely unknown or underfollowed, and some developments are still early-stage, so a perfect score is withheld.
10x Genomics (TXG) Q1 2026: Atera Launch Drives 31% Spatial Consumables Surge, Redefining Market Scale
TXG demonstrates a long reinvestment runway, disruptive model, and self-reinforcing business with increasing customer value, but near-term growth is modest due to the portfolio transition and production ramp constraints. The business is not yet showing exceptional (30%+) growth at the consolidated level, and cash flow is not yet accelerating, but the setup for future inflection is strong. The article reflects this nuance.
Butterfly Network (BFLY) Q2 2026: Embedded Revenue Soars 439% as Platform Flywheel Accelerates
Butterfly demonstrates a long reinvestment runway with high returns, disruptive business model, improving unit economics, and compounding platform effects. Embedded revenue growth is exceptional, but some areas like cash flow and near-term growth rates are not yet at the highest threshold. The business is clearly in growth mode with multiple levers, but some execution and guidance risks temper the signal slightly.
NeuroOne Medical (NMTC) Q3 2025: Gross Margin Jumps to 53.9% as Pain Management Pipeline Expands
NeuroOne demonstrates a long reinvestment runway, disruptive platform potential, improving unit economics, and expanding customer value. Recent margin expansion and pipeline progress are material, but growth and cash flow are not yet at the highest acceleration—guidance and backlog are positive but not exceptional. The business is transitioning toward growth, with some risk around regulatory milestones and commercial execution.
Reddit (RDDT) Q2 2026: Revenue per Employee Hits $1M as Direct User Mix Shifts Monetization Flywheel
Reddit is demonstrating a long reinvestment runway with high returns, a disruptive business model, and accelerating monetization efficiency. There is strong evidence of improving unit economics, business model leverage, and customer value. However, while growth is robust, it is not yet at an exceptional, hyper-growth (40%+) level for future guidance. The business is transitioning from a legacy social platform to a high-growth, automation-driven ecosystem, but some execution risks and reliance on evolving user mix temper the signal slightly.
Sphere Entertainment (SPHR) Q4 2025: Sphere Segment Revenue Surges 60%, Underscoring Immersive Venue Blueprint
Sphere Entertainment demonstrates a disruptive, high-growth business model with a validated reinvestment runway and clear operating leverage. There is a significant recent uptick in revenue and strong signals of customer value expansion and network effects. The business is not yet at the level of exceptional (>30%) future growth guidance, and cash flow is improving but not yet accelerating, but overall the signal is well above average for a new venue model.
Amkor Technology (AMKR) Q2 2026: Computing Revenue Jumps 20% as AI and Advanced Packaging Demand Accelerate
Amkor demonstrates a long reinvestment runway with high returns, clear business model evolution, improving unit economics, and self-reinforcing dynamics via strategic partnerships. Customer value is increasing, and the business is transitioning to a growth profile with disruptive potential. However, growth rates and cash flow acceleration are strong but not exceptional, and near-term headwinds temper the outlook slightly.
TKO (TKO) Q1 2026: Media Rights Surge 23%, Unlocking Multi-Segment Margin Expansion
TKO demonstrates a long reinvestment runway, high-margin contracted revenue, and compounding business model with multiple levers (media rights, FIPs, international expansion). Recent growth is strong but not consistently at the 40%+ level, and while the business is highly resilient and growing, it is not wholly disruptive or accelerating at the most extreme rates. However, the business is clearly a growth platform with high cash flow generation and strategic upside.
Kodiak (KDK) Q3 2025: Driverless Truck Deployments Double, Accelerating DAS Model Scale
Kodiak demonstrates a long reinvestment runway, disruptive asset-light model, and rapid scaling in a nascent, high-growth sector. Customer deployments and recurring revenue are accelerating, and the business model is self-reinforcing with improving unit economics. Some caution is warranted as guidance for growth is strong but not yet exceptional (question 6), and cash flow is not fully accelerating (question 8). Revenue/EPS growth is likely above 20% but not yet 40% (question 9). Overall, the signal is very strong for a new public company, but not at the absolute highest level due to execution and regulatory risks.
LFS Q4 2025: Social Business Revenue Jumps 33% as Policy Reform Unlocks Expansion
LFS demonstrates a long growth runway, clear operating leverage, and a disruptive model, with policy-driven demand and strong competitive moats. However, while growth is robust, it does not consistently exceed 40% across all metrics, and global expansion is still in early stages, warranting a slightly lower score for exceptional forward growth.
ASX Q4 2025: LEAP Services Double to $3.2B, Driving Margin Upside and Capacity Race
ASX demonstrates a long reinvestment runway with high returns, significant recent growth in LEAP services, and improving unit economics. The business model has self-reinforcing aspects and customers are becoming more valuable, but the future, while strong, is not yet exceptional in terms of acceleration. The business is semi-disruptive and cash flow is accelerating. Growth is robust but not consistently above 40%, and the company is clearly a growth business rather than legacy or merely transitioning.
SailPoint (SAIL) Q1 2027: Agentic Pipeline Doubles, AI Identity Drives 20% of Net New ARR
SailPoint demonstrates a long reinvestment runway with high returns, disruptive business model, and clear evidence of accelerating adoption of agentic (AI/non-human) identity governance. Growth rates and backlog are strong, though not all metrics are at the most extreme levels. The business is in transition to a high-growth model, but some financial metrics (cash flow, guidance) remain conservative, keeping the overall signal just below the maximum.
MediaAlpha (MAX) Q2 2026: Open Marketplace Revenue Surges 26% as Carrier Spend Broadens
MediaAlpha demonstrates a long reinvestment runway, disruptive business model, and improving unit economics. The business is clearly in a secular growth phase, with expanding carrier participation and AI-driven differentiation. While growth is strong, it is not accelerating at 40%+ rates, and cash flow is increasing but not yet at an exceptional pace. The outlook is for continued high growth, but not at the most extreme levels.
Navitas (NVTS) Q2 2026: High-Power Revenue Surges 50% as AI Infrastructure Mix Hits Inflection
Navitas is executing a significant business model transformation with strong evidence of a long reinvestment runway, disruptive business model, and customer value deepening. Growth is robust but not yet at extraordinary (40%+) levels, and cash flow is improving but not yet accelerating. The business is positioned as a high-growth, high-potential story but not yet at the absolute upper echelon of signal.
Antarex (ATEX) Q3 2026: OPEX Down 20% as Utility Wireless Platform Accelerates Recurring Revenue Shift
Antarex demonstrates a long reinvestment runway, major commercial and regulatory inflections, improving unit economics, and a clear shift to a high-value recurring revenue model. While growth is strong, it is not yet at the exceptional acceleration threshold for all metrics. The business is clearly transitioning to a high-growth, disruptive model with good but not explosive near-term cash flow acceleration.
Trade Desk (TTD) Q1 2026: JVP Deals Up 55% as Open Internet and AI Drive Next-Phase Platform Leverage
Trade Desk demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and deepening customer value. While growth is strong and there are significant business model advantages, recent guidance and outlook suggest growth is robust but not at hyper-acceleration levels (>40%). Cash flow is strong but not rapidly accelerating. The article signals high strategic value and upside, but the business is already well-followed, tempering the ultimate signal score.
DraftKings (DKNG) Q4 2025: Sportsbook Revenue Jumps 64% as Predictions Pivot Gains Steam
DraftKings demonstrates a long reinvestment runway, significant recent developments (predictions vertical), improving unit economics, a self-reinforcing business model, and increasing customer value. Guidance is conservative but not exceptional; the business model is semi-disruptive, and cash flow is accelerating. Revenue growth is strong but not above 40%, and the company is firmly in the growth category.
Stoke Therapeutics (STOK) Q1 2026: EMPEROR Phase 3 Nears 150-Patient Enrollment, Four-Year OLE Data Deepens Label Leverage
Stoke Therapeutics demonstrates a long reinvestment runway with a disruptive, disease-modifying therapy and a clear path to commercialization. The business model is high-potential with strong data momentum, but revenue/earnings acceleration is still pre-commercial and not yet at the 40%+ growth threshold. The pipeline and platform offer future optionality, but the current growth signal is somewhat capped by regulatory and launch timing risk.
InVivid (IVVD) Q4 2025: Pemgarda Revenue Climbs 31% QoQ, Pivotal VYD2311 Data in Sight
InVivid shows a long reinvestment runway, disruptive model, and improving unit economics with strong commercial uptake. Backlog and revenue growth are robust but not yet explosive (>40%); future growth is promising but not guaranteed. The business is transitioning to a platform with strong but not exceptional forward guidance.
Waystar (WAY) Q2 2026: 40% of Bookings AI-Driven as Platform Consolidation Accelerates
Waystar demonstrates a long reinvestment runway, strong recurring revenue growth, improving unit economics, and high customer retention. AI monetization is now embedded and driving bookings, but while growth is strong (18% YoY, 10% normalized organic), it does not cross the 20%+ threshold for some signal questions. The business is not fully disruptive but is showing semi-disruptive traits, and future guidance is positive but not exceptional. The signal is high but not at the absolute maximum.
Spotify (SPOT) Q4 2025: Gross Margin Expands 80bps as AI Drives User Engagement
Spotify demonstrates a long reinvestment runway, significant recent growth in user engagement and margins, improving unit economics, and a self-reinforcing business model with increasing customer value. While the growth and cash flow trajectory is strong, the ad business remains a watchpoint and some elements (like disruptive potential and future acceleration) are notable but not fully exceptional. Revenue and EPS growth are solid but not at hypergrowth levels.
ICE (ICE) Q2 2026: Market Access $5.7B Deal Expands Fixed Income Network and Recurring Revenue Base
ICE demonstrates a long reinvestment runway, improving unit economics, and a self-reinforcing business model with deepening customer value. The Market Access acquisition is a significant development, but the business is large and mature, limiting runaway growth. AI and data monetization are disruptive, and cash flow is accelerating. The business is a clear growth compounder but not in hypergrowth mode.
Lumexa Imaging (LMRI) Q4 2025: 40% Throughput Gain From AI Drives Advanced Imaging Margin Expansion
Lumexa demonstrates a long reinvestment runway, disruptive technology integration, and improving unit economics. AI adoption and advanced imaging mix are driving margin expansion, and the JV model supports scalable growth. While growth is robust, the forward guidance is solid but not exceptional, and the business, while strong, is not in a hypergrowth phase. The signal is high, but some elements (like revenue growth rate) are under the highest threshold.
Real Brokerage (REAX) Q3 2025: Agent Base Surges 39% as Automation Drives 13% Cost Efficiency Gain
Real Brokerage demonstrates a long reinvestment runway with high returns, disruptive business model, and strong network effects. Agent and transaction growth are rapid, automation is improving economics, and ancillary attach rates are rising. However, while growth is strong, margin headwinds and lack of formal guidance temper the outlook, and the business is not yet at the very highest level of acceleration (e.g., >40% revenue/EPS growth or truly exceptional future guidance).
Solana Company (HSDT) Q4 2025: Staking Yield Outperforms by 60bps, Driving 14% SOL Per Share Accretion
Solana Company demonstrates a long reinvestment runway, clear yield outperformance, improving unit economics, and a disruptive, multi-pronged business model. Customer value is rising, and the business is positioned for growth, but near-term growth rates and cash flow acceleration are not clearly at the highest tier yet. Forward guidance is qualitative, limiting the score on future exceptionalism and acceleration.
Solana Company (HSDT) Q4 2025: Staking Yield Outperforms by 60bps, Driving 14% SOL Per Share Accretion
The business demonstrates a long reinvestment runway with high ROIC potential, disruptive model, and clear yield outperformance. There is evidence of strong capital allocation, improving economics, and strategic expansion. However, the forward outlook and guidance are still qualitative and not yet showing >30% acceleration, and cash flow acceleration is moderate rather than exceptional. The signal is strong, but not at the absolute highest tier due to these forward-looking uncertainties.
DexCom (DXCM) Q2 2026: Gross Margin Jumps 400bps as 15-Day G7 Rollout Accelerates
DexCom demonstrates a long reinvestment runway, clear margin expansion, and strong recurring revenue growth. There are significant developments with the G7 15-day rollout and coverage expansion. Unit economics and operating leverage are improving. The business model is self-reinforcing with growing customer value and cash flow. While not a new disruptor, the company is still a high-growth leader in its category, though growth rates are not hyper-growth (>40%) and some optionality is already priced in.
Howmet Aerospace (HWM) Q4 2025: Gas Turbine Revenue Surges 32% as Spares Penetration Hits New High
Howmet demonstrates a long reinvestment runway with high returns, a disruptive and self-reinforcing business model, and clear growth in spares and gas turbines. The company is not yet accelerating at an exceptional (30%+) rate across the board, and while growth is strong, it is not uniformly above 40%. Some risks remain in execution and integration, but the business is clearly transitioning into a growth phase with substantial upside.
Hyperfine (HYPR) Q1 2026: Gross Margin Expands 940bps as Next-Gen Subsystem Drives Adoption
Hyperfine demonstrates a long reinvestment runway, disruptive business model, and clear margin expansion. There is strong evidence of multi-vertical growth, improving unit economics, and self-reinforcing differentiation (helium-free MRI). Growth is robust but not yet at a consistent >40% level, and cash flow is improving but not yet accelerating. The business is transitioning into a growth phase with high optionality, but some elements (e.g., future backlog, cash flow) are not yet at the highest signal tier.
Xenon Pharmaceuticals (XENE) Q1 2026: $748M Raise Extends Runway, AZK Launch Momentum Accelerates
Xenon has a long reinvestment runway, transformative clinical data, and disruptive potential in CNS. However, while growth is strong, the immediate acceleration is not yet at the 40%+ level, and cash flow is not yet accelerating—hence, conservative scoring on those axes. Still, the signal is very high given the inflection and pipeline optionality.
Bitdeer (BTDR) Q4 2025: Self-Mining Hashrate Surges 306% as AI Data Center Pivot Gains Steam
Bitdeer demonstrates a compelling long-term reinvestment runway, disruptive business model, and clear compounding advantages via vertical integration and proprietary hardware. Recent growth is exceptional (306% YoY in self-mining), but margin compression and the gating of AI revenue to contract timing temper near-term acceleration. The business is transitioning to a dual-engine model with strong optionality, but execution on AI contracts and margin recovery remain key watchpoints.
JFrog (FROG) Q1 2026: Cloud Revenue Surges 50% as Binary Tsunami Drives Platform Expansion
JFrog demonstrates a long reinvestment runway, disruptive model, and strong growth in cloud and enterprise segments. The business is not growing revenue/EPS over 20% annually (guidance at 18.5%), so signal is capped there. The model is self-reinforcing and customer value is deepening, but overage-to-commitment conversion and competitive risk temper the signal slightly. Still, this is a high-signal, thesis-relevant business in the context of AI/DevSecOps.
Privia Health (PRVA) Q1 2026: Attributed Lives Jump 26%, Margin Expansion Signals Durable Platform Leverage
Privia Health demonstrates a long reinvestment runway, clear margin expansion, and strong compounding cash flows. The business model is self-reinforcing with improving unit economics and customer value. While growth is robust and margin expansion compelling, the business is not in hyper-growth territory (>40%), and while disruptive, it is not a new or unique business model in the current healthcare landscape. The outlook is strong, but not exceptional enough for a perfect signal score.
Coherus Oncology (CHRS) Q1 2026: Lactorsi New Patient Starts Jump 21% as Pipeline Readouts Approach
Coherus Oncology demonstrates a long reinvestment runway with high returns, significant recent commercial growth, and improving unit economics. The business model is self-reinforcing with network effects via pipeline/commercial synergies. Customers (accounts) are becoming more valuable, but while future growth is strong and guidance is positive, it falls short of 'exceptional' acceleration. The business is disruptive within immuno-oncology and is transitioning toward a cash flow machine, but not yet at full acceleration. Revenue and EPS growth is solid but not at the highest tier. Overall, the company is a growth business with high strategic signal, but not at the absolute maximum.
Vericel (VCEL) Q1 2026: Burn Care Jumps 90%, Macy Sales Force Drives Sustained Growth
Vericel presents a strong growth profile with a multi-year reinvestment runway, recent step-change in Burn Care, improving margins, and self-reinforcing sales force dynamics. While not all growth rates are above the highest threshold, the business model is semi-disruptive and cash flow is accelerating. Risks around guidance conservatism and sector competition temper the signal, but the setup is well above average for a specialty therapeutics company.
PWR Q2 2026: Backlog Surges to $53.3B as Utility and Tech Demand Compounds
PWR demonstrates a long reinvestment runway, record backlog, and improving unit economics with clear compounding advantages. While growth is strong, it is not consistently above 40% and the business model, while robust, is not fully disruptive. The signal is high but not at the absolute maximum due to these factors.
Selectar Biosciences (CLRB) Q1 2026: $140M Financing Unlocks Phase III WM Launch and Accelerated Approval Path
Selectar demonstrates a long reinvestment runway, recent inflection via clinical data and financing, improving unit economics, and a disruptive model in radiopharmaceuticals. Some uncertainty remains on immediate customer value expansion and cash flow acceleration, but overall signal is very high for a late-stage biotech at this juncture.
Quantum Computing Inc. (QUBT) Q4 2025: $1.55B Capital Raise Fuels Photonics Expansion and LSI Integration
QCI demonstrates a long reinvestment runway, disruptive business model, and clear inflection toward commercial scale. There is a transformative capital raise and M&A, improving unit economics, and a shift to platform revenue. However, while growth is strong, it is not yet exceptional or proven at >40%. Cash flow is not yet accelerating, and guidance is still somewhat conservative. The business is in transition but positioned as a future growth leader.
AMBIC (AMBQ) Q3 2025: Apollo 5 Drives Mix Shift as Edge AI Orders Propel Guidance Above $18M
AMBIC has a long reinvestment runway, strong product mix shift, and evidence of improving unit economics and customer value. The business model is disruptive, with a clear transition to higher-margin Edge AI and IP licensing. While growth guidance is strong, it is not at the exceptional acceleration threshold for some categories. Cash flow is improving but not yet accelerating, and revenue growth, while robust, is not above 40%.
Red Violet (RDVT) Q3 2025: Public Sector Pipeline Expands as EBITDA Margin Hits 39%
Red Violet demonstrates a long reinvestment runway, clear operational leverage, and compounding business model with high retention and margin. While growth is strong, it is not yet at the highest acceleration tier for some questions (e.g., guidance is strong but not over 30% acceleration, and the model is semi-disruptive rather than fully disruptive). The business is a clear growth compounder with high investor relevance.
Blend Labs (BLND) Q1 2026: Autopilot AI Pipeline Hits $10M, Unlocking 10%+ Growth Trajectory
Blend Labs demonstrates a long reinvestment runway, disruptive AI-driven business model, improving unit economics, and self-reinforcing platform effects. The rapid $10M Autopilot pipeline and high customer adoption signal a business evolution, though near-term revenue/EPS growth is likely under 20% due to macro headwinds. Backlog/guidance is strong but not exceptional yet. The business is clearly in growth mode, but cash flow acceleration and future guidance remain somewhat constrained by mortgage cyclicality.
SUI Group (SUIG) Q4 2025: Digital Asset Revenue Jumps 179% as Treasury Activation Accelerates
SUI Group demonstrates a long reinvestment runway with high returns on capital via digital asset strategies, and the business model is disruptive with ecosystem integration. Revenue growth is strong (179%), but not all metrics point to sustained 40%+ growth or exceptional future guidance. Cash flow is improving but not yet accelerating. The business is clearly in growth mode, but some elements (e.g., guidance, cash flow) are not at the highest signal tier.
Hyperion DeFi (HYPD) Q4 2025: Adjusted Gross Profit Surges 87% as DeFi Monetization Scales
HYPD demonstrates a long reinvestment runway with a disruptive DeFi operating model, clear optionality, and rapidly scaling recurring revenues. There is a significant recent inflection in business performance, with strong improvements in unit economics and customer value. The business model is self-reinforcing, and the company is positioned for continued growth and ecosystem expansion. Some uncertainty remains regarding the durability and scalability of new revenue streams, as well as regulatory risk, which tempers the score slightly.
Butterfly Network (BFLY) Q4 2025: Embedded Revenue Jumps 76% on Midjourney AI Deal, Platform Ambitions Sharpen
Butterfly Network shows a long runway with disruptive platform economics, clear improvements in unit economics, and a meaningful business model transition validated by a major AI partnership. While guidance is for strong growth, it is not yet at the exceptional acceleration threshold, and cash flow is only beginning to turn positive. Signal is high but not at the absolute maximum due to some execution risk and the business not being entirely unique in the medtech space.
ServiceTitan (TTAN) Q1 2026: Subscription Revenue Jumps 29% as Enterprise, Pro Products, and Commercial Drive Expansion
ServiceTitan demonstrates a long reinvestment runway, disruptive model, and strong enterprise/commercial momentum. Subscription and usage growth are robust, margins are expanding, and AI adoption is deepening customer value. While growth is strong (not hypergrowth), and FCF is not yet positive, the overall signal is high for durable expansion and margin improvement.
Five9 (FIVN) Q1 2026: AI Revenue Jumps 68%, Expanding Platform Monetization
Five9 demonstrates a long reinvestment runway, disruptive AI-driven business model, compounding economics, and strong customer value expansion. Recent AI revenue growth is significant but not yet explosive enough for top marks on all future/guidance questions. Cash flow is improving but not yet accelerating at the highest level. Overall, the signal is strong and thesis-relevant for investors.
Alkermes (ALKS) Q2 2026: Proprietary Product Sales Jump 34% as Orexin Pipeline Expands
Alkermes demonstrates a long reinvestment runway, clear business model evolution, and improving unit economics. The orexin platform is disruptive with multi-indication potential, and the business is transitioning to growth. However, not all future guidance is exceptional, and cash flow acceleration is moderate. Revenue growth is strong but not consistently above 40%, warranting a conservative approach.
Ascendis Pharma (ASND) Q4 2025: Yorvipath Drives 39% Revenue Growth as Global Launch Scales
Ascendis demonstrates a long reinvestment runway, strong recent growth (39%), improving unit economics, and a self-reinforcing business model with increasing customer value. Guidance and backlog are strong but not yet at an 'exceptional' acceleration. The business model is innovative but not disruptive at platform scale, and growth rates are robust but not consistently above 40%. It is a clear growth business with accelerating cash flow.
BridgeBio Pharma (BBIO) Q1 2026: Atruvi Sales Surge 392%, Buyback Launch Signals Undervalued Pipeline
The business demonstrates a long reinvestment runway, disruptive model, improving unit economics, and durable customer value. There are significant growth drivers (Atruvi surge, pipeline launches) and self-reinforcing dynamics. However, near-term growth is strong but not clearly above 40% for all metrics, and cash flow acceleration is not yet proven, warranting a conservative approach on those questions.
MindWalk (HYFT) Q2 2025: Gross Margin Expands to 65% as Bio-Native AI Platform Drives Strategic Shift
MindWalk demonstrates a long reinvestment runway with high returns, disruptive business model, and clear margin and revenue growth. Backlog/guidance is solid but not yet exceptional, and while cash flow is improving, it is not yet accelerating. Overall, the signal is strong but not perfect due to the early stage of SaaS ramp and asset monetization.
Airbnb (ABNB) Q1 2026: Reserve Now Pay Later Drives 19% GBV Surge, Expands Platform Reach
Airbnb demonstrates a long reinvestment runway, strong product innovation, and improving unit economics. RNPL and AI are driving growth and operational leverage, and international expansion is compounding. However, while growth is robust, it is not at hypergrowth levels (over 40%), and the business model, while disruptive, is not entirely novel at this stage. The signal is strong but not at the absolute maximum due to the company's already established scale and some maturing dynamics.
Butterfly Network (BFLY) Q1 2026: Embedded Revenue Jumps 147% as Platform Leverage Emerges
Butterfly Network demonstrates a long reinvestment runway, disruptive business model, and clear improvement in unit economics and customer value. Embedded and AI-driven revenues are inflecting, but overall top-line growth remains just above 20% and not yet at hypergrowth levels. Cash flow is improving but not yet strongly accelerating. The business is transitioning into a multi-engine growth platform, but some elements are still emerging rather than fully established.
BKV (BKV) Q3 2025: Power Ownership Rises to 75%, Unlocking Strategic Flexibility in ERCOT
BKV demonstrates a long reinvestment runway, disruptive integration of gas, power, and CCUS, and improving unit economics. There is clear business evolution with the majority power JV acquisition and CCUS project momentum. While some growth rates are strong, not all segments are accelerating at >30% or >40% annually, and cash flow is improving but not yet rapidly accelerating. The model is self-reinforcing and growth-oriented, with moderate but not exceptional near-term guidance.
374 Water (SCWO) Q3 2025: Revenue Set to Climb 100% as Waste Destruction Services Scale
The business demonstrates a clear reinvestment runway, disruptive model shift, and strong early commercial traction with high growth guidance. While not all financials are at the 'exceptional' level yet (e.g., cash flow is not yet accelerating, and guidance is for 50-100% growth rather than >40% QoQ), the business is transitioning to a recurring, high-margin services model in a large, regulatory-driven market. Risks remain around capital intensity and scale, but the signal for investors is strong and thesis-relevant.
Coherence Oncology (CHRS) Q3 2025: Lactorsi Demand Up 92% YoY, Pipeline Data Readouts Set for 2026
CHRS is a growth-stage oncology innovator with a long reinvestment runway, disruptive pipeline, and sharply rising Lactorsi demand. The business shows improving unit economics, self-reinforcing model, and deepening customer value. Guidance is for strong growth but not yet exceptional/accelerating, as major inflection depends on 2026 data. Cash flow is improving but not yet a 'machine.' Overall, signal is high but not at the absolute maximum due to pipeline risk and the need for clinical proof.
Inflection (INFQ) Q1 2026: Quantum Revenue Up 14% as Neutral Atom Platform Accelerates Multi-Segment Momentum
Inflection demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong technical/commercial momentum. However, some metrics (cash flow, near-term growth rate, and guidance) are not yet exceptional, with commercial adoption still ramping. The business is clearly growth-oriented, but not all signal elements are at maximum strength.
Regeneron (REGN) Q4 2025: Dupixent Profit Share Jumps 42% as Pipeline Readies 18 New Phase III Trials
Regeneron displays a long reinvestment runway, significant pipeline acceleration, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is cash generative. However, while growth is strong, it is not at the extreme acceleration level for all segments, and the model is not fully disruptive given legacy exposures and payer/regulatory risks.
MercadoLibre (MELI) Q1 2026: 49% Commerce Growth Outpaces Margin Pressure as Investments Accelerate
MercadoLibre demonstrates a long reinvestment runway, disruptive model, and strong compounding unit economics, with clear growth and competitive advantages. While margin and asset quality risks are rising, the topline and engagement metrics indicate continued leadership. Not all metrics are at the highest possible growth acceleration, but the business remains highly interesting for investors.
Bullish (BLSH) Q1 2026: Tokenization Deal Unlocks $4.2B Platform, Sets Stage for 6–8% Growth
Bullish demonstrates a long reinvestment runway, clear business model evolution, improving unit economics, and self-reinforcing platform dynamics. Customer value is deepening, and the Equinity deal is a major inflection point. Guidance is for strong but not hyperbolic growth; future cash flow is improving but not yet accelerating. The business is disruptive and positioned for durable, above-average growth, but near-term growth rates are not in the hypergrowth (>40%) category.
Red Violet (RDVT) Q4 2025: $100K+ Customer Cohort Jumps 32%, Expanding Platform Depth
Red Violet demonstrates a long reinvestment runway, strong cohort expansion, improving unit economics, and a self-reinforcing usage-based model with compounding AI/automation benefits. While growth is robust and the business is transitioning to a scaled, high-margin platform, the absence of clear 40%+ growth and some vertical headwinds temper the score slightly. Still, the business is highly interesting and likely to provide upside if execution continues.
KLA (KLAC) Q4 2026: Advanced Packaging Revenue Surges 70%, Accelerating AI-Driven Process Control Demand
KLA demonstrates a strong reinvestment runway, disruptive positioning, and accelerating growth in high-value segments. While growth is robust, it does not exceed 40% overall, and the business is not entirely unique or underfollowed, which tempers the signal score. However, the business model, backlog, and margin structure all point to compelling investor signal.
Pelthos Therapeutics (PTHS) Q4 2025: Zelsubmi Prescriptions Jump 129%, Expanding At-Home Pediatric Market
Pelthos shows strong signal: rapid prescription growth (129%), expanding payer access, improving unit economics, and a multi-product platform with disruptive at-home treatments. While growth is strong, guidance lacks explicit >30% acceleration, and cash flow is not yet accelerating. Still, the business is clearly transitioning to a high-growth, high-ROIC model with compounding characteristics and disruptive potential in pediatric dermatology.
MindWalk (HYFT) Q1 2026: 45% Revenue Growth Signals Platform Shift After $15M Divestiture
MindWalk demonstrates a strong runway, disruptive platform, and significant margin/revenue mix shift. There is evidence of improving unit economics, customer value, and a strategic inflection post-divestiture. However, while growth is strong, guidance does not indicate >40% acceleration, and cash flow is not yet fully accelerating.
Gemini (GEMI) Q3 2025: Card-Led User Growth Surges 55%, Super App Vision Gains Traction
Gemini demonstrates a long reinvestment runway, disruptive business model, and a major inflection in user/revenue growth. Card-led acquisition is driving deepening engagement and recurring revenue, with strong evidence of improving unit economics and customer value. The business is not yet at the point of exceptional (40%+) growth guidance for the future, and cash flow acceleration is only moderate, not explosive. Still, the strategic and financial signal is very high and relevant for investors seeking upside from a newly public, high-growth fintech/crypto platform.
PSQH Q1 2026: Revenue per Employee Jumps 287% as FinTech Pivot Drives Operating Leverage
PSQH demonstrates a long reinvestment runway, significant operating leverage, and improving unit economics with a disruptive, capital-light FinTech model. Merchant value is increasing, and the business is transitioning to high-growth segments. However, while growth is strong, it does not clearly exceed 40% on a consolidated basis, and cash flow is improving but not yet accelerating. The business is not yet at the very highest tier of signal but is close.
Arteris (AIP) Q4 2025: RPO Climbs 32% as Security Acquisition Expands TAM
Arteris demonstrates strong reinvestment runway, disruptive business model, and clear compounding advantages from AI and security expansion. Recent backlog and RPO growth are high, but future growth guidance is strong rather than exceptional. Cash flow is improving but not yet accelerating, and while growth is robust, it's not consistently over 40%.
Patterson-UTI (PTEN) Q2 2026: High-Spec Rig Upgrades Drive 10% Sequential Revenue Jump, Margin Tailwind Extends Into 2027
PTEN demonstrates a long reinvestment runway, improving unit economics, self-reinforcing business model, and increasing customer value. Recent developments are significant, with margin and revenue inflection from fleet upgrades and contract wins. However, the company is not a hypergrowth disruptor (score capped for question 7), and while growth is strong, it is not consistently over 40% (questions 6 and 9). The business is transitioning to higher-return segments but is not a new, under-the-radar compounder.
Evaxion (EVAX) Q1 2026: 86% Immunogenicity Rate in EVX01 Underscores AI Vaccine Platform Scalability
Evaxion's AI immunology platform demonstrates a long reinvestment runway and disruptive potential, with high immunogenicity data and pipeline breadth. However, the business remains pre-revenue, and while growth and optionality are strong, cash flow is not yet accelerating and forward growth rates, while promising, are not yet proven at >40% annually.
Vicor (VICR) Q2 2026: Backlog Jumps 26% as Advanced Power Demand Outpaces Capacity
Vicor demonstrates a long reinvestment runway, disruptive business model, and strong backlog momentum. Advanced product growth, licensing leverage, and manufacturing constraints create a compelling inflection. However, some uncertainty remains around the durability of licensing renewals and the speed of capacity expansion, slightly tempering the signal score.
AVAV Q4 2026: Counter-UAS Revenue Doubles, Underpinning $2.7B Backlog Surge
AVAV demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong backlog growth. However, growth guidance is solid but not exceptional (>10% but not >40%), and cash flow is not yet accelerating, which tempers the signal score. The business is clearly a growth story with strategic upside, but some metrics are not at the highest inflection.
Recursion (RXRX) Q1 2026: 35% Operating Cost Cut Extends Runway to 2028, Platform Speed Surges
Recursion demonstrates a long reinvestment runway, disruptive AI-enabled platform, improving unit economics, and a growth business profile. There is tangible acceleration in milestone inflows and cost control, but clinical proof is still early and guidance, while positive, is not yet exceptional. Revenue and EPS growth is promising but not yet at the highest tier.
Aurora (AUR) Q1 2026: 200 Driverless Trucks Targeted, Hardware Costs Set to Drop 50%
Aurora demonstrates a long reinvestment runway, major business evolution with scaling, improving unit economics, a self-reinforcing model, and deepening customer value. Guidance is strong but not yet exceptional, and while the business model is disruptive, cash flow and growth rates are not yet at their highest levels. The company is firmly in a growth phase with clear upside, but some execution risks remain.
Calix (CALX) Q2 2026: Software and Services Margin Jumps 810bps as AI-Native Platform Drives Adoption
Calix demonstrates a long reinvestment runway, disruptive business model, and self-reinforcing platform dynamics. There is strong evidence of margin expansion, recurring revenue growth, and customer value deepening. The major acceleration in software margin and RPO is significant, though not quite at the 'exceptional' level for future growth. Cash flow is positive and improving, but not yet dramatically accelerating. The business is clearly in a growth phase, though hardware headwinds temper the overall upside.
Allogene (ALLO) Q1 2026: $200M Capital Raise Extends Runway, Alpha-3 MRD Clearance Hits 58%
Allogene demonstrates a long reinvestment runway, disruptive business model, and improving unit economics with clear clinical and operational momentum. While growth is strong, it is not yet at the exceptional acceleration threshold for the highest scores in every category. The business is transitioning toward high growth, with significant optionality and platform leverage, but not all metrics (cash flow, growth rate) are at maximum inflection.
TerraWolf (WULF) Q1 2026: HPC Lease Revenue Surges 117% as Power-Backed Strategy Takes Hold
TerraWolf demonstrates a long reinvestment runway and disruptive, self-reinforcing business model, with clear evidence of rapid revenue mix shift and improving unit economics. The growth is substantial but not yet at a sustained 40%+ pace, and while cash flow is improving, it is not yet fully accelerating. The business is now a growth story, but some execution and regulatory risks temper the signal.
Oscar Health (OSCR) Q1 2026: Membership Jumps 56% as Tech-Driven Model Fuels Margin Expansion
Oscar Health exhibits a disruptive, tech-driven model with clear reinvestment runway and scalable unit economics. Membership and revenue are growing rapidly, but while margin and cash flow are improving, not all metrics are at hypergrowth levels. Platform initiatives are promising but early-stage, so not all future signals are maxed out.
LIDR Q1 2026: 40% Pipeline Surge Signals Broadening Physical AI Adoption
LIDR demonstrates a long reinvestment runway, disruptive model, improving unit economics, and compounding self-reinforcement. The pipeline surge and cross-vertical adoption are highly positive signals. However, while growth is strong, it is not yet at the 'exceptional' (30%+ acceleration) level for future guidance, and cash flow is not yet accelerating, so a conservative approach slightly lowers the score.
QuantumScape (QS) Q1 2026: Ecosystem Billings Hit $11M as Eagle Line Ramps Toward Multi-Market Scale
QuantumScape demonstrates a long reinvestment runway and disruptive business model with strong ecosystem validation, early monetization, and multi-market expansion. The business model is self-reinforcing and customer value is deepening. However, future growth is promising but not yet at a clearly exceptional (30%+) acceleration, and the cash flow inflection is early-stage. Revenue growth is likely above 20% but not yet at breakout levels. Overall, the signal is high but not at maximum due to commercial execution risk and the early stage of recurring revenue.
MNTN Q1 2026: Gross Margin Surges 1,220bps as AI-Powered Creative Fuels SMB Penetration
MNTN demonstrates a long reinvestment runway, disruptive business model, and strong customer/revenue growth with improving margins and operating leverage. However, growth is not above 40% and cash flow, while improving, is not yet accelerating at the highest level. The business is clearly in a high-growth phase but not at the most extreme end of the spectrum.
Kronos (CRON) Q1 2026: International Revenue Jumps 97% as European Expansion Accelerates
Kronos demonstrates a long reinvestment runway and disruptive business model with strong international growth and operational leverage. While growth rates and backlog acceleration are significant, the business is not yet at an exceptional inflection, and some optionality remains unproven. Cash flow and margin expansion are strong, but the business is not yet growing at a >40% annualized rate.
Neurocrine Biosciences (NBIX) Q1 2026: Ingreza Drives 44% Growth as Chronicity Annualizes Above $600M
Neurocrine demonstrates a long reinvestment runway, significant recent growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, and the business is a clear growth story with accelerating cash flow. However, while guidance is strong, it is not exceptional enough for the highest score, and the business model, while attractive, is not fully disruptive. Revenue growth is above 20% but not consistently over 40%.
Sharplink (SBET) Q1 2026: ETH Holdings Climb to 872K as On-Chain Yield Strategy Scales
Sharplink demonstrates a long reinvestment runway, disruptive business model, and improving unit economics, with significant ETH holdings and yield strategy scaling. However, while growth is strong and the model is self-reinforcing, cash flow acceleration and near-term growth rates are not at the extreme upper end, and guidance is solid but not exceptional. The business is clearly in a high-growth phase with strong strategic optionality.
Flywire (FLYW) Q1 2026: Revenue Surges 43% as Platform Scale and Global Expansion Accelerate
Flywire demonstrates a long reinvestment runway, compounding platform effects, and disruptive business model, with strong international expansion and workflow integration. While growth is robust and margins are expanding, the forward outlook signals some deceleration and normalization, justifying a slightly lower score on future acceleration. Still, the business is clearly in the growth phase with investor-relevant upside.
Surf Air Mobility (SRFM) Q1 2026: Charter Revenue Jumps 77% as SurfOS Drives Margin Expansion
The business shows a long reinvestment runway, disruptive platform potential, strong network effects, and improving unit economics. Charter revenue growth is robust (77%), but not all segments are growing at 40%+, so some scores are reduced. Cash flow is improving but not yet accelerating, and while guidance is raised, the outlook is not yet exceptional. The business is clearly in a growth and inflection phase, but not all signals are maxed.
Cytokinetics (CYTK) Q1 2026: myCORSO Launch Drives $4.8M Debut as HCM Pipeline Expands
Cytokinetics demonstrates a long reinvestment runway with high optionality in muscle biology, a disruptive commercial inflection, and clear early growth. Pipeline expansion and clinical wins are material, but future guidance is not yet at 'exceptional' levels and cash flow is not yet accelerating. Revenue growth is strong but not yet at the highest threshold. The business is now a clear growth story transitioning from R&D to commercial, with substantial upside if execution continues.
Grail (GRAL) Q1 2026: Gallery Test Volume Jumps 50% as Health System Integrations Accelerate
Grail demonstrates a strong growth trajectory, disruptive business model, and improving unit economics. There is clear evidence of a long reinvestment runway and business model compounding with scale. However, some uncertainty remains around regulatory catalysts and cash flow acceleration, and revenue/EPS growth is in the 20-32% range, justifying a slightly lower score for those dimensions.
Archer Aviation (ACHR) Q1 2026: Phase 3 Certification Achieved, Setting Up Multi-Billion Dollar Defense and Civil Flywheel
Archer displays many hallmarks of a high-signal, inflecting business: regulatory leadership, dual-use platform, and early revenue signals. While growth is not yet exceptional (guidance is for increased spend, not explosive revenue), the business model is disruptive and the reinvestment runway is long. Risks remain, but the potential for rapid scale and dual-market flywheel is clear.
Halozyme (HALO) Q1 2026: Royalty Revenue Up 43% as Enhanced Pipeline Sets Up 13 New Launches
Halozyme demonstrates a long reinvestment runway with high returns, strong recent developments (notably a 43% royalty revenue jump and a robust launch pipeline), and improving economics as scale increases. The business model is self-reinforcing with durable contracts and customer value deepening over time. While guidance and backlog visibility are strong, the future growth rate is solid but not at the highest acceleration tier (some pipeline risk remains). The model is disruptive in drug delivery, and cash flow is accelerating. However, growth is more in the 20-40% range than above 40%, and the business is transitioning to its next phase rather than being an early-stage hypergrowth story.
Hims & Hers (HIMS) Q1 2026: Branded Weight Loss Adds 100K+ Monthly Subscribers, Reshapes Platform Growth
Hims & Hers is executing a disruptive, high-growth platform strategy with a long reinvestment runway, strong network effects, and rapid subscriber growth. While guidance is strong, the business is not yet accelerating at an exceptional (>30%) rate, and cash flow is only moderately accelerating. The signal is high due to the scale of the branded GLP-1 pivot and global expansion, but not at the absolute maximum due to some execution and integration risk.
Cerebell (CBLL) Q1 2026: Account Base Expands by 33 as Pediatric, Delirium Launches Broaden TAM
Cerebell demonstrates a long reinvestment runway, disruptive platform expansion, and strong core growth with improving unit economics. Recent launches and record account growth signal meaningful business evolution, though some growth is still ramping (hence 1s for questions 6, 8, and 9). The business is not yet accelerating at the highest possible rates but is clearly a growth platform with expanding TAM and margin leverage.
NOVA Ltd (NVMI) Q4 2025: Advanced Packaging Revenue Jumps 60% as Share Gains Accelerate
NOVA demonstrates a long reinvestment runway with high returns, clear share gains, and advanced packaging growth. There are significant developments (60% advanced packaging growth), improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is transitioning to a cash flow machine. However, some questions (future exceptionalism, disruptive model, and top-line growth rate) are not at the absolute highest level, reflecting a strong but not extraordinary signal for massive upside.
Supermicro (SMCI) Q3 2026: Gross Margin Jumps 58% as DCPBS and Enterprise Mix Drive Profitable Shift
Supermicro demonstrates a long reinvestment runway, disruptive business model evolution, and improving unit economics. There is a record backlog and clear growth signals, but guidance is not for >30% acceleration and cash flow is pressured by working capital swings, so not all signals are top marks. Still, the business is clearly in growth mode with high investor relevance.
Rigetti Computing (RGTI) Q1 2026: 193% Revenue Jump Signals Chiplet Quantum Traction
Rigetti demonstrates a long reinvestment runway, disruptive chiplet-based scaling, and a strong inflection in revenue (193% YoY). Unit economics and customer value are improving, and the modular model is self-reinforcing. The business is transitioning from technical milestone to early commercial adoption, but future growth is not yet exceptional (>30%), cash flow is not yet accelerating, and revenue/EPS growth is just above 20% but under 40%.
Legend Biotech (LEGN) Q1 2026: CARVICTI Ex-U.S. Sales Jump 200% as Early-Line Adoption Accelerates
Legend demonstrates a long reinvestment runway, disruptive business model, and clear revenue/EPS growth potential. Early-line adoption, global expansion, and pipeline catalysts are all strong signals, though cash flow acceleration and near-term growth rates are solid but not yet exceptional. The business is clearly in a growth phase with self-reinforcing model elements and improving economics.
Warner Music Group (WMG) Q2 2026: Catalog Drives 24% OIBDA Surge as AI Monetization Looms
WMG demonstrates a long reinvestment runway with high returns, clear margin expansion, and a transition to AI-driven monetization. While growth is robust and the business is evolving, near-term revenue/EPS growth is high single-digit to double-digit, not above 20%, and AI monetization is not yet fully proven. The model is becoming more self-reinforcing, and the business is a clear leader in its vertical, but the signal is just short of the absolute highest score due to the lag in AI revenue inflection.
LLY Q4 2025: Incretin Portfolio Drives 91% Key Product Growth, Setting Stage for $80B+ 2026
LLY demonstrates a long reinvestment runway, strong unit economics, and a self-reinforcing business model. The business is transitioning into a platform leader with exceptional growth but not all signals (e.g., disruption, 40%+ growth) are maxed out for a mature large-cap. Pipeline and cash flow are strong, but the business is not fully disruptive or at hypergrowth levels.
TransDigm (TDG) Q2 2026: Backlog Surges as Bookings Outpace Shipments Across All Segments
TransDigm demonstrates a long reinvestment runway, consistently high returns on capital, and double-digit growth across all segments. Backlog and bookings are surging, unit economics are strong, and the business model is self-reinforcing with high aftermarket exposure. Cash flow is accelerating, and the company remains a growth business. However, while growth is robust, it is not at the hypergrowth or disruptive level (over 40%+ or exceptional guidance revision), and the business is well-followed with some maturity, so the signal score is conservatively capped below the maximum.
Howmet Aerospace (HWM) Q1 2026: Spares Revenue Climbs to 23% of Sales, Fueling Margin Expansion
Howmet demonstrates a long reinvestment runway, strong margin expansion, improving unit economics, and a self-reinforcing business model via spares and aftermarket leverage. Customer value is deepening, and the business is transitioning into a high-margin, recurring revenue model. However, growth is robust but not hyper-scaling (under 40% revenue/eps), and while the business is semi-disruptive, it is not a pure disruptor. Cash flow is accelerating, but guidance implies growth is strong rather than exceptional. The business is clearly in a growth phase, but not at the most extreme end of the signal spectrum.
EVEX Q1 2026: $500M Order Book Anchors Production, Embraer Synergies Sharpen Cost Edge
Eve Air Mobility demonstrates strong signal: a long reinvestment runway, disruptive business model, improving unit economics, and clear cost/operational synergies from Embraer. The $500M order book and staged payments are evidence of market validation and liquidity discipline. However, growth guidance is not yet exceptional, and cash flow acceleration is not fully proven, so scores are slightly capped. The business is early-stage but positioned for high growth and leverage, with material upside if execution and certification milestones are met.
On Holding (ONON) Q1 2026: Gross Margin Surges to 64.2% as Premium Strategy Scales Globally
ONON demonstrates a long reinvestment runway, premium pricing power, and improving unit economics. There is strong D2C and apparel growth, but not all signals point to hypergrowth (e.g., guidance is strong but not exceptional, and the business is not disruptive in the sense of a platform model). The business is clearly a growth story, but some elements (e.g., revenue growth under 40%) keep it from a perfect signal score.
Magnite (MGNI) Q1 2026: CTV Contribution Surges 30% as Platform Consolidation Accelerates
Magnite demonstrates a long reinvestment runway, strong CTV growth, improving unit economics, and margin expansion. The business model is increasingly self-reinforcing, customer value is rising, and the company is transitioning into a cash flow machine. However, while growth is robust, it is not yet at the highest acceleration threshold, and AI/commerce media disruption is emerging rather than fully mature.
IOVA Q1 2026: Ampagni Revenue Up 38% as TIL Platform Expands Clinical Reach
Iovance demonstrates a long reinvestment runway, rapid commercial growth, and improving unit economics. The business model is self-reinforcing, customer value is increasing, and the company is transitioning into new indications with a disruptive platform. While growth is strong, the acceleration is not yet exceptional across all metrics, and cash flow is improving but not yet accelerating. Overall, the signal is high for investors seeking platform-scale cell therapy exposure.
Veritone (VERI) Q1 2026: VDR Pipeline Surges 500%, Unlocking AI Data Monetization Leverage
Veritone demonstrates a long runway (AI data, public sector, platform expansion), a disruptive model, and a 500% pipeline surge, all pointing to strong optionality and future growth. Unit economics and customer value are improving, but some elements (cash flow, revenue/EPS growth) are not yet exceptional, and the guidance is strong but not explosive. The business is transitioning toward profitability with high strategic signal.
NIAX (NYAX) Q1 2026: Recurring Revenue Hits 74% as Installed Base Tops 1.5 Million Devices
NYAX demonstrates a long reinvestment runway with high ROIC, strong recurring revenue growth, and improving unit economics. The business model is disruptive and self-reinforcing, with clear ARPU and margin expansion. However, cash flow is not yet accelerating and guidance implies strong but not extraordinary growth, tempering the score modestly.
SOPH Q1 2026: Net Dollar Retention Climbs to 117% as Platform Expansion Drives Upsell Momentum
SOPH demonstrates a long reinvestment runway, high net dollar retention, improving unit economics, and clear network effects. The business model is disruptive with recurring revenue and global scale. While growth is strong, guidance is for 20-22% revenue growth, so not quite at the highest acceleration tier. Cash flow is improving but not yet accelerating. The business is firmly in growth mode, with some metrics (like biopharma acceleration) not yet at exceptional levels.
Satellogic (SATL) Q1 2026: Revenue Jumps 80% as Recurring Intelligence Subscriptions Take Hold
Satellogic demonstrates a long reinvestment runway, disruptive recurring model, and improving unit economics. There is strong evidence of business evolution (80% revenue growth, recurring shift, backlog visibility), but some signals (cash flow, growth rate) are not yet exceptional or sustained at the highest level. The business is not widely followed, so the signal is strong but not at the very top.
InVivid (IVVD) Q1 2026: Pemgarda Climbs 22% as Monoclonal Antibody Platform Expands Beyond COVID
InVivid demonstrates a long reinvestment runway with a disruptive, platform-based model and evidence of strong unit economics, customer value expansion, and self-reinforcing dynamics. There are significant recent developments (22% revenue growth, pipeline expansion), but guidance is not exceptional (>30% acceleration), and cash flow is not yet accelerating. The business is in a high-growth, transition-to-scale phase, but not all metrics reach the maximum signal threshold.
HubSpot (HUBS) Q1 2026: AI Credit Consumption Jumps 67% as Agentic Platform Monetization Accelerates
HubSpot demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong upmarket/AI momentum. However, growth is strong but not hyperbolic (under 40%), and some cash flow and guidance signals are good but not exceptional, keeping the score below maximum.
IceCure Medical (ICCM) Q1 2026: North America Sales Surge 84% as FDA Clearance Unlocks Adoption
ICCM demonstrates a strong reinvestment runway, disruptive business model, improving unit economics, and clear commercial inflection. While growth is rapid, it is not yet at the 40%+ level for all metrics, and cash flow acceleration is moderate rather than exceptional. The opportunity is significant, but some upside is contingent on execution and reimbursement milestones.
ThredUp (TDUP) Q1 2026: Active Buyers Surge 25%, Fueling Supply and AI-Driven Marketplace Expansion
ThredUp demonstrates a long reinvestment runway and high ROIC potential, with double-digit buyer and seller growth and a disruptive, self-reinforcing marketplace model. Unit economics are improving, and customer value is deepening. The business is not quite showing exceptional acceleration (over 30% growth) in all metrics, and cash flow is only moderately accelerating, which tempers the signal score. Still, the business is clearly in growth mode with strong optionality and competitive moats.
NextPower (NXT) Q4 2026: Non-Tracker Revenue Set to Jump 40% as Platform Expansion Accelerates
NXT demonstrates a long reinvestment runway, platform expansion, and disruption in the solar market, with strong backlog and growth in high-value non-tracker segments. However, while growth is robust, near-term guidance does not indicate truly exceptional acceleration (>30%), and cash flow is strong but not rapidly accelerating. The business is not entirely unknown, but the signal is high due to its evolving model and industry implications.
Navigator Holdings (NVGS) Q1 2026: Ethylene Terminal Throughput Surges 57%, Unlocking Structural U.S. Export Tailwind
Navigator demonstrates a strong reinvestment runway, record throughput, and clear self-reinforcing business model with improving unit economics and customer value. The business is not scoring a perfect 20 due to the lack of >40% future growth guidance and some uncertainty around the sustainability of tailwinds and infrastructure optionality. However, the runway, capital returns, and structural industry shifts support a high signal score.
Nyxoah (NYXH) Q1 2026: U.S. Revenue Jumps 25% as Genio Adoption Accelerates
Nyxoah is showing strong growth signals: a long reinvestment runway, disruptive model, improving unit economics, and deepening customer value. There is clear commercial momentum and a path to margin expansion, but growth guidance is strong rather than exceptional, and some financial metrics (e.g., cash flow) are still ramping rather than accelerating. The business is firmly in the growth phase with multiple levers for upside.
Axsome Therapeutics (AXSM) Q1 2026: Ovelity Peak Sales Raised to $8B on Alzheimer’s Agitation Expansion
Axsome demonstrates a long reinvestment runway with a disruptive CNS platform, a major new indication, and raised peak sales guidance. While not yet showing 40%+ growth or cash flow acceleration, the dual-indication launch and expanded addressable market provide strong optionality and growth prospects. The business is transitioning to a growth phase, but not all metrics (e.g., cash flow, guidance) are exceptional or at the highest signal threshold.
NeuroPace (NPCE) Q1 2026: RNS System Grows 20% as AI Roadmap, IGE Expansion Drive Guidance Lift
NeuroPace demonstrates a long reinvestment runway, compounding business model, and disruptive AI-enabled platform with expanding indications. There is strong evidence of high growth, improving unit economics, and deepening customer value. While growth is robust (20%), it is not yet at the exceptional (over 30-40%) level for the highest scores in all categories. Some optionality (AI, IGE) is still contingent on execution and regulatory outcomes, but the business is clearly transitioning into a high-growth, high-potential phase.
Kura Oncology (KURA) Q1 2026: ComSifty Captures 40% New Patient Share, Accelerating Class Leadership
Kura Oncology demonstrates a long reinvestment runway and disruptive business model, with clear evidence of rapid market share capture, improving unit economics, and a self-reinforcing backbone strategy. Customer value is deepening via combination use and repeat prescriptions. While growth is strong, some metrics (guidance, cash flow, and growth rates) are not yet at the 'exceptional' threshold for a perfect score, and the business is still in investment mode. Nonetheless, the signal is very high for a biotech at this stage.
Qualcomm (QCOM) Q4 2025: Automotive Revenue Surges 36%, Unlocking Multi-Billion Edge AI and Data Center Path
Qualcomm demonstrates a long reinvestment runway, compounding business model, and strong growth in new verticals (auto, edge AI, data center). There are clear inflections in automotive and IoT, but data center is still early and guidance for exceptional growth is not yet proven. Revenue growth is strong but not consistently above 40%, and while disruptive, the business is not wholly new to investors.
Twist Bioscience (TWST) Q2 2026: Therapeutics Revenue Surges 55% on AI-Driven Demand Expansion
Twist Bioscience demonstrates a long runway for reinvestment at high returns, disruptive business model, improving unit economics, and self-reinforcing platform dynamics. Recent growth is strong, but not at the highest acceleration tier. The business is not yet a cash flow machine, and while growth is robust, guidance and backlog do not indicate >40% acceleration. Nevertheless, the business is clearly in growth mode and is strategically positioned for continued upside.
ACMR Q1 2026: ECP Segment Soars 205% as New Product Cycle Drives Share Gains
ACMR demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong customer value expansion. The ECP segment's growth and global expansion are significant, though not all metrics (e.g., cash flow acceleration, >40% growth) reach the highest bar. The company is in a high-growth transition with clear avenues for compounding, but some signals (e.g., future guidance, cash flow) are not at the most exceptional level.
Procore (PCOR) Q2 2026: Margin Expands 800bps as AI and DroneDeploy Acquisition Accelerate Strategic Shift
Procore demonstrates a long reinvestment runway, disruptive business model, and improving unit economics. The DroneDeploy acquisition, AI-driven growth, and international expansion signal strong optionality. However, growth rates are strong but not yet at the highest acceleration, and cash flow is improving but not rapidly accelerating. The business is transitioning toward growth leadership, but some metrics (e.g., guidance) are not yet exceptional.
Hyperfine (HYPR) Q2 2025: Gross Margin Jumps 800bps as Next-Gen SWOOP Drives Commercial Inflection
Hyperfine demonstrates a disruptive business model with clear reinvestment runway, improving unit economics, and deepening customer value. There is a major inflection in margin and commercial momentum, but overall guidance for 10-20% annual growth is not exceptional, and cash flow is improving but not yet accelerating. The business is transitioning into a growth phase, but not all metrics are at the highest signal threshold.
Clover Health (CLOV) Q1 2026: Membership Jumps 51% as Cohort Maturation Drives Profitability
Clover Health demonstrates a long reinvestment runway, disruptive tech-enabled model, improving unit economics, and strong customer value progression. Membership and revenue growth are very strong, and the business is transitioning to profitability. However, while growth is rapid, it is not yet at the highest tier of acceleration for all metrics (e.g., not every metric is 40%+), and some cash flow and guidance elements are still moderate rather than exceptional.
DarioHealth (DRIO) Q4 2025: Commercial Pipeline Doubles to $122M, Multi-Condition Model Drives Scale
DarioHealth demonstrates a long reinvestment runway, a disruptive platform model, and improving unit economics. While not all growth metrics are above 40%, the pipeline acceleration, margin expansion, and platform leverage are clear. The business is not yet a cash flow machine but is on a credible path. Risks are noted, and the business is a growth platform with substantial optionality, meriting a strong but not perfect signal score.
Real Brokerage (REAX) Q1 2026: Ancillary Revenue Up 34% as Remax Deal Unlocks Platform Leverage
Real Brokerage is at a pivotal inflection, with a long reinvestment runway in platform and ancillary expansion, a disruptive business model, and strong agent and ancillary growth. The Remax deal creates a step-change in recurring revenue and margin potential, although some metrics (cash flow acceleration, near-term growth rates) are not yet exceptional. The business is clearly transitioning into a higher-margin, recurring model, but integration execution remains a key risk.
Establishment Labs (ESTA) Q1 2026: U.S. Revenue Soars 216%, Minimally Invasive Platform Drives Margin Expansion
The business demonstrates a long reinvestment runway, rapid growth, improving unit economics, and a self-reinforcing model with premium pricing and innovation. However, while growth is strong and margins are expanding, the guidance for full-year growth is below 30%, which tempers the score for exceptional future growth. The business is innovative and disruptive within its category, but not at a scale or pace to warrant the highest possible scores across all dimensions.
Cloudastructure (CSAI) Q1 2026: ARR Surpasses $2M as Multi-Site Deployments Drive 271% Revenue Growth
Cloudastructure demonstrates a long reinvestment runway, disruptive SaaS model, rapid contract value and ARR growth, and high customer retention. While growth is strong, some uncertainty remains around margin acceleration and the pace of recurring revenue versus installation-heavy periods. Still, the business is clearly in a high-growth, compounding phase with significant optionality.
VEON (VEON) Q1 2026: Digital Revenues Jump 58%, Now Over 25% of Group Sales
VEON demonstrates a long runway with digital and fintech scaling, improving margins, and multiplay engagement. While growth is strong and the business model is evolving, some elements (AI, full digital transition, macro risk) are still emerging, holding back a perfect score. The business is not yet a hyper-growth outlier but shows clear signals of compounder potential.
Synaptics (SYNA) Q2 2026: Core IoT Surges 53%, Edge AI Pipeline Signals Multi-Year Expansion
Synaptics shows a long runway (edge AI, connectivity), disruptive business model, improving unit economics, and strong growth in core IoT. While growth is strong, near-term guidance is not above 30%, and cash flow is positive but not yet accelerating at an exceptional rate. The business is in a clear growth phase with strategic execution, but not all metrics are at the maximum threshold for signal.
Global-e Online (GLBE) Q1 2026: GMV Jumps 40% as AI Drives Efficiency and Merchant Expansion
Global-e demonstrates a long reinvestment runway with high returns, disruptive business model, improving unit economics, and self-reinforcing platform effects. The recent 40% GMV growth and margin expansion are notable, but full-year guidance implies growth moderates below 40%, and cash flow is not yet accelerating. The business is clearly a growth story but not at the most extreme acceleration, justifying a slightly conservative signal score.
Wix (WIX) Q1 2026: Base44 ARR Soars 50% in Two Months, AI Margin Play Accelerates
Wix demonstrates a long reinvestment runway with high returns via proprietary AI and Base44, which is growing rapidly (50% ARR jump in two months). Unit economics and customer value are improving, and the business model is increasingly self-reinforcing. However, guidance is for mid-teens growth, not >20%+, and cash flow is strong but not yet accelerating. The business is not quite a hypergrowth story, but the transition to AI-powered offerings and Base44 momentum make it a high-signal, thesis-relevant opportunity.
BlackSky (BKSY) Q3 2025: International Backlog Surges to 90%, Anchoring Gen3-Driven Growth
BlackSky displays a long reinvestment runway, disruptive model, and strong international backlog growth. Gen3 adoption and AI differentiation reinforce compounding advantages, and customer value is deepening. However, while growth is strong, near-term revenue and EPS growth guidance is not above 40%, and cash flow is not yet fully accelerating. The business is a clear growth story with some execution and conversion risks.
Nexen (NEXN) Q1 2026: CTV Revenue Rises 12% as Home Screen Inventory Expands
Nexen demonstrates a strong reinvestment runway, disruptive model, improving unit economics, and deepening customer value. CTV and mobile in-app are accelerating, but growth rates are good (not hypergrowth) and cash flow is only moderately accelerating. The business is transitioning to growth, with some risks around execution and adoption, but overall signal is high.
Instacart (CART) Q1 2026: Ad Revenue Jumps 16% as AI and Enterprise Scale Compound Growth
Instacart demonstrates a long reinvestment runway with high returns, a disruptive, compounding business model, and improving unit economics. Ad revenue growth is reaccelerating, and enterprise/in-store tech adds optionality. However, while growth is strong, forward guidance does not indicate a major acceleration (>30%), and cash flow is not yet rapidly accelerating. The business is firmly in the growth category, but not at the very top end for all signal metrics.
Joby Aviation (JOBY) Q1 2026: Manufacturing Output Up 2.5x as EIPP Accelerates Commercial Readiness
Joby demonstrates a long reinvestment runway, major operational ramp, and improving unit economics. The business model is disruptive with network effects and deepening customer value. While growth is strong, the revenue and EPS trajectory is not yet at the highest tier, and cash flow is not yet accelerating. The business is clearly in a growth phase, but some elements (like commercial ramp and exceptional future guidance) are not fully realized, warranting a conservative score.
Virtuix (VTIX) Q4 2026: Gross Margin Swings 31 Points as Defense and Meta Alliances Scale
Virtuix demonstrates a long reinvestment runway with high potential ROIC, disruptive technology, and compounding business model. There are clear signs of business evolution (margin swing, new partnerships, segment acceleration), improving unit economics, and deepening customer value. Recurring revenue and vertical expansion support the thesis, but some caution remains on near-term growth acceleration and cash flow. The business is transitioning toward growth, but not all metrics (e.g., >40% top-line growth, cash flow acceleration) are fully realized yet.
Kyivstar (KYIV) Q4 2025: Digital Revenue Jumps 6x, Pushing Ecosystem Share to 16%
Kyivstar demonstrates a long reinvestment runway, major digital revenue inflection, improving unit economics, and a self-reinforcing ecosystem model. Customer value is deepening, and the business is transitioning to a digital-led growth story. However, guidance for 2026 is prudent rather than exceptional, cash flow is strong but not yet accelerating, and growth rates are moderating into the 20% range. The business is highly strategic but not at the explosive growth phase, warranting a strong but not perfect signal score.
Backblaze (BLZE) Q1 2026: B2 Cloud Storage Surges 24% as AI Pipeline Expands
Backblaze demonstrates a long reinvestment runway, clear business model leverage, and disruptive positioning in AI infrastructure. Growth rates are strong but not yet at the extraordinary threshold for some metrics (e.g., guidance implies high-teens to low-20s growth, not >40%). Margins and customer value are improving, with strong signals of operational leverage and upmarket expansion. However, some elements (like cash flow and guidance) are still transitioning rather than exceptional, and the business, while high-growth, is not yet at hypergrowth scale.
NOVA (ELTK) Q4 2024: Advanced Packaging Doubles to 15% of Product Revenue, Centronics Acquisition Extends Growth Runway
NOVA demonstrates a long reinvestment runway, significant recent growth in advanced packaging, improving unit economics, and a self-reinforcing business model. Customer value is increasing, but future growth, while strong, is not exceptional (not >30%). The model is semi-disruptive with some lateral opportunities, and cash flow is accelerating. Revenue/EPS growth is solid but not extreme (>40%). This is a growth business, but not at the highest possible signal level.
QBTS Q3 2025: Gross Margin Jumps 16 Points as System Sales Model Scales
D-Wave demonstrates a long reinvestment runway, recent step-change in bookings, improving unit economics, and a disruptive/commercial model. However, while growth is strong, revenue and EPS inflection is not yet at the highest acceleration, and cash flow is not yet rapidly accelerating. The signal is high but not at the absolute maximum due to these moderations.
PGEN Q1 2026: Paximius Revenue Jumps 535% as Community Uptake Drives Launch Acceleration
PGEN demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and self-funding trajectory. The launch of Paximius shows a step-change in revenue, with strong adoption and payer access, but future growth is somewhat dependent on durability data and pipeline milestones. Cash flow is improving but not yet accelerating. The business is growth-oriented, but not all signals are at the highest level yet.
MIAX (MIAX) Q4 2025: Options Market Share Jumps to 18.2% as Tech and Product Expansion Drive Margin Surge
MIAX demonstrates a strong reinvestment runway, significant recent growth (market share and ADV), improving unit economics, and a self-reinforcing business model. Customer value is increasing, and cash flow is accelerating. However, while guidance is positive, it does not indicate an exceptional acceleration (>30%). The business model is semi-disruptive, and while revenue/earnings growth is strong, it is not consistently above 40%. Overall, the signal is high but not at the absolute maximum due to some limitations in future growth visibility and disruption potential.
InterDigital (IDCC) Q2 2026: Streaming and Cloud Revenue Hits $110M, Arbitration Sets Up Multi-Year Upside
InterDigital is transitioning into a diversified, high-margin, recurring-revenue business with a long reinvestment runway and expanding addressable market. There are clear business model reinforcements (network effects, standards leadership), improving unit economics, and accelerating cash flow. However, while growth is robust, it is not yet at the highest acceleration tiers, and some uncertainty remains around arbitration timing and magnitude. The business is not fully disruptive but is semi-disruptive in its licensing approach to new verticals. Overall, signal is high but not at the absolute maximum due to these caveats.
VIA (VIA) Q4 2025: Platform Revenue Jumps 30% as Customer Base Expands to 821
VIA demonstrates a long reinvestment runway with high returns, strong recent growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is clearly in a growth phase. While margin expansion is visible, some levers (AI/AV) are not yet fully realized, and growth is strong but not at the most extreme levels for all metrics. The business is disruptive with high potential, but some international and regulatory risks temper the signal.
Insight Molecular Diagnostics (IMDX) Q1 2026: 34 Transplant Centers Join Registry, Signaling Accelerating Adoption Path
IMDX demonstrates a long reinvestment runway, disruptive business model, and improving unit economics, with a self-reinforcing platform and increasing customer value. While growth is not yet exceptional (pending FDA clearance), the business is transitioning to a high-growth phase with visible catalysts. Cash flow is not yet accelerating, and revenue/EPS growth is likely to be 20-40% near-term, but the business is well-positioned for inflection upon regulatory milestones.
Fluence Energy (FLNC) Q1 2026: Backlog Hits $5.5B as U.S. Pipeline Jumps 30%
Fluence demonstrates a long reinvestment runway, disruptive business model, and strong growth signals with a record backlog and pipeline expansion. Unit economics and customer value are improving, and the company is positioned for future upside, especially with data center and long-duration storage not yet in backlog. However, some metrics (cash flow, future guidance) are not yet exceptional, and growth, while strong, is not consistently above 40%.
STXS Q3 2025: MagicSweep Catheter Adds $300K in Two Months, Catalyzing Recurring Revenue Shift
STXS demonstrates a long reinvestment runway with a disruptive, recurring revenue model and expanding digital platform. Recent product launches (MagicSweep, Genesis X) are driving a business evolution and improving unit economics. The business is transitioning toward high-margin recurring revenue and SaaS, but guidance does not quite reach the threshold for 'exceptional' acceleration (over 30%+), and cash flow is improving but not yet rapidly accelerating. The business is clearly in growth mode with strong signals for future upside.
Okeanis Eco Tankers (ECO) Q1 2026: VLCC Spot Rates Jump 45% as Fleet Outperforms Peers
Okeanis Eco Tankers demonstrates a long reinvestment runway, exceptional recent growth, improving unit economics, and strong cash flow acceleration. The business is capitalizing on a unique market window, with a disruptive tilt due to its spot market focus and agile strategy. However, the self-reinforcing model and customer value deepening are present but not as strong as network-effect businesses, warranting slightly lower scores there. The forward outlook and growth trajectory are exceptional, supporting a high but not perfect signal score.
Upstart (UPST) Q4 2025: Originations Up 86% as Secured Lending Scales, Margin Mix Shifts
Upstart demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and deepening customer value. There is strong evidence of rapid growth in secured lending and platform scale, but some metrics (such as future growth guidance and cash flow acceleration) are good rather than exceptional. The business is clearly in a growth phase, but not all signals suggest explosive, outsized upside.
BioHarvest Sciences (BHST) Q4 2025: CDMO Revenue Doubles as Strategic Bet on Plant Cell Tech Accelerates
BioHarvest demonstrates a long reinvestment runway, disruptive model, and improving unit economics. CDMO revenue is doubling, and DTC is premiumizing, but the business is not yet growing at >40% and cash flow is not yet accelerating rapidly. The company is in transition to growth, with significant optionality, but not yet at the highest trajectory.
Chicago Atlantic BDC (LIEN) Q1 2026: $93.9M Originations Signal Regulatory Tailwind and Niche Yield Strength
Chicago Atlantic BDC demonstrates a long reinvestment runway with high ROIC, record originations, improving unit economics, and a self-reinforcing model via regulatory barriers. Customers (borrowers) are becoming more valuable as sector economics improve. While the future is strong, guidance is conservative (not exceptional), and cash flow is stable but not yet accelerating. Growth rates are solid but not hypergrowth (>20% but <40%). The business is clearly a growth story with disruptive elements, but not at the very highest inflection of signal.
Remitly (RELY) Q1 2026: High-Value Sender Volume Surges 73%, Fueling Growth Accelerator Momentum
Remitly exhibits a long reinvestment runway, clear growth accelerators, improving unit economics, and self-reinforcing business model features. The company remains in a growth phase, but the signal is somewhat tempered by guidance for mid-teen revenue growth next quarter and nascent stage of new products.
DAO (DAO) Q4 2025: Online Marketing Surges 37%, AI Subscription Momentum Reshapes Growth Profile
DAO is in the midst of a disruptive, AI-driven transition with a long reinvestment runway, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is moving toward higher-margin, recurring revenues. While growth is strong, it is not yet at hypergrowth levels across all metrics, and some risks remain around execution and international expansion. The signal is high but not the absolute maximum due to these moderating factors.
Madrigal Pharmaceuticals (MDGL) Q1 2026: ResDifera Patient Base Up 2.5x, Pipeline Expansion Accelerates MASH Leadership
Madrigal demonstrates a long reinvestment runway, recent substantial growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is transitioning into a growth phase with disruptive potential. However, cash flow is not yet accelerating, and guidance suggests strong but not exceptional acceleration. The business is likely to grow at a high rate but not at hypergrowth levels.
The Bancorp (TBBK) Q2 2026: FinTech Revenue Jumps 21% as Embedded Platform Nears Launch
TBBK demonstrates a long reinvestment runway, strong compounding dynamics, and clear business model evolution toward high-return FinTech activities. There is strong evidence of accelerating fee growth, buybacks, and operating leverage. However, while growth is robust, it is not yet at the 'exceptional' acceleration threshold for some questions, and the business, while innovative, is not fundamentally disruptive to the same degree as a platform like Square or Stripe. Risks of execution and partner disintermediation are present, but the overall signal for valuation upside and business evolution is high.
LATAM Airlines (LTM) Q4 2025: Premium Revenue Climbs to 23%, Anchoring Margin Expansion
LATAM shows a long reinvestment runway with premium and loyalty growth, clear margin expansion, improving unit economics, and a self-reinforcing business model. While growth is strong, it is not at hypergrowth levels (>40%), and the business is not fully disruptive. The company is a growth leader in its region, but not a new or unknown story.
Arcutis (ARQT) Q1 2026: Zareve Captures 48% Branded Topical Share, Expanding Pediatric Reach
Arcutis displays a long reinvestment runway (pediatric, primary care, pipeline), strong market share momentum, improving unit economics, and a self-reinforcing model (formulary/access, prescriber preference). Customer value is rising, but near-term growth is solid rather than explosive, and while innovation is present, the business is not yet a clear disruptive outlier. Revenue growth is robust but not at hypergrowth levels. The business is in a strong growth phase, but not at the highest level of signal for transformational upside.
Navan (NAVN) Q3 2026: 29% Revenue Growth Anchored by AI-Driven Margin Expansion
Navan demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a disruptive, AI-driven model. Customer value is increasing and the business is clearly in a growth phase. The main limitations are that future guidance, while strong, does not indicate an exceptional (30%+) acceleration, and cash flow is improving but not yet accelerating. Revenue/EPS growth is between 20-40%, not above 40%. Overall, signal is high but not at the absolute maximum.
STMicroelectronics (STM) Q2 2026: Data Center Revenue Target Raised to $2B for 2027 on Optical Connectivity Surge
STM demonstrates a long reinvestment runway, disruptive business model elements (AI, silicon photonics), rising backlog, and robust growth in core verticals. However, margin expansion is delayed by manufacturing transformation and cash flow is not yet accelerating, tempering some immediate upside. The business is clearly in growth mode with strong secular tailwinds, but some execution and cyclical risks remain.
WATT Q1 2026: Gross Margin Expands to 36% as Enterprise Wireless Power Deployments Accelerate
Energist demonstrates a long runway with high returns on capital, a disruptive business model, improving unit economics, and growing customer value. There is a significant business evolution with commercial inflection and margin expansion. However, while growth is strong, it is not yet at the highest acceleration across all metrics (e.g., some categories are not >40% growth), and cash flow is improving but not fully accelerating. The score reflects strong but not absolute signal.
LandBridge (LB) Q1 2026: Surface Royalties Up 41% as Data Center Pipeline Accelerates
LandBridge demonstrates a long reinvestment runway, compounding business model, improving unit economics, and high cash conversion. While digital infrastructure presents optionality and some acceleration, the business is not yet in the hypergrowth phase (hence no 2s for Q6, Q7, Q9). Overall, the signal is strong but just shy of the maximum due to the need for further evidence of digital inflection and growth acceleration.
Live Nation (LYV) Q2 2026: Double-Digit Fan Growth Drives Margin Expansion and Global Venue Buildout
Live Nation demonstrates a long runway for reinvestment at high returns, significant recent growth, improving unit economics, and a self-reinforcing model via venue and ticketing expansion. However, the business, while strong, is already well-followed and not highly disruptive, with some growth capped by market maturity and execution risks in new geographies.
Target Resources (TRGP) Q1 2026: EBITDA Outlook Raised $300M as Permian Volumes Jump 250 MMCFD
TRGP demonstrates a long reinvestment runway, record volume growth, improving unit economics, and self-reinforcing infrastructure. Customers are becoming more valuable and cash flow is accelerating. However, guidance remains conservative and while growth is robust, it is not at the most exceptional levels (>40%). The business model is semi-disruptive rather than fully disruptive, and forward growth is strong but not hyperbolic.
Abcide (ABSI) Q1 2026: $25B AGA TAM Targeted as ABS-201 Pipeline Expands Beyond Hair Loss
Abcide demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and self-reinforcing platform. The business is pre-commercial but has a large TAM, clear growth drivers, and a focused pipeline. While the growth acceleration is not yet exceptional (pending data), the company is positioned as a high-growth, category-creating biotech, warranting a high but not perfect signal score.
AvePoint (AVPT) Q1 2026: SaaS Revenue Mix Climbs to 80%, Channel Drives Margin Leverage
AvePoint demonstrates a strong reinvestment runway, accelerating SaaS transition, improving unit economics, and a self-reinforcing channel model. Growth is robust but not hyper-scaling (ARR up 26%, revenue guidance up 22%), and while the business model is modern and leverages AI, it is not fully disruptive. Cash flow is strong and accelerating. The company is a growth business with high recurring revenue quality, but not at the very top tier of signal due to the absence of 40%+ growth or a truly unique disruptive angle.
AppFolio (APPF) Q2 2026: Premium Tier Adoption Climbs to One in Three Units, Driving Margin Expansion
AppFolio demonstrates a long reinvestment runway, improving unit economics, and a self-reinforcing business model with growing customer value. While growth is robust and margins are expanding, the business is not in the hypergrowth category, and the model is semi-disruptive rather than fully disruptive. The signal is strong but not at the absolute highest tier for upside.
Solana Company (HSDT) Q1 2026: Staking Yield Outperforms by 90bps as APAC Digital Asset Strategy Scales
The business demonstrates a long reinvestment runway, disruptive model, and strong growth signals, including a massive YoY revenue increase and differentiated staking yield. However, some metrics (backlog/guidance) are not yet at an exceptional level, and cash flow is not yet clearly accelerating, so scores are conservative in those areas.
Ovid Therapeutics (OVID) Q4 2025: $60M PIPE Financing Extends Cash Runway Into 2029, Expands Pipeline Scope
Ovid demonstrates a long reinvestment runway, substantial new capital, and a disruptive, de-risked business model with multiple new programs. While the growth outlook is strong, there is not yet evidence of >40% revenue or EPS growth (given clinical stage), and cash flow is not yet accelerating. However, the company is transitioning into a growth platform with clear optionality and potential for significant value creation.
Omada Health (OMDA) Q1 2026: Member Base Surges 51% as PBM Partnerships Expand Platform Reach
Omada demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is transitioning into a high-growth phase, though not yet at the exceptional acceleration threshold for some metrics. The model is disruptive, cash flow is improving, and the business is positioned as a growth company. Some metrics (guidance, cash flow, near-term growth rates) are strong but not at the highest possible levels.
Schmid Group (SHMD) Q4 2025: AI-Driven Order Mix Climbs to 60%, Margin Upside Signals Inflection
Schmid is undergoing a major inflection, with a disruptive business model, strong reinvestment runway, and a rapid mix shift to AI/advanced packaging. Margins and order backlog are improving, and customer value is deepening. However, while growth is strong, it is not yet at the most exceptional (40%+) level, and cash flow acceleration is moderate. Overall, the signal is very high but not at the absolute maximum.
Rubrik (RBRK) Q2 2026: Subscription ARR Jumps 36%, Cloud Security Expansion Drives Margin Upside
Rubrik demonstrates a strong reinvestment runway, high growth, and improving unit economics. The business model is self-reinforcing with deepening customer value and accelerating cash flow. However, some growth drivers (AI/identity) are still early-stage, and revenue normalization is expected as one-time tailwinds fade, which slightly moderates the signal score.
Cloudflare (NET) Q4 2025: Large Customer Revenue Jumps to 73%, Cementing Mission-Critical Status
Cloudflare demonstrates a long reinvestment runway with high ROIC via its platform evolution, strong large customer growth, and developer traction. There is a clear inflection in enterprise and AI-driven demand, and unit economics are stable with high gross margin. The business model is self-reinforcing with a growing developer ecosystem and rising customer value. Guidance is strong but not exceptional (>30% acceleration is not present), and while the model is disruptive, cash flow is only moderately accelerating. Growth rates are robust but not at the highest tier. The company is firmly a growth business, but as a well-followed name, some signal is already priced in.
HeartFlow (HTFL) Q3 2025: 41% Revenue Growth Signals Durable AI-Driven CAD Adoption
HeartFlow demonstrates a long reinvestment runway, disruptive model, and strong unit economics with accelerating adoption and margin leverage. While the current growth is robust and the business is positioned for future outperformance, the delayed impact of next-gen products and cash flow ramp moderate the near-term signal. The business is clearly a growth story, but not yet at the highest acceleration tier for all metrics.
Ambiq (AMBQ) Q4 2025: Non-China Revenue Up 91%, Edge AI Demand Fuels $100M+ Run Rate
Ambiq demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and a clear shift toward higher-value customers with accelerating edge AI adoption. However, while the growth outlook is strong, some metrics (e.g., cash flow acceleration and near-term revenue/eps growth) are not at the highest threshold, and execution risks remain. Signal is high but not maximal due to these factors.
HCM (HCM) Q2 2026: R&D Spend Jumps 287% as ATTC Pipeline Accelerates
HCM displays a long reinvestment runway with high returns, disruptive innovation, and significant recent developments (notably the 287% R&D jump and 70% ex-US growth). Unit economics and customer value are improving, and the business model is self-reinforcing. However, while growth is strong, guidance does not confirm >40% growth across all metrics, and cash flow acceleration is only moderate. The business is clearly in a growth phase, but not all signals are at the highest threshold.
DigiPowerX (DGXX) Q1 2026: $45M CapEx Fuels AI Data Center Pivot as Legacy Revenue Winds Down
DigiPowerX demonstrates a long reinvestment runway, disruptive business model, and strong unit economics with a clear pivot to a high-growth AI infrastructure market. The business is transitioning from legacy to growth, with initial AI revenues and a major contract in place. However, the business is early in its ramp, and while growth is strong, it is not yet exceptional or proven at scale, warranting a conservative deduction on future growth and cash flow acceleration.
Yum China (YUMC) Q2 2026: 1,200 Net New Stores Signal Brand Acceleration and Margin Expansion
Yum China displays a long reinvestment runway (store expansion, franchise growth), improving unit economics, and self-reinforcing business model elements (brand ownership, modular innovation). Customers are becoming more valuable, and cash flow is accelerating. However, growth guidance is high-single-digit to double-digit rather than hypergrowth, and while the business is clearly growth-oriented, the signal is not at the absolute highest tier for disruption or >40% growth.
SurgePays (SURG) Q1 2026: 71% Prepaid Surge Reveals Compounding Multi-Channel Model
SurgePays demonstrates a long reinvestment runway, disruptive compounding model, and substantial recent growth with strong unit economics. Backlog/guidance is positive but not yet exceptional; cash flow is improving but not accelerating. Revenue growth is strong but just below the highest tier. Overall, the signal is high for an emerging platform business.
MITK Q1 2026: Fraud & Identity Revenue Jumps 30% as Platform Unification Drives Adoption
MITK demonstrates a long reinvestment runway, strong network effects, improving unit economics, and high customer value. Backlog and guidance revisions are positive but not exceptional. The business model is semi-disruptive with cash flow acceleration, but growth rates are solid rather than explosive. The company is clearly in a growth phase rather than legacy or transition.
ArcSys (ARXS) Q2 2026: Organic Growth Surges 21%, Margin Expansion Signals Operating Leverage
ArcSys demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing business model. Customer value deepening, accelerating cash flow, and growth orientation are clear. While growth is strong, it is not at the most extreme levels for all signal questions, and the business—though high quality—is not exceptionally disruptive or growing at >40% rates, warranting a slightly conservative signal score.
Butterfly Network (BFLY) Q3 2025: IQ3 Drives 85% Probe Volume, AI and Chip Roadmap Signal Multi-Year Leverage
Butterfly Network demonstrates a long reinvestment runway, disruptive business model, and strong product/AI platform momentum. The IQ3 shift, chip roadmap, and AI flywheel are all high-signal, while enterprise deal timing and software churn temper near-term growth acceleration. The business is clearly in a growth phase with potential for further upside if execution continues.
Microsoft (MSFT) Q4 2026: Azure Surges 41% as AI Demand Outpaces Supply
Microsoft demonstrates a long reinvestment runway, exceptional cloud growth, and improving unit economics with a disruptive, self-reinforcing business model. However, as a mega-cap and well-followed company, some upside is capped, and growth, while strong, is not at the hyper-growth level for all segments. The signal is very high but not at the absolute maximum due to scale and maturity.
CAVA (CAVA) Q1 2026: New Restaurant Productivity Tops 100%, Extending Unit Economics Strength
CAVA demonstrates a long reinvestment runway, strong unit economics, and clear evidence of compounding network effects via digital and loyalty channels. Recent growth is robust, but not at the highest acceleration tier. The model is semi-disruptive, with some lateral optionality, and cash flow is accelerating. Revenue and EPS growth are strong but not consistently above 40%. The business is a clear growth story with high investor relevance.
ELUT Q1 2026: NXT 41X FDA Pathway Lifts Confidence as 80% Margin Platform Scales
ELUT is positioned for high-margin growth with a disruptive platform, long runway, and clear execution on regulatory and manufacturing fronts. While the business is not yet accelerating at the highest possible growth rates (pending FDA approval), the setup is strong, and the strategic pivot and asset divestitures increase focus and signal. Some elements (cash flow, growth rates) are not yet at peak levels, justifying a slightly conservative score.
CME (CME) Q4 2025: Market Data Revenue Surges 13% as Event Contracts and Crypto Drive New Growth
CME demonstrates a long reinvestment runway, strong recent growth in new products (event contracts, crypto), improving unit economics and self-reinforcing data/model effects. Customer value is increasing, and the business is a clear growth leader, though not at hypergrowth levels. Some areas (guidance, disruptiveness) are strong but not exceptional, and revenue growth is robust but not over 40%.
iQIYI (IQ) Q1 2026: Overseas Membership Revenue Climbs 40%, AI Content Ecosystem Accelerates
iQIYI demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and strong international growth (notably 40%+ overseas membership revenue). However, not all segments are accelerating at 30%+ and cash flow is only moderately improving, so a perfect score is not warranted.
EREN Digital (YRD) Q1 2026: Internet Insurance Grows 38% QoQ, Anchoring AI Ecosystem Expansion
The article demonstrates a business with a long reinvestment runway, disruptive AI-driven business model, improving unit economics, and rapidly growing digital insurance segment. While growth is strong, it is not consistently above 40% across all segments, and cash flow is improving but not yet fully accelerating. The business is clearly in a growth phase with significant optionality, though some metrics (like future guidance) are not exceptional enough to warrant perfect marks.
Merum Pharmaceuticals (MIRM) Q1 2026: Rare Disease Platform Expands With $200M Global FOP Opportunity
Merum demonstrates a long reinvestment runway, disruptive expansion into new rare disease markets, and improving unit economics. Recent developments (FOP asset, pipeline catalysts, raised guidance) are significant, but not all signals are at the highest threshold (e.g., cash flow acceleration, growth rates). The business is clearly transitioning to a multi-asset growth platform, but some elements (like backlog/guidance) are strong rather than exceptional.
Oncology Institute (TOI) Q1 2026: Pharmacy Revenue Jumps 78% on Capitated Lives Expansion
TOI demonstrates a long reinvestment runway with high returns on capital, significant growth in pharmacy and capitation, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is moving toward growth, but guidance does not yet show exceptional acceleration (>30%). The model is semi-disruptive, cash flow is improving, and the company is transitioning to growth, but not all signals are at the highest threshold.
374Water (SCWO) Q2 2025: Pipeline Grows to $1.8B as PFAS Destruction Demand Accelerates
374Water presents a long reinvestment runway, disruptive technology, and a pipeline that could drive high growth, but capital intensity and early-stage execution risk temper the signal. Backlog and guidance are strong but not yet at the exceptional acceleration threshold. Margins and cash flow are not yet proven, but business model and market tailwinds are evident. Signal is high due to the inflection, but not perfect given execution and funding risks.
Netskope (NTSK) Q1 2027: New Logo ARR Jumps 59% as AI Security Suite Accelerates Platform Adoption
Netskope demonstrates a long reinvestment runway, disruptive AI-native business model, improving unit economics, and strong customer value expansion. Recent new logo ARR growth is significant but not at the highest threshold for acceleration. Cash flow is improving but not yet accelerating, and revenue/EPS growth is strong but not above 40%. The business is clearly in growth mode with exceptional platform leverage, but some watchpoints remain on execution and full cash flow inflection.
PAR Technology (PAR) Q1 2026: ARR Jumps 16% as AI-Driven Platform Sharpens Margin Expansion
PAR Technology demonstrates a long reinvestment runway, clear business model transition, and disruptive potential with AI monetization and multi-product attach. There is strong evidence of improving unit economics, customer value, and operating leverage. While growth is robust, guidance does not indicate >40% acceleration, so some scores are held back. The business is not a household name but is showing emerging leadership in its segment.
Personalis (PSNL) Q1 2026: Test Volume Jumps 26% as Ultra-Sensitive MRD Drives Share Gains
Personalis demonstrates a long reinvestment runway, disruptive business model, and clear compounding advantages (technology, Tempus partnership, pharma backlog). Recent test volume growth and backlog visibility are strong, but margin recovery and cash flow acceleration are not yet exceptional, and forward growth is solid but not hyperbolic. The business is in a high-growth, scale-up phase but still faces execution and reimbursement risks.
CPAY Q1 2026: Alpha Grows 17%, Cross-Border Sales Surge as Portfolio Rotation Deepens
CPAY demonstrates a strong reinvestment runway, significant recent developments (cross-border growth >40%, Alpha 17% growth), improving unit economics, and a self-reinforcing platform. Customer value is increasing, and the business is transitioning to a higher-growth, higher-margin model. However, while guidance is raised and growth is strong, it is not consistently over 40%, and the business model, while innovative, is not fully disruptive. Overall, the signal is high but not at the absolute maximum.
Twilio (TWLO) Q4 2025: Voice AI Drives 60%+ Growth, Cementing Platform Differentiation
Twilio demonstrates a long reinvestment runway, disruptive business model, and compounding platform advantages. Voice AI and multi-product adoption are accelerating, with strong evidence of cross-sell and solution selling. Margins are resilient despite optical headwinds. However, guidance implies growth is strong but not yet at hypergrowth levels (>30%), and cash flow is improving but not rapidly accelerating. The business is clearly in a growth phase, but not all metrics are at the highest possible inflection.
HeartFlow (HTFL) Q1 2026: Plaque Revenue Guide Raised 23% as Platform Expansion Accelerates
HeartFlow demonstrates a long reinvestment runway, disruptive platform model, improving unit economics, and a growing data moat. Plaque revenue and install base are inflecting, but the business is still early in adoption and not yet at full cash flow acceleration or 40%+ top-line growth. The signal is high due to rapid platform expansion and AI leverage, but some metrics remain just below the highest thresholds.
Netskope (NTSK) Q1 2027: New Logo ARR Surges 59% as AI Security Pipeline Accelerates
Netskope demonstrates high growth, a disruptive model, and improving unit economics, with AI security as a new growth engine. However, cash flow is not yet accelerating and forward growth is strong but not yet at exceptional levels. The business is positioned as a growth leader, but execution risk and the nascent stage of AI monetization temper the score.
Tiendas 3B (TBBB) Q1 2026: Net Store Count Jumps 20% as Expansion Engine Drives Market Share
Tiendas 3B demonstrates a long reinvestment runway, accelerating store and revenue growth, improving unit economics, and a self-reinforcing business model. Private label penetration and self-funded expansion highlight durability and scalability. While growth is robust, it is not yet at the highest 'exceptional' level for future guidance, and the model, while disruptive for Mexico, is a known hard-discount format. The business is clearly in a high-growth phase, but not all signals reach maximum disruption or acceleration.
Reliant (RAL) Q2 2026: Test & Measurement Margin Jumps 750bps as Electrification and Defense Drive Demand
Reliant demonstrates a long reinvestment runway, strong margin expansion, and growing backlog, all supported by secular growth drivers in electrification, AI, and defense. Productivity programs and capital allocation discipline are accelerating cash flow and profitability. However, some moderation is warranted due to short-cycle exposure, guidance that, while raised, is not accelerating at an exceptional rate, and the business model, while strong, is not fully disruptive. Growth rates are robust but not consistently above 40%, and some risk of normalization exists.
Protara Therapeutics (TARA) Q1 2026: 83% Clinical Success in STARBORN-1 Drives BLA Pathway for TARA-002
TARA has a long reinvestment runway with disruptive potential in rare disease, a first-mover advantage, and strong interim clinical data suggesting a high growth trajectory if approved. The business model is platform-based with expansion opportunities, and customer value is likely to deepen if approved. However, cash flow is not yet accelerating (pre-commercial), and while growth prospects are strong, not all metrics (e.g., >40% growth) are yet visible; thus, the score is conservatively capped.
SoundHound (SOUN) Q1 2026: Core Auto and IoT Business Surges 88% Amid OASIS Platform Unification
SoundHound demonstrates a long reinvestment runway, recent significant organic and M&A-driven growth, improving unit economics, and a self-reinforcing platform model. Customer value is deepening, and the business is disruptive with a focus on proprietary AI. However, some uncertainty remains around the pace of post-acquisition growth and the degree of cash flow acceleration, tempering the top-end signal score.
Enovix (ENVX) Q3 2025: Smartphone Battery Revenue Jumps 85% as Fab2 Capacity Scales
Enovix shows strong disruptive potential, a long reinvestment runway, and improving unit economics, with high customer engagement and validation. However, the business is not yet at a stage of exceptional growth (over 30% acceleration) and cash flow is not yet accelerating. The risk of execution on customer qualification tempers the overall signal, but the business is clearly positioned for a pivotal inflection.
Huron (HURN) Q2 2026: AI-Driven Digital Bookings Up 20%+ as Outcome-Based Model Gains Scale
Huron demonstrates a strong reinvestment runway in high-return managed services and AI-driven digital transformation. There is a clear inflection in digital bookings and managed services growth, with improving unit economics and a self-reinforcing model. Customer value is rising, and the business is transitioning to higher recurring revenue and margins. However, while growth is strong, it is not at the hypergrowth (40%+) level, and the business model, while differentiated, is not fully disruptive on a market-wide scale. The signal is high but not maximal due to these factors.
MITK Q2 2026: Fraud & Identity Revenue Jumps 28% as AI-Driven Attacks Accelerate Customer Expansion
MITK demonstrates a long reinvestment runway, strong network effects, improving unit economics, and a growing SaaS mix. While growth is robust and the business is transitioning to higher quality revenue, it is not at hypergrowth levels and faces some legacy headwinds. The model is semi-disruptive with strong optionality, but not a clear-cut 40%+ growth story.
Enova (ENVA) Q2 2026: Originations Surge 27%, Grasshopper Bank Synergies Set to Drive 25% EPS Accretion
Enova demonstrates a long reinvestment runway with high returns, strong growth (27% originations, 30%+ EPS guidance), and improving unit economics. The business model shows some self-reinforcing elements (analytics, scale), but network effects are not dominant. Customer value is growing but not deeply compounding. The Grasshopper Bank acquisition is a major development, and the company is transitioning to a cash flow machine with accelerating metrics. Revenue/EPS growth is robust, and the business is clearly in a growth phase.
Shoulder Innovations (SI) Q1 2026: Core Surgeon Volume Up 51%, Platform Expansion Accelerates
Shoulder Innovations shows a long reinvestment runway and strong compounding dynamics: core surgeon volume up 51%, revenue up 65%, and robust margin expansion. The commercial model is self-reinforcing and disruptive in its niche. Customer value is deepening (higher units per surgeon, increased adoption). However, guidance implies growth moderates under 40% for the year, and while cash flow is improving, it is not yet accelerating. The business is still transitioning to full profitability, so not all signals are maxed.
Beta Technologies (BETA) Q1 2026: EIPP Wins Pull Forward Commercialization by 1 Year, Backlog Hits $3.9B
Beta has a long reinvestment runway, disruptive business model, and is shifting into early commercialization with strong backlog and infrastructure momentum. There are clear network effects and improving unit economics, but the business is not yet showing >40% revenue growth or cash flow acceleration. Guidance is good but not exceptional, so the score is conservative. The business is clearly in the growth phase with high strategic signal.
Full Truck Alliance (YMM) Q1 2026: Transaction Service Revenue Jumps 33% on Platform Quality and AI Leverage
YMM demonstrates a long reinvestment runway with high returns, a significant business model pivot, and improving unit economics. The business model is becoming more self-reinforcing with AI and network effects, and customer value is increasing. While growth is strong, it's not at hypergrowth levels (over 40%), and the business model is semi-disruptive rather than fully disruptive. Cash flow is accelerating, and the company is solidly in growth mode, but the signal is slightly tempered by the lack of truly exceptional (40%+) forward guidance and the business's status as a known, scaled player.
Baidu (BIDU) Q4 2025: AI Cloud Infra Subscription Revenue Surges 143%, Anchoring Core Shift
Baidu demonstrates a long reinvestment runway, disruptive AI infrastructure growth, improving unit economics, and a transition to a recurring revenue model. While not all metrics are at the highest growth tier (e.g., overall revenue growth is held back by legacy drag), the business model, capital allocation, and global scaling ambitions signal high strategic value and upside potential.
Owlet (OWLT) Q1 2026: Subscription Penetration Hits 34%, Driving Recurring Revenue Model Shift
Owlet demonstrates a strong shift to recurring revenue with high margin and retention, a disruptive model in a shrinking category, and clear evidence of operational discipline and compounding advantages. However, while growth is strong, it is not yet at the exceptional acceleration threshold for some metrics, and cash flow is improving but not yet rapidly accelerating.
Zillow Group (Z) Q4 2025: Rentals Revenue Jumps 45% as Multifamily Listings Surge
Zillow is showing strong growth, margin expansion, and platform network effects, with clear evidence of reinvestment runway and improving economics. However, while growth is robust, it is not accelerating at an exceptional (40%+) level for the overall business, and the business model—while platform-driven—is not entirely disruptive in the industry context. Cash flow is improving but not yet at a truly exceptional rate.
MarketAxess (MKTX) Q1 2026: Non-U.S. Revenue Jumps 20% as International Initiatives Outpace U.S. Credit
MarketAxess demonstrates a long reinvestment runway, strong recent growth in international and protocol-driven segments, and improving unit economics. The business model shows emerging network effects and data moats, with customers becoming more valuable. While not all metrics are at the highest growth threshold (e.g., some growth rates are below 40%), the business is clearly transitioning to a higher-growth, more diversified model with potential for significant upside.
Fluence Energy (FLNC) Q2 2026: Data Center Pipeline Surges 30% as Hyperscaler Demand Compresses Cycle
Fluence Energy demonstrates a long reinvestment runway, a disruptive pivot to hyperscaler/data center demand, and clear improvement in operating leverage and margin profile. The pipeline surge and rapid-cycle MSAs are significant, but the business is not yet at an exceptional acceleration (over 30-40% growth in all metrics), and some questions remain about sustained cash flow and global margin durability. The model is disruptive with high optionality, but not yet a runaway high-growth story.
Allegro MicroSystems (ALGM) Q4 2026: Data Center Sales Jump 41%, Fueling New Growth Pillar
Allegro demonstrates a long reinvestment runway, clear recent growth inflection (notably in data center), and strong unit economics. The business model is increasingly self-reinforcing, with rising customer value and robust, though not exceptional, future guidance. While disruptive elements are present, the business is not wholly transformative. Cash flow is improving but not yet accelerating at the highest tier. Growth rates are strong but not hypergrowth, and the company is solidly in a growth phase rather than transition or maturity.
VYX Q1 2026: VCP Contract Value Jumps 75%, Marking SaaS Shift and Data Leverage
The business demonstrates a long reinvestment runway, a disruptive SaaS model, and a significant contract value inflection. Unit economics and margins are improving, and the platform shift is self-reinforcing with regulatory and data moats. However, customer value deepening and growth rates, while solid, are not yet exceptional across all segments, and cash flow acceleration is moderate. The signal is strong but not maximal due to some lingering legacy drag and segment divergence.
CCEC (CCEC) Q1 2026: LNG Revenue Backlog Surges to $2.9B with 97 Years of Contracted Coverage
CCEC demonstrates a long reinvestment runway with high returns, a major backlog surge, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the backlog/guidance is strong but not at the highest acceleration. The business model is semi-disruptive with some lateral opportunities. Cash flow is improving but not yet accelerating rapidly. Revenue/EPS growth is strong but not at the highest tier. CCEC is clearly a growth business, but not at the highest signal level for every dimension.
Ormat Technologies (ORA) Q1 2026: Energy Storage Revenue Up 153% as EGS Pipeline Accelerates
Ormat demonstrates a long reinvestment runway (storage and EGS), with recent storage growth and backlog acceleration. Unit economics in storage are volatile but show improvement; model is self-reinforcing via contracts and technology. Customers are becoming more valuable through blend-and-extend PPAs. Guidance is steady, not exceptional. The business is disruptive (EGS, storage), but cash flow acceleration is moderate. Revenue and EPS growth are solid but not over 40%. The business is in a growth phase.
PICS (PICS) Q1 2026: Secured Credit Powers 116% Portfolio Growth, Margin Leverage Signals Durable Model
PicPay demonstrates a strong reinvestment runway, rapid credit portfolio growth, improving unit economics, and a self-reinforcing digital model. Customer value is rising and the business is clearly in a growth phase. However, while growth is strong, it is not at the extreme/exceptional level in every area (e.g., future guidance is robust but not 40%+ across all metrics). The business is innovative but not fully disruptive by global standards. Cash flow is improving, but not yet accelerating at the highest tier. The signal is strong but not at the absolute maximum.
Grid Dynamics (GDYN) Q1 2026: AI Revenue Jumps 60% as Platform Margins Outpace Legacy Services
Grid Dynamics is showing a strong inflection with a long runway, high AI growth, and improving economics. However, while growth is robust, it is not yet at the most exceptional level (30%+ acceleration or >40% growth across the board), and the business—while highly promising—still faces concentration and execution risks. The signal is strong but not at the absolute highest tier for disruption or growth.
Playtika (PLTK) Q1 2026: Disney Solitaire Drives 72% Sequential Growth, D2C Run Rate Hits $1.2B
Playtika shows strong signals: a long reinvestment runway (D2C, new IP), material growth from Disney Solitaire, improving unit economics, and self-reinforcing D2C advantages. Customer value is increasing, and the business is transitioning to higher growth and cash flow durability. However, the growth outlook is not yet exceptional (not >30–40%), and while the business is semi-disruptive, it is not a category-defining disruptor. Cash flow is improving but not yet accelerating, and annualized growth, while strong, is not hypergrowth. Overall, the business is a growth story with some legacy elements, but not at the highest possible signal level.
Veracyte (VCYT) Q2 2026: Prosigna Launch and 20% Decipher Growth Signal Expanding Oncology Franchise
Veracyte demonstrates a strong growth profile with new launches, expanding addressable markets, and improving unit economics. While the business model shows self-reinforcing elements and customer value is deepening, some uncertainty remains around the pace of MRD scaling and reimbursement for new launches. The business is not yet at an exceptional acceleration (>30%), and while disruptive, it is not a wholly new platform. Revenue growth is strong but not hypergrowth (>40%).
Karo (KARO) Q1 2027: South Africa Subscriber Net Adds Surge 92%, Reinforcing Platform Scale
Karoo demonstrates a long reinvestment runway, clear growth drivers, improving unit economics, and a self-reinforcing SaaS model with strong retention. However, while growth is robust and the model is attractive, it is not at the most exceptional level in terms of acceleration or disruption, and some metrics (ARPU, logistics margins) show moderation. Signal is high but not at the absolute maximum for a small/mid-cap SaaS.
PTC Therapeutics (PTCT) Q1 2026: Suffiance Drives 47% Product Revenue Growth, Recasts Global Rare Disease Trajectory
PTC Therapeutics demonstrates a long reinvestment runway with high returns, a major growth inflection from Suffiance, and improving unit economics. The business model is self-reinforcing with strong customer value improvement. However, while growth is robust, not all signal criteria are exceptional (e.g., guidance/growth acceleration is strong but not over 30%+). The business is disruptive within rare disease, but not a tech platform—hence, some scores are conservative.
SARO Q1 2026: Engine Services Margin Exceeds 14% Post Inventory Burn, Military Outlook Raised
SARO demonstrates a long reinvestment runway with high ROIC potential, strong recent growth, improving unit economics, and a business model that is becoming more self-reinforcing as scale increases. Customer value is rising, and the business is transitioning into a higher-margin, higher-growth phase, though not yet at an exceptional/accelerating level for all metrics. The model is semi-disruptive, and cash flow is improving, but not yet a full acceleration. Growth rates are solid but not at the hypergrowth threshold. Overall, the signal is strong but not at the very highest level.
Alignment Healthcare (ALHC) Q2 2026: Membership Up 31% as Embedded Margin Leverage Expands
ALHC shows a long reinvestment runway, strong recent membership growth, improving unit economics, and a self-reinforcing platform. Customer value is increasing through cohort maturation, and the business is positioned as a growth platform. However, while growth is strong, it is not at a hyper-accelerated level in all areas, and some uncertainty remains around regulatory headwinds and execution risk in new markets. The model is semi-disruptive, with strong but not exceptional cash flow acceleration and guidance. Overall, the signal is high, but not at the absolute peak for disruptive, high-velocity growth.
GEVO (GEVO) Q1 2026: EBITDA Run Rate Doubles to $30M as Carbon Markets, Expansion Initiatives Accelerate
GEVO is demonstrating strong growth and margin expansion, with a long reinvestment runway, improving unit economics, and a platform business model. However, while growth is robust, some signals (like exceptional future acceleration or disruptive model) are present but not at the highest level, and some forward projections remain contingent on execution and regulatory outcomes.
Kingsway (KFS) Q1 2026: KSX Revenue Soars 81% as Portfolio Operating Leverage Accelerates
Kingsway demonstrates a long reinvestment runway, clear operating leverage, and improving unit economics. There is broad-based growth, a robust acquisition pipeline, and a self-reinforcing business model. While growth is strong, it is not yet at an exceptional acceleration rate, and the business model—though compounding—is not highly disruptive. Signal is high for a holding company, but not at the absolute top end for unique upside.
Tandem Diabetes Care (TNDM) Q1 2026: Gross Margin Jumps 500bps as PAYGO and Direct Model Expand
Tandem is showing strong margin expansion, a multi-year growth runway, and a business model transition with compounding advantages. However, PAYGO/pharmacy adoption is still early and not yet proven at scale, and while growth is strong, it is not yet at the hypergrowth levels to warrant the highest scores on all questions. The business is transitioning with clear upside but not yet in the 'exceptional' or 'giant' category.
Vista (VIST) Q2 2026: Production Surges 32% as Bandurria Sur Acquisition Accelerates Scale
Vista demonstrates a long reinvestment runway, a disruptive model within its geography, and clear growth momentum from both organic and inorganic sources. However, while production and EBITDA are growing rapidly, some uncertainty remains around the exceptionalism of future growth (guidance is solid but not accelerating >30%), and cash flow acceleration, while strong, is not at maximum velocity. The business is transitioning to a larger scale and is not yet a clear outlier in global energy, but signal remains high.
Crinetics (CRNX) Q1 2026: Palsonify Achieves 70% Reimbursement, Broadening Acromegaly Market Penetration
Crinetics demonstrates a long reinvestment runway with high returns, rapid growth in its launch asset, improving unit economics, and a self-reinforcing model. While growth is strong and the business is transitioning into a leader, the signal is slightly muted by the lack of 40%+ growth or truly exceptional guidance revisions, and the business, while promising, is still early in its commercial ramp.
TSS Inc. (TSSI) Q1 2026: Systems Integration Soars 88%, Accelerating AI Margin Shift
TSS Inc. is showing strong signs of a business model transition with a long reinvestment runway, high margin expansion, and clear growth levers tied to AI infrastructure. While the growth is substantial and the model is becoming more disruptive, the company is not yet at the level of hypergrowth (40%+ overall), and some risks remain around customer concentration and operational bottlenecks. Nevertheless, the signal is strong for an inflecting, higher-margin business.
Silvaco (SVCO) Q1 2026: FTCO Drives 26% Revenue Growth as AI Pipeline Doubles
Silvaco demonstrates strong growth, margin expansion, and a pivot to higher-value segments with clear evidence of a reinvestment runway and improving economics. However, some elements (guidance, pipeline conversion, and cash flow) are still in transition, and the business, while promising, is not yet showing truly exceptional or disruptive upside by sector standards.
Interactive Brokers (IBKR) Q2 2026: Margin Loan Interest Up 39% as Account Growth Drives Record Activity
IBKR demonstrates a long reinvestment runway, robust growth, improving unit economics, and a self-reinforcing model with expanding customer value. However, while growth and innovation are strong, the business is mature and well-followed, which tempers the upside signal. The growth outlook is solid but not truly exceptional or disruptive at the scale of a new category leader, and revenue/EPS growth is likely to be strong but not hyper-growth. The signal is high but not at the very top end for a widely covered, large-cap financial.
BitDeer (BTDR) Q1 2026: AI Cloud ARR Jumps 105% in One Month, Margin Recovery Hinges on A4 Rollout
BitDeer demonstrates a long reinvestment runway with high ROIC potential as it pivots to AI infrastructure. There are significant recent developments in AI cloud ARR and GPU utilization, and unit economics are improving. The business model is becoming self-reinforcing, and customer value is increasing. However, while growth is strong, some runway and execution uncertainty remain, and not all metrics are at the exceptional threshold. The business is moving from legacy to growth, but some elements (like AI contract execution) are still unproven at scale.
Neuraxis (NRXS) Q1 2026: 33% ASP Lift Signals Reimbursement-Driven Margin Expansion
Neuraxis demonstrates a strong growth profile (80% YoY revenue growth, 33% ASP lift, margin expansion), a disruptive reimbursement-led commercial model, and clear evidence of scaling in high-value channels. However, the business is still dependent on payer expansion and not yet at the exceptional growth/acceleration threshold for every signal metric (e.g., future guidance is strong but not >30% acceleration, and adult expansion is still a future lever). The business is not yet a giant, but the self-reinforcing model, improving unit economics, and channel diversification signal high upside.
Howard Hughes (HHH) Q1 2026: MPC EBT Jumps 33% as Capital Allocation Shifts Toward Insurance
Howard Hughes is at a strategic inflection with a clear capital allocation shift toward insurance, a long reinvestment runway, and improving unit economics in real estate. However, the insurance pivot is not yet proven, growth is strong but not at hypergrowth levels, and some optionality is still unproven. The business is transitioning to growth, but not all metrics are at the highest thresholds for signal.
FIS (FIS) Q1 2026: Recurring ACV Jumps 24% as AI and Digital Asset Initiatives Accelerate
FIS demonstrates strong recurring revenue growth, margin expansion, and clear strategic positioning in regulated AI and digital assets. There is strong evidence of improving unit economics, a self-reinforcing model, and increasing customer value. However, the reinvestment runway is moderate (not truly uncapped), and while growth is robust, it is not at the highest acceleration levels for most metrics. The business is transitioning to higher-quality revenue but is not a breakout disruptor on the scale of a new platform monopoly.
Monday.com (MNDY) Q1 2026: AI Drives 10% of Net New ARR, Reshaping Platform Monetization
Monday.com is undergoing a significant business model transition with early AI monetization, a long reinvestment runway, and evidence of self-reinforcing enterprise stickiness. While growth is strong, the company is not yet at hypergrowth levels (>40%), and some uncertainty remains around the pace of AI revenue ramp and margin evolution.
Kodiak Gas Services (KGS) Q1 2026: Power Infrastructure Revenue Guide Hits $125M as Data Center Demand Drives 260MW Orders
Kodiak demonstrates a long reinvestment runway (distributed power buildout), significant recent developments (260MW orders, new revenue guidance), and improving unit economics (record margins, utilization). The model is increasingly self-reinforcing via long-term contracts and technology investments. However, while customer value is improving, evidence for deepening ARPU/retention is moderate. The business is not quite at hypergrowth, but shows strong growth and optionality, with some capital intensity risks tempering the overall signal.
SIBN Q1 2026: Granite DRG Tailwind Unlocks $50K Per Procedure Upside
SIBN shows strong reinvestment runway, disruptive model, and operating leverage. The DRG change is a significant catalyst, but some signals (international scale, pipeline launches) are not yet fully realized, warranting a conservative mark-down. Growth is strong but not yet at hypergrowth levels, and some lateral opportunities are still emerging.
T1 Energy (TE) Q1 2026: Gross Margin Expands 10 Points as G2 Austin Build Accelerates
T1 Energy demonstrates a long reinvestment runway with high returns, margin expansion, and a strong policy-driven growth catalyst (G2 Austin). While backlog and revenue growth are robust, the business is not yet showing 40%+ growth or truly exceptional acceleration. The business model is semi-disruptive, with some legacy elements, and cash flow is improving but not yet accelerating. Overall, the signal is strong but not at the highest possible level.
JD.com (JD) Q1 2026: Marketplace and Marketing Revenues Jump 19% as Platform Ecosystem Surges
JD.com exhibits a long reinvestment runway, strong growth in high-margin platform revenues, improving unit economics, and self-reinforcing business model traits. Customer value is deepening, and the business is transitioning to a more diversified, profitable model. However, growth outlook is strong but not at an exceptional, hypergrowth level, and some business lines (food delivery, international) are still scaling with risks. The model is disruptive but not at the most extreme end, and cash flow is improving but not yet accelerating at the highest rate.
Brightstar (BRSL) Q1 2026: iLottery Wagers Jump 30%, Anchoring Digital Growth Trajectory
Brightstar demonstrates a strong digital growth runway (iLottery, eInstant), improving margins, and a self-reinforcing model with omnichannel and AI-driven efficiencies. However, some caution is warranted due to contract volatility, near-term headwinds, and only moderate evidence of exceptional future growth (guidance is for H2 acceleration, but Q2 is guided down). The business is transitioning but not yet a pure high-growth outlier.
Arteris (AIP) Q1 2026: ACV Plus Royalties Up 39% as Data Center and Cybersecurity Drive Mix Shift
Arteris demonstrates a long reinvestment runway with high returns (data center/AI/security), significant recent growth (39% ACV+royalties, 67% royalty growth), improving unit economics, and a self-reinforcing business model (IP, royalties, cross-sell). Customer value is deepening, and the business is in growth mode, but guidance/forward growth is strong rather than exceptional, and security/IP disruption is promising but not yet fully proven or at massive scale.
Goosehead Insurance (GSHD) Q2 2026: Franchise Payments Jump 35%, Fueling Productivity Flywheel
GSHD demonstrates a long reinvestment runway, improving unit economics, self-reinforcing model, and growing customer value. There is strong growth, but not at the most exceptional levels for every metric (e.g., guidance and cash flow are good but not explosive, and the business model is semi-disruptive rather than fully disruptive). The article identifies these strengths but also notes expense growth and execution risks, tempering the overall signal score.
Alibaba (BABA) Q4 2026: AI-Driven Cloud External Revenue Surges 40% as Model ARR Crosses $5B
Alibaba’s AI/cloud pivot and proprietary chip strategy provide a long reinvestment runway and margin expansion levers. There is strong evidence of business model evolution and improving unit economics, but some areas (e.g., consumer AI monetization, cash flow ramp) are not yet exceptional or disruptive enough for the highest scores. Growth is strong but not at the extreme acceleration threshold.
Infinity Natural Resources (INR) Q1 2026: Midstream Utilization at 25% Unlocks Margin Tailwind
INR has a long reinvestment runway with high returns, clear margin and scale inflection, and a platform for future growth. While the business is transitioning into a more integrated and flexible model, not all growth metrics are in the highest acceleration band, and some uncertainty remains around third-party throughput ramp. Still, the business has strong strategic signal and upside potential.
Tower Semiconductor (TSEM) Q1 2026: $1.3B Silicon Photonics Commitments Anchor Multi-Year Growth Visibility
Tower Semiconductor demonstrates a long reinvestment runway, clear margin and revenue acceleration, and visible growth through multi-year contracts and prepayments. While growth is strong and the business model is evolving, some elements (e.g., future guidance, disruptive potential) are promising but not yet at the highest conviction level for a 20/20 score.
NovoCure (NVCR) Q2 2026: Optune Pax Scripts Surge 200%, Catalyzing Multi-Indication Growth Trajectory
NovoCure demonstrates a long reinvestment runway, disruptive model, and accelerating growth in new indications, with strong evidence of improving unit economics and customer value. While the growth outlook is robust and the business is transitioning to profitability, not every signal is exceptional or at maximum velocity, warranting a slightly conservative score.
MindWalk Holdings (HYFT) Q4 2026: Recurring Platform Revenue Debuts as Gross Margin Hits 59%
The business is at a strategic inflection with the first recurring SaaS revenues, margin expansion, and a defensible moat in proprietary biological context. There is a long reinvestment runway, clear model shift, and disruptive potential. However, SaaS revenue is still nascent, and while the growth trajectory is promising, it is not yet at the level of exceptional acceleration or proven customer deepening. The business is transitioning but not yet a giant, so the signal is strong but not at the highest possible level.
ClearPoint Neuro (CLPT) Q1 2026: 43% Revenue Expansion Anchored by Aeroflow Integration and Device Growth
ClearPoint demonstrates a strong reinvestment runway, improving unit economics, and a disruptive hybrid business model. There is clear evidence of operational leverage and growth, but the business is not yet at the level of a hypergrowth giant or a category-defining platform. While the recent acquisition and integration are significant, the fundamental business is still subscale in some segments, and guidance does not point to 40%+ ongoing growth or exceptional acceleration, warranting a conservative approach to the highest signal scores.
Grab a Gun (PEW) Q1 2026: Pew Logistics Gross Margin Surges to 70%, Unlocking Platform Leverage
Grab a Gun is at an inflection point with a high-margin, platform-driven business model and clear regulatory optionality. While runway and margin expansion are evident, the business is not yet in hypergrowth territory and some optionality (such as regulatory changes) is not fully realized. The signal is strong, but not at the absolute highest level due to the business’s scale and pace of transformation.
Rapid Microbiosystems (RPID) Q1 2026: Consumables Surge 30%, Margin Inflection Anchors FY Trajectory
RPID demonstrates strong recurring revenue growth, improving unit economics, and a credible path to margin expansion, but the business is not yet at hypergrowth or fully disruptive scale. The reinvestment runway is long, and the business model is becoming self-reinforcing, but some elements (guidance, growth rates, model disruption) are not yet exceptional or industry-defining. The business is clearly transitioning to a growth phase with improving fundamentals, but upside is moderate rather than explosive.
Precision Optics (POCI) Q3 2026: Gross Margin Jumps to 24% as Manufacturing Scale Drives Inflection
POCI is demonstrating a strong reinvestment runway with clear margin expansion and multiple new growth avenues (production ramps, Unity platform). The business has moved through a clear inflection, with doubled revenue and sharply improved gross margins, indicating improving unit economics. The model is increasingly self-reinforcing through customer partnerships and platform leverage, and customer value is increasing. However, while growth is strong, it is not at the hypergrowth (40%+) level, and some risk remains in pipeline execution and Unity adoption. The business is transitioning from engineering to scalable manufacturing, supporting a high but not perfect signal score.
NOVA (NVMI) Q1 2026: Memory Mix Rises to 34% as DRAM Demand Accelerates Metrology Growth
NOVA demonstrates strong growth, a clear reinvestment runway, and improving economics, with record memory demand and metrology intensity. However, the business is not a true disruptor and growth, while robust, is not at the most extreme levels. Risks remain around cyclicality and regional competition, slightly tempering the overall signal score.
LPA (LPA) Q1 2026: Peru Revenue Jumps 40% as Mexico Expansion Accelerates Platform Scale
LPA demonstrates a long reinvestment runway, clear platform shift with the Mexico expansion, improving unit economics, and strong customer stickiness. However, while growth is robust, it is not at the 'exceptional' 40%+ level across the board, and cash flow acceleration is not fully proven yet. The business is growth-oriented but faces some headwinds that temper the signal score.
SuperCom (SPCB) Q1 2026: U.S. ARR Jumps 180% as Cloud-Driven Expansion Reshapes Margin Profile
SuperCom is showing a business model transition with a long runway (U.S. ARR growth, margin expansion, cloud/SaaS shift), but while growth is strong, the business is not yet at the level of a hypergrowth or disruptive compounding machine. Unit economics, customer value, and self-reinforcing model are all improving, but the business is still in transition and faces execution risk. Signal is high but not at the absolute maximum due to the company's size, moderate TAM, and some remaining project-based revenue.
KULR Q1 2026: Gross Margin Triples to 29% as Battery Platform Scaling Accelerates
KULR demonstrates a long reinvestment runway, clear margin inflection, and expanding end-markets, supported by operational leverage and vertical integration. However, while growth is strong and the business is transitioning to scale, some elements (guidance acceleration, disruptive model, and cash flow) are not yet at the highest threshold. The business is not yet showing 40%+ growth or exceptional acceleration, and while disruptive, the platform is still in early stages of broad market dominance.
XBP (XBP) Q1 2026: Pipeline TCV Jumps 45% as AI Workflow Shift Drives Margin Upside
XBP demonstrates strong signals: long reinvestment runway, significant pipeline growth, improving unit economics, self-reinforcing business model, and increasing customer value. However, growth guidance is cautious (not clearly >30%), and while the business is transitioning to high-growth, the near-term outlook is still somewhat conservative. The business model is semi-disruptive but not at the scale of a category-defining disruptor. Execution and conversion risks temper the overall signal.
KARO Q4 2026: 90% Free Cash Flow Surge Underscores Durable SaaS Model Despite Margin Compression
Karo demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing business model. Customer value is improving but diluted by lower-ARPU regions. The business is not quite exceptional on future growth but is solidly in the growth category, with strong cash flow and operational leverage. The model is semi-disruptive and the business is not yet at hypergrowth, but fundamentals are very strong.
Faraday Future (FFAI) Q1 2026: Robotics Revenue Jumps 62% as EAI Ecosystem Flywheel Accelerates
Faraday Future is at a clear inflection point, with strong early growth and a disruptive, asset-light model in robotics. The business has a long runway and is transitioning from legacy burn to platform monetization, but recurring revenue and customer deepening are still early. Guidance is raised, but not at exceptional acceleration levels yet. The model is disruptive, but cash flow and revenue growth are not yet at the highest tier. Execution and funding remain key risks.
BAP Q1 2026: YAPE Drives 65% Revenue Per User Growth, Accelerating Digital Monetization
BAP demonstrates a long reinvestment runway, clear operating leverage, and strong digital platform monetization, with YAPE showing exceptional growth and margin expansion. However, some caution is warranted regarding the sustainability of recent tailwinds (e.g., pension inflows), competitive risks, and macro uncertainty, which modestly temper the signal score.
Nasdaq (NDAQ) Q2 2026: Index AUM Tops $1 Trillion as Platform Diversification Drives 17% Solutions Growth
Nasdaq demonstrates a strong recurring revenue engine, platform leverage, and secular growth drivers. While reinvestment runway and business model compounding are clear, some metrics (unit economics, growth acceleration) are strong but not at the highest possible level. The business is not fundamentally disruptive, and some growth rates are under the highest threshold, but overall signal is high for a large-cap financial infrastructure leader.
Renew Energy Global (RNW) Q4 2026: Manufacturing EBITDA Jumps 15% as Solar Pivot Accelerates
RNW demonstrates a long reinvestment runway, recent growth in manufacturing EBITDA, improving unit economics, and a self-reinforcing vertically integrated model. Customer value is deepening via CNI/hyperscaler demand. Forward guidance is strong but not at the exceptional acceleration threshold. The business is semi-disruptive, with cash flow and revenue growth in the 20–40% range. The signal is high but not at the absolute top end due to some moderating factors (e.g., margin moderation, grid constraints).
Intel (INTC) Q2 2026: AI-Driven Segments Power 70% of Revenue as CapEx Surges 40%
Intel demonstrates a long reinvestment runway (CapEx ramp, advanced packaging, foundry), strong recent growth (AI-driven businesses 70% of revenue), improving unit economics (margin expansion), and deepening customer value (custom silicon, foundry wins). However, persistent supply constraints and competitive risks temper the outlook, and while growth is robust, it is not exceptional (not >40%). The business is transitioning but not fully disruptive, and while cash flow is improving, it's not yet accelerating at an exceptional pace.
Amer Sports (AS) Q1 2026: DTC Surges 45%, Accelerating Global Brand Expansion
Amer Sports demonstrates a long reinvestment runway, premium brand momentum, and improving unit economics with a disruptive DTC business model. Growth is robust (but not hyper-growth), and there are signs of accelerating margins and cash flow. However, the growth rate is not exceptional enough for the highest marks, and the business—while strong—is not a new or highly underfollowed story, which tempers the signal score.
Esquire Financial (ESQ) Q2 2026: Litigation Loans Jump 41% Ahead of $2B Signature Merger
Esquire demonstrates a long reinvestment runway with high ROIC in litigation lending, and the 41% YoY growth is a material business evolution. Unit economics and business model strength are evident, with high yields and core deposit growth. Customer value is deepening, and the business is a clear growth story, but not fully disruptive or with 40%+ overall revenue/EPS growth. Cash flow is improving, but not at an accelerating rate. The merger offers significant optionality but is not a paradigm shift, and while growth is strong, it is not at the highest possible levels for all signal criteria.
AT Renew (RERE) Q1 2026: 32% Revenue Acceleration Anchored by 45% DTC Shift
AT Renew demonstrates a long reinvestment runway, clear growth inflection, improving unit economics, and a self-reinforcing model. Customer value is deepening and the business model is semi-disruptive. However, while growth is strong, it is not exceptional enough for top marks, and some optionality (AI/international) is still emerging rather than proven. Revenue and EPS growth are robust but not in the highest acceleration band.
West Pharmaceutical (WST) Q2 2026: HVP Components Surge 18%, Driving Guidance Lift and Margin Expansion
West Pharmaceutical shows a long reinvestment runway, clear mix shift, and margin expansion. However, while growth is strong and durable, the business is not entirely disruptive and guidance, while raised, is not at the highest acceleration. The signal is strong for an established leader, but not at the highest level of novelty or upside.
WaterBridge Infrastructure (WBI) Q4 2025: Speedway Phase 2 Adds $100M CapEx, Unlocking Multi-Year Growth Visibility
WaterBridge demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and deepening customer relationships. However, while the business is clearly transitioning to a growth platform with margin and volume upside, the degree of disruption and growth acceleration is strong but not truly exceptional or unique in the infrastructure space. Guidance is conservative and upside is likely but not guaranteed to be explosive. Thus, while the signal is high, it does not reach the absolute maximum.
West Pharmaceutical (WST) Q4 2025: HVP Components Surge 15%, Driving Margin Expansion and Multi-Year Growth Visibility
West has a long reinvestment runway, double-digit HVP growth, improving margins, and strong customer stickiness. However, while growth is robust, it is not at hypergrowth levels (>40%). The business is not highly disruptive but benefits from regulatory and secular healthcare tailwinds. Cash flow is strong and accelerating, but not at an exceptional rate. Overall, the signal is high but not at the very top end for a business of this maturity and visibility.
Caddler (CDLR) Q1 2026: €2.7B Backlog Anchors Multi-Year Offshore Wind Visibility
Caddler demonstrates a long reinvestment runway, high backlog growth, improving unit economics, and a self-reinforcing model with strong customer relationships. However, while the business is transitioning to higher growth, near-term profit is still weighed by costs, and the business model, while differentiated, is not fully disruptive. Growth is strong but not at exceptional levels yet.
BZ Q1 2026: AI-Driven Closed-Loop Revenue Surges 50% as Platform Diversifies User Base
BZ demonstrates a strong reinvestment runway, clear network effects, improving unit economics, and a disruptive business model, with blue-collar and AI-driven services accelerating growth. While not every signal is maximal (e.g., growth acceleration not above 30%, and cash flow not yet sharply accelerating), the business is positioned as a growth platform with meaningful optionality and competitive differentiation.
StepStone Group (STEP) Q4 2026: Fee-Earning AUM Surges $38B, Unlocking Multi-Channel Growth Leverage
StepStone shows strong growth, with record AUM additions, robust private wealth inflows, and a large pipeline of undeployed capital. The business model is diversifying with data monetization and DC channel expansion, but some elements (future growth rates, exceptional guidance) are not at the highest level of signal. The business is a growth platform with clear reinvestment opportunities, but not fully disruptive or showing 40%+ growth across all metrics.
Himalaya Shipping (HSHP) Q1 2026: Spot Exposure Drives 48% Index Premium, Dividend Capacity Expands
HSHP demonstrates a long reinvestment runway, premium growth versus peers, and improving unit economics. There is strong evidence of customer value expansion and cash flow acceleration. While the business model is not fully disruptive, it is differentiated and leverages sector constraints. Growth is robust but not hyper-scaling, and there is some vulnerability to market cycles, capping the signal score below the maximum.
Finvolution (FINV) Q1 2026: Overseas Revenue Jumps 35%, Solidifying Second Growth Engine
Finvolution demonstrates a clear transition to a two-engine growth model with strong reinvestment potential, improving unit economics, and self-reinforcing business model through AI and technology. Overseas segment growth and profitability are significant, but while the business is moving toward higher growth, it is not yet in the hypergrowth or disruptive category. The future outlook is strong, but not exceptional enough to warrant top marks on all signal axes.
Take-Two Interactive (TTWO) Q4 2026: GTA 6 Launch Drives 20% Net Bookings Growth Outlook
Take-Two has a long reinvestment runway and high returns on capital, especially with GTA 6 and a robust pipeline. There is a major business evolution with the GTA 6 launch and a 20% net bookings step-up. Unit economics and customer value are improving through live services, though some moderation is expected in mature titles. The business model is self-reinforcing via live ops and DTC, but not fully disruptive. Cash flow is strong but not rapidly accelerating. Growth is expected to be over 20% but under 40%. The business is clearly in a growth phase, but not all signals are exceptional or disruptive enough for a perfect score.
Edwards Lifesciences (EW) Q2 2026: TMTT Jumps 45% as Multi-Platform Portfolio Drives Durable Growth
Edwards exhibits a long reinvestment runway, exceptional segment growth (TMTT up 45%), improving unit economics, and self-reinforcing business model elements. Customer value is deepening, and the business is firmly in a growth phase. However, while guidance is raised and backlog is strong, the future outlook is not quite 'exceptional' (30%+ acceleration) across the whole business, and the business model, while innovative, is not fully disruptive nor is cash flow acceleration at the highest level. Revenue and EPS growth is solid but not consistently above 40%. Thus, some signal points are conservatively marked down.
SLB (SLB) Q2 2026: Data Center Revenue Surges 80% as Digital and Deepwater Drive Multi-Year Upcycle
SLB demonstrates a strong reinvestment runway with digital, data center, and deepwater growth. There is a significant uptick in data center revenue (80% YoY), improving margins, and recurring digital revenue. However, some signal points are tempered by the business's scale, maturity, and the fact that SLB is a well-followed, large-cap name, so valuation upside may be less asymmetric than for a smaller disruptor. The business is transitioning but not fully disruptive, and while growth is strong, it is not at hypergrowth levels.
PSTG Q1 2027: 73% Evergreen One Growth Drives Subscription Momentum Amidst Volatile Supply Chain
PSTG demonstrates a long reinvestment runway, disruptive subscription growth, improving unit economics, and a self-reinforcing business model. However, while growth is strong, it is not at the absolute top tier (over 40% annualized for total business), and some uncertainty remains around hyperscale ramp and supply chain volatility. The business is a clear growth story but not at the most exceptional level for signal.
SQM (SQM) Q1 2026: Lithium Volumes Surge 25% as Atacama Partnership Drives Expansion
SQM demonstrates a long reinvestment runway, recent significant volume growth, improving unit economics, and a self-reinforcing model in lithium. However, not all signal questions reach the highest bar: guidance and growth, while strong, are not at the most exceptional levels; the business model is semi-disruptive but not fully disruptive; and cash flow acceleration, while present, is not extreme. The business is a clear growth story but faces capital allocation and policy risks.
AMSC (AMSC) Q4 2025: 40% Backlog Surge Signals Multi-Segment Demand Tailwind
AMSC demonstrates a long reinvestment runway, a significant 40% backlog surge, and improving unit economics and margins. The business model is diversifying and showing signs of self-reinforcement, with customer value deepening and a strong growth outlook. However, while growth is robust, guidance and backlog suggest more of a solid acceleration than an exceptional, hyper-growth scenario. The model is semi-disruptive with some legacy elements, and cash flow is improving but not yet at a runaway pace. Overall, the signal is strong but not at the absolute highest level.
Futu (FUTU) Q1 2026: Overseas AUM Surges 47% as International Expansion Outpaces Regulatory Drag
Futu demonstrates a long reinvestment runway, strong international AUM growth, improving margins, and a self-reinforcing model. However, while growth is strong, it is not at the hypergrowth (40%+) level across all vectors, and some business lines (crypto, prediction markets) are still optionality rather than core drivers. The business is transitioning to a growth model with clear upside, but regulatory risk and competitive intensity temper the overall signal.
UiPath (PATH) Q1 2027: AI Drives 6x Larger Expansion Deals, Orchestration Demand Reshapes Platform Adoption
UiPath demonstrates strong growth, a platform shift, and clear AI-driven expansion, but as a well-followed public SaaS name, the upside is somewhat constrained compared to less-covered disruptors. The business model is evolving with improving unit economics, customer value, and cash flow, but the reinvestment runway and disruptive potential, while good, are not at the highest tier. Growth is robust but not hyper-scaling. The signal is strong, but not maximal given the company's maturity and industry context.
MongoDB (MDB) Q1 2027: Atlas Revenue Jumps 29%, AI Adoption Accelerates Platform Stickiness
MongoDB demonstrates a long reinvestment runway, improving unit economics, self-reinforcing business model, and growing customer value. The business is disruptive with accelerating cash flow and is positioned for above-average growth, but not at a hypergrowth (40%+) rate. There is no recent massive uptick in growth or backlog to justify a perfect score, but the AI adoption and platform stickiness provide strong signal.
Pampa Energía (PAM) Q1 2026: Rincón de Aranda Drives 48% EBITDA Surge, Sets $4.5B Growth Platform
Pampa Energía demonstrates a long reinvestment runway, clear operational leverage, improving unit economics, and a vertically integrated, self-reinforcing business model. Customer value is increasing with vertical integration, and the business is positioned for growth rather than legacy stagnation. However, while growth is strong, it is not at the highest acceleration levels and some risks remain around regulatory and execution factors. The business is semi-disruptive but not a pure disruptor, and cash flow is not yet accelerating due to heavy capex, capping the signal score below the maximum.
Elowit (ELWT) Q4 2025: Billed Units Up 77% as Recurring Revenue Engine Accelerates
Elowit demonstrates a long reinvestment runway, disruptive business model, and significant growth in billed units and recurring revenue. Unit economics and customer value are improving, and the business is transitioning toward higher-margin, recurring revenue streams. While growth is strong, guidance and backlog changes are good but not exceptional, and cash flow acceleration is moderate at this stage. The business is clearly in a growth phase, but not yet at the highest acceleration tier.
VersaBank (VBNK) Q2 2026: U.S. Structured Receivable Program Surges 29%, Unlocking Operating Leverage
VersaBank is demonstrating a long reinvestment runway, strong unit economics, and a disruptive digital asset strategy, with clear operating leverage. However, some initiatives (notably digital asset monetization) are still early-stage, and growth, while strong, is not yet at the highest acceleration threshold. The business is transitioning into a high-growth phase, but not all signals are at maximum strength.
Peltos Therapeutics (PTHS) Q1 2026: Zelsuvmi Prescriptions Jump 25% as PBM Access Doubles Units Dispensed
Peltos demonstrates strong prescription growth, expanding coverage, and clear operational leverage, indicating a long runway with high returns. However, while growth is robust, it is not yet at an exceptional or disruptive level, and some uncertainties remain regarding the future impact of new launches and payer dynamics. The signal is high but not at the absolute upper bound for a truly exceptional, disruptive growth story.
Rambus (RMBS) Q2 2026: Product Revenue Jumps 22%, DDR5 and IP Drive Multi-Year Growth Setup
Rambus demonstrates strong growth drivers (DDR5, AI, IP), high returns on capital, and a multi-year growth setup, but the business is not a new disruptor and some elements (like revenue growth) remain below hypergrowth thresholds. The business is not entirely unique or unknown, so signal is slightly discounted despite robust underlying performance.
PowerFleet (AIOT) Q4 2026: Services Revenue Hits 81% Mix, Driving 330bps Margin Expansion
PowerFleet demonstrates a long reinvestment runway, significant business evolution, improving unit economics, and a self-reinforcing SaaS model. Customers appear to be increasing in value and the business is transitioning to a growth phase. However, while the growth and margin expansion are strong, the business is not yet at hyper-growth or fully disruptive scale, and some guidance is solid but not exceptional, leading to a slightly conservative signal score.
OFRM Q1 2026: Price Mix Surges 20% as Cooler Innovation Drives Velocity
OFRM exhibits strong growth dynamics: a long reinvestment runway, disruptive innovation, and improving unit economics. The business is not yet at the highest tier of exceptional future growth (guidance is conservative and margin expansion is managed, not explosive), but the signals for sustained double-digit expansion, pricing power, and channel leverage are robust. Some lateral/disruptive opportunity is present but not dominant.
Arista Networks (ANET) Q3 2025: AI Center Revenue Target Raised to $2.75B, Cementing Multi-Year Growth Visibility
Arista is a growth business with a long reinvestment runway and strong positioning in a secular AI buildout. There is clear evidence of improving unit economics, self-reinforcing business model, and increasing customer value. While growth is robust, the business is not a new or undiscovered story, and some upside is already reflected in consensus expectations.
Bilibili (BILI) Q3 2025: Advertising Revenue Jumps 23% as AI and Engagement Drive Margin Expansion
Bilibili demonstrates a strong reinvestment runway, clear business model evolution, improving unit economics, and self-reinforcing ecosystem. Customer value is deepening, and the business is moving toward higher margins and cash flow. However, growth is robust but not at the most exceptional levels (most guidance and backlog signals are positive but not hyper-growth). The business model is semi-disruptive but not entirely novel, and while revenue/EPS growth is solid, it is not consistently above 40%. Overall, the signal is strong but not at the absolute highest tier.
WaterBridge (WBI) Q4 2025: Speedway Phase 2 Adds $100M CapEx, Accelerating Delaware Basin Expansion
WaterBridge demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and compounding business model advantages. Customer value is increasing, and the business is positioned for growth, but future acceleration is plausible rather than exceptional. The model is semi-disruptive, and cash flow is improving but not yet accelerating at a dramatic pace. Revenue and EPS growth are strong but under 40%. Overall, the signal is high but not at the absolute top end.
Incyte (INCY) Q2 2026: Core Business Ex-Jakafi Up 44%, Pipeline and Launches Diversify Growth
Incyte exhibits a strong reinvestment runway, business model evolution, and improving unit economics, with non-Jakafi assets growing rapidly. However, while growth is robust, the signal is dampened by the lack of a truly disruptive model and only moderate evidence of accelerating cash flow and >40% overall growth. The business is clearly transitioning to a diversified growth platform, but some pipeline and launch risks temper the signal.
Strata Critical Medical (SRTA) Q1 2026: Clinical Revenue Jumps 27% as Platform Integration Accelerates
SRTA demonstrates strong growth, expanding margins, and a clear reinvestment runway with a disruptive integrated platform model. While guidance is reiterated (not raised) and growth is robust but not hyperbolic, the business is not yet at the very highest signal level. Still, the combination of platform integration, M&A, and industry tailwinds offers notable upside and investor relevance.
Bilibili (BILI) Q4 2025: Advertising Revenue Surges 27% as AI Drives Platform Monetization
Bilibili demonstrates a long reinvestment runway, strong unit economics, compounding business model, and deepening customer value. There is clear evidence of accelerating ad revenue and margin expansion. However, while growth is robust, it is not at a hypergrowth (40%+) level, and the business, while emerging as a leader, is not entirely disruptive in the sense of creating a new category. Cash flow is improving but not yet at a runaway acceleration pace. The business is a growth story, but some metrics (such as growth rates and guidance) fall just short of the highest signal marks.
Carpenter Technology (CRS) Q4 2026: SAO Margins Hit 37.8%, Lifting FY27 Growth Floor
Carpenter Technology shows a long reinvestment runway and high ROIC, with clear margin and free cash flow expansion. There is strong evidence of high growth and operational leverage, but the business is relatively well-known and not in a hyper-growth phase (guidance is strong but not >40% growth). The model is self-reinforcing with high customer stickiness and barriers, but not fully disruptive. Cash flow is accelerating but not at an extreme rate. Overall, signal is high, but not at the absolute top end due to the business's maturity and sector familiarity.
Element Solutions (ESI) Q2 2026: Electronics Segment Surges 20%, Raising Full-Year Guidance
ESI demonstrates a long reinvestment runway, strong unit economics, and a self-reinforcing business model with expanding margins and customer value. The business is not fully disruptive but is semi-disruptive with high growth in specific verticals. Growth is strong but not at the highest acceleration tier, and some risks/uncertainties moderate the signal score.
Biodesics (BDSX) Q3 2025: Primary Care Test Orders Jump 75% as Sales Expansion Drives Adoption
Biodesics is demonstrating strong growth signals: primary care test orders up 75%, gross margin expansion, and a doubling of development services revenue. The business model is becoming more self-reinforcing via digital and operational leverage, and partnerships provide optionality. However, while growth is robust, it is not yet at the 40%+ inflection or disruptive scale that would warrant a higher signal score. The business is not yet a household name or proven compounding outlier, but has credible upside.
Enovix (ENVX) Q4 2025: Defense Drives 38% Annual Growth as Smart Eyewear Orders Launch Commercialization
Enovix demonstrates a long reinvestment runway, high growth in defense and smart eyewear, and improving unit economics. However, some uncertainty remains around smartphone commercialization and the ultimate pace of growth, so not all signal criteria are maximized.
Digital Realty (DLR) Q4 2025: Backlog Hits $1.4B as Interconnection Bookings Jump 35%
Digital Realty demonstrates a strong reinvestment runway, compounding business model, and high customer value. The backlog and interconnection growth are significant, but the business is a large, established REIT, so some signal is muted relative to earlier-stage disruptors. Guidance is solid but not exceptional (>30% growth), and while the model is evolving, it is not fully disruptive. Growth is strong but not hyper-growth, and some risks around execution and complexity remain.
RBC (RBC) Q2 2026: Backlog Surges 86% to $1.6B, A&D Demand Drives Capacity Expansion
RBC demonstrates a long reinvestment runway with high returns, an exceptional surge in backlog, and accelerating growth in A&D. Unit economics and cash flow are improving, and the business is transitioning toward a higher-margin, growth phase. However, the business model is not fully disruptive (mainly industrial/A&D manufacturing), and while customer value is improving, it does not show the deepening engagement of a pure compounding platform. Revenue growth is strong but not consistently above 40%, and lateral optionality is moderate. Overall, the signal is high but not at the absolute maximum.
Manhattan Associates (MANH) Q2 2026: Cloud Revenue Jumps 26% as Active Editions Expand TAM
Manhattan Associates demonstrates a strong reinvestment runway, clear inflection in business model, improving unit economics, and a self-reinforcing cloud/AI platform. However, while growth is robust and strategic levers are in play, the business is not in hypergrowth territory (no >40% revenue/EPS acceleration), and some disruption/optionality is still emerging rather than fully proven. The business is highly investable but not at the very highest signal threshold.
BKV (BKV) Q2 2025: Barnett Acquisition Adds 100 MMCFE/D, Extending Low-Decline Inventory Runway
BKV demonstrates a long reinvestment runway, operational outperformance, and a self-reinforcing business model with expanding CCUS and power opportunities. Unit economics are improving, customer value is deepening, and the business is positioned as a growth platform. However, while growth is strong, it is not at a hypergrowth (40%+) level, and some elements (CCUS, premium power) remain in early scaling stages. The business is disruptive but not at the most extreme edge, and cash flow acceleration is moderate rather than explosive.
Baker Hughes (BKR) Q4 2025: Power Systems Orders Surge 150%, Anchoring $32B Backlog Expansion
Baker Hughes shows a strong growth pivot with a long reinvestment runway, record backlog, and accelerating power systems orders. Unit economics and customer value are improving. However, some aspects such as business model disruption and growth rates are strong but not at the most exceptional/transformative level, keeping the signal score slightly below the maximum.
Tradeweb (TW) Q4 2025: Non-Rates Segments Drive 42% of Growth as International, Digital, and Credit Scale
Tradeweb shows a strong reinvestment runway with high returns, significant recent growth in non-rates and international segments, improving unit economics, and a self-reinforcing business model. Customer value is rising, and the business is positioned for secular growth, but digital asset revenue is still volatile and some growth rates are not exceptional (>30%). The business model is semi-disruptive rather than fully disruptive, and while cash flow is growing, it is not yet accelerating at the highest level.
Antero Resources (AR) Q4 2025: HG Deal Lifts Production Base 30%, Unlocks Five-Year Inventory Extension
AR shows a long reinvestment runway, transformational scale from the HG deal, improving unit economics, and a self-reinforcing model. Customer value is increasing and the business is positioned for growth, but not all signals are exceptional (e.g., guidance is strong but not 30%+ acceleration, and the model is not fully disruptive). The business is growth-oriented but not at the highest possible signal tier.
Amgen (AMGN) Q2 2025: Volume Surges 13% as 15 Brands Deliver Double-Digit Growth
Amgen demonstrates a long reinvestment runway, strong volume growth, improving unit economics, and a self-reinforcing business model through its diversified portfolio and biosimilars. Customer value is deepening, and the business is firmly in the growth category. However, while future growth is robust, it is not exceptional enough (30%+ acceleration) to warrant a perfect score. The business model is innovative but not fully disruptive, and cash flow is growing but not accelerating at a transformative rate.
Crane NXT (CXT) Q4 2025: International Currency Backlog Surges 30%, Fueling Capacity Expansion
Crane NXT demonstrates a strong reinvestment runway, major backlog uptick, improving unit economics, and deepening customer stickiness. The business model is partially disruptive with recurring revenue streams, but some elements (CPI) are mature and face headwinds. Growth is robust but not hyper-scaling, and some risk remains around margin expansion and integration. Signal is strong but not exceptional due to these execution and industry constraints.
Ascendis Pharma (ASND) Q4 2025: Yorvipath Uptake Lifts 187M Euro, Sets Stage for 10-Country Expansion
Ascendis demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is transitioning to growth. However, there are some areas (future growth acceleration, disruptive model, cash flow acceleration, and >40% revenue/eps growth) where the company is strong but not at the highest possible signal threshold, meriting a conservative approach to scoring.
Pampa Energía (PAM) Q4 2025: Rincón de Aranda Drives 32% Output Surge, Power Margins Expand Under Market Shift
Pampa Energía demonstrates a strong growth runway with high-return reinvestment, significant production ramp, and improving unit economics. The business model shows increasing self-reinforcement via vertical integration. However, some signal areas are capped by Argentina’s regulatory volatility and capital intensity, with growth and cash flow not yet at the most exceptional levels. The business is at a strategic inflection but not a clear outlier for runaway growth.
BlackRock Coffee Bar (BRCB) Q1 2026: Segmented Loyalty Offers Double Engagement, Fueling 24% Growth
BRCB shows a strong reinvestment runway, improving unit economics, and clear digital/loyalty-driven business model advantages. While growth is robust, it is not yet at a hyper-scaling level, and competitive/comp headwinds temper the signal. Still, the business is a clear growth story with some disruptive elements and compounding advantages.
ON (ON) Q4 2025: AI Data Center Revenue Surpasses $250M, Reshaping Power Semiconductor Growth Mix
ON is undergoing a structural business model shift with a long reinvestment runway (AI, automotive, industrial electrification). The AI data center segment has become a material growth driver, and margin expansion levers are visible. However, while growth is strong, the outlook does not indicate truly exceptional (40%+) acceleration, and some elements (e.g., future cash flow acceleration, disruptive model) are present but not at the highest level. Risks and cyclicality remain, keeping the score below the maximum.
ELUT Q2 2025: LU Pro Drives 49% Sequential Growth, Margin Expansion Signals Scalable Platform
ELUT demonstrates a strong reinvestment runway, rapid sequential growth, improving unit economics, and a business model with emerging self-reinforcing elements. Customer value is increasing, but the future, while bright, is not yet exceptional or fully de-risked. The business is transitioning into growth, but some risks and uncertainties remain, especially in pipeline execution.
Williams (WMB) Q4 2025: Power Projects Drive $7.3B Growth Platform, Doubling Down on 10%+ EBITDA Target
Williams is showing a clear strategic pivot with a long reinvestment runway, high returns on capital, and strong backlog growth. Unit economics are improving, the business model is increasingly self-reinforcing, and customer value is rising. However, the growth, while strong, is not at the highest acceleration levels (over 40%), and the business—while evolving—is not a pure disruptive model. Cash flow is improving but not yet at an accelerating pace, and forward growth is strong but not exceptional.
Solstice Advanced Materials (SOLS) Q2 2026: Electronics Revenue Climbs 15% on Semiconductor Demand Surge
Solstice demonstrates strong secular growth drivers, capacity expansion, and a major acquisition, but most segments are not yet showing explosive (40%+) growth, and the business model—while exposed to secular trends—is not fully disruptive. Margins are temporarily pressured, and while growth is robust, the signal is somewhat tempered by execution and integration risks.
CorePay (CPAY) Q4 2025: Corporate Payments Up 16% as Portfolio Rotation Accelerates
CorePay exhibits strong growth, high returns on capital, and a clear portfolio rotation toward higher-margin businesses. While the business is in transition, the inflection is significant, with double-digit growth, visible runway, and accretive M&A. However, some legacy and integration risks temper the signal score.
CorePay (CPAY) Q4 2025: Corporate Payments Up 16% as Portfolio Rotation Accelerates
CorePay demonstrates a long reinvestment runway, clear business model evolution, and improving unit economics. Growth is strong but not yet at a hypergrowth (40%+) level. The business model is semi-disruptive, with some legacy exposure. Cash flow is improving but not yet accelerating at the highest tier. The business is firmly in growth mode, but not all signal levers are maxed; some areas (e.g., future growth acceleration, disruptive model) are present but not exceptional.
Edwards Lifesciences (EW) Q4 2025: TMTT Grows 40%, Expanding Next-Gen Valve Leadership
Edwards demonstrates a long reinvestment runway, strong growth in TMTT, improving unit economics, and self-reinforcing business model with sticky share gains. Customer value is deepening, and the business is transitioning toward higher cash flow. However, while growth is robust, it is not exceptional or disruptive enough to warrant top scores in all categories, and guidance implies mid-teens rather than hypergrowth. The business is a growth leader but not a new or undiscovered story.
Lumexa Imaging (LMRI) Q4 2025: 40% Throughput Gain From AI Drives Advanced Imaging Margin Expansion
Lumexa demonstrates a long reinvestment runway, high ROIC potential, and a disruptive, capital-light model with clear margin expansion and advanced modality growth. The 40% AI-driven throughput gain is a material business evolution, and unit economics are improving. However, while growth is strong, guidance and backlog do not indicate 30%+ acceleration, and some elements (cash flow, revenue growth) are solid but not truly exceptional. The business is a growth compounder but not at the highest tier of signal.
Ascendis Pharma (ASND) Q4 2025: Yorvipath Uptake Lifts 187M Euro, Sets Stage for 10-Country Expansion
Ascendis shows strong reinvestment runway, commercial inflection, and evidence of improving unit economics and customer value. The business model is self-reinforcing with potential for operational leverage. Guidance is ambitious and growth is credible, but the business is not yet an obvious hypergrowth outlier, and some pipeline/label expansion is still pending, warranting a slightly conservative score.
RadNet (RDNT) Q2 2025: Advanced Imaging Mix Rises 102bps as AI and Capacity Initiatives Drive Margin Expansion
RadNet demonstrates a long reinvestment runway, strong recent developments, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is in growth mode with accelerating cash flow. However, while digital health and AI are promising, the external platform opportunity is still developing and not yet exceptional, and growth, while strong, does not consistently exceed 40% across all metrics. The business is semi-disruptive with some legacy elements, so scores are rounded down where warranted.
RadNet (RDNT) Q2 2025: Advanced Imaging Mix Rises 102bps as AI and Capacity Initiatives Drive Margin Expansion
RadNet demonstrates a long reinvestment runway at high returns, clear margin expansion, and a shift to higher-value modalities. There are recent significant developments (AI rollout, margin expansion, acquisitions) and strong unit economics. The business model is becoming more self-reinforcing, with some disruption potential. However, while growth is accelerating, it is not yet at an exceptional level (>30% across the board), and digital health externalization is still emerging. The business is growth-oriented, but not at the highest possible signal for disruptive upside.
Q (Q) Q4 2025: ICS Segment Surges 12%, Accelerating Margin Expansion and Advanced Node Content
Q demonstrates a strong reinvestment runway, clear margin expansion, and business model leverage via ICS and advanced node exposure. Growth is robust but not hyper-accelerating (>40%), and while the business is innovative, it is not fully disruptive versus legacy models. Cash flow is strong but not rapidly accelerating. The business is a growth leader, but not delivering the highest signal on every axis.
BioLife Solutions (BLFS) Q2 2025: Cell Processing Revenue Up 28% as BPM Share Hits 70% of U.S. CGT Trials
BLFS demonstrates a long reinvestment runway, dominant market share in a growing field, and improving unit economics. The business model is self-reinforcing with strong customer embeddedness and increasing ARPU potential. While growth is robust, it is not universally exceptional (not exceeding 40%+), and some aspects (cash flow, disruptive model, future guidance) are positive but not at the highest threshold. The company is a clear growth business with strong optionality, but not a hypergrowth or highly disruptive outlier.
TPG (TPG) Q4 2025: Capital Formation Surges 71% as Diversification Accelerates Fee Power
TPG demonstrates a strong reinvestment runway, record capital formation, improving unit economics, and a self-reinforcing model with deepening customer value. However, while growth is robust, it is not at the extreme acceleration threshold for the highest scores in all categories. The business is transitioning toward a growth phase with significant optionality, but some elements (like fee rate compression and execution risk) temper the signal score. Still, the platform's evolution and earnings power make it highly relevant for investors.
BioLife Solutions (BLFS) Q2 2025: Cell Processing Revenue Up 28% as BPM Share Hits 70% of U.S. CGT Trials
BLFS shows strong recurring revenue, margin expansion, and embeddedness in a high-growth sector, with signs of durable competitive advantage. While growth rates and guidance are robust, some metrics (like future acceleration and disruptive potential) are promising but not yet exceptional, warranting a slightly conservative signal score.
Oracle (ORCL) Q3 2026: Multi-Cloud Database Revenue Surges 531%, Unlocking Recurring Cloud Profitability
Oracle is a well-followed, large-cap business, so the signal score is capped by its maturity and visibility. However, the article demonstrates a rare acceleration in growth, a major business model shift, strong margin expansion, and a large backlog conversion. While not a new disruptor, the scale and velocity of change provide above-average signal for a mature tech platform.
Corneet Digital (KRNT) Q4 2025: AIC Revenue Surges 104% as Recurring Model Reshapes Core
Corneet Digital is undergoing a major business model transformation with a long reinvestment runway and compounding recurring revenue. Recent AIC revenue growth is exceptional, but near-term topline growth is muted due to the transition. Unit economics, customer value, and business model quality are improving, but the company is not yet a hypergrowth outlier and faces some execution risk in new verticals.
Alchemy Technology (ALKT) Q2 2026: Bank Clients Now 30% of Launches, Platform Expansion Drives Margin Upside
Alchemy demonstrates a long reinvestment runway, strong recurring revenue model, improving margins, and clear ARPU expansion, supported by a shifting customer mix and platform adoption. While not a breakout hypergrowth story, the business shows above-market growth, margin expansion, and compounding potential. The model is not truly disruptive but benefits from SaaS platform dynamics and sector tailwinds.
EOG (EOG) Q4 2025: Free Cash Flow Up 20% in New Three-Year Plan, Multi-Basin Model Extends Durability
EOG demonstrates a long reinvestment runway, significant free cash flow growth, improving unit economics, and a resilient, diversified business model. However, while growth is strong, it is not in the hypergrowth (>40%) category, and customer value deepening is present but not exceptional. The business is growth-oriented but not disruptive, and future guidance is solid but not extraordinary.
Adaptive Biotechnologies (ADPT) Q4 2025: MRD Revenue Jumps 46% as ASP and Volume Tailwinds Strengthen
Adaptive Biotechnologies shows a strong reinvestment runway, clear margin and ASP inflection, and business model leverage. Growth rates are high but not explosive enough for top marks, and while data monetization is emerging, it is not yet fully proven or disruptive. The business is transitioning to profitability, with strong signals in MRD but still some execution risk and uncertainty in immune medicine scale.
QRVO Q2 2026: $500M Synergy Target Signals Scale Leap as Skyworks Merger Redefines RF Landscape
The merger creates a scaled, diversified platform with a long reinvestment runway, improving margins, and strong customer stickiness. However, growth rates are not guided above 20% annually, and while the business is transitioning toward higher growth, it is not yet a clear hyper-growth or highly disruptive story. The business model is semi-disruptive, and cash flow is accelerating but not yet at the highest tier. The signal is strong but not at the absolute maximum due to these moderating factors.
Allegro MicroSystems (ALGM) Q1 2026: E-Mobility Sales Jump 31% as Design Wins Fuel Strategic Tailwind
Allegro shows strong secular tailwinds, margin expansion, and design win momentum in high-growth verticals. However, while growth is robust and the business model is attractive, the evidence for exceptional future acceleration (over 30-40% growth) is not fully present. The business is not a clear-cut disruptor but is showing solid growth characteristics.
Regeneron (REGN) Q2 2026: Dupixent Drives 38% Growth, Pipeline Milestones Build Multi-Front Momentum
Regeneron demonstrates a long reinvestment runway with high returns, significant growth in key franchises, and improving unit economics. The business model is self-reinforcing and customer value is increasing. While future growth is strong, it is not exceptional or fully disruptive, and cash flow acceleration is moderate. Revenue and EPS growth is robust but not above 40% annually. Overall, the business is a clear growth story, but not at the very highest level of signal.
NBR Q2 2026: International EBITDA Margin Expands 127bps as Saudi Growth and Tech Upside Accelerate
NBR demonstrates a long reinvestment runway, clear margin and technology-driven business model improvements, and international scale. While growth is strong and the business is transitioning toward higher quality, it does not quite reach the threshold for exceptional acceleration or disruptive model, and some metrics are just shy of the highest possible signal.
Q (Q) Q4 2025: ICS Segment Surges 12%, Accelerating Margin Expansion and Advanced Node Content
Q demonstrates a long reinvestment runway, double-digit growth in ICS, improving unit economics, and a self-reinforcing business model with increasing advanced node content. However, while guidance and transformation targets are strong, the business is not truly disruptive and growth, while robust, is not at the highest tier for all signal metrics.
Antarex (ATEX) Q3 2026: OPEX Down 20% as Recurring Revenue Model Accelerates Utility Adoption
Antarex demonstrates a long reinvestment runway with high returns, clear business model evolution, improving unit economics, and deepening customer value. However, while growth is strong and the model is transitioning to recurring revenue, the business is not yet at the point of exceptional, sustained acceleration (e.g., >40% growth or industry-defining disruption). Regulatory risks and the need for further customer conversion temper the signal slightly.
Adaptive Biotechnologies (ADPT) Q4 2025: MRD Revenue Jumps 46% as ASP and Volume Tailwinds Strengthen
Adaptive Biotechnologies demonstrates a long reinvestment runway, disruptive business model, and improving unit economics. There is strong growth in MRD revenue and margin, but the business is not at the level of a hypergrowth breakout or a totally unique platform, so signal is strong but not at the absolute maximum. Some future projections (e.g., immune medicine monetization) are early-stage, and guidance is robust but not at an exceptional acceleration level.
RBC Bearings (RBC) Q4 2026: Aerospace & Defense Surges 41%, Backlog Hits $2.3B as Submarine and Missile Ramps Accelerate
RBC Bearings demonstrates a long reinvestment runway, clear growth in backlog, and improving unit economics. The business model is increasingly self-reinforcing with content expansion and customer deepening. However, the growth outlook, while strong, is not fully exceptional (most guidance is high teens, not >30%), and the business is not fundamentally disruptive or likely to deliver 40%+ annual growth. Cash flow is growing but not yet accelerating at a dramatic pace. The company is a strong growth story but not a breakout or hypergrowth disruptor.
Supermicro (SMCI) Q1 2026: $13B GB300 Orders Signal AI Data Center Surge Despite Margin Compression
SMCI demonstrates a long reinvestment runway, disruptive business model, and strong growth signals with record orders and backlog. However, margin compression, execution risk, and working capital strain moderate the overall signal, and while growth is robust, it is not at the most exceptional level across all criteria.
FICO (FICO) Q3 2026: Platform ARR Surges 62% as Legacy Migrations Accelerate
FICO demonstrates a long reinvestment runway, accelerating platform growth, improving unit economics, and a self-reinforcing model. However, mortgage concentration and some competitive/regulatory risks cap the signal score. The business is transitioning but not yet at the highest growth inflection, so scores are conservatively rounded down.
Antarex (ATEX) Q3 2026: OPEX Down 20% as Recurring Revenue Model Accelerates Utility Adoption
Antarex is transitioning into a recurring revenue model with strong operating leverage, a large addressable market, and regulatory catalysts. The business is not yet showing 40%+ growth or exceptional backlog expansion, but has clear growth signals, improving unit economics, and a disruptive model in a sector with high barriers. Cash flow is improving, but not yet accelerating at an exceptional level. The company is at a strategic inflection, but not an explosive growth phase.
Blackstone (BX) Q2 2025: Fee-Related Earnings Surge 31% as Private Credit and Wealth Inflows Accelerate
Blackstone demonstrates a strong multi-engine growth model with clear reinvestment runway, robust fee-based earnings, and secular growth levers in private credit and wealth. While most metrics are exceptional (AUM growth, credit/wealth momentum, embedded earnings power), some elements like the realization ramp and real estate recovery are still gradual, capping the signal score below perfect. The business is high-quality and compounding, but not at the disruptive/exceptional inflection point that would merit a higher score.
RadNet (RDNT) Q1 2026: Digital Health ARR Surges 95%, Unlocking AI-Driven Margin Expansion
RadNet demonstrates a long reinvestment runway, strong growth in digital health ARR, improving unit economics, and a self-reinforcing business model. While the growth is robust, some elements (e.g., exceptional future guidance or disruptive potential) are strong but not at the highest possible level. The business is clearly in a growth phase, but not every signal dimension is maxed out.
Twilio (TWLO) Q4 2025: Voice AI Revenue Surges 60%, Catalyzing Platform Shift
Twilio demonstrates a long reinvestment runway with high returns (AI, multi-product), strong recent growth in Voice AI and large deals, improving unit economics and customer value, and a self-reinforcing platform model. While growth is strong, it is not exceptional sector-wide, and some elements (business model disruption, cash flow acceleration, revenue/EPS growth rate) are solid but not at the highest end of the scale. The business is clearly a growth business, but not at the most explosive stage.
CorePay (CPAY) Q3 2025: Corporate Payments Surges 17% as Segment Approaches 40% of Revenue
CPAY demonstrates strong reinvestment runway, double-digit growth, improving unit economics, and self-reinforcing business model. Customer value is increasing, and the business is positioned for continued growth, though not at an exceptional acceleration. Stablecoin and M&A provide optionality, but the business is not fully disruptive nor at 40%+ growth, warranting a conservative signal score.
IEX Q2 2026: 28% Order Surge Anchors Multi-Year Visibility in Data Center and Defense
IEX demonstrates a strong secular growth runway with high returns on capital, a significant order inflection, and improving unit economics. The business model is self-reinforcing with rising recurring revenue and high-value customer relationships. However, while the growth is robust, it is not quite at the most exceptional (over 40% growth) level, and some elements (such as future cash flow acceleration and disruptive potential) are present but not extreme. The business is clearly a growth story with high visibility but not at the very highest signal tier.
Vertex (VRTX) Q3 2025: Genavix Prescriptions Surge to 300,000 as Renal Pipeline Accelerates
Vertex demonstrates a strong reinvestment runway, clear growth in new franchises, and improving unit economics, but some signal is restrained by the business's scale, competitive risk, and the fact that it is already a well-followed large-cap. The most exceptional growth is in Genavix and the renal pipeline, but overall business transformation is still developing, not yet explosive across all metrics.
MindWalk (HYFT) Q1 2026: Netherlands Divestiture Adds $16.1M, Accelerating Shift to AI Platform Model
MindWalk’s transformation to a high-margin, scalable AI platform with divestiture proceeds and early SaaS traction signals substantial upside. The business model is disruptive with a long runway, and unit economics are improving. However, evidence of accelerating cash flow and customer value deepening is emerging rather than fully established, and growth, while strong, is not yet at the highest tier. The opportunity is significant but not yet proven at the highest level.
Cellebrite (CLBT) Q4 2025: ARR Mix Shift to 14% High-Growth Solutions Signals Platform Acceleration
Cellebrite demonstrates a long reinvestment runway with expanding high-growth ARR, improving unit economics, and a self-reinforcing SaaS/cloud model. While the ARR mix shift and new data sources are compelling, growth rates are strong but not explosive, and some elements (AI monetization, federal catalysts) are still optionality rather than base case. The business is transitioning to a growth platform, but the signal is slightly muted by the lack of 40%+ growth or a truly disruptive inflection.
ProPetro (PUMP) Q2 2026: Contracted Power Jumps 46% to 350MW as Data Center Pipeline Builds
ProPetro demonstrates a long reinvestment runway and significant recent business developments, particularly in the ProPower segment. Unit economics and business model self-reinforcement are improving, with customers becoming more valuable. While growth is strong, it is not yet exceptional or at hypergrowth levels, and the business model is semi-disruptive rather than fully disruptive. Cash flow is accelerating but not yet at peak levels. The company is transitioning into a growth business but is not yet in the highest growth cohort.
Glaukos (GKOS) Q2 2026: Epioxa Drives 90bps Gross Margin Gain as Launch Momentum Builds
Glaukos demonstrates a long reinvestment runway, high-margin product launches, improving unit economics, and a self-reinforcing business model. However, while growth is strong, some forward guidance is conservative and there is not clear evidence of >40% growth or truly exceptional acceleration. The business model is innovative but not radically disruptive. Cash flow is improving but not yet a clear machine. Signal is strong but not at the highest tier for a truly paradigm-shifting business.
Redwire (RDW) Q4 2025: Backlog Hits $411M as Production Mix Drives 41% Growth Outlook
Redwire exhibits a long reinvestment runway, significant backlog growth, improving unit economics, and a more self-reinforcing model post-acquisition. Customer value is increasing, and the business is transitioning to growth, but margin recovery and execution risk temper the exceptional signal. Growth is strong but not yet at the highest tier, and the business model, while improving, is not fully disruptive.
Amentum (AMTM) Q1 2026: Nuclear Awards Surpass $1B, Accelerating High-Margin Backlog Shift
Amentum is showing clear improvement in margin mix, backlog quality, and multi-year growth trajectory, with significant nuclear and space contract wins. While the business is transitioning strongly toward higher-margin, compounding opportunities, growth rates and cash flow are not yet at the most exceptional levels, and the business is not fully disruptive. Still, the signal is above average for investor relevance.
PTC Therapeutics (PTCT) Q2 2026: Suffiance Drives 21% Sequential Growth, Global Launch Expands Revenue Base
PTC demonstrates a substantial reinvestment runway, rapid product growth, improving unit economics, and a self-reinforcing rare disease platform. Customer value is increasing, but guidance and backlog growth are strong rather than exceptional. The business model is semi-disruptive, with accelerating but not explosive cash flow and revenue growth. The company is a clear growth business but not at the highest tier of signal for transformative upside.
Jumia (JMIA) Q4 2025: Physical Goods GMV Jumps 38% as Scale Drives Margin Progress
Jumia demonstrates a strong reinvestment runway, clear operating leverage, improving unit economics, and deepening customer value. There is significant GMV and order growth, and the business model is showing early signs of network effects and defensibility. However, advertising monetization is still nascent, and while growth is strong, it is not yet at the 'exceptional' acceleration level for all signal questions. The business is transitioning to growth, but some levers (e.g., cash flow and disruptive model) are not fully proven, warranting a slightly conservative score.
MACOM (MTSI) Q1 2026: Data Center Outlook Raised to 40% as 1.6T Optical Demand Accelerates
MACOM demonstrates strong reinvestment potential, clear margin and revenue growth, and a diversified model with secular tailwinds. However, while the growth profile is robust and guidance is strong, the business is not at the most disruptive or hypergrowth end of the spectrum, and some signals (guidance, cash flow, model disruption) are good but not exceptional.
Qualcomm (QCOM) Q3 2026: Automotive Revenue Surges 61% as Data Center and Non-Handset Mix Accelerate Diversification
Qualcomm is executing a material business mix shift with strong growth in automotive and data center, but some signal is capped by the business's large cap status and ongoing margin/cost headwinds. The reinvestment runway is clear, but true step-change acceleration is still emerging.
IBEX (IBEX) Q2 2026: Health Tech Surges 35%, Shifting Margin and Growth Mix
IBEX demonstrates a long reinvestment runway, clear business evolution with health tech and AI, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is transitioning to higher growth and margin verticals. However, guidance and backlog growth are good but not exceptional, and the business model, while evolving, is not fully disruptive. Cash flow is improving but not yet accelerating, and growth is strong but not at the highest tier.
Equinix (EQIX) Q3 2025: Pre-Sold Bookings Jump to $185M, Fueling Accelerated Capacity Expansion
Equinix demonstrates a long reinvestment runway, accelerating bookings, improving unit economics, and a self-reinforcing model with high customer value. While growth is strong, it is not at hypergrowth (40%+) levels, and the business is not fundamentally disruptive but rather a scaled incumbent with strong competitive advantages. Signal is high but not at the absolute maximum due to these factors.
Neurocrine Biosciences (NBIX) Q4 2025: Chronicity Captures 10% CAH Share in First Year, Pipeline Readies for Data Surge
Neurocrine demonstrates a long reinvestment runway, strong recent growth, improving economics, and deepening customer value. The business model is self-reinforcing and disruptive within its categories, but the growth outlook, while very strong, does not quite reach the highest acceleration tier (>40%). Cash flow is strong but not yet accelerating at the highest rate. The business is clearly a growth platform, but the pipeline and market opportunity, while robust, are not entirely unique or explosive versus the most exceptional biotech stories.
ArcSys (ARXS) Q1 2026: Backlog Covers 90% of Year, Locking in 18% Growth Visibility
ArcSys demonstrates a long reinvestment runway, strong backlog-driven growth, improving unit economics, and a self-reinforcing business model. However, while growth and margin expansion are strong, the business model—though robust—is not highly disruptive, and forward growth (while solid) is not at the hyper-growth threshold. Cash flow is improving but not yet accelerating dramatically, and guidance for future growth is strong but not exceptional.
LiveRamp (RAMP) Q4 2026: 2.9% EPS Accretion Forecast as Publicis Bets on Data Co-Creation
LiveRamp shows a strong SaaS growth profile with high retention, margin expansion, and a long reinvestment runway, but international scaling and revenue synergy realization remain unproven. The business model is self-reinforcing with some disruptive elements, but the future outlook is solid rather than exceptional. Revenue and EPS growth is strong but not at hypergrowth levels.
BAM Q3 2025: $106B Fundraising Wave Unlocks Next-Gen Growth Engines
BAM demonstrates a long reinvestment runway, strong business model, improving unit economics, and clear platform compounding. However, while growth is robust, some areas (guidance, cash flow acceleration, disruptive model) are good but not exceptional, and the business is already well-followed, which tempers the signal score.
Comstock Resources (CRK) Q4 2025: Reserve Additions Replace 229% of Production, Western Hainesville Growth in Focus
Comstock demonstrates a long reinvestment runway, disruptive elements (midstream monetization, data center/LNG demand), and improving unit economics, but is still a commodity business with some execution and market risks. Growth is solid but not hyper-accelerating (most guidance is high single to low double digits). The business is transitioning to a higher-growth phase but is not yet at the level of a breakout compounder.
Explore Infrastructure (XIFR) Q4 2025: $1.1B SEPF Buyout Reduces Third-Party Equity, Unlocks Portfolio Control
Explore Infrastructure demonstrates a long reinvestment runway with high-return repowering and storage projects, major capital structure simplification, and improving cash flow retention. The business model is increasingly self-reinforcing, with customer value and asset monetization optionality improving. While growth is solid and the outlook is positive, the business is not yet in an exceptional hyper-growth phase, and some model elements remain traditional. Signal is strong, but not at the highest level for disruptive growth.
Vinci Compass (VINP) Q1 2026: Fee-Related Earnings Jump 47% as Argentina Expansion, AI Investment Drive Platform Scale
Vinci Compass demonstrates a long reinvestment runway, strong growth in fee-related earnings, improving unit economics, and a self-reinforcing business model with regional and technological advantages. However, while growth is robust, it is not at an exceptional acceleration rate across all metrics, and some elements (e.g., cash flow, disruptive potential) are promising but not fully proven.
Unity (UNIT) Q1 2026: Fiber Revenue Climbs 15% as Hyperscaler AI Demand Accelerates
Unity demonstrates a strong reinvestment runway, clear growth in fiber and recurring revenue, and improving unit economics. However, while growth is robust, it is not yet at the exceptional acceleration level in all areas, and some elements (like disruptive potential and cash flow acceleration) are present but not at the highest threshold. The business is in transition to a growth model, with strong signals but not maximal in every dimension.
BRCB Q4 2025: 52% EBITDA Growth Anchors Aggressive 1,000-Unit Expansion Path
BRCB demonstrates a long reinvestment runway, strong unit economics, and a self-reinforcing business model with deepening customer value. There is clear evidence of growth and margin expansion, but the business is not a disruptive tech platform, and growth—while robust—is not at the hypergrowth/exceptional level (>40%) in the forward outlook. The risk of cost and competitive headwinds tempers the signal score slightly. The business is a growth compounder but not a breakout disruptor.
Novo Nordisk (NVO) Q1 2026: Obesity Care Sales Jump 22% as Oral Wegovy Redefines Category
Novo Nordisk exhibits a strong reinvestment runway in obesity and rare disease, with clear evidence of pipeline momentum and strategic transformation. However, near-term growth is tempered by price compression and patent cliffs, and while the business is not a new discovery, the transition to obesity leadership provides meaningful valuation upside. The signal is high, but capped by the maturity of the core diabetes franchise and the competitive, payer-driven risks in the U.S. market.
Intapp (INTA) Q2 2026: Cloud ARR Jumps 31% as AI-Driven Expansion Accelerates
Intapp demonstrates a strong growth profile with a notable cloud ARR jump, high net retention, and expanding enterprise penetration. The business model shows signs of self-reinforcement (partner leverage, vertical AI), improving unit economics, and a clear runway, but lacks the truly exceptional acceleration or disruption needed for a perfect score. The company is more a high-quality vertical SaaS compounder than a hyper-growth disruptor, justifying a strong but not top-tier signal rating.
Dynatrace (DT) Q3 2026: Log Management Surges 100%+, Fueling ARR Momentum and Platform Expansion
Dynatrace demonstrates a long reinvestment runway, strong unit economics, a self-reinforcing platform, and deepening customer value. While growth is robust and logs are a breakout category, ARR growth is high but not explosive, and the business is not a new disruptor. The signal is strong, but not at the highest possible level for an under-the-radar or explosive growth story.
Affirm (AFRM) Q2 2026: Active Merchants Surge 42% as Card and “Other” Verticals Broaden Growth Base
Affirm demonstrates strong reinvestment potential, accelerating merchant and card growth, improving unit economics, and a self-reinforcing platform. However, the business is not in hyper-growth mode (GMV guidance is 30%), and while the model is disruptive, the competitive field is crowded and regulatory risk is present. Signal is strong but not at the highest possible level due to growth moderation and sector maturity.
RADCOM (RDCM) Q4 2025: Gross Margin Climbs to 77.6% as AI and 5G Drive Expansion
RADCOM shows a strong reinvestment runway, record profitability, and high gross margins, with clear optionality in AI and Tier 1 expansion. Recent growth is strong but not at hypergrowth levels. Unit economics and customer value are improving. The business model has some self-reinforcing elements but is not a pure platform or network effect play. Growth is solid but not explosive, and while the outlook is good, it is not exceptional. The company is transitioning toward higher growth, but some uncertainty remains around pipeline conversion and partnership monetization.
Regeneron (REGN) Q1 2026: Dupixent Drives 31% Growth, Pipeline Sets Up Multi-Blockbuster Visibility
Regeneron demonstrates a long reinvestment runway, strong unit economics, compounding business model, and growing customer value. There is evidence of significant growth in key franchises and a diversified pipeline. However, while the growth is strong, it is not consistently above 40%, and some pipeline elements are not fully de-risked, keeping the signal score slightly below maximum.
Rivian (RIVN) Q4 2025: Software & Services Revenue Surges 60%, Anchoring Gross Profit Turnaround
Rivian demonstrates a long reinvestment runway, strong recent growth in software and services, and improving unit economics. The business model is becoming more self-reinforcing, customers are increasing in value, and the future outlook is positive but not yet exceptional. While the business is disruptive and shows good cash flow trajectory, the growth rates and business transition are strong but not at the very highest level, warranting a conservative signal score.
Virtu Financial (VIRT) Q2 2026: Trading Capital Surges 70% to $3.4B as Talent and Tech Drive Platform Growth
Virtu demonstrates a long reinvestment runway with high ROIC, a significant uptick in capital base and profitability, and improving unit economics. The business model is self-reinforcing through technology and talent, and customer value is deepening. However, while growth is strong and diversified, it does not clearly exceed 40% YoY, and the business, though innovative, is not fundamentally disruptive or poised for hypergrowth. Cash flow is robust but not yet accelerating at a transformational pace. The company is a growth business with some transition elements.
NeuroOne Medical (NMTC) Q2 2026: 1RF Revenue Jumps 72% as Clinical Adoption Expands
NeuroOne shows a long reinvestment runway, strong recent growth, improving unit economics, and a self-reinforcing business model driven by clinical data. Customer value is increasing, and the business is transitioning toward growth, but some pipeline and international catalysts remain prospective rather than realized. Cash flow is not yet accelerating, and guidance implies solid but not exceptional near-term growth. Signal is high for a small-cap medtech, but not at the extreme end of disruptive or hypergrowth.
Wealthfront (WLTH) Q1 2027: Investment Advisory Assets Surge 39% as Cross-Product Incentives Deepen Platform Engagement
Wealthfront demonstrates a long reinvestment runway, strong growth in advisory assets, and improving client engagement metrics. The business model is self-reinforcing with automation and cross-product incentives, but some elements (cash flow, disruption, future growth pace) are good but not exceptional. The company is transitioning toward a multi-product platform with strong growth characteristics but is not yet at the level of a hyper-growth or highly disruptive business.
HepsiBurada (HEPS) Q4 2025: 89% Off-Platform Logistics Surge Reshapes Margin Mix
HepsiBurada demonstrates a strong shift toward high-margin, platform-adjacent services with clear reinvestment avenues (logistics, fintech). There is evidence of rapid growth in off-platform logistics and lending, improved unit economics, and a business model with emerging self-reinforcing dynamics. However, macro headwinds and lack of explicit guidance temper the outlook, and while disruptive, the business is not yet at the highest level of signal for runaway growth or cash flow.
Cognex (CGNX) Q1 2026: Semi Revenue Surges Above 20%, AI-Driven Productivity Reshapes Growth Path
Cognex demonstrates strong growth in key segments, robust margin management, and a clear AI-driven reinvestment runway, with evidence of improving unit economics and customer value. However, management's caution on second-half visibility and the transition from cost actions to productivity temper the exceptionalism of the signal. The business model is innovative but not fully disruptive, and while growth is strong, it is not at a hypergrowth inflection.
First Solar (FSLR) Q2 2026: Gross Margin Surges to 57% on Tariff Benefits and U.S. Manufacturing Scale
First Solar demonstrates a strong competitive moat in U.S. manufacturing, high backlog, and pricing power, with clear policy-driven growth levers. However, while growth is robust, some metrics (like revenue and EPS growth) are not at hypergrowth levels, and policy risk tempers the signal. The business is not entirely disruptive (solar module manufacturing is established), but technology and policy alignment provide upside. Backlog and margin expansion are positive, but not all signals point to explosive near-term growth.
DLocal (DLO) Q1 2026: Africa and Asia Gross Profit Jumps 16%, Diversifying Growth Engine
DLocal demonstrates a long reinvestment runway, recent significant growth in new regions, improving unit economics, and a self-reinforcing business model. Customer value is increasing and the business is transitioning to a new phase, but not all metrics are at the highest acceleration, and some elements (like cash flow and guidance) are good but not exceptional. The business is growth-oriented with some disruptive aspects but not at the most extreme levels of signal.
ClearPoint Neuro (CLPT) Q3 2025: ERIS Merger Adds $9M Platform, Expands Addressable Market by $500M
ClearPoint demonstrates a long reinvestment runway, significant new developments (ERIS merger, CRO launch), and improving unit economics. The business model is self-reinforcing and recurring, with customer value deepening. However, some elements (future growth, disruption, and cash flow) are not yet at the highest level of acceleration, and guidance is good but not exceptional.
Dutch Bros (BROS) Q4 2025: Shop Count Surges 16% as Pipeline Doubles, Cementing 2,029 Goal
Dutch Bros demonstrates a long growth runway, improving unit economics, network effects through loyalty, and strong customer value expansion. However, while growth is robust, it is not at an exceptional (40%+) level, and some innovation levers (food, urban formats) are still in early stages. The business is not disruptive at the level of a new platform, but is semi-disruptive within its segment. Margins and cash flow are improving, but not yet at an accelerating level. The business is clearly a growth story, but not at the most extreme end of the spectrum.
Audia (ADEA) Q1 2026: AMD Deal Drives 28% Non-Pay TV Recurring Revenue Growth, CEO Transition Looms
Audia demonstrates a long reinvestment runway, disruptive IP model, improving unit economics, and clear business mix shift. However, while growth is strong, it is not yet at the highest acceleration levels (30%+), and some business model risks remain due to legacy exposure and leadership transition. The signal is high, but not at the absolute peak for an unknown or truly exceptional growth story.
Real Brokerage (REAX) Q4 2025: Agent Count Surges 31% as Platform Model Drives Durable Leverage
Real Brokerage demonstrates a long reinvestment runway with high returns, significant recent growth (agent count +31%, transactions +38%), improving unit economics, and a compounding platform model. Customer value (retention, engagement) is deepening, and the business is in a strong growth phase. However, near-term margin pressure, dependency on ancillary scaling, and some execution risk temper the score. The business is not entirely disruptive nor growing at a hyper-growth (40%+) rate, so the signal is strong but not perfect.
NovationBio (NUVB) Q1 2026: First-Line Shift Lifts Ibtrozi Revenue 18% as Patient Mix Rebalances
NovationBio demonstrates a long reinvestment runway, major recent business evolution (first-line shift), improving unit economics, and a self-reinforcing model. Customers are becoming more valuable, and the business is transitioning to a growth phase with a disruptive model. However, while growth is strong, it is not yet in the exceptional (40%+) range, and cash flow acceleration is moderate rather than explosive. Pipeline optionality and international expansion add to the signal, but some elements (testing bottleneck, pipeline risk) temper the overall upside.
Solstice Advanced Materials (SOLS) Q1 2026: Nuclear Sales Soar 27%, Accelerating Expansion Pipeline
Solstice demonstrates strong secular growth drivers in nuclear and electronic materials, with clear reinvestment opportunities and improving unit economics. Backlog and guidance are rising, but not at an exceptional (30%+) rate. The business model is semi-disruptive, with some legacy elements in refrigerants. Cash flow and revenue growth are robust but not hyper-growth. Overall, the signal is strong but not at the absolute highest level due to the absence of explosive acceleration or disruptive dominance.
Vertex (VRTX) Q1 2026: Non-CF Portfolio Drives 25% of Growth as Renal Franchise Accelerates
Vertex shows a strong reinvestment runway with new franchises, double-digit growth in non-CF products, improving economics, and a self-reinforcing business model. The renal franchise and gene-editing launches are disruptive, but not yet at exceptional growth rates, and some risk remains in pipeline execution and margin normalization. The business is clearly in a growth phase, but not all signals are at the highest possible level for disruption or acceleration.
CryoPort (CYRX) Q1 2026: Commercial Cell & Gene Therapy Revenue Jumps 26% as Pipeline Matures
CryoPort demonstrates a long reinvestment runway, recent major business evolution, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is positioned as a growth company. However, while growth is strong, it is not accelerating at the highest tier. The business model is semi-disruptive, and cash flow is improving but not yet rapidly accelerating. Revenue and EPS growth are above 20% but below 40%.
ARES (ARES) Q4 2025: Fundraising Surges 37%, Secondaries and Real Assets Drive Diversification Tailwind
ARES demonstrates a long reinvestment runway, strong business evolution (fundraising up 37%, real assets and secondaries scaling), improving unit economics, and a self-reinforcing, diversified model. Customer value is increasing and the business is a clear growth platform, but not yet at the most exceptional acceleration levels in every metric (e.g., not >40% growth in all areas). The business is highly investable but not an unknown or deeply underappreciated opportunity.
EVGO (EVGO) Q1 2026: AV and Ancillary Revenue Surges 300%, Highlighting New Growth Pathways
EVgo shows a long reinvestment runway, a major recent revenue inflection in AV/ancillary, improving unit economics, and self-reinforcing business model elements (contracted revenue, rideshare/AV partnerships). Customer value is deepening, but future growth is not yet exceptional/accelerating above 30%. The business model is semi-disruptive, and cash flow is improving but not yet accelerating. Revenue growth is strong but not over 40%. EVgo is a growth business, but not yet a category-defining breakout.
IQVIA (IQV) Q1 2026: $34.2B Backlog Sets New High as AI-Driven Demand Accelerates Across Segments
IQVIA demonstrates a long reinvestment runway, AI-driven growth, and strong backlog, with disruptive business model elements and accelerating demand. However, while revenue and EPS growth are solid, they do not exceed 20%+ annually, and unit economics, while improving, are not yet at giant scale. Cash flow is improving but not yet accelerating. Signal is strong but not at the very highest echelon for explosive upside.
GlobalFoundries (GFS) Q1 2026: Gross Margin Expands 510bps as Optical Networking Demand Drives Mix Shift
GFS demonstrates a strong reinvestment runway, structural margin expansion, and improving unit economics with clear secular growth drivers. Capacity is oversubscribed, and the business is transitioning to higher-margin, recurring revenue streams. However, some elements (such as overall revenue growth rates and exceptional future guidance) are solid but not at the highest possible signal level. The business is not entirely unique or undiscovered, and while the mix shift is important, the upside is not explosive.
Sphere Entertainment (SPHR) Q1 2026: Sphere Segment Revenue Jumps 70% as Vegas Model Scales
Sphere Entertainment demonstrates a strong reinvestment runway, clear business model evolution, and improving unit economics. The Las Vegas venue is a proof point for scalable expansion, and advertising/content monetization levers are deepening. However, some risks remain (MSG Networks drag, execution risk, and expansion uncertainties), and while growth is robust, it falls short of the most extreme acceleration required for top scores on some metrics. The business is disruptive and transitioning into a growth phase, but not yet at the most exceptional level of signal.
Guidewire (GWRE) Q3 2025: ARR Surges Toward $1B as Cloud Deals Drive 32% Subscription Growth
Guidewire demonstrates a long reinvestment runway, strong recent growth, improving unit economics, and self-reinforcing business model. Customer value is deepening, and the business is a clear growth story. However, guidance for next year is strong but not exceptional (17-18% ARR growth). The business is not disruptive in the sense of a new category, and cash flow is improving but not yet at a breakout acceleration.
Turning Point Brands (TPB) Q1 2026: Modern Oral Revenue Soars 167% as Channel Expansion Accelerates
TPB is executing a clear pivot to a high-growth, high-barrier category with significant reinvestment runway and disruptive potential. Modern oral revenue is growing rapidly, with strong channel expansion and improving unit economics anticipated, but margin recovery and cash flow are not yet realized. While the business model is moving toward self-reinforcement and customer value deepening, execution and regulatory risks remain. The signal is high but not perfect due to some near-term uncertainties.
Williams (WMB) Q1 2026: Power Project Backlog Drives 9% Base Growth Trajectory
Williams demonstrates a long reinvestment runway, clear backlog growth, and improving unit economics, with a disruptive model emerging in power/data center segments. However, while growth is robust and visibility is high, the business is not in hypergrowth territory, and some elements (cash flow, guidance revision) are strong but not exceptional. The company is a leader in its space, but the upside is more about solid compounding than a step-change in valuation.
Freshworks (FRSH) Q1 2026: EX ARR Jumps 27% as Enterprise Wins Fuel Strategic Shift
Freshworks shows a strong reinvestment runway, improving unit economics, and growing enterprise customer base. AI integration and operational discipline support a self-reinforcing business model. However, growth rates are not hyper-scaling, and while the business is transitioning to a higher-value mix, it is not yet showing explosive acceleration or fully disruptive characteristics.
Adaptive Biotechnologies (ADPT) Q1 2026: MRD Revenue Jumps 53% as Community and Blood-Based Testing Hit Milestones
Adaptive Biotechnologies demonstrates strong growth, margin expansion, and a clear reinvestment runway with improving unit economics and customer value. However, pharma revenue remains lumpy and some risks around policy and execution temper the signal. The business is disruptive but not at the most exceptional growth inflection, warranting a conservative approach to the highest scores.
Affirm (AFRM) Q2 2026: Affirm Card GMV Up 160% as Product Diversification Accelerates
Affirm demonstrates a long reinvestment runway, disruptive business model, and improving unit economics with clear evidence of high growth in card GMV and merchant diversification. However, some growth rates are decelerating and international/vertical expansion is early-stage, limiting the score on exceptional future growth and business model disruption.
Navitas (NVTS) Q1 2026: High-Power Revenue Jumps 35% as AI Infrastructure Drives Mix Shift
Navitas demonstrates a long reinvestment runway with high returns (AI/data center/grid), disruptive business model, and strong customer value expansion. Recent growth and backlog are significant but not at the highest acceleration tier. Unit economics are improving but not yet at giant scale. The business is growth-oriented with clear optionality, but some execution and scaling risks remain.
Schrödinger (SDGR) Q1 2026: Hosted Software Share Jumps to 34% as Agentic AI Launch Nears
SDGR demonstrates a long reinvestment runway, recent significant business evolution (hosted transition, agentic AI launch), improving unit economics, and a self-reinforcing platform model. Customer value is improving but not yet consistently deepening. Future growth is good, though not yet exceptional, and while the business is disruptive and transitioning to a growth model, cash flow acceleration and >20% growth are present but not at the highest level.
Exelixis (EXEL) Q1 2026: CaboMedics TRX Volume Up 14% as ZANSA Franchise Build Accelerates
Exelixis demonstrates a strong reinvestment runway, robust prescription and revenue growth, improving unit economics, and a self-reinforcing business model with expanding franchises. While the pipeline is broad and disruptive elements are present, the near-term growth outlook is solid but not explosive (sub-40% guidance, not all signals are exceptional). Cash flow is strong but not yet accelerating at an extraordinary rate. The business is a clear growth story, but not at the absolute highest level of signal for a transformative inflection.
Allegro MicroSystems (ALGM) Q1 2026: E-Mobility Sales Jump 31% as Design Wins Fuel Strategic Tailwind
Allegro demonstrates a long reinvestment runway with high returns, recent double-digit growth in strategic segments, improving unit economics, and a self-reinforcing business model. Customer value is deepening, and the business is positioned for further growth, though not at the most exceptional (over 40%) rates in the near term. The business is disruptive and transitioning toward cash flow acceleration, but not all signal criteria are at the highest level.
TransMedics (TMDX) Q1 2026: R&D Investment Surges 45% as Gen 3.0 and CHOPS Expand TAM
TransMedics demonstrates a long reinvestment runway with high returns, disruptive platform expansion, and multiple growth catalysts (Gen 3.0, OCS Kidney, European logistics). While revenue/EPS growth is strong, it does not exceed 40%, and some metrics (customer value, cash flow) are moderate rather than exceptional. The business is clearly in a growth phase with self-reinforcing elements and optionality, but not all aspects are at the highest signal level.
Arista Networks (ANET) Q1 2026: AI Revenue Target Raised to $3.5B as Supply Chain Drives Margin Trade-Offs
Arista demonstrates a long reinvestment runway, a disruptive business model, and strong growth in AI-related demand, with significant backlog and revenue acceleration. However, supply chain constraints and margin pressures temper the signal, and while growth is robust, it is not at an exceptional (40%+) level for the whole business. The business is clearly a growth story with some cash flow acceleration, but not all aspects are at the highest signal threshold.
Spire Global (SPIR) Q1 2026: Core Revenue Up 13% as 76% of Year’s Target Locked In
Spire demonstrates a long reinvestment runway, significant recent growth, improving unit economics, and a self-reinforcing business model. Customers are becoming more valuable, and the business is on a growth trajectory, but some elements (such as degree of disruption and cash flow acceleration) are strong but not exceptional, and guidance is for over 50% core growth, but not all segments are growing at 40%+. The business is not yet a giant, but it is clearly transitioning to a high-growth, high-visibility model.
Hagerty (HGTY) Q1 2026: Earned Premiums Surge 42% as Platform Control Reshapes Profitability
Hagerty's business is showing strong compounding characteristics, with a long reinvestment runway, clear margin expansion, and distribution flywheel effects. However, while growth is robust, it is not at the hypergrowth (40%+) level, and some model elements (e.g., marketplace, international) are still emerging rather than fully disruptive. Cash flow is ramping but not yet accelerating at the highest levels. The business is a clear growth story, but not a once-in-a-decade breakout.
OSS (OSS) Q1 2026: Bookings Nearly Double to $15M, Pipeline Signals Multi-Year AI Compute Upside
OSS demonstrates a long reinvestment runway, significant bookings acceleration, improving unit economics, and a self-reinforcing business model. Customer value is increasing, and the business is transitioning to higher growth, but guidance and backlog do not yet point to truly exceptional (30%+) acceleration, and the business is not fully disruptive versus sector leaders. Supply chain risks and execution on program conversion temper the highest scores, but the signal is strong and above average.
VibeMed (VMD) Q1 2026: Free Cash Flow Surges $8.3M as Sleep and Maternal Health Scale
VibeMed is showing a strong business model transition with recurring, capital-light revenue now the growth engine, improved margins, and free cash flow. However, growth rates and guidance, while robust, are not at the highest levels (e.g., >40% acceleration or exceptional backlog), and the model, while attractive, is not fully disruptive or unique within the sector. The risk profile is improved but not without ongoing regulatory and executional risk.
Dutch Bros (BROS) Q4 2025: Shop Count Jumps 16% as Pipeline, Food, and Loyalty Drive Expansion
Dutch Bros demonstrates a long reinvestment runway, clear growth acceleration, improving unit economics, and a self-reinforcing business model with digital/loyalty ecosystem. Customer value is deepening, and the business is a growth model, but near-term margin headwinds and only moderate acceleration in some signals (guidance, disruptive model, cash flow) cap the score below the maximum. The business is not entirely unique or undiscovered, slightly reducing signal.
ECARX (ECX) Q4 2025: Antora Shipments Hit 1 Million as Global Platform Penetration Accelerates
ECARX demonstrates strong growth, global expansion, and improving economics, with credible evidence of a long runway and platform scale. However, some signals (exceptional future growth, disruptive model, accelerating cash flow) are present but not at the highest possible level, and the business is not a new, under-followed name. The risk of execution in new markets slightly tempers the overall signal.
Sunrun (RUN) Q1 2026: Storage Attachment Hits 73% as Direct Sales Model Drives Market Share Gains
Sunrun demonstrates a clear long-term reinvestment runway with high ROIC potential, disruptive business model, and accelerating storage-led growth. However, some metrics such as cash flow and growth rates, while improving, are not yet at the most exceptional levels. The business is not a new discovery but remains highly investable with strong signals for future value creation.
LifeMD (LFMD) Q1 2026: 42,000 Net Subscriber Surge Signals Durable Platform Expansion
LifeMD shows strong platform momentum, high subscriber growth, and margin expansion levers. The business is transitioning to higher retention, insurance-backed revenue, and scaling pharmacy/AI, but revenue growth is not yet explosive and cash flow is not yet accelerating. The model is disruptive, but not yet at a giant scale or with >40% top-line growth.
Dutch Bros (BROS) Q1 2026: 31% Revenue Surge Anchors Raised Guidance and Expansion Ambition
Dutch Bros demonstrates a long reinvestment runway, recent significant growth, improving unit economics, and a self-reinforcing business model. Customer value is deepening and the business is solidly in growth mode, but while the future outlook is strong, growth is not yet exceptional enough for top marks on all questions. The business model is semi-disruptive, and while cash flow and revenue growth are robust, they do not consistently exceed the highest thresholds for the most aggressive signal scoring.
TD SYNNEX (SNX) Q2 2026: HIVE Billings Surge 117% as Hyperscaler Pipeline Expands
TD SYNNEX demonstrates a long reinvestment runway, triple-digit growth in HIVE, improving unit economics, and self-reinforcing business model characteristics. Customer value is increasing and the business is transitioning to a higher-growth profile. However, acceleration is not at the highest level in all categories (e.g., future guidance is strong but not >30% acceleration), and some aspects (business model disruption, cash flow) are not at maximum signal. The business is investable and growth-oriented, but not an undiscovered or hyper-exceptional opportunity.
Cineverse (CNVS) Q4 2026: Acquisitions Add $11.6M, Reshaping Tech-Driven Revenue Base
Cineverse shows a long reinvestment runway with high returns, a step-change in growth from acquisitions, improving unit economics, and a self-reinforcing platform model. Customer value is rising, but future growth, while strong, is not yet exceptional. The business model is semi-disruptive, and while cash flow and revenue are improving, they are not yet at hypergrowth levels. This is a transitioning, high-growth business but not yet a category-defining outlier.
APYX Q1 2026: Aon Drives 36% Surgical Aesthetics Surge, Sets Stage for Power Lipo Expansion
APYX demonstrates a strong growth trajectory with a long reinvestment runway, improving unit economics, and a self-reinforcing business model. However, while the growth is robust, it is not at the highest acceleration tier (>40%), and the disruption level is moderate rather than extreme. Cash flow is improving but not yet accelerating, and guidance revisions are positive but not exceptional. The business is a clear growth story, but not at the most explosive level.
Privia Health (UHS) Q1 2026: Attributed Lives Jump 26%, Sharpening Value-Based Care Leverage
Privia Health demonstrates a long reinvestment runway, rapid attributed lives growth, improving unit economics, and a self-reinforcing model with high provider retention and referral flywheel. The business is not fully disruptive but shows strong semi-disruptive traits. Guidance and backlog visibility are strong, but not at exceptional acceleration. Revenue and EBITDA growth are solid but not at hypergrowth levels. The business is a clear growth compounder, but not at the most extreme end of the spectrum.
Genmab (GMAB) Q1 2026: Epkinley Drives 52% Global Growth, Pipeline Readouts Set Up Multi-Asset Launches
Genmab is showing strong commercial momentum, pipeline acceleration, and diversified growth, but does not have the extraordinary 40%+ near-term growth or disruptive model that would justify a perfect signal score. The business is high quality, with a long runway and multiple levers, but some metrics (like future growth guidance and cash flow acceleration) are good, not exceptional.
Octave Specialty Group (OSG) Q1 2026: Insurance Distribution Revenue Jumps 92% as MGA Platform Strategy Accelerates
OSG demonstrates a strong reinvestment runway, breakout growth in insurance distribution (92% YoY, 42% organic), and improving margins. The business model is evolving toward a self-reinforcing MGA platform with AI/data advantages, but some signals (guidance unchanged, growth moderating after Q1, not clearly disruptive sector-wide) cap the score. Still, the signal is strong for investors seeking compounding specialty insurance platforms.
Notable Signals (12-15)
Articles with useful investment signals worth considering
QRVO Q2 2026: $500M Synergy Target Signals Scale Leap as Skyworks Merger Redefines RF Landscape
The merger creates a scaled, diversified player with a long reinvestment runway and clear margin expansion levers. Synergies and backlog growth are significant, but the business, while transforming, is not disruptive at the level of a new platform or network effect, and revenue growth is not projected above 40%. The outlook is strong but not at the very highest signal tier due to execution and regulatory risks, and the fact that both companies are already well-known in the space.
WESCO (WCC) Q4 2025: Data Center Sales Surge 50%, Securing Structural Growth Tailwind
WESCO demonstrates strong secular tailwinds, high growth in key segments, and improving customer value, but as a distributor, its business model is not deeply self-reinforcing or disruptive. Growth is solid but not at a hyper-scaler level, and while margins and cash flow are improving, they are not at an exceptional inflection. The signal is strong for a legacy industrial pivot, but not at the highest level of business model compounding or disruption.
PDF Solutions (PDFS) Q4 2025: Recurring Revenue Jumps 41% as AI Collaboration Drives Platform Expansion
PDF Solutions demonstrates a strong reinvestment runway, significant recurring revenue growth, and improving unit economics. The business is transitioning toward a platform model with some self-reinforcing elements, but network effects are not yet dominant. Customer value is deepening, and the outlook is solid, though not exceptional. The business model is semi-disruptive with moderate cash flow acceleration. Revenue and EPS growth are strong but not hypergrowth. Overall, the signal is high but not at the level of a truly exceptional, disruptive compounder.
Illuma (ALMU) Q3 2026: 6 New Contracts Secure $5M+ in R&D Funding as AI Datacom Demand Accelerates
Illuma presents a compelling runway with disruptive technology and strong validation through government contracts. There is significant optionality and a clear path to accelerated growth if customer qualification is achieved. However, unit economics and customer value are not yet proven at scale, and the business remains pre-commercial, tempering the highest signal scores. Growth is promising but not yet exceptional; commercial inflection is contingent on execution.
Backblaze (BLZE) Q2 2025: B2 Revenue Accelerates 29% as AI Storage Demand Scales
Backblaze demonstrates a strong reinvestment runway with accelerating B2 growth, major AI-driven business evolution, and improving unit economics. Customer value is deepening, and the business is transitioning to a growth profile. However, network effects and disruptive model signals are present but not yet dominant, and cash flow and growth rates, while strong, are not at the very highest tier. Overall, signal is high but not maximal due to some concentration and legacy drag risks.
Trip.com Group (TCOM) Q1 2026: Inbound Travel Surges 90%, Fueling Platform Diversification
Trip.com demonstrates a long reinvestment runway, significant recent developments (90% inbound growth), and improving unit economics. The business model shows some self-reinforcing elements (AI, ecosystem), but customer value improvement is moderate (not consistently deepening). Near-term growth is moderating, so future outlook is good but not exceptional. The model is semi-disruptive, and cash flow is improving but not rapidly accelerating. Growth rates are strong but not at the hypergrowth threshold. The business is clearly in growth mode, but some signals are tempered by regulatory and macro headwinds.
STAAR Surgical (STAA) Q1 2026: China Drives 120% Sales Surge, Margin Leverage Emerges
STAAR Surgical demonstrates a strong growth reset, premiumization, and margin inflection, with clear reinvestment runway in China and improving unit economics. However, some signal is tempered by management's guidance caution, macro/geopolitical risk, and moderate disruption relative to more transformative models.
HASI Q4 2025: New Investments Jump 87%, Capital Efficiency Drives ROE Expansion
HASI demonstrates a long reinvestment runway, a major jump in investment activity, and accelerating cash flow/ROE. However, customer value and business model self-reinforcement are improving but not yet exceptional, and while growth is strong, some of it is driven by one-off deals. The business is transitioning toward a more recurring, stable model but is not yet at the highest signal level for disruptive compounding.
Carvana (CVNA) Q2 2026: Retail Units Jump 38% as Inventory Expansion Unlocks Regional Growth
Carvana exhibits strong growth signals: a long reinvestment runway, double-digit unit and revenue growth, improving unit economics, and a clear transition to profitability. However, the business model, while innovative, is not fully disruptive, and some self-reinforcing dynamics are still emerging rather than deeply entrenched. Growth rates are high but not consistently at the hyper-growth threshold, and some margin and operational risks temper the signal score.
Acadia Realty Trust (AKR) Q2 2026: Street Retail Rent Spreads Hit 91% as Scale Accelerates NOI Growth
Acadia exhibits strong growth signals: record rent spreads, accelerating leasing, and embedded multi-year upside. However, as a REIT focused on a relatively mature asset class, the reinvestment runway is solid but not exceptional, and growth rates, while impressive for the sector, do not reach the highest echelons of disruption or scalability. The business is transitioning to a higher-growth, more capital-efficient model, but faces risks of yield compression and sector competition that cap the signal score.
BTQ (BTQ) Q3 2025: QSSN Targets $1B+ Revenue as Korea Stablecoin Pilots Scale
BTQ demonstrates a long reinvestment runway and is positioned at a major inflection point driven by regulatory mandates, with the potential for explosive revenue growth if adoption materializes. However, the business is still in early commercialization, with unit economics and customer value deepening not yet fully proven at scale. The model is disruptive and self-reinforcing, but the near-term acceleration is contingent on regulatory enforcement and pilot conversion.
Forum Markets (FRMM) Q4 2025: $103M Cash Fuels 2026 Asset Ramp as Tokenization Model Scales
Forum Markets offers a disruptive, high-growth business model with a long reinvestment runway and clear compounding advantages from its asset origination and tokenization strategy. While some metrics (unit economics, customer value, near-term cash flow) are only moderately improving or not yet exceptional, the company's pivot and guidance suggest strong growth potential. The signal is high, but not every dimension is fully de-risked or accelerating at the highest level.
Loar Holdings (LOAR) Q1 2026: EBITDA Margin Hits 40.5% as $700M Pipeline Fuels Long-Term Growth
Loar Holdings demonstrates a long reinvestment runway, improving unit economics, compounding business model, and deepening customer value. However, while growth is strong and guidance is upwardly revised, there is no evidence of a recent 40%+ surge or truly exceptional acceleration. The model is semi-disruptive but not transformative, and growth rates are solid but not hyper-growth. The signal is strong but not at the highest possible level for a lesser-known or structurally unique business.
Dragonfly (DPRO) Q4 2025: Cash Surges to $90M as Multi-Mission Drone Demand Accelerates
Dragonfly has a long reinvestment runway, clear disruptive potential, and is positioned for a multi-year growth cycle, but current unit economics and customer value expansion are still in transition. Revenue growth is strong but not yet at hypergrowth levels, and while the business is not mature or stalling, it is not yet a proven giant.
1&1 Green Technologies (YDDL) Q4 2025: Copper Alloy Revenue Climbs 37% as Margin Expansion Outpaces Growth
YDDL exhibits strong regulatory barriers, margin expansion, and a clear growth runway with international expansion and battery recycling. However, some signal points are moderated by product mix risk (brass alloy weakness), lack of quantified forward guidance, and early-stage nature of the battery recycling initiative. The business is transitioning from a niche, regulatory-protected player to a growth platform, but some elements (e.g., customer value deepening, cash flow acceleration) are not yet exceptional.
StubHub (STUB) Q1 2026: 400bps Margin Expansion Signals Marketplace Scale Payoff
StubHub demonstrates strong margin expansion, cash flow leverage, and self-reinforcing network effects. The business model is robust with improving unit economics and customer value, and there is clear evidence of scale benefits. However, growth rates are solid but not in the hypergrowth category, and while the business is innovative, it is not fully disruptive. Signal is strong but not at the highest possible level.
ZKH (ZKH) Q1 2026: SME GMV Up 20% as AI-Driven Platform Penetrates Manufacturing
ZKH demonstrates a long runway with reinvestment at high returns, significant growth in SME and private label GMV, and improving unit economics. The platform is disruptive with accelerating cash flow potential and is transitioning into a growth business. However, network effects and customer value deepening are emerging but not yet fully proven, and revenue/earnings growth is strong but not at hypergrowth levels.
CleanSpark (CLSK) Q2 2026: 1.8 GW Contracted Power Secured as AI Data Center Pivot Accelerates
CleanSpark demonstrates a long reinvestment runway, recent significant business developments, and a disruptive, self-reinforcing business model. However, while the pivot to AI/digital infrastructure is promising, unit economics and customer value deepening are not yet exceptional or proven at scale, and growth outlook is strong but not explosive. The business is transitioning rapidly, but not all signal metrics are at the highest possible level.
Nyxoah (NYXH) Q2 2026: U.S. Net Revenue Jumps 25% as Genio Adoption Expands
Nyxoah demonstrates clear growth, improving unit economics, and a long reinvestment runway. However, the business model, while innovative, is not fully disruptive and faces some risk from coding/reimbursement changes and competitive response. Cash flow is not yet accelerating, and while growth is robust, it is not at a hyper-scaling level. Signal is strong but not at the highest tier for upside.
NetSol Technologies (NTWK) Q2 2026: Services Revenue Jumps 41% as AI-Driven Platforms Expand
NetSol demonstrates a strong growth profile with a long reinvestment runway, double-digit revenue growth, improving unit economics, and increasing customer value. The business is transitioning toward a recurring, high-margin model with evidence of margin expansion and strong contract wins. However, while AI integration and platform stickiness are emerging, network effects and disruptive potential are not yet fully proven, and growth, though robust, is not at hypergrowth levels.
GE Vernova (GEV) Q2 2026: Backlog Surges $13B, Locking in Multi-Year Power Demand
GE Vernova demonstrates a long reinvestment runway, major backlog uptick, improving unit economics, and a self-reinforcing model in power and electrification. However, customer value deepening and future growth, while positive, are not exceptional across all segments, and the business—while strong—is not disruptive or accelerating at the highest possible rates. Signal is strong but not at the absolute maximum due to wind segment drag and some legacy exposure.
MARA Q1 2026: Longridge Adds 65% Capacity, Anchoring Power-Led AI Infrastructure Pivot
MARA is at a major strategic inflection with long runway and disruptive potential, but not all metrics are at the highest threshold yet. The business model is shifting with clear optionality and strong power assets, but unit economics and customer value deepening are still in transition. Growth is strong but not yet at the very highest tier, and execution risk remains.
Penguin Solutions (PENG) Q1 2026: Memory Revenue Jumps 41%, Powering AI Infrastructure Shift
Penguin Solutions demonstrates a strong pivot to high-growth AI infrastructure and memory markets, with evidence of a long reinvestment runway, major segment growth, and improving unit economics. However, some elements (such as customer value deepening, future guidance, and disruptive potential) are solid but not exceptional, and the company is still transitioning away from legacy business. The signal is strong for a mid-cap, but not at the highest level for explosive upside.
Bakkt (BKKT) Q4 2025: Adjusted EBITDA Loss Narrows $24M as Platform Reset Unlocks Clean Growth Path
Bakkt shows a long reinvestment runway, disruptive business model, and regulatory moat. While the reset is promising, current growth is not yet exceptional, and customer value metrics are improving but not yet outstanding. The business is transitioning into growth, but some signals (unit economics, cash flow acceleration, and revenue growth rates) are not yet at the highest tier.
IMSR (IMSR) Q4 2025: Cash Rises to $298M After HCM2 Deal, Enabling Aggressive Fleet Buildout
IMSR is at a strategic inflection with a long reinvestment runway, disruptive modular reactor design, and strong capital position. There is clear evidence of significant developments (capital raise, regulatory progress, commercial pipeline), but as a pre-revenue company, unit economics and customer value are not yet proven at scale. Growth potential is high, but execution and regulatory risks remain. The business is transitioning toward growth, with signals of optionality and disruptive potential, but not all metrics (e.g., accelerating cash flow, proven recurring revenue) are fully visible yet.
Fennec (FENC) Q1 2026: PEDMARK Sales Surge 73% as Commercial Expansion Unlocks New Patient Access
Fennec shows strong revenue growth, expanding addressable market, and improving unit economics, with a clear path to further scale. However, some elements (business model defensibility, international ramp, and pipeline optionality) are emerging but not yet proven, and near-term growth, while strong, is not yet at the most exceptional level. The business is clearly transitioning to growth but not yet fully de-risked as a compounding franchise.
Diamondback Energy (FANG) Q1 2026: 200+ DUCs Drawn as Permian Activity Accelerates on Supply Shock
Diamondback demonstrates a strong reinvestment runway, immediate growth acceleration, and improving unit economics. While the business model is robust and partially self-reinforcing, it is not fully disruptive or network-based. Customer value and future growth are improving but not exceptional. The business is a clear growth story, but not at the highest possible signal for compounding or disruption.
Analog Devices (ADI) Q2 2026: Industrial Segment Jumps 56% as AI and Automation Drive Record Margins
ADI shows strong secular growth and margin expansion, with clear improvements in unit economics and customer value. However, the business is well-known and mature in some areas, with only moderate reinvestment runway and self-reinforcing dynamics. The Empower acquisition and AI/data center tailwinds are significant, but future upside may be capped by capacity and macro risks.
Lesaka (LSAK) Q2 2026: Consumer Lending Originations Surge 88% as Platform Model Scales
Lesaka exhibits strong growth in consumer lending and enterprise, with an 88% increase in originations and margin expansion. The Bank Zero acquisition provides a structural catalyst for funding and profitability. However, Merchant division transformation and some customer value metrics are still stabilizing, and while disruptive potential is present, the business is not yet a breakout giant. Signal is strong but not at the absolute highest level due to some execution and competitive risks.
Vericel (VCEL) Q2 2026: Macy Drives 23% Growth as $200M Buyback Signals Confident Cash Trajectory
Vericel demonstrates a long reinvestment runway and robust growth (Q2 revenue up 22%, Macy at 23%), with improving unit economics and growing customer value. The business is not quite a disruptive model, but has elements of innovation in cell therapy. There is some self-reinforcing dynamic, but not as strong as true network effects. Growth is strong but not at the highest acceleration tier (>40%), and while cash flow is healthy, it's not yet a cash machine. The business is a clear growth story, but not a breakout hyper-growth or disruptive platform.
Procore (PCOR) Q4 2025: 22% RPO Growth Signals Upmarket Momentum and AI-Led Expansion
Procore demonstrates a long reinvestment runway, improving unit economics, deepening customer value, and a self-reinforcing business model. Margin and cash flow leverage are evident, and the business is solidly in a growth phase. However, while growth is strong, it is not at the 'exceptional' (40%+) level, and recent developments, while positive, are not transformative enough for full marks. The business model is semi-disruptive rather than fully disruptive, and international/AI upside is still developing.
BioLife Solutions (BLFS) Q1 2026: BPM Revenue Jumps 25% as Commercial Therapy Penetration Deepens
BioLife Solutions is demonstrating a long reinvestment runway and is embedded in a high-growth sector, with commercial therapy adoption driving recurring revenue. There is clear evidence of strong recent growth and backlog, but unit economics are currently pressured by mix/yield issues, so not fully compounding yet. The business model has self-reinforcing aspects (switching costs, integration), and customer value is deepening. Future growth is strong but not yet exceptional (guidance is 17-20% for the year). The business is transitioning to a high-quality, recurring-revenue model but is not yet at the level of a giant platform. Cash flow is improving but not yet accelerating. The business is not fully disruptive, but is semi-disruptive in the CGT tools niche.
Nexa Resources (NEXA) Q1 2026: Silver Price Surge Drives $100M Cash Flow Step-Up, Margin Leverage Unlocked
Nexa demonstrates strong cash flow inflection and deleveraging, with a long mine life and reserve growth potential. However, while the business is improving, it is not a disruptive model and some compounding characteristics (network effects, customer value deepening) are only modest. Growth is solid but not at hypergrowth levels, and some risks (commodity prices, regulatory) temper the signal.
InmuneBio (INMB) Q1 2025: Alzheimer’s Addressable Market Expands to 70% on APOE4 Biomarker Shift
INMB's business is early-stage but shows strong optionality, a disruptive approach, and a major TAM expansion. However, some questions around recurring revenue, customer value deepening, and cash flow limit the signal. Growth potential is high, but execution and regulatory risks remain, capping the score.
TRX (TRX) Q4 2025: Q4 Gross Margin Climbs to 53% as Expansion Drives Cash Flow Surge
TRX demonstrates a strong reinvestment runway, clear recent inflection in margins and cash flow, and a self-funded expansion model. However, while the model is promising, it is not yet a proven self-reinforcing compounding flywheel, and customer value growth is limited by the nature of the gold mining business. The business is transitioning to growth, but not at the 40%+ level. Execution and regulatory risks temper the upside.
Target Hospitality (TH) Q1 2026: WHS Segment Set to Exceed 45% of Revenue as $1.3B Contracts Ramp
Target Hospitality demonstrates a long reinvestment runway with high returns, a significant recent uptick in contract wins, and improving unit economics. Customer value is deepening, and the business is transitioning to a more growth-oriented model. However, some elements (like network effects and disruptive business model) are present but not fully mature or exceptional. Growth rates and cash flow are improving but not at the highest levels. The signal is strong, but not at the highest end due to moderate disruption and some execution risk.
BAM Q2 2025: Fee-Bearing Capital Rises 10% as AI and Wealth Channel Drive Expansion
BAM demonstrates a strong growth profile with secular tailwinds, a disruptive model, and expanding fee-bearing capital. However, some metrics (unit economics, customer value, cash flow) are improving but not yet exceptional. The business is a clear growth story, but not all signals are at the highest level.
Hasbro (HAS) Q4 2025: Wizards Segment Surges 86%, Anchoring Multi-Year Growth Strategy
Hasbro's Wizards segment shows strong growth and high margins, but the overall business is not a new or underfollowed story and faces some maturity in its core segments. The recent surge in the Wizards segment is a significant development, but the broader company is not likely to deliver outsized upside or become a giant. The business model is becoming more self-reinforcing, and customer value is deepening, but the future growth outlook is solid rather than exceptional. Risks around tariffs, royalties, and execution on digital investments moderate the signal score.
Venue (VENU) Q1 2026: Asset Base Jumps 25% as Premium Venue Pipeline Surges Past 45 Markets
Venue demonstrates a long reinvestment runway, disruptive business model, and strong pipeline momentum, with clear evidence of capital-efficient growth and institutional validation. However, operational leverage and margin realization remain future levers rather than present realities, and while revenue is growing, it is not at a sustained 40%+ pace. Customer value and cash flow are improving but not yet exceptional. The business is growth-oriented and has strong optionality, but some elements (unit economics, recurring revenue, and cash flow) are still in transition.
Westport (WPRT) Q1 2026: Suspira Revenue Jumps 33%, Accelerating Path to Capital Efficiency
Westport demonstrates a long reinvestment runway with improving unit economics and a disruptive business model. Suspira's growth and margin inflection support a transition to cash generation, though customer value deepening and exceptional future growth are not yet fully proven. The company is in a growth phase but not at the highest tier of acceleration or defensibility.
Solana Company (HSDT) Q3 2025: $500M PIPE Fuels Digital Asset Treasury Pivot, 2.3M SOL Accumulated
The business has a long reinvestment runway and is undergoing a significant pivot with strong capital backing. There is evidence of improving unit economics and a disruptive business model, but some elements—such as customer value and cash flow acceleration—are only modestly improving. The company is a growth business, but volatility and risk temper the signal score.
VolitionRx (VNRX) Q1 2026: Revenue Jumps 300% as Licensing Pipeline Expands to 12 Major Partners
The business demonstrates a long reinvestment runway, recent inflection in revenue, and clear disruptive potential with multiple licensing negotiations and new product verticals. However, some elements (unit economics, customer value, cash flow) are still emerging or not yet at scale, and recurring revenue is not fully proven. The signal is strong for a small-cap diagnostics company but not at the level of a proven, high-growth compounding machine.
Tyler Technologies (TYL) Q4 2025: SaaS Flips Surge 65% as Cloud Shift Accelerates
Tyler Technologies is a high-quality vertical SaaS business with strong recurring revenue growth, improving unit economics, and expanding margins. However, while the company demonstrates a long runway and disruptive elements (cloud migration, embedded payments, AI), it is a well-known public sector SaaS leader—limiting the upside surprise for investors. There is no evidence of a sudden, massive business inflection (>40% growth), and guidance, while strong, is not exceptional. The business is transitioning to higher quality revenue, but growth rates are not at the hyper-growth level.
Tradeweb (TW) Q2 2026: International Drives 65% of Revenue Growth as Electronification Deepens
Tradeweb shows a long reinvestment runway, major international growth, and deepening business model advantages. However, unit economics and cash flow are improving but not at the highest level, and while the business is disruptive, it is not a new or highly underfollowed story. Growth is strong but not hyper-scaling, and some segments remain challenged.
AEP (AEP) Q4 2025: Contracted Load Doubles to 56 GW, Unlocking Multi-Billion Capital Upside
AEP is a well-known, large-cap utility with a strong capital plan and a clear growth catalyst in contracted load, but as a regulated utility, its reinvestment runway, business model disruptiveness, and cash flow acceleration are somewhat capped compared to more disruptive sectors. The doubling of contracted load and capital plan expansion are highly material, but the underlying business remains rate-based with moderate optionality.
Powell Industries (POWL) Q2 2026: Backlog Surges 33%, Data Center Mega-Order Extends Growth Horizon
Powell Industries demonstrates a long reinvestment runway, significant backlog growth, and improving unit economics. The business is transitioning toward growth, with exceptional near-term visibility and a disruptive angle via data center and government/defense verticals. However, some self-reinforcing and customer value dynamics are still emerging, and the business, while showing high signal, is not yet at the level of a dominant, compounding platform.
VIA (VIA) Q1 2026: Pipeline Grows to $650M as Full-Network Transit Strategy Accelerates
VIA demonstrates a long reinvestment runway, disruptive business model, and clear strategic pivot, but revenue growth is in the 25-30% range—not hypergrowth. Unit economics and customer value are improving but not at an exceptional rate. The pipeline is robust and backlog is growing, but margin expansion and cash flow acceleration are still in early stages. The business is a growth company with strong optionality, but the signal is tempered by some execution and market risks.
SIFY (SIFY) Q1 2026: Data Center Capacity to Jump 64% as CapEx Surges
SIFY demonstrates a long reinvestment runway with high returns, recent significant growth, and improving unit economics. The business model is self-reinforcing with network effects, but customer value deepening is only modest. Growth outlook is strong but not yet exceptional, and while the business is disruptive, some risks (funding, margins) temper the signal score.
Coinbase (COIN) Q2 2026: Bitcoin Share Shrinks to 12% as Platform Diversifies Revenue Base
Coinbase demonstrates a long runway for reinvestment, significant business evolution, and a disruptive, self-reinforcing platform model. However, while the business is diversifying and growing, some metrics (unit economics, customer value, cash flow, growth rates) are improving but not yet exceptional. The business is positioned for further growth, but not at the highest acceleration tier.
SILC Q2 2026: Design Wins Drive 59% Revenue Surge, AI Inference Upside Signals Multi-Year Growth
Silicom is showing a multi-year growth inflection with strong reinvestment runway, accelerating design win conversion, and early AI inference traction. However, while the business is transitioning to high growth, the magnitude and sustainability of AI upside and customer value deepening are not yet fully proven, so scores are conservative for signal.
NESR (NESR) Q1 2026: Jafura Ramp Drives 33% Revenue Surge, Dividend and Buyback Initiated
NESR shows strong growth, margin expansion, and capital return initiation, signaling above-average business momentum and optionality. However, some signals (network effects, customer value deepening, true disruption) are present but not at the highest level, and growth, while robust, is not at a hypergrowth or fully disruptive tier.
Pulse Biosciences (PLSE) Q1 2026: NSPFA Clinical Milestones Tighten Pivotal Trial Timeline
Pulse Biosciences is at a pivotal moment with disruptive technology, a sharpened business focus, and accelerating clinical milestones. The business model and clinical data suggest significant upside and disruption potential, though near-term revenue and cash flow are still limited, and some metrics (unit economics, customer value) are not yet at scale.
CVRX (CVRX) Q1 2026: U.S. Heart Failure Revenue Climbs 22% as Barostim Adoption Expands
CVRX shows strong growth and a disruptive model with a potentially large market expansion via BenefitHF. However, while the reinvestment runway and recent developments are strong, some metrics (customer value, cash flow, growth rate) are only moderately improving or still developing, and the business model, while innovative, is not yet fully self-reinforcing at scale. The business is a clear growth story but not yet at the highest signal tier.
Oracle (ORCL) Q2 2026: RPO Soars 433%, Fueling Cloud and AI Platform Expansion
Oracle demonstrates a significant inflection with the RPO surge and accelerating cloud/AI growth, but as a well-known large cap, runway and disruption are capped compared to earlier-stage businesses. The business model is evolving but not fully disruptive, and while growth is strong, it is not at the level of hypergrowth or highly novel businesses. Still, there is clear evidence of improved unit economics, backlog-driven visibility, and platform compounding effects.
Backblaze (BLZE) Q2 2025: B2 Revenue Accelerates 29% as AI Storage Demand Scales
Backblaze demonstrates strong growth in B2 cloud storage with a long reinvestment runway and improving unit economics. There is a major AI-driven inflection and growing enterprise mix, but some business model elements (network effects, disruption) are emerging rather than fully entrenched. Growth is robust but not at the highest acceleration tier, and legacy headwinds remain a drag.
Bowman (BWMN) Q1 2026: Backlog Jumps 56% as Large Awards Fuel 20%+ Growth Outlook
Bowman demonstrates a long runway with high returns, a major backlog surge, and accelerating growth. Unit economics are improving, and the business is transitioning toward a more self-reinforcing model, though network effects are not yet dominant. Customer value is increasing but not consistently deepening. The outlook is for strong growth, but not at hypergrowth levels across all metrics. The business is disruptive within its sector but not a category-defining platform. Cash flow is improving but not yet a machine. Overall, the company is at an inflection, but the upside is significant rather than exceptional.
PBF (PBF) Q4 2025: Heavy Sour Leverage Drives $200M Annual Upside as Martinez Nears Restart
PBF has a long reinvestment runway, clear leverage to heavy sour spreads, and is positioned for margin expansion with Martinez. There are significant cost savings and operational improvements, but customer value deepening and growth acceleration are moderate rather than exceptional. The business is not fully disruptive, and while growth is strong, it is not at the highest tier. The business is a clear growth story, but not a hypergrowth or highly disruptive one.
EOG (EOG) Q2 2025: Encino Acquisition Drives 9% Production Lift, Unlocks Multi-Basin Upside
EOG demonstrates a long reinvestment runway, immediate production/guidance uplift from Encino, and improving unit economics. However, while the business is showing strong growth and optionality, its model is not highly disruptive and some elements (international expansion, technology rollout) are still emerging. Revenue/EPS growth is strong but not at the highest tier, and cash flow is improving but not rapidly accelerating. The business is clearly a growth operator, but not with the most exceptional signal profile.
Metallus (MTUS) Q1 2026: Order Book Surges 40%, Driving Multi-Segment Volume Upside
Metallus demonstrates strong growth signals: a 40% surge in the order book, operational upgrades, and broad-based volume gains, with improving profitability and cash flow. However, the business model, while benefiting from policy tailwinds and some switching cost, is not deeply disruptive, and customer value expansion is moderate rather than exceptional. Revenue and EPS growth are strong but not at the highest tier.
PDD (PDD) Q1 2026: First-Party Brand Investment Hits RMB 15B, Reshaping Supply Chain Strategy
PDD is undertaking a major transformation with a long reinvestment runway and disruptive supply chain moves, supporting a high signal score. There is a significant recent development (RMB 15B first-party investment) and strong growth in transaction services. However, unit economics and customer value are improving but not exceptional, and forward guidance is for high investment rather than clear acceleration. The business is disruptive and growth-oriented but not at the highest level of runaway momentum.
NewAmsterdam (NAMS) Q1 2026: Interim PREVAIL Analysis Accelerates Timeline, Boosts Statistical Power
NAMS demonstrates a long reinvestment runway with a potentially disruptive CETP inhibitor, a major trial inflection, and a clear growth trajectory if the interim analysis is positive. While the business is not yet a cash flow machine and some metrics are not fully proven (unit economics/customer value deepening), the combination of accelerated pivotal data, regulatory tailwinds, and a high-stakes clinical readout provides strong signal.
CleanSpark (CLSK) Q1 2026: $600M Buybacks Signal Shift From Mining to AI Infrastructure
CleanSpark demonstrates a long reinvestment runway with a clear pivot to AI infrastructure and disciplined capital allocation. There are significant developments with the $600M buyback and AI campus expansion, but not all unit economics are clearly improving yet, and customer value deepening is still in early stages. The business model is becoming disruptive with lateral opportunities, and the outlook is for strong growth, though not at hypergrowth levels yet. Overall, the signal is strong but not at the highest possible level due to the transitional nature and some execution risks.
GoDaddy (GDDY) Q2 2026: Aero Bookings Surge 5x to $50M, Accelerating AI-Led Platform Shift
GoDaddy's Aero platform shows strong early traction and a clear inflection, with bookings up 5x. There is evidence of improving unit economics, customer value, and margin durability. However, the reinvestment runway and self-reinforcing model are only moderately compelling relative to the most disruptive businesses, and overall growth rates, while solid, are not in the top decile. Execution risk and legacy transition temper the signal score.
Coursera (COUR) Q2 2026: Subscription Mix Hits 85%, Accelerating Margin Expansion and AI-Driven Platform Shift
Coursera shows a long reinvestment runway with a disruptive, self-reinforcing business model and accelerating margin improvement. While the subscription shift and margin expansion are significant, customer value deepening and future growth rates are good but not exceptional (NRR softness, guidance not >40% growth). The business is moving from transition to growth, but some metrics are not yet at the highest threshold for signal.
BMRN Q1 2026: Amicus Acquisition Adds $500M, Driving 20% Growth Trajectory Shift
BioMarin demonstrates a long reinvestment runway and has delivered a step-change in growth with the Amicus acquisition, immediately raising its growth baseline. Significant developments and strong backlog are evident, with clear improvement in unit economics and a business model that is partially self-reinforcing. Customer value is improving, but not consistently deepening yet. The future outlook is strong, with some elements of disruption and cash flow improvement, but not all metrics are at the highest threshold for a truly exceptional, disruptive growth story.
Red Violet (RDVT) Q2 2025: Contractual Revenue Rises to 77%, Locking in Platform Stickiness
Red Violet demonstrates a strong recurring revenue base, improving unit economics, and margin expansion through automation. While the business is showing solid growth and operational leverage, there is no evidence of a massive (40%+) inflection or disruptive model that would warrant a perfect signal score. The business is transitioning toward greater embeddedness and scale, but is not yet a breakout hypergrowth story.
HASI (HASI) Q1 2026: Grid-Connected Pipeline Surges 26%, Pushing Self-Funding Model Forward
HASI demonstrates a long reinvestment runway, significant pipeline growth, improving unit economics, and a self-reinforcing business model. However, while the business is growing and capital-light, the growth rates and business model, while strong, are not truly exceptional or disruptive at the highest level, and customer value deepening is only modestly evidenced.
BlackRock Coffee Bar (BRCB) Q3 2025: Loyalty Transactions Hit 64%, Driving Deeper Customer Engagement
BlackRock Coffee Bar demonstrates strong growth, high loyalty penetration, improving unit economics, and margin expansion, indicating a solid business model with a long runway. However, while the model is compelling, it is not fully disruptive and there is some uncertainty around the pace of future acceleration and competitive intensity. The business is clearly a growth story but not yet at the level of a generational compounder or disruptive platform, warranting a slightly conservative signal score.
TIGO Q1 2026: Colombia Acquisition Lifts Service Revenue 45%, Margin Expansion in Focus
TIGO demonstrates a long reinvestment runway with high returns due to the Coltel acquisition and operational playbook. There is a significant recent development (Colombia integration) driving growth, with improving unit economics and cash flow. However, while the business model is strengthening, network effects and customer value deepening are present but not yet fully compounding. Future guidance is positive but not yet exceptional. The business is transitioning toward growth, but integration and execution risk remain, moderating the overall signal score.
PAYS Q1 2026: Patient Affordability Surges 82%, Overtakes Plasma as Top Revenue Driver
PAYS is showing a strong business inflection with patient affordability growth and margin expansion, but its reinvestment runway is moderate rather than exceptional, and the business model is semi-disruptive, not fully disruptive. Unit economics and customer value are clearly improving, and the business is transitioning to a higher-margin profile. While plasma remains steady, the overall growth rate is strong but not at the highest tier, and some risks remain around regulatory and industry consolidation.
Fractal (GUTS) Q1 2026: Pivotal Trial Progress Sets Up Three Data Catalysts Into Year-End
Fractal is pre-commercial but positioned for a potentially large, high-growth opportunity if pivotal data are positive. The business model is disruptive with a long runway, and there are clear catalysts for rapid value creation. However, as a clinical-stage company, unit economics and customer value are not yet proven, and there is binary risk around trial outcomes and regulatory acceptance. Growth potential is strong, but the business is not yet a cash flow machine and faces execution risk.
Graham (GHM) Q3 2026: Backlog Surges 34% as FlacTech Acquisition Unlocks New Platform Scale
Graham demonstrates a long reinvestment runway with high returns, a major backlog surge, and improving unit economics. Recurring revenue is rising and customer value is deepening. However, the business model is not fully self-reinforcing yet (integration and execution risks remain), and while growth is strong, it is not at the highest levels in every dimension. The business is transitioning to a higher-quality, recurring model but is not yet a fully disruptive platform.
FLEX (FLEX) Q3 2026: Data Center Revenue Jumps 35% as Power and Compute Mix Drive Margin Expansion
Flex is transitioning toward a higher-margin, secular growth profile with strong evidence of reinvestment runway and business model evolution. Data center revenue growth (35%) and margin expansion are significant, but the business is not a pure hypergrowth or disruptive story—legacy consumer drag and moderate guidance temper the overall signal. Still, the mix shift, capital discipline, and sector positioning offer meaningful upside.
Digi International (DGII) Q2 2026: ARR Jumps 50% as Solutions Integration Accelerates Margin Expansion
Digi International shows strong ARR growth, margin expansion, and cash flow acceleration, indicating a solid growth trajectory and operational leverage. However, while the business is clearly improving, it is not yet a category-defining disruptor and some elements (network effects, customer value deepening, exceptional future guidance) are present but not at the highest level. The company is transitioning toward high-quality compounding but does not score at the absolute top for signal.
Welltower (WELL) Q2 2026: Senior Housing Drives 25% FFO Surge as Portfolio Rotation Pays Off
Welltower demonstrates strong growth, margin expansion, and disciplined capital allocation, with clear evidence of business model evolution and compounding potential. However, the business is a large, well-followed REIT with a more mature profile and less disruptive upside than earlier-stage or less well-known companies. The signal is high for a sector leader but not at the very top end of the spectrum for transformative upside.
Cognition Therapeutics (CGTX) Q4 2025: Zervimicine Slows DLB Psychosis Progression by 86%, Shifting Pipeline Priority
CGTX demonstrates a long growth runway with high returns potential, a significant recent clinical inflection (86% slowing in DLB psychosis), and a disruptive business model targeting high-unmet-need CNS indications. However, scale/unit economics and customer value deepening are less proven at this stage, and while growth potential is high, it is not yet realized in revenues or EPS. The signal is strong for a clinical-stage biotech but not at the level of a proven compounding business.
Upstart (UPST) Q1 2026: Originations Surge 61% as Core Personal Loans Anchor Profit Strategy
Upstart is showing a long reinvestment runway, disruptive business model, and strong growth signals. However, some metrics (unit economics, customer value, and growth rates) are improving but not yet exceptional, and the business is not a new, undiscovered story. Signal is strong but not at the absolute highest level.
Dynatrace (DT) Q4 2026: Logs Consumption Surges 100% as Platform Consolidation Accelerates
Dynatrace demonstrates a strong reinvestment runway, recent significant category growth in logs, and self-reinforcing platform effects. Customer value is deepening and the business model is semi-disruptive, but not fully. Cash flow is strong but not yet accelerating, and while growth is robust, it is not at the hypergrowth threshold. The company is clearly a growth business, but some metrics (unit economics, future guidance) are not at the highest end of the spectrum for signal.
Harrow (HROW) Q1 2026: VEVY Net Pricing Reset Lifts Outlook as Demand Surges 25%
Harrow demonstrates a strong growth trajectory with clear demand acceleration, improving unit economics, and a robust product pipeline. However, while the business is transitioning to growth, it is not yet fully disruptive or compounding at the highest levels. Some risks remain around execution and competitive responses.
NanoNuclear (NNE) Q2 2026: $569M Liquidity Fuels First NRC Microreactor CPA Milestone
NanoNuclear is at a genuine inflection point with first-mover regulatory advantage, strong liquidity, and a disruptive, vertically integrated business model. However, while growth prospects and optionality are strong, unit economics and customer value deepening are still emerging rather than fully proven, and guidance does not yet indicate hyper-growth. The signal is high but not at the absolute maximum for a business at this stage.
RadNet (RDNT) Q3 2025: Digital Health Revenue Jumps 51%, AI Margin Leverage Emerges
RadNet shows clear growth and margin expansion, with digital health and AI providing a new runway. However, the core imaging business is mature and the reinvestment runway, while improved by software, is not as long or high-ROIC as pure tech disruptors. There is a significant uptick in digital health growth (51% YoY, 112% AI revenue growth), but overall company growth is not at hypergrowth levels. Unit economics are improving, especially in digital health. The business model is evolving toward self-reinforcement but is not yet fully compounding. Customer value is deepening within digital health, and guidance is positive but not exceptional. The business is transitioning toward a platform model, but legacy elements remain.
EH (EH) Q1 2026: Non-Human Carrying Revenue Hits 40%, Diversifying Beyond eVTOL Delivery
EH is at a pivotal moment with a disruptive model and long runway, as indicated by regulatory progress and global expansion. However, unit economics and customer value are improving but not yet exceptional, and while growth is strong, it is not at runaway levels. The business is transitioning into growth, but risks and execution hurdles temper the overall signal.
Wealthfront (WLTH) Q4 2026: Investment Advisory Assets Surge 29% as Cash-to-Invest Flows Hit Record Levels
Wealthfront demonstrates a strong growth profile with a long reinvestment runway and high client engagement, but not all signal criteria are fully met. While there is clear growth and some disruptive elements, the business model is not yet at giant scale, and some metrics (unit economics, business model self-reinforcement) are improving but not exceptional. The business is transitioning to deeper multi-product engagement, with strong but not extraordinary growth rates.
VinFast (VFS) Q1 2026: Two-Wheeler Deliveries Surge 219% as Asset-Light Shift Accelerates
VinFast demonstrates strong growth potential (runway, disruptive model, new markets) and is executing a strategic pivot, but margin headwinds, incentive costs, and B2B mix limit near-term upside. Unit economics are improving but not yet at scale, and although the business is moving toward growth, profitability is not imminent. The signal is strong but not at the highest level due to execution and margin risks.
Agilysys (AGYS) Q1 2027: Subscription Revenue Jumps 26%, PMS Outpaces POS for First Time
Agilysys demonstrates a strong growth runway, with recurring revenue, backlog, and margin expansion. PMS overtaking POS and accelerating AI adoption are important. However, while the business is transitioning to higher growth, the model is not highly disruptive and some metrics (unit economics, customer value, cash flow) are improving but not yet outstanding. The signal is strong but not exceptional for a vertical SaaS business of this scale.
Veeva (VEEV) Q1 2027: Falcon AI Set to Displace High-Volume Labor, Targeting Tens of Millions of Documents
Veeva demonstrates a long reinvestment runway with disruptive potential (Falcon/agentic labor) and is making a bold pivot into new markets. There are clear growth levers and some evidence of improving economics, but most AI-driven monetization is still in early innings, and the business is not yet showing rapid acceleration in growth or cash flow. The business model is semi-disruptive, and the core remains healthy, but the full upside is contingent on execution and adoption, tempering the signal score.
Epsilon Energy (EPSN) Q4 2025: Proved Reserves Surge 86% on Powder River Basin Acquisition
Epsilon's reinvestment runway, recent transformative acquisition, and reserve/production growth are clear. However, while the business is improving, it is not a disruptive or exceptional growth story, and some business model elements (network effects, customer value deepening) are not as strong as in top-tier compounders. The business is transitioning into a growth phase, but signal is capped by sector cyclicality and lack of true structural disruption.
AIXC (AIXC) Q4 2025: $41M Capital Infusion Ignites AI-Blockchain Infrastructure Pivot
AIXC has a long runway and disruptive model with regulatory tailwinds and capital for growth, but commercial traction is still unproven. Unit economics and customer value are not yet demonstrated, and revenue growth is projected rather than realized. The business is transitioning with potential for high growth, but significant execution risk remains.
Ambarella (AMBA) Q1 2027: $800M Hanwha LTA Signals Multi-Year Edge AI Revenue Upside
Ambarella demonstrates a long reinvestment runway with high returns on capital potential, a major LTA, and strong positioning in high-growth edge AI, automotive, and robotics. However, not all unit economics or customer metrics are clearly improving at a giant scale, and some elements (cash flow, revenue growth) are moderate rather than exceptional. The business is growth-oriented and semi-disruptive, but not yet at the level of a hypergrowth, compounding platform.
Park Aerospace (PKE) Q4 2025: Missile Systems Quadruple Demand Drives $7.1M C2B Fabric Surge
Park Aerospace is experiencing a significant, defense-driven inflection with strong order visibility and capital discipline. However, while the runway is long, some elements (unit economics, customer value deepening, business model self-reinforcement) are only partially established or have constraints, and commercial upside is capped by external bottlenecks.
Indi Semiconductor (INDI) Q1 2026: Core ADAS Surges 20% as Vision Pipeline Overtakes Radar
Indi Semiconductor is showing strong growth drivers—core ADAS and vision portfolios are ramping, and the business is pivoting to higher-margin, secular growth areas. There is a long reinvestment runway and disruptive elements in photonics/quantum, but not all business model aspects are fully self-reinforcing or exceptional yet. Growth is solid but not at the highest acceleration across all vectors; thus, the signal is strong but not maximal.
AIXC (AIXC) Q4 2025: $41M Capital Infusion Ignites AI-Blockchain Infrastructure Pivot
AIXC demonstrates a long reinvestment runway and disruptive business model with the AI-blockchain pivot and RWA focus (Q1, Q7). The $41M capital raise and user growth signal major business evolution (Q2), but commercial revenue is not yet proven and unit economics remain to be validated (Q3, Q5, Q8). The platform has emerging self-reinforcing elements (Q4), and the future outlook is positive but not yet exceptional (Q6, Q9). The business is clearly transitioning to growth (Q10), but execution risk and governance complexity temper the signal.
Alchemy Technologies (ALKT) Q2 2025: Mantle Adds 39 New Clients, Elevating Cross-Sell and ARR Visibility
The business demonstrates strong growth, improving unit economics, and high customer value with a robust ARR backlog and cross-sell momentum from the Mantle acquisition. However, while the business model is attractive and the runway is solid, it is not highly disruptive or unique within SaaS, and the reinvestment runway, while good, is not exceptional. Growth is strong but not hyper-scaling, and cash flow is improving but not yet a standout. The signal is strong but not at the highest level for uniqueness or market impact.
Arbe Robotics (ARBE) Q1 2026: System Revenue Mix Lifts AUP, Defense and AI Orders Expand Pipeline
Arbe is transitioning into higher-value, multi-market radar systems with a disruptive model and new verticals (defense, AI), signaling a longer runway and optionality. However, unit economics and customer value deepening are still developing, and growth, while promising, is not yet at hypergrowth levels. The business is not yet a cash flow machine, and the backlog, while improved, is still modest. The signal is strong for a small-cap, but not at the highest level for immediate upside.
AMBR Q1 2026: AMM Launch Targets Recurring Revenue as Digital Asset Margins Compress
AMBER is making a foundational business model transition with the launch of agentic infrastructure and recurring revenue products, indicating a long reinvestment runway and disruptive potential. However, current unit economics and customer value deepening are only moderately improving, and while guidance signals growth, it is not yet exceptional. The business is growth-oriented with a disruptive model, but actual acceleration and compounding effects are still emerging.
XPEV Q1 2026: International Revenue to Exceed 20% as Four Global Models Launch
Xpeng is at a strategic inflection with a disruptive pivot to physical AI, international expansion, and new high-growth segments. However, some signal is tempered by lack of proven recurring revenue and margin volatility, and unit economics are not yet clearly giant-scale. The business is growth-oriented, but not yet exhibiting exceptional, proven compounding metrics.
Epsilon Energy (EPSN) Q4 2025: Proved Reserves Surge 86% on Powder River Basin Acquisition
Epsilon now possesses a multi-year reinvestment runway with high-return inventory from the Peak acquisition. There is a significant uptick in reserves and production, but growth is not at hyper-scaler levels. Unit economics and cash flow are improving, but the business model is not fully self-reinforcing. Customer value and business model disruption are moderate. Cash flow is improving, but not dramatically accelerating. Growth is solid but not explosive, and the business is transitioning into a growth phase.
Red Violet (RDVT) Q2 2025: Contractual Revenue Rises to 77%, Locking in Platform Stickiness
Red Violet demonstrates strong recurring revenue, improving margins, and embedded customer relationships, indicating a robust business model. However, growth rates are good but not explosive (under 40%), and while enterprise pipeline is promising, there is no evidence of a step-change in growth or backlog. The model is self-reinforcing but not fully disruptive, and while cash flow is accelerating, the business is not at breakout velocity.
Milrose Properties (MRP) Q1 2026: Non-Lennar Portfolio Jumps to 31% as Builder Demand Shifts to Off-Balance Sheet Land
Milrose demonstrates a long reinvestment runway, structural tailwinds, and a disruptive platform model, but some metrics (unit economics, customer value, and growth rates) are improving at a moderate rather than exceptional pace. The business is not yet showing explosive growth or backlog inflection, but its positioning and model are clearly attractive for investors seeking compounding, recurring revenue, and industry read-through.
Arrowhead Pharmaceuticals (ARWR) Q1 2026: $1.33B Capital Infusion Powers Pipeline, Redemplo Launch Sets Commercial Trajectory
Arrowhead is at a key inflection, moving from development to commercial stage with strong capital and a robust late-stage pipeline. There is a long reinvestment runway and the potential for high returns, with disruptive RNAi technology and expanding indications. However, the business is still early in its commercial ramp, with unit economics and customer value deepening but not yet proven at scale. Growth is likely to be strong but not yet at hypergrowth levels, and milestone dependence introduces volatility.
Ingram Micro (INGM) Q2 2026: xVantage Drives 40% Operating Income Growth as AI Platform Scales
While the company is executing well and showing strong growth, it is not a truly disruptive business model and the reinvestment runway, while solid, is not exceptional. The business is more a leader in digital transformation within IT distribution than a paradigm-shifting disruptor. Growth rates and backlog are strong but not at the level of a hypergrowth platform.
Baidu (BIDU) Q2 2025: AI Cloud Revenue Jumps 27% as ApolloGo Scales Global Partnerships
Baidu demonstrates a long reinvestment runway and disruptive business model with strong growth in AI Cloud and ApolloGo. However, unit economics and customer value, while improving, are not yet exceptional. Growth is accelerating but not at the highest tier, and cash flow is pressured by heavy investment. The business is in a clear transition to growth, but risks and execution uncertainty temper the overall signal.
PODD Q1 2026: International Revenue Jumps 45% as Omnipod 5 Drives Global Penetration
Insulet demonstrates a long reinvestment runway, improving unit economics, and a disruptive, self-reinforcing business model. However, while growth is robust, there is not a recent 40%+ inflection in the overall business, and future guidance implies strong but not explosive acceleration. Customer value is improving but not consistently deepening at the highest level. The business is solidly in growth mode, but not at the very highest signal tier for near-term upside.
Ocean Power Technologies (OPTT) Q4 2026: Backlog Jumps 58% as Integrated Maritime Platform Strategy Takes Hold
OPT has a long reinvestment runway and a disruptive, platform-based model with a strong recent backlog uptick. However, unit economics and cash flow are not yet clearly improving, and recurring revenue/customer value is still in transition. Growth is strong but not explosive, and risk remains around execution and margin recovery.
Realmada Therapeutics (RLMD) Q1 2026: $160M Capital Infusion Extends Runway for Phase III NMIBC Program
Realmada is pre-revenue but has a long cash runway and a potentially disruptive product with strong clinical data and patent protection. However, while the business model shows optionality and growth potential, the lack of revenue and proven customer value limits the signal. Execution risk is high, and the company is not yet demonstrating compounding self-reinforcement or accelerating cash flow. Some disruption and growth are evident, but the thesis is not yet fully de-risked or exceptional.
Customers Bancorp (CUBI) Q2 2026: Non-Interest Deposits Hit 32%, AI-Driven Efficiency Targets Unlocked
The business is showing strong growth, margin expansion, and clear operational leverage, with AI and payments platform expansion providing moderate optionality and disruption. However, as a regional bank, the reinvestment runway and network effects are somewhat capped versus true platform businesses, and the business, while improving, is not at the highest level of disruptive growth or compounding.
NUTEX Health (NUTX) Q2 2025: Arbitration Revenue Hits 71% of Hospital Segment, Fueling Cash Flow Surge
NUTEX is showing strong growth and margin expansion driven by a regulatory arbitrage opportunity, but the long-term reinvestment runway and business model durability are questionable due to high regulatory and collection risk. While current growth is exceptional, the model is not clearly self-reinforcing and is exposed to legislative changes, capping the signal score.
LaFrost (LFS) Q1 2025: Social Business Revenue Climbs to 28% of Mix, Powered by Club Support Expansion
LaFrost is at a strategic inflection with strong policy tailwinds, rapid segment growth, and margin improvement. However, while the business model is evolving and shows some self-reinforcing elements, network effects and deepening customer value are still emerging rather than entrenched. Growth is robust but not yet at hyper-growth levels, and some risks remain around execution, international expansion, and the durability of policy-driven demand.
Echo Wave Power (WAVE) Q2 2025: R&D Spend Jumps 25% as Portugal Megaproject Nears Launch
Echo Wave Power is a high-risk, high-upside early-stage business with a disruptive model and global partnerships. There is a long reinvestment runway and clear growth signals (R&D, pipeline, global deals). However, evidence of accelerating cash flow, consistent unit economics improvement, and customer value deepening is still nascent. Execution risk and unproven commercial conversion temper the signal score.
NUTEX Health (NUTX) Q2 2025: Arbitration Revenue Hits 71% of Hospital Segment, Fueling Cash Flow Surge
NUTEX exhibits strong recent growth and margin expansion driven by arbitration, with clear operational leverage and cash flow acceleration. However, the business is highly dependent on a single regulatory mechanism (NSA arbitration), limiting its reinvestment runway and compounding advantages. While the growth is robust, the sustainability and optionality are constrained by regulatory and collection risks. The model is disruptive for out-of-network providers but not broadly across healthcare, and customer value deepening is modest. The business is in a strong growth phase, but risk concentration tempers the signal score.
Live Oak Bancshares (LOB) Q2 2026: Efficiency Ratio Improves 8 Points as Deposit Mix Shifts
Live Oak shows a long reinvestment runway and strong recent developments (significant deposit mix shift, AI rollout, and record loan originations). Unit economics and efficiency are improving, and the business is growing with clear optionality. However, network effects and customer value deepening are present but not dominant, and while growth is strong, it is not at hypergrowth levels. The business is innovative but not fully disruptive, and cash flow is improving but not accelerating dramatically. Overall, signal is strong but not exceptional for a well-followed digital bank.
Genesis (GNSS) Q1 2026: Hardware Revenue Jumps 220% as Backlog Hits $58M, Software Pipeline Expands
Genesis shows strong near-term growth, a robust backlog, and margin expansion, but the business is not yet a clear, dominant compounding platform. While the hardware momentum and software pipeline are promising, the business model's self-reinforcement and customer value deepening are emerging rather than fully proven. Growth is strong but not at a hyper-scaler or category-defining level.
QuantumScape (QS) Q4 2025: Customer Billings Reach $19.5M as Eagle Line Sets Scale Blueprint
QuantumScape shows a long runway (licensing, multiple verticals), a major inflection with first billings and Eagle Line, and a disruptive, capital-light model. However, unit economics and customer value deepening are still emerging rather than proven, and while growth is visible, it is not yet at hypergrowth levels. The business is transitioning to commercialization but not yet a proven cash flow machine. The signal is strong for a strategic investor, but not exceptional given execution risks and early monetization stage.
Rush Street Interactive (RSI) Q2 2026: Latin America Revenue Jumps 195%, Casino-First Model Accelerates Share Gains
RSI shows strong growth, particularly in Latin America, with improving unit economics and customer metrics. While there are significant positive developments and a clear growth trajectory, the business, while attractive, is not wholly disruptive or offering a uniquely long reinvestment runway. Some elements (network effects, disruptive model, cash flow acceleration) are present but not at the highest possible level for a truly exceptional signal score.
Firefly Aerospace (FLY) Q2 2025: $1.3B Backlog and 25.7% Margin Signal National Security and Lunar Tailwinds
Firefly demonstrates a long reinvestment runway with high returns, recent significant backlog growth, and a disruptive business model with strong government and commercial tailwinds. However, while margin and data streams are improving, unit economics and customer value deepening are still emerging and not yet compounding at scale. Cash flow is improving but not yet accelerating, and revenue/earnings growth is likely to be strong but volatile due to milestone-based recognition. The business is transitioning from early-stage to growth, with high potential but some execution risk.
Belite Bio (BLTE) Q2 2025: Dragon Phase 3 Nears 24-Month Endpoint, FDA Single-Study Approval Path in Focus
Belite Bio is a late-stage biotech with high optionality and a clear regulatory path, but lacks commercial proof points and recurring revenue. The business is not yet self-reinforcing, and while the runway and regulatory clarity are strong, there is still significant execution and trial readout risk. Signal is strong for a biotech, but not at the highest level due to pre-commercial status.
Concentra (CON) Q1 2026: Workers’ Comp Visits Jump 9.6%, Driving Margin Expansion and Guidance Raise
Concentra exhibits strong growth, margin expansion, and a clear reinvestment runway, especially in on-site clinics and workers' comp. However, while the business is improving, it is not a classic high-compounding, disruptive model—growth is robust but not explosive, and advantages are emerging but not yet deeply entrenched. The signal is high for a healthcare services business, but not at the level of a true platform or network-effect-driven company.
Nautilus Biotechnology (NAUT) Q2 2025: Operating Expenses Down 18% as Platform Validation Accelerates
Nautilus has a long reinvestment runway and disruptive platform, with strong recent validation and strategic collaborations. However, the business remains pre-revenue and unit economics, customer value expansion, and growth rates are not yet proven at scale. The signal is high for early-stage innovation, but near-term financial impact and upside are not yet clear, warranting a conservative score.
Dynatrace (DT) Q3 2026: Log Management Surpasses $100M, Fueling AI-Driven Platform Upside
Dynatrace is a strong growth business with clear double-digit ARR and consumption growth, exceptional log management expansion, and robust enterprise traction. However, the reinvestment runway and business model disruption are not at the highest tier, given the competitive landscape and some maturity in core segments. The signal is strong but not at the highest level for a truly transformative or undiscovered business.
Meridian Holdings (MRDN) Q2 2026: Net Debt Down 65% as New Customer Registrations Surge 37%
The business is showing strong growth, operational leverage, and deleveraging, but the reinvestment runway and self-reinforcing dynamics are notable but not exceptional. There are some disruptive elements and strong cash flow, but the business is not a clear outlier or household name with massive upside. Signal is solid but not extraordinary.
Velo3D (VELO) Q4 2025: Backlog Doubles to $31M, Signaling Accelerating Defense and Aerospace Demand
Velo3D shows a long reinvestment runway and disruptive model with strong backlog growth and a strategic pivot to high-margin services. However, some elements (unit economics, customer value deepening, and cash flow acceleration) are not yet fully proven or at scale, and backlog conversion risk tempers the signal. Growth is robust but not at the highest acceleration threshold.
FTW Q1 2026: $1B ABS Facility Unlocks Acquisition Runway, Dividend Set to Rise 11%
Presidio's business model is disruptive for the sector (acquisition-focused, tech-enabled, non-drilling), has a long reinvestment runway, and is positioned for growth. However, not all signals are 'giant' level yet: unit economics and customer value are improving but not at the highest tier, and future growth is strong but not 40%+ annualized. Still, the model and capital structure provide clear, differentiated signal for investors.
EOLS Q1 2026: Evelis Rewards Membership Surges 27%, Accelerating Platform Engagement
Evolus shows a long reinvestment runway, clear growth levers, and improving customer value, but the business is not highly disruptive and unit economics, while strong, are not yet at giant scale. The business is transitioning to growth with some acceleration, but not at an exceptional pace. The model is differentiated but not completely defensible against larger competitors, and while cash flow is improving, it is not yet a cash machine. The signal is solid but not extraordinary.
Evaxion (EVAX) Q4 2025: Cash Runway Extended to 2027 as AI Immunology Drives Pipeline Momentum
Evaxion has a long reinvestment runway, recent significant developments (cash runway extension, partnerships), and a disruptive AI-driven business model. However, improvements in unit economics, customer value, and cash flow are present but not exceptional; the business is transitioning to growth but not yet at breakout velocity.
Diamedic Therapeutics (DMAC) Q1 2026: R&D Expenses Rise 40% as Remedy 2 Stroke Trial Surpasses 70% Enrollment
Diamedic offers a long reinvestment runway with disruptive potential in vascular/pregnancy indications and global trial expansion. Remedy 2 and the preeclampsia programs represent potentially high-growth opportunities, but the business is still pre-commercial with uncertain unit economics and customer value. There is strong momentum (70%+ enrollment, R&D up 40%), but not yet evidence of accelerating cash flow or >40% near-term growth. The business is growth-oriented but still faces binary clinical/regulatory risks.
ElectroMed (ELMD) Q3 2026: Operating Income Jumps 76% as SmartVest Penetration Accelerates
ElectroMed is demonstrating strong growth, margin expansion, and a long runway in an underpenetrated market, but some signal questions (network effects, customer value, disruption, cash flow acceleration) are not fully at the highest level—there is strong execution, but not all elements point to exceptional, compounding signal or disruptive business model.
Merlin (MRLN) Q1 2026: $183M Cash Infusion Extends Runway for Autonomous Aviation Platform
Merlin has a long reinvestment runway, disruptive platform potential, and strong capital position. However, current growth is modest, unit economics are not yet proven at scale, and recurring revenue is still early-stage. The business is transitioning to growth but lacks evidence of >20% top-line acceleration or exceptional customer monetization. Signal is above average due to platform optionality and industry paradigm shift, but not at the highest tier due to early-stage risk.
Forum Markets (FRMM) Q1 2026: 28% Share Buyback Reshapes Capital Base, AI Asset Pipeline Accelerates
Forum Markets is in a high-growth, disruptive vertical (AI infrastructure financing, tokenization), and the 28% buyback is a major capital allocation event. However, while the business model has significant potential, the current scale and financials reflect a transition phase, with some uncertainty around execution and pace of recurring revenue growth. The signal is strong but not at the highest level due to these transitional risks and the early stage of some initiatives.
Generac (GNRC) Q2 2026: Data Center Backlog Jumps $1B, Tripling Capacity Runway
Generac demonstrates a significant strategic inflection with a $1.6B data center backlog and multi-year visibility, supporting a growth thesis. However, while the reinvestment runway and growth are strong, some signals (unit economics, self-reinforcing model, customer value) are promising but not yet at the highest level of compounding or disruption. The business is clearly transitioning to a higher-growth phase, but some risks and execution dependencies temper the upside.
CMBT Q1 2026: Dry Bulk Spot Exposure Drives 20%+ Cash Flow Upside as Cycle Peaks
CMBT demonstrates strong near-term cash flow growth and capital allocation optionality due to current cycle conditions and operational execution. However, as a shipping operator, it faces inherent cyclicality, limited long-term reinvestment runway, and its business model, while opportunistic, is not deeply disruptive or compounding. The signal is high for near-term upside, but structural signal is moderate due to sector dynamics and lack of a unique moat.
Liberty Energy (LBRT) Q2 2026: Power CapEx Surges 50% as 3 GW Buildout Accelerates
Liberty Energy is transitioning to a high-growth digital power infrastructure platform, with a long reinvestment runway and a disruptive business model. There are significant recent developments (3 GW buildout, CapEx surge), but margin and unit economics are pressured in the near term. Customer value and business model self-reinforcement are emerging but not yet fully proven. The business is not yet showing exceptional growth metrics (>40% YoY), but the trajectory is strong and the strategy is thesis-relevant for investors.
Nautilus Biotechnology (NAUT) Q4 2025: Operating Expenses Down 23% as Platform Nears Commercialization
Nautilus is transitioning to commercialization with a potentially disruptive proteomics platform and a long reinvestment runway. There are recent pivotal developments (Voyager launch, early access program) and strategic partnerships, but the business is still pre-revenue and unit economics are not yet proven at scale. Growth potential is high, but execution risk remains and the signal is somewhat tempered by the lack of current recurring revenue and the need to prove broad customer adoption.
TMC (TMC) Q1 2026: Allseas Funds Majority of Pre-Production CapEx as Regulatory Path Clears
TMC is positioned at a major inflection with regulatory progress, partner-funded CapEx, and strategic ambition in a high-potential, early-stage sector. However, while the reinvestment runway and disruptive potential are strong, unit economics and cash flow are not yet proven or accelerating, and the business is not yet at a scale or growth rate to warrant top marks. The signal is strong but reflects the early, high-risk, high-upside stage of the business.
Exodus (EXOD) Q1 2026: Monovate Acquisition Targets 40% Revenue Mix Shift by 2027
Exodus is undergoing a major strategic pivot with significant potential for value creation, as evidenced by the Monovate acquisition and new recurring revenue streams. The business is moving toward a disruptive, high-optional model with a long runway, but current financials remain vulnerable to crypto cycles and recurring revenue is not yet scaled. While the future could be exceptional if execution succeeds, the present signal is limited by integration risk, lack of immediate growth acceleration, and early-stage adoption in new segments.
BitDigital (NRXP) Q1 2026: WhiteFiber Stake Hits $322M as Mining Shrinks to 13% of Revenue
BitDigital is in the midst of a strategic transition with a long reinvestment runway (AI infrastructure, Ethereum staking), and recent developments are material (WhiteFiber stake, revenue mix shift). However, while the business model is disruptive and growth-oriented, unit economics and customer value are still volatile and somewhat dependent on external factors (crypto prices, regulatory clarity). The business is not yet a consistent cash flow machine, and growth, while strong, is not exceptional across every metric. The company is no longer a legacy business, but is not yet a proven compounder.
Yatra (YTRA) Q2 2026: Corporate Travel Adds 34 Clients, Drives 48% Revenue Lift
Yatra demonstrates strong growth, margin expansion, and clear strategic execution in a high-growth, under-penetrated market. The corporate travel runway and digital adoption provide evidence of future upside. However, while the business is outpacing the industry, the model is not fully self-reinforcing or disruptive at platform scale, and some metrics (ARPU, unit economics) are improving but not exceptional. Risks around restructuring and competitive intensity temper the signal.
NIU (NIU) Q1 2026: China Electric Motorcycle Sales Triple as Brand Penetrates Tier 2 and 3 Cities
NIU demonstrates a strong growth pivot with triple-digit motorcycle sales growth and a large addressable market, suggesting a long reinvestment runway. There is a major business evolution in China, but overseas remains challenged. Unit economics are improving in China but mixed internationally. The business model has some self-reinforcing aspects (O2O, brand), but not at the level of a dominant network effect. Customer value is improving in motorcycles but not across the board. Guidance implies good (but not exceptional) growth. The business is semi-disruptive and transitioning to a growth phase, but international drag and margin reset temper the overall signal.
WTTR Q1 2026: Water Infrastructure Revenue Jumps 19% as Commercialization Accelerates
WTTR demonstrates a strong reinvestment runway, recent backlog and revenue growth, and improving unit economics. However, while the model is capital-light and expanding, it is not fully disruptive or compounding at the highest level yet. Customer value and cash flow are improving but not exceptional, and guidance upgrades are meaningful but not extraordinary. The business is clearly in growth mode but not at the highest possible signal tier.
EYPT Q1 2026: $88M R&D Spend Accelerates DuraView Phase 3, Eyes Midyear AMD Data Catalyst
EYPT presents strong signal as a late-stage clinical biopharma with a potentially disruptive therapy (DuraView) targeting a large, growing market. The reinvestment runway is long if successful, recent developments are significant, and the business is on the cusp of a major inflection. However, as a pre-commercial company, evidence of self-reinforcing economics and cash flow is still emerging, and some elements (unit economics, customer value expansion) are not yet proven. The signal is strong but not at the highest possible level due to these uncertainties.
MindWalk Holdings (HYFT) Q3 2026: Recurring Revenue Model Launches as U.S. Business Doubles
MindWalk is at a business model inflection with a SaaS transition and strong North American growth, suggesting runway and some disruptive potential. However, while the recurring revenue and pipeline catalysts are promising, scale and margin expansion are not yet proven, and customer value deepening is still emerging. Growth rates are strong but not explosive, and while the model is disruptive, the evidence for compounding self-reinforcement and cash flow acceleration is moderate at this stage.
Verica Pharmaceuticals (VRCA) Q4 2025: YCANTH Revenue Doubles, Margin Expands to 85.7% as Pipeline Advances
Verica shows strong reinvestment potential, a business model shift, and clear pipeline momentum. However, while the business is improving, some elements (network effects, customer value deepening, disruptive model) are present but not yet fully proven or exceptional. Growth is robust but not at the highest acceleration tiers, and the business, though transformed, is not yet a category-defining compounder.
Atlanticus (ATLC) Q1 2026: Mercury Acquisition Drives 97% Revenue Expansion, Integration Outpaces Plan
Atlanticus demonstrates strong growth and integration execution, with a long runway and improving economics. However, the business model is not fully disruptive, and while growth is robust, it is not at hypergrowth levels. Customer value and self-reinforcement are improving but not exceptional. The signal is solid but not extraordinary for a specialty finance player.
Bit Digital (BTBT) Q1 2026: Ethereum Holdings Reach $327M as Mining Shrinks to 13% of Revenue
Bit Digital is making a major business model transition with a long runway in Ethereum and AI infrastructure, and management is actively pursuing growth and cash flow compounding. However, unit economics and customer value deepening are only moderately improving, and near-term growth is not exceptional given the revenue contraction and volatility. The business is strategic and disruptive, but risks and execution challenges temper the overall signal.
Mink Therapeutics (INKT) Q1 2026: 90-Patient ARDS Trial Launch Signals Pivotal Data Path
Mink Therapeutics is at a strategic inflection with a potentially disruptive allogeneic cell therapy platform and a pivotal ARDS trial. The reinvestment runway is long, and the business model is disruptive with non-dilutive funding and scalability. However, unit economics, customer value, and cash flow are not yet visibly accelerating, and growth, while promising, is not yet at the highest tier. Risks remain around execution, regulatory clarity, and future financing.
Neovolta (NEOV) Q3 2026: Gross Margin Jumps to 46% as Georgia Facility Nears Production
Neovolta is at an operational inflection with a long runway and disruptive potential, especially as domestic manufacturing ramps and multi-vertical expansion accelerates. However, gross margin improvement is partly due to accounting adjustments, and while growth is strong, it is not yet at the level of a clear giant. Some metrics (unit economics, customer value, cash flow) are improving but not yet exceptional, warranting a conservative scoring.
AIRJ Q1 2026: $55M Impairment Masks Commercial Pipeline Progress as Prime System Goes Live
AIRJ has a long reinvestment runway with disruptive potential and strong growth signals (Prime system launch, data center demand, WPA model). However, commercial ramp is still pending (2027 inflection), unit economics are not yet proven at scale, and cash flow is not yet accelerating. There is clear growth optionality and disruptive potential, but the business is still transitioning from R&D to commercial validation, limiting the immediate signal score.
TK Group (TNK) Q2 2026: Spot Tanker Rates Surge 50%, Unlocking Record Cash and Fleet Renewal Leverage
The signal is strong due to record spot rates, all-time high cash generation, and clear evidence of business evolution (fleet renewal, asset sales at premiums). However, the business is highly cyclical and levered to spot rates, with the reinvestment runway limited by sector dynamics and lacking true structural disruption. Some self-reinforcing elements are present (balance sheet strength, asset renewal), but the tanker business remains exposed to exogenous factors and not a secular compounder.
Ranpak (PACK) Q2 2026: Automation Revenue Soars 139%, Reshaping Margin and Growth Profile
Ranpak is showing a major business mix shift with automation scaling rapidly, a long reinvestment runway, and strong recent growth. While unit economics and margin leverage are improving, some elements (business model self-reinforcement, customer value deepening, disruptive potential, and cash flow acceleration) are not yet fully proven or exceptional. The business is transitioning toward growth but not yet a clear outlier, warranting a conservative signal score.
Biodesic (BDSX) Q1 2026: Diagnostic Test Volumes Jump 29% as Primary Care Channel Expands Reach
Biodesic shows strong growth, margin expansion, and a credible path to profitability, with clear evidence of a reinvestment runway and operational leverage. However, while the business is growing, it is not a category-defining disruptor yet, and some metrics (customer value, business model self-reinforcement, cash flow acceleration) are improving but not exceptional. The business is not likely to deliver 40%+ sustained growth, and some signals are moderate rather than outstanding.
CurbLine Properties (CURB) Q4 2025: $700M Investment Pipeline Drives 12% FFO Growth Ambition
CURB shows a long reinvestment runway, recent strong growth, and improving unit economics. The business model is somewhat self-reinforcing but not network-driven. Customer value is improving modestly, with good but not exceptional forward guidance. The model is capital efficient and semi-disruptive within REITs, but not a tech-like disruptor. Cash flow and growth are solid but not at hypergrowth levels. The business is a clear growth story, though not one with extreme upside or unique network effects.
Genco Shipping (GNK) Q1 2026: Dividend Surges 133% as Cape Size Leverage Drives $2.50 Per Share Outlook
Genco demonstrates strong recent growth, clear dividend upside, and improving cash flow, but as a shipping business, its reinvestment runway and business model defensibility are more moderate compared to highly disruptive or tech-driven businesses. The proxy battle adds uncertainty but also strategic significance. The signal is high for a cyclical business, though the industry context tempers the maximum score.
AMG (AMG) Q2 2026: Alternatives Hit 60% of Earnings, $29B Quarterly Inflows Accelerate Shift
AMG is undergoing a significant business model shift with strong inflows and margin expansion in alternatives, but the underlying business, while improving, is not highly disruptive and remains in a consolidating, competitive industry. The growth is meaningful but not at the hyper-growth level, and while cash flow and capital returns are strong, the reinvestment runway is solid but not exceptional.
TPR Q3 2026: Coach Drives 29% Revenue Growth, Gen Z Acquisition Powers Compounding Flywheel
Tapestry demonstrates strong growth, especially at Coach, with significant new customer acquisition and margin expansion. However, the business is not highly disruptive or unique in the broader context of luxury retail, and the reinvestment runway—while solid—is not exceptional or open-ended. The growth is strong but not at the level of a transformative business model, and Kate Spade remains a drag. The signal is good, but not at the highest tier for investor upside.
Dario Health (DRIO) Q1 2026: Channel Reach Expands to 175M Covered Lives, Unlocking Platform Scale
Dario Health is at a major inflection, with a strong channel-driven runway and disruptive model. However, unit economics, customer value, and cash flow are improving but not yet at 'giant' levels. The business is transitioning to high-margin growth, but not all signal criteria are fully met for maximum scores.
Rumble (RUM) Q1 2026: Northern Data Deal to Add 22,000 GPUs, Cloud Revenue Set to Eclipse Video
Rumble’s pivot to cloud/AI infrastructure and the Northern Data deal present a long runway with disruptive potential, but much of the growth and monetization is still in the early innings. There is strong evidence of transformation and institutional validation, but execution and integration risks temper the signal. Revenue and EPS growth are not yet at the highest tier, and while the business is transitioning to growth, the inflection remains to be proven.
CVRX (CVRX) Q4 2025: Category 1 CPT Code Unlocks 46% Medicare Advantage Approval, Setting Stage for Growth Acceleration
CVRX demonstrates a long reinvestment runway and disruptive business model, with a major reimbursement inflection (Category 1 CPT code) and a large clinical trial set to triple the addressable market. However, while growth prospects are strong, current unit economics and cash flow are not yet exceptional, and most metrics (ARPU, cash flow, revenue/EPS growth) are improving but not at the highest tier. The business is transitioning to growth, but profitability and network effects are still developing.
RenovoRx (RNXT) Q1 2026: Active Cancer Centers Double to 16, Catalyzing Commercial Inflection
RenovoRx demonstrates strong growth inflection, high margins, and a scalable commercial model, but the business is still early-stage and not yet at giant scale. The reinvestment runway is long, but some levers (network effects, customer value deepening) are not yet fully proven or exceptional. The business is transitioning to growth but not yet a disruptive, dominant player.
CS Disco (LAW) Q1 2026: $124M Large-Customer Revenue Signals AI-Driven Litigation Platform Shift
CS Disco shows a long reinvestment runway, strong recent growth in large customer revenue, and a disruptive AI platform model with evidence of increasing enterprise traction. However, some metrics (unit economics, customer value, cash flow) are improving but not yet exceptional, and the business is still transitioning rather than fully scaled, capping the signal score.
CBIS (CBUS) Q1 2026: $8M Expense Cut Accelerates Commercialization Path in Rice and Biofragrances
CBIS offers a long reinvestment runway and disruptive potential, with recent regulatory and commercial progress. However, while growth and optionality are evident, the business is still transitioning to commercial scale, and revenue/earnings acceleration is not yet at the highest tier. Some metrics (unit economics, customer value) are improving but not yet exceptional, and execution risk remains.
TK (TK) Q2 2026: Spot Tanker Rates Surge 50%, Fueling Record Cash and Strategic Optionality
TK is a cyclical, asset-intensive business experiencing a period of exceptional profitability due to market dislocation, but does not have a long-term, self-reinforcing growth model or disruptive business model. The current surge is significant but likely temporary. Cash flow is accelerating, and the business is in a growth phase, but the reinvestment runway is moderate and dependent on external factors.
AuthID (AUID) Q1 2026: Quantum-Resistant Platform Launches as Pipeline of 20+ Enterprise POCs Sets Stage for Step-Change Growth
AuthID is positioned at a strategic inflection with a disruptive, quantum-resistant platform and a pipeline of high-value enterprise POCs, giving it long runway and optionality. However, the business is still early in converting pipeline to revenue, and while growth is strong, it is not yet at massive scale or self-reinforcing network effects. Cash flow and customer value are improving but not yet exceptional.
United States Antimony (UAMY) Q1 2026: Zeolite Shipments Surge 66% as Critical Minerals Platform Expands
UAMY demonstrates a strong strategic pivot and significant growth optionality, especially with federal contracts and multi-mineral diversification. There are clear signs of accelerating demand (notably zeolite shipments up 66% and government contracts) and a disruptive, government-aligned business model. However, actual improvements in unit economics, customer value, and cash flow are still in transition, and growth rates, while strong, are not yet at the highest threshold across all metrics. Execution risk and dependence on government milestones temper the signal slightly.
Alpha Cognition (ACOG) Q1 2026: 62% Zunvel Demand Surge Signals Inflection in Long-Term Care Penetration
Alpha Cognition has a compelling inflection and growth runway in long-term care, but some elements (unit economics, customer value, business model defensibility) are still emerging and not yet at the level of a giant, self-reinforcing platform. Growth is strong but not yet exceptional, and the business, while disruptive, faces payer and execution risks that temper the overall signal.
MindWalk Holdings (HYFT) Q4 2025: Recurring Platform Revenue Debuts, Gross Margin Expands to 61%
MindWalk is at an inflection point with the debut of recurring SaaS revenue and strong gross margin expansion, suggesting a disruptive, high-optional business model. However, platform revenue is still nascent and the majority of revenue remains project-based, so the signal is not yet at the highest level. There is clear growth and some disruptive potential, but the business is not yet a scaled, high-velocity compounding platform.
Autolus Therapeutics (AUTL) Q1 2026: Gross Margin Turns Positive as Center Penetration Reaches 73
Autolus is at a growth inflection, with positive gross margin, accelerating center penetration, and a pipeline of catalysts. While the commercial model is scaling and margin trajectory is improving, the business model’s self-reinforcement and customer value deepening are emerging but not yet proven at scale. The growth profile is strong but not yet at the very highest tier, and some risks remain around execution and competitive dynamics.
Canadian Solar (CSIQ) Q1 2026: U.S. Module Output Hits 45% of Mix as Domestic Margins Outperform
Canadian Solar demonstrates a long reinvestment runway with high returns possible from U.S. manufacturing and storage integration. There are significant developments (U.S. shift, backlog), but not all financial signals are exceptional—growth is solid but not at hypergrowth levels. Unit economics are improving, though not yet at giant scale. The business model is semi-disruptive, and recurring revenue is growing, but cash flow and customer value metrics are not all at the highest levels. This is a growth business with moderate but not extraordinary signal.
Picard Medical (PMI) Q4 2025: U.S. Revenue Jumps 34% as Artificial Heart Adoption Intensifies
Picard Medical is at a strategic inflection with a disruptive, innovation-led pipeline and a clear margin-expansion story. The U.S. market focus and Emperor platform create a long runway, but unit economics and self-reinforcing business model are still emerging. Growth is strong but not yet at hyper-scaler levels, and risks around execution and capital needs remain. The signal is high for a small-cap medtech, but not at the level of an established compounding giant.
A2Z (AZ) Q1 2026: Contracted Backlog Surges to $195M as Smart Cart Deployments Shift to Scale
A2Z shows a long reinvestment runway with a disruptive business model and a major backlog inflection, but some metrics (unit economics, customer value, cash flow acceleration) are still early or only moderately improving. Growth is strong but not yet at hypergrowth levels. Signal is strong but not at maximum due to the early stage and some execution risk.
Karyopharm (KPTI) Q1 2026: Sentry OS Hazard Ratio at 0.43 Signals Potential Myelofibrosis Paradigm Shift
Karyopharm is at a major inflection with clear late-stage pipeline catalysts and strong survival data, but it is not yet a proven high-growth compounder and faces execution and competitive risks. The business is transitioning, not yet a proven cash flow machine, and while signals are strong, the company is not yet a clear outlier for valuation upside.
Brookfield (BN) Q1 2026: Fee-Bearing Capital Rises 12% as Real Asset Flows Accelerate
Brookfield demonstrates a long reinvestment runway, significant fundraising momentum, and a self-reinforcing business model with real asset and insurance scale. However, while growth is robust, it is not at hypergrowth levels and some metrics (unit economics, customer value, cash flow acceleration) are improving but not exceptional. The business is a clear compounder, but not a disruptive, high-velocity growth story.
Terrestrial Energy (IMSR) Q1 2026: 7.8 GW Pipeline Anchors Commercial Path as Regulatory Milestones Accelerate
The business demonstrates a long reinvestment runway, disruptive model, and strong regulatory/commercial progress, but is still in a pre-revenue phase with execution risk and no evidence of accelerating cash flow or >40% growth yet. Unit economics and customer value are promising but not yet proven at scale. The signal is strong for a nuclear startup, but not at the highest level due to early stage and lack of concrete financial upside at this point.
TK Tankers (TNK) Q1 2026: Spot Rates Top $141K, Driving Record Cash and Fleet Renewal
While the business is currently experiencing windfall conditions and has strong cash flow, the core model is cyclical and lacks the deep, long-term compounding characteristics of the most exceptional businesses. The asset rotation and spot exposure are well-executed, but the reinvestment runway is limited by shipping sector cyclicality, and the business does not have truly disruptive or defensible moats. Growth is strong but sustainability is uncertain.
TK Group (TK) Q1 2026: Spot Tanker Rates Soar Above $120,000, Unlocking Record Cash Flow and Fleet Renewal Firepower
The business is experiencing a period of exceptional cash flow and growth driven by external disruptions, but the underlying business model is not highly disruptive or self-reinforcing long-term. There is strong near-term growth and operational leverage, but the sustainability of these conditions is uncertain, and the reinvestment runway may be capped by asset inflation and industry cyclicality.
LightWave Logic (LWLG) Q1 2026: Addressable Market for AI Optical Transceivers Jumps 176% to $47B
LWLG is positioned in a structurally expanding market with disruptive technology and long reinvestment runway. However, unit economics and cash flow are not yet proven at scale, and customer ramp is gated by external foundry constraints. The growth profile is strong, but not yet at the inflection/acceleration phase, and some self-reinforcing advantages are emerging but not fully established.
MindWalk (HYFT) Q3 2026: 52% Revenue Surge Signals Recurring Platform Model Inflection
MindWalk is at a strategic inflection with the platform model emerging and U.S. market traction, but recurring revenue is still nascent and pipeline data is pending. The business model is disruptive with a long runway, but unit economics and customer value are still developing. Revenue growth is strong but not yet at hypergrowth levels. The company is transitioning into a growth business, but execution risk remains high.
Bridger Aerospace (BAER) Q1 2026: Sensor Aircraft Hours Double, Ignis Platform Launch Targets Tech-Led Growth
Bridger Aerospace shows a strong technology-driven growth story with a disruptive SaaS angle and long runway, but not all metrics are at the highest signal. Unit economics and customer value are improving but not yet at giant scale, and cash flow is set to improve but not currently accelerating. The business is transitioning rapidly toward growth, but some execution and adoption risks remain.
USIO (USIO) Q1 2026: Card Revenue Jumps 23% as PayFac Drives Record Volumes
USIO is showing strong growth, a clear inflection with PayFac and digital payments, and improving margins. While the business demonstrates good optionality and some disruptive elements, it is not yet at the scale or trajectory of a truly exceptional, high-compounding business. Backlog and growth are solid but not explosive, and while unit economics and cash flow are improving, they are not yet at 'giant' levels. The business is transitioning toward a stronger model but is not fully there.
Keele Infrastructure (KEEL) Q1 2026: $533M Liquidity Fuels Three-Site Lease Push in Supply-Constrained Markets
Keele's pivot creates a long reinvestment runway with disruptive potential in digital infrastructure, ample liquidity, and clear growth levers. However, lease conversion and unit economics are not yet proven, and while the model is attractive, the business is not yet at escape velocity—execution risk remains high. The signal is strong for a transitioning, high-upside story, but not yet a proven compounder.
Dexcom (DXCM) Q4 2025: G7 15-Day Rollout Drives 200bps Margin Expansion, Unlocking Global Growth Levers
Dexcom has a long reinvestment runway, clear product and geographic expansion levers, and is showing strong international momentum with double-digit growth. However, some metrics (unit economics, customer value, cash flow) are improving but not at an exceptional rate. The business is growth-oriented and innovative, but not disruptive enough for a perfect signal score, and near-term growth is solid but not explosive.
TRX Gold (TRX) Q3 2026: Throughput Rises 60% as Mill Expansion Sets Up Next Phase of Growth
TRX Gold shows strong operational momentum, a self-funded growth strategy, and a large expansion runway. However, while improvements are notable, the business model is not highly disruptive and customer value deepening is moderate. Growth is robust but not at the extreme end, and some elements (network effects, exceptional acceleration) are present but not dominant.
1&1 Green Technologies (YDDL) Q2 2025: Copper Ingot Sales Surge 125%, Margin Expands 340bps on Supply Chain Advantage
The business is showing strong growth, clear margin expansion, and benefits from a structural trade advantage. However, while the runway is promising and the business is transitioning to growth, there is some concentration risk (heavy reliance on copper) and not all aspects (customer value, business model disruption, cash flow) are exceptional or fully proven yet. Signal is strong for a smallcap industrial, but not at the highest level.
Ginkgo Bioworks (DNA) Q1 2026: Revenue Falls 49% as Autonomous Lab Bet Scales to 103 Racks
Ginkgo is a disruptive, high-upside business with a long reinvestment runway and clear strategic pivot. However, revenue and customer metrics are not yet showing breakout growth or improving unit economics; the business is still in a high-risk, proof phase. The signal is strong due to the bold transition and clear inflection, but the lack of current growth traction and the binary risk profile temper the overall score.
Wealthfront (WLTH) Q3 2026: Cross-Product Adoption Tops 60% as Cash-to-Invest Shift Accelerates
Wealthfront has a long reinvestment runway, strong unit economics, and a self-reinforcing model with improving customer value. However, there is no evidence of a recent massive growth inflection (no >40% growth or backlog surge), and while the model is disruptive, it is not unique in fintech. The business is a growth story, but the signal is tempered by the lack of recent extraordinary acceleration.
Nektar Therapeutics (NKTR) Q1 2026: Phase 3 Readiness Advances, 9-12 Month Durability Data in Focus
Nektar has a disruptive, high-upside asset in Rezpeg with a potentially long reinvestment runway if durability is validated. Recent developments are significant with pivotal trial readiness and durability data, but commercial metrics and unit economics remain to be proven at scale. The business is transitioning toward growth but is not yet a proven compounding machine.
Bitdeer (BTDR) Q4 2025: Self-Mining Revenue Surges 306% as AI Infrastructure Pivot Accelerates
Bitdeer is at a strategic inflection with a potentially long runway (AI infrastructure, proprietary ASICs), but execution, margin compression, and capital intensity temper the upside. Some self-reinforcing dynamics are present but not yet deeply compounding; growth is strong but not hyper-scaling, and profitability/cash flow are not yet robust. Signal is above average, but execution risk and business model transition lower the score.
American Battery Technology Company (ABAT) Q3 2026: Gross Margin Turns Positive as Revenue Jumps 64% on Recycling Scale
ABAT is at an inflection with positive gross margin and strong revenue growth, but the business is still early-stage and not yet demonstrating fully compounding customer value or an unassailable self-reinforcing model. While the growth runway is long and disruptive potential is present, execution risks and reliance on regulatory milestones temper the signal. The trajectory is promising, but not yet exceptional or de-risked.
Firefly Aerospace (FLY) Q3 2025: Backlog Climbs to $1.3B as SciTech Acquisition Expands Defense Pipeline
Firefly shows a long reinvestment runway, a disruptive business model, and a large backlog driven by national security and lunar opportunities. However, unit economics and customer value deepening are still emerging, and while growth is strong, it's not yet at the exceptional level for signal. Cash flow is negative and risks remain around execution and government contract timing.
American Battery Technology (ABAT) Q2 2026: Revenue Quadruples as Reno Plant Nears Break-Even
ABAT demonstrates a strong reinvestment runway, a major recent revenue inflection, and improving unit economics. The business model is semi-disruptive with some self-reinforcing elements, but not fully entrenched yet. Customer value and future growth outlook are improving but not exceptional. Cash flow is ramping but not yet a 'machine.' Revenue/EPS growth is strong but not at hypergrowth levels. The company is transitioning to growth, but execution and market risks remain.
TWFG (TWFG) Q1 2026: Organic Growth Set to Accelerate as Takeout Renewals Drive Double-Digit Tailwind
TWFG demonstrates strong organic growth, a clear reinvestment runway, and disciplined capital allocation. While the business is not fundamentally disruptive or likely to accelerate at >40% rates, it is positioned as a high-quality compounder with robust growth, margin upside, and prudent risk management. However, network effects and deepening customer value are less pronounced, and growth, while strong, is not at the highest tier.
DEC Q1 2026: Oklahoma Inventory Hits 1,000 Locations, Unlocking Multi-Decade Growth Optionality
DEC presents a long reinvestment runway and a structural inventory inflection, with clear capital discipline and strategic flexibility. However, while the business is transitioning to a growth platform, there is not yet evidence of explosive growth or markedly improving unit economics. The model is innovative and disruptive for the sector, but not yet at the level of a dominant, high-growth compounder.
Hyliion (HYLN) Q1 2026: Military Revenue Quadruples, Carno Demand Pipeline Hits 750 Units
Hyliion is at an early but credible inflection, with a disruptive product, strong military and data center demand, and a large LOI pipeline. However, unit economics and self-reinforcing advantages are still emerging, not yet proven at scale. Revenue and EPS growth are promising but not yet at hypergrowth levels. The business is growth-oriented with a long runway, but commercial conversion and execution risks temper the near-term signal.
Palomar Holdings (PLMR) Q1 2026: Specialty Premiums Surge 42% as Portfolio Diversification Drives Resilience
Palomar is showing strong premium/revenue growth, especially in new specialty lines, and is executing on portfolio diversification and capital deployment. While the business is not a platform or network-effect giant, it is demonstrating above-average growth, improving unit economics, and a self-reinforcing model via diversification and AI adoption. However, the reinvestment runway is moderate, and the business, while high quality, is not exceptionally disruptive or likely to deliver outsized upside relative to more unique or underfollowed stories.
Arcus Biosciences (RCUS) Q4 2025: Castatafan ORR Rises to 45%, Sharpening RCC Leadership Ambition
Arcus is positioned as a potential disruptor in RCC with a best-in-class asset, a long reinvestment runway, and a disruptive business model. However, the business is not yet showing exceptional growth rates or cash flow acceleration, and some elements (unit economics, customer value, self-reinforcement) are promising but not definitively proven. The signal is strong but not at the highest level due to pipeline risk and execution uncertainties.
CBOE (CBOE) Q4 2025: Derivatives Net Revenue Surges 38% as Zero DTE Drives Record Volumes
CBOE shows strong growth in core derivatives, especially zero DTE, with evidence of customer value expansion and revenue/EPS growth. However, as an established exchange, its reinvestment runway and disruptive potential are moderate compared to earlier-stage or less mature platforms. There are significant developments (zero DTE, international retail), but some elements (network effects, self-reinforcement) are only partially evident. The signal is strong but not at the highest possible level due to the business's maturity and competitive/regulatory risks.
Sensus Healthcare (SRTS) Q4 2025: New CPT Codes Unlock 300% Reimbursement Surge, Redefining Growth Path
Sensus has a long reinvestment runway and recent developments (CPT code-driven reimbursement certainty) that could unlock significant growth. Unit economics and profitability are expected to improve, but evidence of deepening customer value and self-reinforcing business model is still emerging. The business is transitioning from a legacy customer-concentration model to a diversified, growth-oriented model, but not all metrics point to exceptional or disruptive status yet.
Amneal (AMRX) Q2 2026: Biosimilar Pipeline Expands to Six Launches, Unlocking $14B Market Access
Amneal is transitioning toward defensible, higher-margin growth with a long runway in biosimilars and complex generics. While the business model shows some self-reinforcing traits, network effects and customer value deepening are not yet fully established. Growth is strong but not explosive, and the business is not disruptive at the highest level. The article surfaces a clear growth path, but the opportunity is not so exceptional as to warrant a top signal score.
Abiona Therapeutics (ABEO) Q1 2026: ZivaSkin Drives $8.7M Launch Revenue as QTC Network Expands to Six
Abiona demonstrates a long reinvestment runway with the ZivaSkin launch and oncology pipeline, and recent developments show a sharp revenue uptick and backlog growth. Unit economics are improving with scale, but the self-reinforcing nature and customer value deepening are present but not yet fully proven. Guidance and backlog suggest strong growth, but not yet at an exceptional level. The business is semi-disruptive with moderate cash flow acceleration. Growth rates are good but not yet explosive, and the business is transitioning into a growth phase.
Teledyne (TDY) Q2 2026: Backlog Surges to $5B, Digital Imaging Margin Hits 25%
Teledyne is a high-quality compounder with a strong backlog, margin expansion, and accelerating cash flow, but the business is relatively mature and well-followed. While digital imaging and unmanned systems provide some optionality and growth, the overall reinvestment runway is not exceptional. There are clear signals of growth, but not at a level that would suggest outsized near-term upside or a disruptive business model.
STXS Q1 2026: MAGIC Catheter Ramp Targets $10M+ Quarterly Recurring Revenue Run Rate
Stereotaxis is undergoing a meaningful business model transition with a potentially long runway and disruptive model. However, the near-term growth is not yet at the exceptional level (over 40%+), and while the business is moving to higher recurring revenue, production and customer transitions are gating factors. Unit economics are improving but not yet at 'giant' scale. The business is positioned for growth but faces execution risk and some uncertainty in customer adoption and manufacturing ramp.
Castle Biosciences (CSTL) Q2 2026: TissueCypher Volumes Surge 63% as Pipeline Expansion Accelerates
Castle Biosciences shows strong growth in a core product (TissueCypher), with a long runway and evidence of reinvestment at scale. However, some elements (unit economics, customer value, disruptive potential) are promising but not yet exceptional or fully proven across the portfolio. Margins are under pressure and pipeline assets are still early, so the upside is solid but not extraordinary.
Spectral AI (MDAI) Q1 2026: $31.7M BARDA Acceleration Anchors DeepView Commercialization Timeline
Spectral AI is at an inflection with a disruptive product and non-dilutive funding, but most metrics (unit economics, customer value, cash flow, and growth rates) are not yet proven at scale. The business model is disruptive with a long runway if adoption occurs, but risk remains high until commercial traction is demonstrated. The signal is solid but not exceptional due to lack of demonstrated commercial ramp.
Allot (ALLT) Q1 2026: CCAS Revenue Jumps 59%, Recurring Base Hits 67% of Total
Allot is undergoing a strong transition to a recurring, high-margin model with robust growth in CCAS and clear evidence of an inflection in profitability and cash flow. However, the business is not a breakout, hypergrowth story and faces execution risks in CSP adoption and Smart project conversion. The model is semi-disruptive with some self-reinforcing elements, but customer value deepening and unit economics, while improving, are not yet at giant-scale levels. The signal is solid but not extraordinary.
OmniAb (OABI) Q1 2026: Milestone Revenue Surges 243% on Pipeline Progress, Guidance Raised
OmniAb shows a long reinvestment runway, recent step-change in milestone revenue, and a disruptive royalty-driven business model. However, unit economics and customer value are improving but not yet exceptional. The future is promising but still dependent on partner execution and milestone lumpiness. Guidance is raised, but growth is not yet at the 40%+ level, and royalty ramp is still developing.
Codexis (CDXS) Q1 2026: Gross Margin Expands 16 Points as Ecosynthesis Platform Gains Traction
Codexis demonstrates a disruptive business model with a long reinvestment runway and strong recent developments (margin expansion, pipeline growth, capacity investment). While the business is transitioning toward growth and shows signs of accelerating demand, some elements (unit economics, customer value, cash flow) are still emerging rather than fully proven, warranting a more conservative signal score.
Plexus (PLXS) Q3 2026: Funnel Expands 23% to $4.5B, Powering Multi-Year Growth Visibility
Plexus shows strong growth, a record funnel, and above-market revenue expansion with high ROIC, but its business model, while showing some sector leadership and operational leverage, is not deeply disruptive or self-reinforcing at the level of a true compounding giant. Customer value and cash flow are improving but not exceptional, and sector cyclicality remains a risk.
WiseKey (WKEY) Q4 2025: Cash Surges 370% as Quantum Pipeline Tops $200M
WiseKey shows high potential with a long reinvestment runway, disruptive business model, and regulatory tailwinds, but some areas (unit economics, customer value, cash flow) remain in transition with risks around execution and commercialization. Growth is strong but not yet at hypergrowth levels, and some compounding advantages are still emerging rather than fully proven.
QSI Q1 2026: Proteus Read Length Doubles, Setting Stage for Commercial Launch
QSI is at a major technical inflection with the Proteus platform, suggesting a long runway and disruptive potential. However, recurring revenue and unit economics are not yet proven at scale, and while the business is transitioning to growth, near-term financials are muted and contingent on execution. The business model is disruptive, but some compounding advantages are still emerging rather than fully realized.
Fabrinet (FN) Q3 2026: Data Center Interconnect Revenue Jumps 90%, Fueling Multi-Vector Growth
Fabrinet shows strong growth vectors, capacity expansion, and customer diversification, with clear signals of long-term reinvestment opportunity and a disruptive business model. However, unit economics improvements and customer value deepening are present but not exceptional, and near-term risks (supply chain, margin) moderate the overall signal. Growth is strong but not at the highest tier, and the business, while transitioning to multi-vector growth, is not yet at the level of a runaway compounding platform.
Loop Industries (LOOP) Q1 2027: $28M Gujarat Subsidy Boosts India Project Economics, Modular Model Scales in Europe
Loop’s business model is disruptive with a long runway (India and Europe), and the modular/licensing pivot signals high optionality. The recent $28M subsidy and new contracts are significant, but growth is not yet explosive or at scale—unit economics are improving but not proven giant-level. Customer value is improving but still dependent on contract conversion. The business is transitioning to growth, but execution risk and reliance on external funding temper the signal score.
QuantumScape (QS) Q2 2026: Customer Billings Surpass 2025, Multi-Vertical Ramp Accelerates
QuantumScape shows a long reinvestment runway, disruptive model, and growth business characteristics. However, while there is strong commercial progress and vertical expansion, unit economics and customer value deepening are still emerging rather than fully proven, and financial performance is not yet exceptional. The business is not yet at the stage of explosive growth or cash flow, but the signal is above average due to the multi-vertical ramp and strategic partnerships.
SHLS Q1 2026: Backlog Climbs 18% as Data Center and Solar Orders Fuel Visibility
Shoals demonstrates a strong reinvestment runway, record backlog growth, improving unit economics, and a growth business profile. However, while the business is expanding into new verticals, not all aspects are clearly disruptive or self-reinforcing at scale yet. Customer value is improving but not consistently deepening, and while guidance is raised, the future is good but not exceptional. Revenue growth is strong but not hypergrowth, and cash flow acceleration is moderate.
Rhythm Pharmaceuticals (RYTM) Q1 2026: HO Launch Drives 27% International Revenue Surge, Setting Up Global Expansion
Rhythm shows a long reinvestment runway, recent significant developments (notably the HO launch and international acceleration), and is positioned as a disruptive rare disease platform. However, while growth is strong, some metrics (unit economics, customer value, cash flow, and revenue/EPS growth) are improving but not yet exceptional or proven at scale, warranting a conservative approach to scoring.
KOPN Q1 2026: $21.5M Thermal Award and 19.9% Fabric AI Stake Signal Defense-AI Inflection
Kopin is at a strategic inflection with a potentially long reinvestment runway (defense + AI), recent major contract wins, and a disruptive business model shift. However, some signals (unit economics, customer value, cash flow acceleration) are promising but not yet fully proven, so scores are conservative. The business is transitioning to growth but not yet at giant scale.
New Ellis (NUWE) Q1 2026: Pediatrics Now 50% of U.S. Revenue as Cardiorenal Platform Expands
The business shows strong growth in a defensible pediatric niche and is executing on a platform expansion strategy, but it is still early in proving durable compounding advantages or exceptional future growth. There is evidence of improving unit economics and a move toward recurring revenue, but network effects and customer value deepening are not yet fully established. Guidance is positive but not exceptional, and the business is not yet a clear compounding outlier.
EcoWave Power (WAVE) Q1 2026: Operating Loss Narrows 11% as AI-Driven Energy Demand Accelerates
EcoWave Power is positioned in a high-growth, disruptive segment with a long reinvestment runway and visible AI-driven demand tailwinds. However, while the company is transitioning to commercialization and has global project momentum, unit economics and customer value expansion are still emerging rather than proven. Cash flow is not yet accelerating, and growth, while promising, is not yet at the breakneck pace of a true breakout. The signal is strong but not exceptional.
PayPal (PYPL) Q1 2026: Fastlane Drives 80% Guest Checkout Conversion, Reinventing Merchant Holiday Strategies
Fastlane is a significant product innovation with clear evidence of improved conversion and early traction, but PayPal is a well-known, mature business and the article does not indicate a dramatic acceleration in overall company growth or profitability. The signal is strong for a major product lever, but not for a company-wide inflection or disruptive business model, warranting a conservative score.
GeoPark (GPRK) Q1 2026: Argentina Output Set to Quadruple, Transforming Growth Trajectory
GeoPark's Argentina Vaca Muerta ramp provides a clear reinvestment runway and potential for high returns, with a significant inflection in production and guidance. However, while the growth outlook is strong, the business model is not deeply disruptive, and some unit economics and customer value metrics are only modestly improving. The company is transitioning from a legacy asset base to a growth engine, but some risk factors and the traditional nature of oil & gas cap the overall signal score.
SAB Bio (SABS) Q1 2026: $95M Capital Raise Extends Runway, Safeguard Enrollment Hits Key Milestone
SAB Bio demonstrates a long reinvestment runway and recent pivotal developments with regulatory de-risking and capital raise. However, as a pre-revenue biotech, unit economics and customer value are not established, and while the business model is disruptive, self-reinforcement and cash flow are not yet proven. Growth potential is high, but ultimate value is contingent on clinical outcomes.
Quantum Computing Inc. (QUBT) Q1 2026: Acquisitions Drive $3.7M Revenue Surge, Integration Expands Quantum Platform
QUBT shows a long reinvestment runway with high optionality due to the acquisitions and manufacturing buildout. There is a step-change in growth (acquisition-driven), but organic growth is still early. Unit economics and customer value are improving but not yet proven at scale. The business model is disruptive, and cash flow is improving but not yet accelerating. Growth is strong but not consistently above 40%. The business is transitioning to growth, but execution risk remains high.
Endeavour Silver (EXK) Q1 2026: Revenue Soars 230% as Terranera and Colpa Drive Production Surge
Endeavour Silver demonstrates a long reinvestment runway, a major recent step-change in growth, and improving unit economics. The business model is not fully self-reinforcing (commodity exposure limits compounding), and customer value deepening is modest given sector dynamics. Growth is strong but not exceptional, and while capital allocation is disciplined, the business remains cyclical and exposed to permitting and commodity risks. Still, the transformation and outlook provide above-average signal for investors.
Supergroup (SGHC) Q1 2026: Africa Revenue Jumps 53% as Segment Reporting Reveals Margin Expansion Path
The business shows a strong reinvestment runway in Africa with high growth and margin expansion, and recent developments (Africa +53% revenue, group margin up) are significant. Unit economics are improving, but the business model, while robust, is not highly disruptive or compounding. Customer value is increasing but not at exceptional rates. Guidance is held steady, suggesting conservatism rather than acceleration. The business is growth-oriented but not at hyper-growth rates (>40%). Overall, signal is solid but not at the highest possible level due to the mature casino model and competitive/regulatory risks.
AdaptHealth (AHCO) Q1 2026: Capitated Revenue Surges to 9.2% of Mix, Driving Margin Reset
AdaptHealth is in transition to a higher-growth, higher-margin model with a long runway via capitated contracts and tech adoption. However, the business is not highly disruptive and the customer value expansion, while positive, is not exceptional. Revenue growth is strong but not at hypergrowth levels, and some elements (e.g., AI benefits, pipeline) are still emerging.
JBT Merrill (JBTM) Q1 2026: Protein Solutions Margin Surges 500bps as Poultry Demand Drives Order Book
JBT Merrill shows a strong reinvestment runway in protein solutions and a significant margin inflection, with backlog/order book growth and clear margin expansion. However, the business is not fully disruptive and has moderate, not exceptional, growth rates in some segments. Unit economics are improving but not at a scale to be a giant, and legacy headwinds in warehouse automation temper the overall signal. The business is transitioning to growth but is not in hypergrowth territory.
TechNova (TKNO) Q1 2026: Clinical Solutions Revenue Surges 85% as Diversified Demand Signals Inflection
TechNova shows strong signals of a growth business with a long reinvestment runway, exceptional segment growth, and improving unit economics. However, compounding business model advantages, customer value deepening, and disruptive potential are present but not fully proven or exceptional. Guidance and outlook are solid but not explosive, and while the business is not legacy or stalling, it is not yet at the level of a hypergrowth or category-defining company.
Viper Energy (VNOM) Q1 2026: Riverbend Acquisition Adds 3,000 Net Royalty Acres, Ups Organic Growth Outlook
VNOM demonstrates a strong reinvestment runway and is executing on material acquisitions, but the business is not highly disruptive or likely to deliver breakout growth above 20-40% annually. The royalty model is self-reinforcing but not unique, and while cash flow is strong and accelerating, the company remains exposed to commodity price risk and operator activity. The signal is above average for the space, but not exceptional or highly differentiated in terms of future upside.
Alkermes (ALKS) Q1 2026: Proprietary Portfolio Sales Surge 38% as Orexin Pipeline Expands
Alkermes shows a long reinvestment runway with strong growth in proprietary sales and a broadening pipeline. There are significant recent developments (Avidel/Lumerize, pipeline expansion), but while momentum is strong, the business is not yet at the level of a giant or clear compounding model. Unit economics and customer value are improving, but not dramatically. The business is disruptive in its orexin franchise, but overall growth, while robust, is not at hypergrowth levels. The company is transitioning into a growth phase with substantial optionality, but some areas (cash flow, margin, and competitive moat) are still developing.
Ocugen (OCGN) Q1 2026: $37.5M Capital Raise Extends Runway as Three BLA Filings Targeted by 2028
Ocugen has a long reinvestment runway and disruptive gene therapy business model, with multiple late-stage programs and a strengthened balance sheet. There are significant upcoming inflection points and a clear transition toward commercialization. However, as a pre-revenue biotech, improvements in unit economics and customer value are prospective rather than demonstrated, and while growth potential is high, actual revenue acceleration remains to be seen. The business is positioned for growth but has not yet proven compounding self-reinforcement or cash flow acceleration.
NOVT Q1 2026: Bookings Surge 37% as GenAI and Medical Consumables Fuel Multi-Segment Upside
Novanta is showing strong growth signals (bookings up 37%, new product revenue up 50%, double-digit segment growth), but the business is not a paradigm-shifting disruptor nor does it have a truly exceptional reinvestment runway. Unit economics, customer value, and cash flow are all improving, but the business model is more evolutionary than revolutionary. The company is a growth business with multiple levers, but not likely to deliver 40%+ annual growth or outsized upside compared to more disruptive peers.
Lucid (LCID) Q1 2026: Uber Robotaxi Commitment Jumps 75% to 35,000 Vehicles, Extending Demand Visibility
Lucid demonstrates a long reinvestment runway, major partnership expansion, and disruptive business model with recurring revenue potential. However, margin and unit economics remain challenged, and execution risk is high. The business is transitioning toward scale but not yet a proven cash flow machine. Growth is improving but not yet exceptional, and customer value expansion is only emerging. The signal is strong but not at the highest tier due to operational fragility and the need for further execution.
Ensign Group (ENSG) Q1 2026: 99 Acquisitions Fuel 18% Revenue Growth, Guidance Raised on Occupancy Surge
Ensign Group is showing strong growth and integration capability, with a long reinvestment runway, double-digit revenue growth, improving unit economics, and a clear growth orientation. However, network effects and customer value deepening are present but not dominant, and the business, while strong, is not highly disruptive or likely to deliver hypergrowth. Cash flow and guidance are solid but not exceptional. The signal is above average but not at the highest tier for upside or disruption.
Sphere Entertainment (SPHR) Q2 2026: Sphere Segment Grows 30% as Content and Venue Expansion Accelerate
Sphere has a long runway with high optionality and disruptive business model, but some metrics (unit economics, customer value, cash flow acceleration) are improving but not yet exceptional. Growth is strong but not hyper-scaling, and some areas (e.g., MSG Networks drag, content pipeline risk) temper the overall signal.
UMC (UMC) Q2 2026: AI Revenue Set to Triple, $5B CapEx Fuels Silicon Photonics Expansion
UMC is showing a clear growth pivot with a large capex commitment and AI revenue set to triple, but the business remains somewhat mature and competitive. Unit economics and customer value are improving, but not at the level of a breakout giant. The business is transitioning toward growth, but not all signals are at the highest level.
Quantum Computing Inc. (QUBT) Q3 2025: $1.25B Capital Infusion Powers Photonic Scale-Up
QUBT demonstrates a long reinvestment runway and a disruptive business model, with a significant capital infusion and early commercial wins signaling inflection. However, unit economics, customer value, and cash flow acceleration are not yet proven at scale, and revenue growth, while promising, is not yet exceptional. The business is transitioning to growth, but execution and pipeline conversion risks remain.
Enphase Energy (ENPH) Q2 2026: Europe Grows 35% as Battery and Data Center Bets Reshape Portfolio
Enphase has a long reinvestment runway (Europe, commercial, data centers) and is pivoting to higher growth segments. There is a 35% uptick in European growth and strong battery adoption, but overall company growth is more modest due to U.S. headwinds. Unit economics and customer value are improving in Europe, but less so in the U.S. The business model is becoming more self-reinforcing with financing and platform leverage, but still has limited recurring revenue. There is clear disruption potential and cash flow is positive, but not yet accelerating. Revenue growth is moderate, with some high-growth pockets, but the overall business is transitioning, not yet a pure growth engine.
HeartBeam (BEAT) Q1 2026: Operating Cash Outflow Down 19% as Lean Launch Model Extends Runway
HeartBeam is early-stage with a disruptive model and clear growth levers, but lacks full evidence of compounding unit economics or customer value deepening yet. Recent developments are positive but not at the scale of a true inflection. Strong optionality and capital discipline, but not yet a proven high-velocity compounding business.
PURR Q3 2026: Hype Token Holdings Drive $198M Unrealized Gain, Validator Launch Expands Ecosystem Role
PURR shows a disruptive model with a long runway and clear optionality (validator, RWA, outcome markets). The quarter featured a significant gain from token appreciation, but volatility and dependency on a single asset cap the signal. Unit economics are not clearly improving with scale yet, and customer value deepening is nascent. The business is not yet a cash flow machine, but growth and ecosystem expansion are evident. The signal is strong for a niche digital asset play, but not at the highest level for broad institutional upside.
Axogen (AXGN) Q2 2026: Breast Segment Drives 47% Growth, Reshaping Margin Mix
Axogen shows a strong growth runway in the breast segment, with evidence of double-digit growth and expanding market opportunity. However, gross margin compression and some business model risks limit the score. The business is not disruptive at a platform level yet, and while growth is strong, it is not at hypergrowth levels. The signal is solid but not exceptional given the company's scale and margin profile.
Sabio Holdings (STAA) Q2 2025: Programmatic Sales Surge 94% as Platform Diversifies Ahead of Election Cycle
Sabio demonstrates a strong reinvestment runway, significant recent growth (especially programmatic and international), and improving unit economics. However, the business model, while evolving, is not yet fully self-reinforcing or disruptive versus larger peers. Customer value is improving but not consistently deepening, and cash flow is not yet accelerating. Growth rates are strong but not at the highest tier, and the business is in transition with growth characteristics. The signal is solid but not exceptional due to the competitive landscape and some execution risks.
Unicure (QURE) Q2 2026: $188M Cash Infusion Extends Runway as AMT-130 BLA Nears Submission
Unicure is at a pivotal stage with a potentially transformative asset (AMT-130), a long cash runway, and regulatory clarity. However, while the reinvestment runway and disruption potential are strong, the business is not yet demonstrating accelerating cash flow or revenue growth, and unit economics/customer value are not fully proven. The model is disruptive, but the signal is capped by execution risk and the binary nature of the lead asset.
Rivian (RIVN) Q2 2026: R2 Launch Drives 27% Revenue Jump, Sets Stage for Mass Market Expansion
Rivian is at an inflection point with the R2 launch and strong software growth, offering a long reinvestment runway and disruptive potential. However, margin and unit economics are not yet clearly improving, and some metrics (customer value, cash flow, growth rates) are positive but not exceptional. The business model has high potential, but execution risk and competitive threats remain, limiting the signal score.
SBC (SBC) Q4 2025: Average Revenue Per Customer Jumps 11% as Clinic Model Rebounds
SBC shows signs of renewed growth, improving unit economics, and a multi-pronged strategic evolution. However, while the reinvestment runway is strong and there are clear growth levers, some elements (network effects, customer value deepening, and disruptive model) are emerging rather than fully established, and international expansion is still early-stage. The business is transitioning to growth but not yet at hypergrowth or exceptional disruption.
BlackSky (BKSY) Q2 2025: International Backlog Surges to 85% on Gen 3 Satellite Demand
BlackSky shows a strong international growth inflection, major backlog expansion, and a path to recurring high-margin revenue, but its business model is not yet fully self-reinforcing or disruptive at scale. Unit economics and cash flow are improving but not yet exceptional, and the business, while growth-oriented, does not clearly demonstrate 40%+ top-line acceleration or a truly dominant, compounding model. Signal is strong but not at the highest possible level.
QBTS Q2 2025: Cash Surges 170% QoQ, Fueling Accelerated R&D and M&A Ambitions
QBTS demonstrates a disruptive business model with a long reinvestment runway and recent transformative capital inflow. There are significant developments (170% QoQ cash increase, new technical milestones), but unit economics and customer value deepening are still emerging and not yet proven at scale. Growth is solid but not yet at the highest acceleration tier. The business is transitioning toward growth, but execution risk and the need for pilot-to-production conversion temper the overall signal.
Verica Pharmaceuticals (VRCA) Q3 2025: YCAMP Dispensed Units Up 33% as Focused Commercial Model Drives Expansion
Verica has a credible reinvestment runway with high returns, a very strong sequential unit growth, and improving unit economics. The business model is semi-disruptive but not clearly compounding with scale yet. Customer value is improving, but not consistently deepening. Guidance and backlog are positive but not exceptional. The business is transitioning toward growth but hasn't achieved breakout status. Revenue and EPS growth are strong but not at the highest tier. Overall, signal is solid but not at the level of a truly exceptional, high-upside business.
Caspi KZ (KSPI) Q1 2026: E-Commerce GMV Jumps 41% as Value-Added Services Accelerate Monetization
Caspi KZ displays a strong growth profile in e-commerce and value-added services, with high reinvestment potential and customer engagement deepening. There is no evidence of a massive near-term inflection, but the business is clearly in growth mode with some disruptive characteristics. Margins in payments and FinTech are under pressure, and while the dual-market strategy is promising, it is not yet an exceptional, high-velocity growth story across all segments.
AMBQ Q2 2025: China Revenue Falls to 12% as Edge AI Mix Drives Gross Margin to 43%
AMBQ is in a transitional but high-upside phase: long reinvestment runway, disruptive edge AI/IP model, and a significant pivot away from China. However, while margin and mix are improving, unit economics are not yet clearly scaling, and customer value deepening is still emerging. Growth is not yet at hyper-scale, and some execution risk remains, so signal is strong but not at the highest level.
StreamX (STEX) Q1 2026: $50M Debt Retired, Institutional Partnerships Set Stage for Tokenized Asset Scale
StreamX displays a long reinvestment runway, disruptive business model, and clear inflection with debt retired and institutional partnerships secured. However, the business is still pre-revenue with only early proof of concept and modest AUM, so unit economics and customer value deepening are not yet fully demonstrated. Growth is expected but not yet proven at a high rate. The signal is above average for a new platform, but not yet at the level of a proven compounding flywheel.
Evaxion (EVAX) Q3 2025: MSD Option Adds $7.5M, Extends Runway to 2027 as Pipeline Advances
Evaxion shows a strong reinvestment runway, a major external validation, and a disruptive platform business model. However, while the partnership and pipeline expansion are significant, there is not yet evidence of explosive growth in unit economics, customer value, or cash flow acceleration. The business is clearly growth-oriented and has potential for further upside, but some metrics (like recurring revenue growth and compounding model advantages) are still emerging rather than fully proven.
Bicara Therapeutics (BCAX) Q1 2026: Cash Runway Extended to 2029 as Fisera Nears Key Phase 3 Milestone
Bicara demonstrates a long reinvestment runway with potential high returns, significant recent developments, and a disruptive business model. However, while the business is transitioning to commercial stage with clear growth prospects, some elements (like improving unit economics, deepening customer value, and accelerating cash flow) are only moderately evidenced or still developing. The business is high-growth and thesis-relevant, but not all signal criteria are met at the highest level.
Artivion (AORT) Q4 2025: Stent Graft Revenue Jumps 36%, Propelling Double-Digit Growth Outlook
Artivion demonstrates a long reinvestment runway at high returns (Q1), recent significant growth (Q2), and improving unit economics (Q3). The business model is semi-self-reinforcing (Q4) and customers are modestly becoming more valuable (Q5). While backlog and guidance are strong, they are not exceptional (Q6). The model is semi-disruptive with lateral opportunities (Q7). Cash flow is moderately accelerating (Q8), and revenue/eps growth is in the 10-14% range (Q9). The business is a clear growth story (Q10). Signal is somewhat tempered by the business's niche and moderate scale, but overall remains strong.
AstraZeneca (AZN) Q4 2025: Oncology Surges 17% as Pipeline Catalysts Drive $10B+ Peak Revenue Potential
AstraZeneca has a strong reinvestment runway, significant pipeline catalysts, and a self-reinforcing business model, but as a large-cap pharma, its growth profile is robust but not explosive. Unit economics and customer value are improving but not at the level of a hypergrowth disruptor. The signal is strong but not at the very highest level for upside surprise.
Fermi (FRMI) Q1 2026: $1.4B Infrastructure Build Secures 2.2 GW Power Lead as Leadership Overhaul Targets Binding Tenant in 90 Days
Fermi demonstrates a disruptive business model with a long runway and unique asset position, but has not yet converted those assets into revenue or proven improving unit economics. The business is at a critical inflection point, with exceptional future potential if it secures tenants and executes, but current results are not yet exceptional. The company is not yet a cash flow machine, and while the opportunity is large, execution risk remains high. The signal is strong but not at the maximum due to lack of current revenue conversion and proven customer value expansion.
ProtoLabs (PRLB) Q4 2025: U.S. CNC Revenue Surges 35% as Production Pivot Accelerates
ProtoLabs is showing strong growth in U.S. CNC and sheet metal (double-digit, with CNC up 35%), and revenue per customer is rising. However, the business is still in transition with Europe weak and margin expansion deferred. The model is moving toward greater self-reinforcement but not yet at scale. There is clear upside, but the company is not yet a high-growth, high-ROIC compounding machine across all geographies, and certain segments are lagging.
BeLight Bio (BLTE) Q4 2025: Cash Surges to $773M as Phase 3 Stargardt Program Hits 36% Lesion Reduction
BeLight Bio exhibits a strong signal profile: it is at a pivotal inflection with a first-in-class asset and a major cash runway, and the business model is disruptive for rare ophthalmology. However, some signal questions (unit economics, customer value, cash flow) are not fully proven at scale due to the pre-commercial stage, and while growth potential is strong, it is not yet exceptional or fully de-risked. Still, the company is positioned as a growth business with high strategic optionality.
IQVIA (IQV) Q2 2026: R&D Bookings Surge 19%, Backlog Quality and AI Differentiation Drive Guidance Raise
IQVIA shows strong growth in bookings, backlog, and margin leverage, with AI as a differentiator and clear customer value expansion. However, the reinvestment runway, self-reinforcing model, and disruptive potential are somewhat capped by the CRO industry structure and mature client base. Growth is robust but not at the highest acceleration, so signal is solid but not exceptional.
BeLight Bio (BLTE) Q4 2025: Cash Surges to $773M as Phase 3 Stargardt Program Hits 36% Lesion Reduction
BeLight Bio is at a major inflection with a first-in-class asset and significant cash reserves, indicating a long reinvestment runway and disruptive potential. The pivotal trial result is a major development, but not all metrics (unit economics, customer value, cash flow) are fully proven at this stage. The business is transitioning from clinical to commercial, with strong potential but not yet demonstrating all the hallmarks of a compounding giant. Signal is high due to the pivotal event and rare disease focus, but some elements are still emerging.
Procipio (PRPO) Q4 2025: Gross Margin Jumps to 90% on Pathology Scale, Shifting to Growth Mode
Procipio has a long reinvestment runway, significant margin expansion, and is at a growth inflection, but not all signal elements are maximized: unit economics are improving but not yet at giant scale, customer value is improving but not consistently deepening, and while the business is transitioning to growth, revenue/eps growth is not yet above 40%. The business model is semi-disruptive, and cash flow is improving but not yet accelerating at a high rate.
Lucid Diagnostics (PAVM) Q2 2025: Revenue Climbs 40% as Medicare Milestone Nears
Lucid Diagnostics demonstrates a long reinvestment runway, a disruptive model, and a clear upcoming inflection (Medicare coverage). The business is not yet at scale (unit economics and cash flow are not fully proven), but signals for rapid future growth and margin leverage are present. Some areas (customer value, self-reinforcement, cash flow) are promising but not yet exceptional or fully de-risked.
Roll Mata Therapeutics (RLMD) Q2 2025: NDV-01 Achieves 91% Response Rate, Expands Bladder Cancer Opportunity
RLMD is pre-commercial but shows a long runway with a disruptive therapy in NMIBC and a novel neuropsychiatric asset. The 91% response rate is a major positive inflection, but the business is still in transition and not yet demonstrating compounding economics or accelerating cash flow. The business model is innovative but not yet self-reinforcing; customer value and future growth are promising but unproven at scale.
Welltower (WELL) Q4 2025: Senior Housing Drives 36% Revenue Surge, Margin Expansion Sets 2026 Growth Trajectory
Welltower is showing strong growth, margin expansion, and a strategic shift to higher-return assets, but as a large, well-followed REIT, its reinvestment runway and disruptive potential are somewhat capped. The developments are significant but not transformative for the sector, and while cash flow is accelerating, the business model is not fundamentally disruptive. Signal is high for a REIT, but not at the level of a true compounding disruptor.
Cineverse (CNVS) Q4 2025: Matchpoint Targets $5M+ Studio Deals as Tech Division Matures
Cineverse demonstrates a clear pivot to a higher-margin, tech-driven model with significant optionality in enterprise SaaS and AI monetization. While the reinvestment runway and disruptive potential are present, the business is still transitioning and not yet showing blockbuster growth or fully compounding network effects. Unit economics and cash flow are improving, but customer value and future growth, while promising, are not yet exceptional or proven at scale. The story is thesis-worthy but not at the highest level of signal.
CurbLine Properties (CURB) Q2 2026: Acquisition Pace Doubles to $1B Target, Scaling Convenience Real Estate Platform
CURB demonstrates a strong growth trajectory, capital efficiency, and a scalable platform with significant acquisition momentum. While the business is not a disruptive technology platform and some metrics (like customer value and business model self-reinforcement) are still developing, the company’s roll-up strategy, low capex, and improving national tenant engagement indicate above-average signal for sector investors.
Wiley (WLY) Q4 2026: AI Revenue Doubles to $49M, Unlocking Recurring Growth Flywheel
Wiley is showing meaningful growth in AI recurring revenue, but the overall business is not yet a hyper-growth story. There is a clear inflection in a segment, but core research growth is single digits. The business model is evolving and has some self-reinforcing characteristics but is not yet a dominant compounding flywheel. Cash flow is improving, but not yet at an exceptional acceleration. The business is transitioning toward higher quality, but the overall signal is moderate-high, not exceptional.
EME Q4 2025: RPOs Surge 31% to $13.25B, Data Center Visibility Extends Multi-Year Growth
EME shows strong backlog growth and unit economics, with some disruptive elements in data centers and recurring services. However, the business is not truly a high-multiple, disruptive compounder, and its reinvestment runway—while robust—is not exceptional. The signal is high relative to most industrials, but this is a well-followed, large business with moderate long-term upside.
Alnylam (ALNY) Q2 2026: Amvutra First-Line Penetration Drives 74% TTR Revenue Growth Amid Guidance Reset
Alnylam has a strong growth profile, a disruptive RNAi platform, and a long reinvestment runway. However, while first-line growth is strong, some metrics (unit economics, future guidance, customer value) are improving but not exceptional. The business is not in hypergrowth, and competitive/payer risks temper the signal.
Coda Octopus (CODA) Q2 2026: Defense Engineering Jumps 38% as Marine Tech Faces Geopolitical Drag
Coda Octopus has a long reinvestment runway in defense, recent significant developments (Navy approval, defense segment growth), and some disruptive technology. However, unit economics are not clearly compounding yet, and customer value deepening is early-stage. The future is promising but not yet exceptional (pending recurring revenue inflection). Revenue growth is moderate, and the business is transitioning toward growth but not at hypergrowth levels. Signal is solid but not extraordinary.
Carrier (CARR) Q2 2026: Data Center Orders Quadruple, Backlog Surges to $8B+
Carrier's quadrupling data center orders and record backlog signal a major secular growth inflection, with guidance and backlog supporting a strong near-term outlook. However, margin pressure and the legacy nature of some segments temper the signal score. The business model is evolving, but some elements (unit economics, self-reinforcement, customer value deepening) are not yet fully proven or exceptional. The signal is strong but not at the highest level due to these caveats.
International Seaways (INSW) Q1 2026: Dividend Surges 111% as Spot TCEs Top $100K
INSW is showing strong growth, capital returns, and cash generation, with a significant dividend increase and spot rates at historic highs. However, the business model is not fundamentally disruptive and the reinvestment runway is solid but not extraordinary. The business is exposed to external volatility, and while current performance is exceptional, the long-term compounding characteristics and disruptive optionality are moderate for the sector.
Realmada Therapeutics (RLMD) Q1 2026: $160M Capital Infusion Extends Runway for Phase III NMIBC Program
Realmada has a long reinvestment runway with a large capital infusion and pipeline optionality. There is a significant clinical inflection with strong Phase II data and a patent extension, but the business is still pre-revenue and not yet demonstrating compounding network effects or clear accelerating cash flow. Growth potential is high but not yet proven at scale, and the overall business model is promising but not clearly disruptive. The thesis is investable but not at the extreme end of signal.
Trevi Therapeutics (TRVI) Q1 2026: $172M Cash Extends Runway to 2030 as Phase 3 Chronic Cough Trials Launch
Trevi has a long cash runway and multiple late-stage clinical trials, suggesting a long reinvestment runway and potential for high returns if successful. There are significant upcoming catalysts, but the business is still clinical-stage, and true unit economic improvements or self-reinforcing compounding effects are not yet demonstrated. The business is transitioning to potential growth, but not yet proven as a high-growth or disruptive platform. The signal is strong for a small-cap biotech, but not at the level of a proven compounding growth machine.
IPG Photonics (IPGP) Q4 2025: Non-Materials Processing Jumps to 14% of Sales as Diversification Accelerates
IPG Photonics is showing a credible shift toward higher-value, less cyclical segments, with double-digit growth in new areas and a long reinvestment runway. However, margin normalization is still in progress, and while growth is solid, it is not yet at the level of a breakout, highly disruptive business. The business is transitioning with strong prospects, but not all levers are firing at maximum signal.
Tamborin Resources (TBN) Q2 2026: $91M Cash Sets Stage for First Gas and Multi-Well Expansion
Tamborin is at a pivotal pre-production phase with a long runway and infrastructure-driven growth potential. However, while the reinvestment runway and recent developments are strong, unit economics and business model self-reinforcement are not yet proven, and customer value deepening is only modestly improving. The business is transitioning to growth but is not yet demonstrating exceptional acceleration or disruptive model characteristics.
Ultragenyx (RARE) Q2 2025: Pipeline Drives 20% Revenue Growth as Phase III Programs Reach Inflection
Ultragenyx has a strong late-stage pipeline and growth trajectory, with double-digit revenue growth and approaching pivotal data. However, the business is not an undiscovered or underappreciated gem, and some aspects (unit economics, self-reinforcing model, customer value) are only moderately improving or not exceptional. The signal is strong but not at the level of a truly unique, high-upside opportunity.
Arrowhead Pharmaceuticals (ARWR) Q1 2026: $1.33B Capital Infusion Powers Pipeline, Redemplo Launch Sets Commercial Trajectory
Arrowhead shows strong signals of growth and inflection, with a major capital raise, first commercial product launch, and multiple late-stage pipeline assets. However, much of the growth is still dependent on execution and upcoming data—unit economics and business model self-reinforcement are promising but not yet proven at scale. The company is not yet a cash flow machine, and while it is transitioning to growth, its future is not fully de-risked.
Achieve Life Sciences (ACHV) Q1 2026: $180M Financing Secured, U.S. Manufacturing Shift De-Risks Commercial Launch
ACHV is transitioning from late-stage development to commercial execution with a large market opportunity and strong capital position, but it is not yet a proven high-growth machine. The business model is potentially disruptive and there is clear differentiation, but commercial and cash flow acceleration remain unproven. The signal is above average but not exceptional given the pre-launch stage and execution risks.
HPE (HPE) Q2 2026: Orders Double, Backlog Hits Record as AI and Networking Demand Surges
While HPE is showing acceleration in demand, backlog, and margin expansion, it is a large, well-known incumbent rather than a disruptive new growth story. The reinvestment runway is moderate, not exceptional, and while backlog and orders are up sharply, the business model is not fundamentally disruptive. Cash flow is improving and growth is strong, but not at the level of a hyper-growth or highly disruptive business. The signal is solid for a mature enterprise, but not at the highest level for upside.
Capital One (COF) Q2 2026: Domestic Card Purchase Volume Jumps 26% as Discover Integration Drives Scale
Capital One is showing strong growth and integration-driven upside, with a major acquisition and expanding platform. However, the business, while evolving, is still a scaled incumbent with some capped legacy elements and not a pure disruptor. The reinvestment runway is solid but not exceptional. Growth is strong but not at the highest levels, and while the business is transitioning into a more tech-driven model, it is not yet a giant or highly disruptive. The article surfaces material signals, but the business is already well-followed and established, which tempers the upside.
Arlo (ARLO) Q1 2026: Samsung Partnership to Reach Hundreds of Millions, Expanding Service-Only TAM
Arlo is transitioning to a higher-margin, recurring revenue model with a long runway via platform partnerships and new verticals. However, while the growth outlook is strong, some elements (unit economics, self-reinforcement, customer value) are improving but not yet at the highest levels of compounding. The business is not yet at the scale or disruptive threshold to warrant a higher signal score, and risks around execution and adoption remain.
Mirion Technologies (MIR) Q2 2026: Backlog Climbs 40%, Locking in Nuclear Demand Visibility
Mirion is exposed to a strong, long-term nuclear growth trend with high backlog growth (40%), recurring revenue, and margin expansion. However, organic growth is only modest and some business model elements (unit economics, customer value, self-reinforcement) are improving but not exceptional. The business is well-positioned, but not a disruptive, hyper-growth story—it's a high-quality, visible growth compounder, but not at the highest signal tier.
Vishay (VSH) Q1 2026: Book-to-Bill Jumps to 1.34 as Backlog Surges 21% on Broad-Based Demand
While the business is showing a significant inflection in backlog and book-to-bill, Vishay is a relatively mature, diversified components manufacturer, not a disruptive or high-ROIC compounder. The backlog and book-to-bill surge is notable, but the business model is not self-reinforcing in the sense of network effects or data loops. Unit economics and customer value are improving, but not at an exceptional rate. Growth is strong but not at a hypergrowth level, and free cash flow is pressured by capex. The signal is solid and above average, but the business is not likely to provide the kind of upside or unique optionality that would warrant a higher signal score.
City Trends (CTRN) Q1 2026: Comp Sales Jump 13.9%, Unlocking Multi-Year Growth Runway
City Trends is showing strong momentum with double-digit comps, margin expansion, and a credible multi-year growth runway. However, as a value retail business, its reinvestment runway and self-reinforcing model are not as deep or disruptive as higher-scoring growth businesses. The signal is solid but not exceptional given the business model and sector.
Turkcell (TKC) Q1 2026: 5G Launch Drives 661,000 Postpaid Net Adds, Cementing Market Leadership
Turkcell shows a strong reinvestment runway and a significant 5G-driven growth event, but ARPU and unit economics are only modestly improving due to inflation and contract lag. The business model is semi-disruptive, with some self-reinforcing elements (digital/fintech) but not at the level of a true platform giant. Revenue and EPS growth is solid but not explosive, and cash flow is improving but not yet accelerating. Overall, the signal is above average but not exceptional for a telecom incumbent.
Ardmore Shipping (ASC) Q4 2025: MR Tanker Rates Triple Break-Even, Extending Earnings Runway
Ardmore Shipping is benefiting from an exceptional market environment, with rates and earnings well above break-even and a strong outlook. However, as a shipping business, its reinvestment runway is moderate (not exceptional), and the business model, while flexible and efficient, is not highly disruptive. Backlog and future guidance are strong but not at hypergrowth levels. The business is a clear growth story but not a transformative one.
Stevanato Group (STVN) Q1 2026: GLP-1 Revenue Jumps to 22%, Cartridge Capacity Fully Booked
Stevanato shows strong growth in high-value solutions and GLP-1 demand, with a long runway and visible capacity expansion. However, the business is not exceptionally disruptive, and some metrics (unit economics, customer value, cash flow) are improving but not at a giant scale. Engineering segment recovery is still a watchpoint, keeping signal below the maximum.
GE (GE) Q2 2026: Orders Surge 17% as $170B Services Backlog Anchors Multi-Year Growth
While GE Aerospace demonstrates strong execution, backlog-driven visibility, and improving unit economics, it is a large, mature business with moderate rather than exceptional reinvestment runway. The business model is self-reinforcing and recurring, but growth rates, while solid, are not hyper-scaling or disruptive. Margin expansion is gated by platform maturation, and while the company is transitioning into a more service-driven model, it is not a breakout growth story likely to deliver major upside from here. Signal is good but not extraordinary given GE's scale and profile.
Wheaton Precious Metals (WPM) Q1 2026: Antamina Deal Adds $4.3B Leverage, Sets Stage for 50% Growth by 2030
Wheaton’s business is entering a new phase with a long reinvestment runway (massive Antamina deal, robust pipeline, and expansion into new jurisdictions). The growth rate is high (50% by 2030) but not at the level of an emerging hyper-growth disruptor, and the model, while asset-light and scalable, is not fundamentally disruptive in the tech sense. Unit economics and customer value are improving but not compounding at the highest rates. The business is transitioning into a larger, more complex phase, but with some execution and integration risks.
Ardmore Shipping (ASC) Q4 2025: MR Tanker Rates Surge 3x Above Break-Even, Unlocking Cash Flow Flexibility
While the company is benefiting from a cyclical high and strong cash flow, the business is not fundamentally disruptive or offering a truly exceptional long-term reinvestment runway. The surge in rates and backlog is notable and the business is currently in a growth phase, but much of the upside is tied to market conditions rather than structural competitive advantages or network effects. There is some innovation and capital allocation agility, but the business model is not deeply self-reinforcing. Revenue and EPS growth are likely strong but not at the highest tier.
Aluma (ALMU) Q2 2026: Initial Sales Orders Signal Early Commercial Traction as $38.6M Cash Fuels Expansion
Aluma exhibits strong early-stage signal: long reinvestment runway, disruptive technology, and clear inflection from R&D to commercialization. However, unit economics and customer value are still emerging, not yet proven to be compounding. The business is not yet growing at 20%+ annualized revenue or EPS, and the cash flow story is still moderate. The overall signal is positive for a high-risk, early-stage growth story, but not at the level of a proven compounding business.
EME Q3 2025: Data Center RPOs Surge 80% as Miller Electric Adds $700M Backlog
EMCOR is positioned for above-market growth with a strong backlog and secular tailwinds, particularly in data centers. The Miller Electric acquisition is significant, but the business is not highly disruptive or likely to deliver outsized, compounding returns typical of a platform with a long reinvestment runway. Margins are strong but management signals stability rather than further expansion. Growth is robust but not at hyper-growth levels, and the business, while a leader, is not a new or under-the-radar story.
STEM (STEM) Q1 2026: PowerTrack Software Grows 16%, Utility-Scale Bookings Double, Margin Durability Proves Out
STEM has a long reinvestment runway and is transitioning to a high-margin, recurring SaaS model with international and utility-scale opportunities. There is significant growth in utility-scale bookings and margin expansion, but ARR growth is modest and hardware sales are lumpy. Unit economics are improving but not yet at 'giant' scale. The business model is semi-disruptive, with some self-reinforcing elements, but not yet fully compounding. The business is a growth story, but not in hypergrowth mode; revenue and EPS growth are likely to be moderate. Cash flow is improving but not yet accelerating.
Capricor Therapeutics (CAPR) Q1 2026: $36.8M Operating Expense Signals Full-Scale Launch Readiness Amid NS Pharma Standoff
Capricor is at a major inflection point with a pending first-in-class approval and a large rare disease opportunity, supported by strong cash reserves and a move to commercial independence. However, the reinvestment runway, compounding advantages, and customer value deepening are not yet proven at scale, and execution risks remain high. The business is clearly transitioning to growth, but the disruptive potential and model self-reinforcement are still emerging rather than fully established.
EQT (EQT) Q2 2026: Compression Projects Drive 90 BCFE Guidance Lift, Unlocking Structural Margin Upside
While EQT demonstrates strong operational momentum, margin expansion, and clear growth optionality, it remains a large, well-followed business in a mature sector. The reinvestment runway is solid but not exceptional, and while backlog and contract wins are notable, the business is not poised for hypergrowth. The business model is improving but not truly disruptive. Cash flow is growing, but the acceleration is moderate. Overall, the signal is strong but not at the highest level for a well-known, large-cap operator.
5E Advanced Materials (FEAM) Q3 2026: First 7,500-Ton Offtake Deal Unlocks Commercialization Milestone
FEAM has a long reinvestment runway and just hit a major commercial milestone, but much of the business model's self-reinforcement and customer value deepening are still prospective. The company is at a growth inflection, but not yet showing exceptional acceleration or clear disruptive dominance. Execution risk and the need to convert pipeline to revenue cap the signal score.
LightInTheBox (LITB) Q1 2026: Branded Apparel Jumps 81%, Now 24% of Revenue
The business shows strong recent growth in branded apparel (81%), a clear mix shift, and a double-digit revenue acceleration, but the overall company does not have a proven long-term reinvestment runway at high returns (question 1). There is a significant business evolution (question 2), and unit economics are improving (question 3). The business model is evolving but not yet self-reinforcing at scale (question 4). Customer value is improving but not yet exceptional (question 5). Growth is good but not exceptional (question 6, 9). The model is semi-disruptive with some lateral opportunities (question 7). Cash flow is improving but not yet a 'machine' (question 8). The business is in a growth phase (question 10).
ELF (ELF) Q3 2026: Rode Adds $128M, Driving 38% Sales Surge and Global Expansion
ELF exhibits above-average signal due to its reinvestment runway, recent Rode-driven growth, and international expansion, but organic core growth is moderating and margin pressure persists. The business is not a new disruptor and is already well-followed, which tempers the score. Some metrics (unit economics, customer value, self-reinforcement) are improving but not exceptionally so.
Zebra Technologies (ZBRA) Q4 2025: RFID Momentum Drives Double-Digit Growth, $1B Buyback Expansion Signals Confidence
Zebra is a high-quality operator with clear secular tailwinds in RFID and automation, and the buyback signals confidence. However, the business is not a 'giant' in terms of network effects or customer value deepening, and growth is solid but not explosive. While the strategic mix shift and capital allocation are strong, most signals reflect a disciplined, high-single/low-double digit growth trajectory rather than a disruptive, high-velocity compounder.
Crescendo (CXDO) Q3 2025: Software Solutions Surge 28%, AI and Cloud Fuel Multi-Year Growth Runway
Crescendo demonstrates a strong growth trajectory, high-margin software expansion, and a multi-year reinvestment runway. However, some elements (unit economics, network effects, customer value deepening) are positive but not yet exceptional or fully proven, and international/AI adoption is still in early stages.
Trisalis Life Sciences (TLSI) Q1 2026: PEDD Study Delivers $7,700 Per Patient Cost Avoidance, Driving Platform Validation
The business is positioned for growth with a validated platform, expanding TAM, and a high margin model. However, while the evidence and commercial expansion are positive, the business is not yet demonstrating truly exceptional acceleration or disruptive network effects. Growth and cash flow are improving but not at a step-change or market-defining pace. The signal is strong but not at the highest possible level for a breakout or dominant platform.
Coherus (CHRS) Q4 2025: Lactorsi Revenue Doubles, Funding 70% Market Share Push
Coherus has a long reinvestment runway via Lactorsi funding the pipeline, and recent revenue growth is significant. However, while the business is transitioning to growth, much of the future value is contingent on clinical execution and competitive dynamics in a crowded field. Unit economics and self-reinforcing model signals are present but not yet proven at scale. The business is not yet a clear high-growth compounding machine, but the inflection potential is real.
Atomera (ATOM) Q4 2025: MST Proves 2nm Diffusion Block, Unlocking Next-Gen Node Adoption
Atomera demonstrates a long reinvestment runway and a disruptive business model validated at the 2nm node, which is a significant industry milestone. However, the business remains pre-commercial, with no meaningful revenue yet and only modest improvements in unit economics and customer value. There is some acceleration in pipeline activity but not yet in financials. The model is partially self-reinforcing, but execution risk and cash burn remain high. The company is transitioning toward growth, but is not yet a high-growth business with accelerating cash flows or revenue.
KLIC Q1 2026: General Semiconductor Revenue Surges 90%, Advanced Packaging Drives Upside
KLIC exhibits strong cyclical recovery and clear growth in advanced packaging and memory, with some disruptive elements and improving unit economics. However, the business is not a pure high-growth compounder, and while there are pockets of strong momentum, the overall signal is solid but not exceptional. The reinvestment runway is moderate, and disruption is emerging but not dominant. The business is transitioning from cyclical trough to growth but lacks the extraordinary optionality or runaway economics of a true outlier.
V2X (VVX) Q1 2026: Backlog Surges 24% to $13.8B, Locking In Multi-Year Revenue Visibility
V2X demonstrates a strong backlog, high visibility, and a clear growth trajectory, but while the business is growing and innovating, it does not fully exhibit the disruptive, high-velocity characteristics required for a top signal score. Some elements, such as unit economics and business model self-reinforcement, are improving but not yet exceptional.
DoubleVerify (DV) Q1 2026: Social Activation Surges 92% as AI Drives Margin Expansion
DV is growing and transitioning toward higher-growth segments, but the business is not in a hypergrowth phase (guidance for 8–10% growth). Social activation is a standout, but the overall business is not yet a compounding giant. There is evidence of improving margins, some disruptive elements, and growth, but not all signal criteria are met at the highest level.
AmpliTech (AMPG) Q4 2025: $78M O-RAN Pipeline Validates 165% Revenue Surge, Margin Recovery in Sight
AmpliTech demonstrates a long reinvestment runway and recent transformative growth with major LOIs, but some elements (unit economics, self-reinforcement, customer value, cash flow, and growth rates) are promising but not yet exceptional or fully proven. The business is transitioning to growth, but risks around LOI conversion and margin recovery temper the signal. The story is compelling but not in the top decile for disruptive upside or proven compounding.
Uranium Energy Corp (UEC) Q3 2026: Cost per Pound Rises to $54.61 Amid Regulatory Delays, Production Ramp Set for Q4
UEC has a long runway and is positioned for growth, but the business is not yet showing exceptional acceleration or disruptive economics. While the vertical integration and policy tailwinds are positive, execution and regulatory risks moderate the signal. The business is transitioning to growth, but not at a pace or scale to warrant a top signal score.
Veru (VERU) Q2 2026: R&D Spend Falls 53% as Obesity Pipeline Focus Sharpens
Veru is a high-risk, high-reward clinical-stage biotech with a very long runway if successful, but currently only a single asset and no revenue. There is meaningful disruption potential and a large addressable market, but the business is binary and not yet demonstrating compounding economics, cash flow, or accelerating growth. The signal is moderate given the stage, with upside if clinical results are positive.
Sprout Social (SPT) Q1 2026: 30K+ Customer Segment Hits 60% of Revenue, Signaling Strategic Shift
Sprout Social is showing a strong upmarket shift, AI product traction, and improved margin outlook, but the business is not disruptive at scale and some metrics (unit economics, customer value, cash flow) are improving only moderately. The business is transitioning to higher-value segments but is not yet a breakout growth story with 40%+ growth or a fundamentally disruptive model.
Fathom Pharmaceuticals (PHAT) Q2 2026: Operating Profit Turns Positive as Revenue Jumps 88%, GI-First Strategy Delivers
Fathom is showing strong revenue growth, a recent operating profit inflection, and potential for further expansion through pipeline and label expansion, but its business model is not deeply disruptive and reinvestment runway is moderate rather than exceptional. Some metrics (unit economics, cash flow) are improving but not yet at a 'giant' level. Growth is robust but not hyper-scale, and the company is transitioning from inflection to growth, not yet a clear long-term compounder.
Varonis (VRNS) Q4 2025: SaaS ARR Jumps 32% as Legacy On-Prem Fades, AI Security Bets Intensify
Varonis is executing a late-stage SaaS transition with strong ARR growth and a clear move into AI security, but the business is not a breakout hypergrowth story and faces transition headwinds. Unit economics are good but not exceptional, and while the runway is solid, it's not undiscovered or uniquely disruptive. Signal is strong but not at the highest level for valuation upside.
Genesis (GNSS) Q1 2026: Hardware Revenue Jumps 220% as Backlog Hits $58M, Software Pipeline Expands
Genesis is pivoting to a more balanced hardware/software model, showing strong recent growth and backlog expansion. However, the business is not clearly disruptive, and while unit economics and margins are improving, the long-term reinvestment runway and self-reinforcing advantages are not yet proven at scale. Revenue growth is strong but not at the very highest tier, and some upside is already reflected in the business trajectory.
Bio-Techne (TECH) Q3 2026: Comet Platform Backlog Up 65% as Spatial Biology Momentum Builds
Bio-Techne shows strong growth in spatial biology (COMET backlog +65%), but the broader business is still contending with biotech end-market volatility and order timing. There is evidence of improving unit economics, margin expansion, and disruptive elements (AI, spatial biology), but the reinvestment runway is moderate and the business is not yet in hyper-growth territory. The signal is solid, but not exceptional or unique enough for a higher score.
Waterdrop (WDH) Q1 2026: Insurance Income Jumps 74%, AI and User Acquisition Drive Expansion
Waterdrop demonstrates a strong growth runway, recent significant top-line acceleration, and a willingness to reinvest for scale. However, some aspects (unit economics, self-reinforcing model, customer value deepening) are promising but not yet exceptional or proven at scale. The business is transitioning toward a more disruptive, AI-driven model but remains highly dependent on insurance, with some concentration risk. Growth is robust but not at hypergrowth levels, and while cash flow is strong, it is not yet accelerating dramatically.
Livanova (LIVN) Q1 2026: Cardiopulmonary Output to Rise 60% by 2030 as Market Share Jumps
Livanova is demonstrating a strong reinvestment runway (manufacturing expansion, new product launches), with recent double-digit growth and share gains in cardiopulmonary. However, while there are signs of improving unit economics and some self-reinforcing elements (digital health, reimbursement), these are not yet at the level of a compounding giant. Customer value is improving but not dramatically so. OSA is a disruptive adjacency but faces reimbursement and ramp risks. Cash flow is solid but not accelerating. Growth rates are good but not hyper-growth, and the business is transitioning toward higher growth rather than already being a breakout. The signal is strong but not exceptional.
Petrobras (PBR) Q1 2026: Oil Output Jumps 30% as Pre-Salt Expansion Accelerates
While Petrobras demonstrates strong operational momentum, pre-salt expansion, and clear capital discipline, it is a well-known, mature operator with moderate reinvestment optionality and some legacy market constraints. The business is not fundamentally disruptive, and while growth is strong, it is not at the level of a high-velocity compounder or an underappreciated inflection. Signal is solid but not exceptional for a company of this scale and visibility.
Mercury Systems (MRCY) Q3 2026: Backlog Jumps 18% as Production Ramps and Margin Expansion Takes Hold
Mercury is transitioning to higher-rate production with margin and backlog inflection, and guidance is improving, but the business is not a hypergrowth or highly disruptive model. Reinvestment runway is moderate, not exceptional; backlog and margin expansion are material but not explosive. The business is solidly growth-oriented but not likely to deliver 40%+ growth or truly exceptional upside, and the model is not network-effect driven.
AMLX Q1 2026: Avexatide Phase III Completion Sets Up Pivotal Q3 Data Readout
AMLX is on the cusp of a pivotal data readout for a first-in-class therapy, with a strong balance sheet and multi-asset pipeline. However, the business is still pre-commercial, with no revenue and some risk around customer value, self-reinforcement, and cash flow scalability. While the inflection is real and the pipeline is diversified, the signal is not maximal due to execution and regulatory risk, and the business is not yet demonstrating accelerating growth or disruptive economics.
Opal Fuels (OPAL) Q1 2026: RNG Production Rises 9% as Fleet Conversion Momentum Builds
Opal Fuels shows a long reinvestment runway and a major business evolution with accelerating fleet conversions, but unit economics and business model self-reinforcement are still emerging, not yet at the level of a compounding giant. Customer value is improving but not yet deepening consistently. Guidance is stable but not exceptional. The business is semi-disruptive and transitioning toward growth, but not yet a top-tier growth/compounder profile. The overall signal is strong but not extraordinary.
Lyft (LYFT) Q1 2026: High-Value Modes Up 35% as Mix Shift Drives Margin Upside
Lyft is showing clear business evolution with a mix shift to premium, strong international growth, and new revenue streams (AV, ads, loyalty). However, while growth is robust, the business is not fully disruptive or showing >40% growth across the board, and some levers (network effects, cash flow, ARPU) are improving but not yet at exceptional levels. The signal is solid but not at the highest tier for a truly exceptional or underappreciated growth story.
Roll Mata Therapeutics (RLMD) Q2 2025: NDV-01 Achieves 91% Response Rate, Expands Bladder Cancer Opportunity
While the company demonstrates a potentially long reinvestment runway and recent significant clinical progress, the business is still pre-commercial and faces execution and regulatory risks. Unit economics and self-reinforcement are promising but not yet proven at scale. Growth prospects are strong but not yet at the level of a clear, exceptional breakout.
Broadwind (BWEN) Q1 2026: Gearing Orders Surge 66% as Wind Exit Reshapes Core Growth Path
Broadwind is transitioning from a legacy, policy-dependent business to higher-growth, more defensible segments with substantial backlog and improving economics. However, while order growth and backlog visibility are exceptional, the business is not yet a clear high-ROIC compounder and faces execution risks. The model is improving but not yet deeply self-reinforcing, and while growth is strong, it is not at the level of a truly disruptive, high-multiple business.
Telos (TLS) Q1 2026: Revenue Surges 56% as Security Solutions Pipeline Hits $500M
Telos is showing strong growth and margin improvement, with a sizable pipeline and double-digit revenue increases, but it is not a truly exceptional or disruptive business. The reinvestment runway is moderate, and while there are some self-reinforcing elements and optionality, the business is still primarily government contract-driven with some seasonality and execution risk. Growth is solid but not at hypergrowth levels, and the model is not deeply disruptive.
Constellium (CSTM) Q2 2026: Adjusted EBITDA Surges 88% as Recycling and Aerospace Drive Early Target Achievement
While Constellium is delivering record results and achieving targets ahead of schedule, it remains a mature, capital-intensive business with moderate reinvestment optionality. The recent growth is notable but largely driven by cyclical and commodity tailwinds (scrap spreads, aerospace demand) rather than unique, compounding business model advantages. The business is showing growth and strong execution, but lacks the disruptive, high-ROIC profile or runaway unit economics that would merit a higher signal score.
Cipher Digital (CIFR) Q1 2026: Contracted Revenue Surges to $11.4B, Anchoring 10-Year Cash Flow Visibility
Cipher Digital demonstrates a major business model pivot with long-term contracted revenue and a multi-gigawatt pipeline, supporting a strong growth narrative and high cash flow visibility. However, while the reinvestment runway is long and recent developments are significant, some elements (unit economics, business model self-reinforcement, customer value deepening, and cash flow acceleration) are promising but not yet exceptional or proven at scale. Risks around pipeline conversion and tenant concentration remain, tempering the signal score.
Palomar Holdings (PLMR) Q4 2025: Net Income Surges 62% as Diversification and Retention Drive Expansion
Palomar is transitioning to a growth business with diversification and improved unit economics. There are strong growth signals in new lines, but not all metrics (such as reinvestment runway, network effects, or disruptive potential) are at the highest level. The business is not a clear outlier or a highly disruptive model, and while growth is robust, it is not exceptional across all dimensions.
BlackBerry (BB) Q1 2027: QNX Revenue Surges 26% as GEM and Physical AI Expand TAM
BlackBerry demonstrates strong growth, margin expansion, and a clear pivot to profitable segments, but the business is not highly disruptive or unknown, and while the runway is expanding, it is not yet proven to be exceptionally long or high-ROIC. There are significant step-change developments, but some metrics (e.g., reinvestment, model self-reinforcement, customer value) are improving but not at the highest level.
Five Below (FIVE) Q1 2026: Comp Sales Surge 23% as Trend Amplification and Store Expansion Accelerate Growth
Five Below shows strong recent growth and margin expansion, with evidence of improving unit economics and a growth business profile. However, the reinvestment runway, business model defensibility, and customer value deepening are not exceptional—digital and loyalty are early-stage, and macro/tariff headwinds limit the upside. The model is semi-disruptive but not unique, and future growth is solid but not likely to consistently exceed 20-40% annually.
Merion Technologies (MIR) Q4 2025: Nuclear Power Orders Surge 52% as Backlog Hits Record High
Merion demonstrates a long reinvestment runway, significant backlog growth, and a strong pivot toward nuclear power, supporting the growth narrative. However, some signal questions are conservatively scored lower due to the transitional nature of the business, limited evidence of compounding network effects, and only moderate improvements in unit economics and customer value. While the growth outlook is strong, the business is not uniquely disruptive nor is it poised for hyper-growth, warranting a cautious approach to the highest signal marks.
Coda Octopus (CODA) Q2 2025: Revenue Jumps 32% as Ecoscope and David Drive Defense Adoption
Coda Octopus demonstrates a long reinvestment runway with defense adoption and new product launches, and recent revenue growth is significant. However, margin and unit economics have near-term volatility and are not yet clearly compounding. The business model has some self-reinforcing elements (ecosystem effects), but these are still developing. Customer value is improving, but not yet at a transformative pace. The outlook is positive, but not exceptional (no >30% growth guidance). The business is a growth story but not a category-defining disruptor at this stage.
Syntec Optics (OPTX) Q2 2025: Customer Demand Up to 200% Fuels Capacity Push Amid Filing Delays
The business is experiencing surging demand (200%+), suggesting a long runway and growth potential. However, lack of current financials, execution risk, and the early stage of diversification initiatives limit the score. Unit economics are targeted for improvement but not yet proven at scale. The business model has some integration advantages but is not clearly disruptive or self-reinforcing at this stage. Revenue and EPS growth are likely strong but not definitively over 40%. The company is a growth business, but execution and regulatory risks temper the signal.
Neurocrine Biosciences (NBIX) Q2 2026: Pro Forma Sales Approach $1B as Portfolio Diversifies Beyond Ingreza
Neurocrine demonstrates a clear transition to a multi-product, growth-oriented business with a long reinvestment runway and strong commercial momentum. However, while there are strong growth signals and pipeline optionality, unit economics and self-reinforcing model features are not yet at the highest level, and the growth profile, while robust, is not extraordinary or disruptive enough to warrant full marks across all signal dimensions.
Blend Labs (BLND) Q4 2025: Pipeline Up 40% as Agentic AI Drives Product Bundling Shift
Blend shows strong growth signals with a 40% pipeline increase and AI-driven product evolution, but its reinvestment runway and business model disruption are moderate rather than exceptional. While margins and cash flow are improving, and the business is positioned for growth, the company operates in a competitive, regulated space with some customer concentration and volatility. The signals are solid but not at the level of a truly exceptional, high-upside business.
Certara (CERT) Q1 2026: Software Bookings Surge 20% as AI Platform and Portfolio Realignment Take Hold
Certara exhibits a moderate-to-strong signal profile: the business has a long reinvestment runway with strategic AI investments, a significant bookings uptick, and a growth-oriented repositioning. However, revenue and EPS growth are modest (0-4% guidance), unit economics are only modestly improving, and the business model—while differentiated—is not fully disruptive or compounding. The risk of execution and only moderate acceleration in growth tempers the signal score.
Rockwell Automation (ROK) Q2 2026: Software and Control Margin Surges 480bps as Data Center, AI, and Warehouse Automation Drive Expansion
Rockwell is showing strong growth in new verticals and recurring revenue, but as a well-followed, large-cap industrial, some limitations exist in terms of reinvestment runway and disruption. The business model is evolving, but not fully disruptive. Growth is solid and accelerating in certain areas (data center, warehouse), but overall company guidance and market context cap the upside. The article captures a material business evolution, but not an exceptional, high-multiple inflection.
Comstock Resources (CRK) Q1 2026: Western Hainesville Wells Average 29 MMCF/D, Power Hub Deal Reshapes Demand Visibility
Comstock has a long reinvestment runway, a transformative demand anchor, and is positioned for growth, but unit economics and business model self-reinforcement are not yet exceptional. The business is not disruptive, but semi-disruptive, and while growth is improving, it is not at hypergrowth levels. The signal is strong for a traditional E&P, but not as high as for a truly exceptional or disruptive business.
Sunoco (SUN) Q1 2026: Fuel Volume Surges 82% as Parkland and Tankwood Scale Up Global Reach
While the business shows strong growth, global expansion, and accretive M&A, it is still a fuel distribution/logistics company with some legacy characteristics and moderate reinvestment runway. There is a significant uptick in growth and backlog from acquisitions, but the underlying business is not disruptive or uniquely high-ROIC, and future cash flow normalization is noted. The signal is solid but not exceptional for a widely followed, mature sector name.
GCT Semiconductor (GCTS) Q1 2026: 5G Chipset Shipments Surge 58% as Commercial Ramp Accelerates
GCT is at a commercialization inflection with a long runway, strong growth in 5G chipset shipments, and customer diversification. However, the business is still early-stage, with some uncertainty in unit economics and self-reinforcing model. Growth is strong but not yet exceptional, and while disruptive, the company is not yet a proven giant.
EPAM (EPAM) Q2 2025: AI-Native Revenue Up Double Digits, Driving 18% Broad-Based Growth
EPAM demonstrates a long reinvestment runway, clear recent growth acceleration, and strong positioning in AI-native services. However, while growth is robust, the business model is not fully disruptive and unit economics improvements are present but not exceptional. The company is transitioning into a growth phase, but some signal areas (e.g., cash flow acceleration, disruptive business model, and exceptional future growth) are moderate rather than outstanding.
Hafnia (HAFN) Q1 2026: Net Profit Surges 3x as Hormuz Closure Drives Freight Tightness
While the business is experiencing a step-change due to external shocks, the underlying reinvestment runway is moderate, not exceptional. There is a major recent event (Hormuz) and strong cash flow, but the business model is not deeply self-reinforcing or disruptive, and future growth is highly contingent on external factors normalizing. The signal is good but not at the level of a structurally compounding, high-ROIC, or highly disruptive business.
Ultragenyx (RARE) Q1 2026: 64% Ex-U.S. FKESA Growth Signals Pipeline-Driven Revenue Inflection
Ultragenyx has a long reinvestment runway with a disruptive, pipeline-driven model and strong growth signals, but execution risk, high R&D burden, and pipeline binary outcomes temper the signal. Unit economics and self-reinforcement are present but not yet at the scale of a compounding giant. Growth is strong but not yet at hypergrowth levels.
Pagaya (PGY) Q1 2026: Auto Volume Doubles, Platform Diversification Drives Margin Expansion
Pagaya demonstrates a solid reinvestment runway and recent growth in auto lending, but the business, while growing, is not yet showing exceptional acceleration across all metrics. Unit economics and customer value are improving, but not at a transformative pace. The business model is evolving toward self-reinforcement and disruption, but competitive and regulatory risks remain. The company is a growth business, but not one with an extraordinary signal or unique upside relative to the most elite opportunities.
StubHub (STUB) Q4 2025: Market Share Climbs to 50% as Margin Expansion Strategy Takes Hold
StubHub demonstrates strong network effects, operating leverage, and a clear margin expansion path, but does not show evidence of a recent massive business inflection or 40%+ growth. The business is not accelerating at a disruptive rate, and while the model is robust, the future growth guidance is solid but not exceptional. The article signals a high-quality, scaled business but not one with outsized near-term upside.
Ventas (VTR) Q2 2026: SHOP Investments Jump to $4.5B, Cementing 60% Portfolio Pivot
Ventas is executing a significant pivot with accelerating investment and NOI growth in a segment with demographic tailwinds. However, while growth is robust and the business is transitioning to a higher-growth model, the runway is not as long or disruptive as a true platform business. Unit economics and margin expansion are strong, but customer value and business model self-reinforcement are only moderately improving. The business is growth-oriented but not a transformational compounder, which tempers the overall signal score.
908 Devices (MASS) Q1 2026: NearLab Acquisition Adds $2.5M Revenue, Accelerates Recurring Model Shift
MASS is transitioning toward a high-quality recurring revenue model with a visible reinvestment runway and improving margin structure. While the NearLab acquisition and recurring revenue shift are promising, the company is not yet showing explosive growth or scale economics typical of a giant. Some signals of compounding (data moat, AI analytics) are present but not fully proven, and the business, while growing, is not yet exceptional in its category. The growth profile is solid but not hyper-growth, and the business model is semi-disruptive rather than transformative.
Urogen Pharma (URGN) Q1 2026: Zesturi Prescriber Base Grows 151%, Validating Community Penetration Strategy
Urogen demonstrates a strong growth profile with a long reinvestment runway, major recent developments (151% prescriber growth), and a disruptive, non-surgical therapy model. However, while the business is transitioning to growth and showing accelerating adoption, some elements (unit economics, self-reinforcement, customer value) are still emerging and not yet at the highest signal levels. Revenue and EPS growth are likely to be strong, but not necessarily above 40% annually. The business is not yet a giant, but the signal is well above average for a specialty pharma launch.
CytomX Therapeutics (CTMX) Q1 2026: Cash Runway Extends to 2028 as Varsetta-M Enrollment Hits 113
CytomX offers a compelling inflection with a long cash runway, pivotal asset in late-stage development, and a differentiated ADC platform. However, while the business has growth potential and a disruptive approach, unit economics and customer deepening are not yet proven at scale. The business is transitioning to a pipeline-driven model, and while the outlook is strong, it is not yet a clear high-growth compounding story.
Be Light Bio (BLTE) Q1 2026: SG&A Rises 179% as Commercial Launch Readiness Accelerates
BLTE is at a major inflection, moving from clinical to commercial stage with a large cash position and a potentially disruptive therapy in a rare disease with high pricing power. However, while the growth runway and business model are promising, true network effects and proven customer value deepening are not yet fully evident. Unit economics, future guidance, and cash flow are not yet proven at scale, and the business, while transitioning to growth, still faces significant execution and regulatory risks.
USEG Q1 2026: $130M 45Q Credit Stream Unlocks Multi-Phase Carbon Monetization Path
USEG is at a key transition point with a scalable, multi-phase platform and multiple monetization levers. The runway is long, with high-ROIC potential, and recent developments (capital stack, offtake contracts, regulatory catalysts) are significant. However, some elements (unit economics, self-reinforcing model, customer value) are still emerging and not yet proven at scale, moderating the signal score.
AMBQ Q1 2026: Non-Wearables Double, Diversification Lowers Top 3 Customer Concentration to 71%
AMBIC is diversifying and growing rapidly, with strong runway and some disruptive elements, but customer concentration and profitability lag keep the upside in check. Unit economics and business model self-reinforcement are improving but not yet at the highest level. The business is transitioning toward growth but not yet a breakout compounder.
Agios Pharmaceuticals (AGIO) Q4 2025: Pyruvate Kinase Franchise Revenue Jumps 86% as Thalassemia Launch Begins
Agios demonstrates a long reinvestment runway, major recent growth with the thalassemia launch, and strong pipeline optionality. However, the business is not yet proven as self-reinforcing, and while growth is strong, some elements (unit economics, customer value, cash flow) are still ramping and not fully de-risked. The business is transitioning to multi-franchise status but is not yet a proven high-growth compounding story.
Willis Lease Finance (WLFC) Q1 2026: Lease Utilization Jumps 6 Points as Engine-Centric Demand Drives Record Revenue
WLFC demonstrates a solid reinvestment runway, strong recent developments (record utilization/revenue), and a transition toward fee-based, capital-light growth. Unit economics and business model are improving, but not to the level of a giant platform yet. Customer value and cash flow are improving moderately. The business is growth-oriented, but the signal is capped by its niche and the absence of disruptive or hyper-growth dynamics.
Iron Mountain (IRM) Q4 2025: Data Center Revenue Jumps 39% as Growth Engines Reshape Portfolio
Iron Mountain demonstrates strong growth in new business lines, especially data centers and ALM, with significant backlog and double-digit guidance. However, the business is not a pure-play disruptor and retains a large legacy component, limiting the reinvestment runway and self-reinforcing dynamics compared to true tech compounders. Unit economics and customer value are improving, but not at the pace of the most exceptional growth businesses. Signal is solid, but not at the highest echelon for valuation upside.
HII (HII) Q2 2026: Shipbuilding Revenue Jumps 16% as Throughput and Contract Wins Drive Guidance Raise
HII is showing strong growth and margin improvement, with a robust backlog and expanding opportunities in autonomy. However, as a large, established defense contractor, much of the growth is incremental and tied to government budgets rather than disruptive reinvestment or runaway economics. While Mission Technologies and unmanned systems provide some optionality, overall signal is moderate due to the industry’s mature dynamics and the company’s reliance on contract cadence.
ElectroCorp (ECOR) Q1 2026: VA Device Revenue Jumps 48% as Penetration Remains Early
ElectroCorp has a long reinvestment runway and is early in federal channel penetration, with strong recent growth and margin expansion. However, while growth is robust and the business model is partially self-reinforcing, unit economics and customer value are improving but not exceptional. The business is not yet at the level of a giant platform, and while growth is strong, it is not at hypergrowth levels. The signal is above average due to the early penetration and federal channel opportunity, but not at the highest tier for disruption or scale.
Dycom (DY) Q1 2027: Backlog Surges 25% as Fiber and Data Center Demand Accelerates
While Dycom demonstrates strong growth and a clear inflection point with a 25% sequential backlog increase and margin expansion, it is still a specialty contractor in a structurally growing but competitive market. The reinvestment runway and business model are solid but not truly exceptional or disruptive. Growth is strong but not at a hypergrowth (40%+) level, and while backlog and guidance are robust, the business remains tied to project execution and integration risk. The article signals above-average but not outstanding valuation upside.
XTIA Q1 2026: Drone Nerds Platform Drives $160M Revenue Target as Margin Expansion Accelerates
XTIA demonstrates a credible transformation and targets high growth, but the business is not yet at a scale or trajectory to warrant a top signal score. There are clear reinvestment opportunities and some disruptive elements, but unit economics and customer value are still maturing. Growth is robust but not yet exceptional, and the business model, while improving, does not yet show the deep, self-reinforcing characteristics of a platform giant. There is upside, but also execution and integration risk.
EVH Q1 2026: Performance Suite Revenue Jumps 26% as Oncology Drives Expansion
The business is pivoting to risk-based, high-growth oncology and automation, with clear reinvestment runway and recent significant growth in the Performance Suite. However, some metrics (unit economics, self-reinforcement, customer value) are improving but not yet exceptional, and the company is not a category-creating disruptor. Revenue growth is solid but not hypergrowth, and exchange headwinds temper near-term upside.
WhiteFiber (WYFI) Q4 2025: $865M NC1 Contract Locks In Hyperscale Demand, Cloud Revenue Reset Near-Term
WhiteFiber demonstrates a strong growth runway, a major new contract, and clear evidence of operating leverage and margin improvement. However, while there is optionality and disruption, some elements (unit economics, business model self-reinforcement, customer value deepening, and cash flow acceleration) are present but not yet at the highest level of compounding or disruption. The business is in transition, with high growth potential but not yet a breakout category leader.
LUXE (LUXE) Q3 2026: MyTheresa U.S. Sales Surge 34%, Margin Expansion Drives Group Profitability
LUXE shows strong U.S. growth and margin expansion, but the reinvestment runway is moderate and the business model, while improving, is not highly disruptive. Unit economics and cash flow are improving, but not at an exceptional rate. The transformation is positive but the upside is not extraordinary or unique by public equity standards.
CLRB Q4 2025: R&D Spend Falls 57% as Regulatory Milestones Unlock Accelerated Approval Path
Selectar Biosciences demonstrates a long reinvestment runway with recent regulatory milestones and a broadened addressable market. However, while growth potential is present, the business model’s self-reinforcing characteristics and customer value deepening are moderate, not yet proven at scale. The company is transitioning toward growth but remains dependent on upcoming data and execution, limiting the signal score. The business is not yet exceptional or dominant, and future upside is contingent on pivotal trial success and capital raises.
CMCM Q1 2026: Robotics and AI Segments Surge 176%, Reshaping Revenue Mix
CMCM is showing a strong pivot to high-growth AI and robotics segments with triple-digit growth and a clear strategic focus. However, some areas such as unit economics, business model self-reinforcement, and customer value deepening are not yet proven or are only modestly improving. The business remains in transition, with legacy segments still material to overall results.
10X Genomics (TXG) Q4 2025: Spatial Consumables Surge 14% as Xenium Drives Portfolio Shift
TXG shows a strong consumables growth runway and a pivot toward AI and clinical markets, but margin and unit economic improvements are moderate, and the business model, while evolving, is not exceptionally disruptive or high-growth at this stage. Revenue and EPS growth are solid but not explosive.
MSCI (MSCI) Q2 2026: Hedge Fund Subscription Run Rate Triples, Index Net New Sales Up 41%
MSCI demonstrates a strong reinvestment runway, major growth in hedge fund and private asset segments, and is in the early innings of AI monetization. However, fee compression, sustainability headwinds, and some segments with modest rather than explosive growth temper the signal. The business is not wholly disruptive nor growing at hypergrowth rates, but it is solidly in a multi-year secular growth cycle with clear optionality.
NFE (NFE) Q1 2025: $1.055B Jamaica Sale Accelerates Deleveraging and Asset-Backed Financing Shift
NFE’s asset sale, deleveraging, and pivot to long-term contracted cash flows signal a meaningful business evolution, but the company is not a high-growth disruptor and much of the upside is contingent on execution of Brazil and Puerto Rico projects. While the business is transitioning to higher-quality recurring earnings, the reinvestment runway is solid but not exceptional, and the growth profile is moderate rather than explosive.
Quantum Computing Inc. (QUBT) Q2 2025: $200M Capital Infusion Fuels Integrated Quantum-Photonic Ramp
QUBT demonstrates a long reinvestment runway with disruptive potential, a major capital infusion, and a clear roadmap toward integration and commercialization. The business is still early-stage with modest current revenue, so unit economics and customer value are not yet proven at scale. The business model is disruptive, and the industry is at an inflection, but growth rates are not yet extraordinary and the company remains in transition toward scale.
PowerFleet (AIOT) Q3 2026: Recurring Services Hit 80% of Revenue as Landmark Public Sector Win Reshapes Growth Trajectory
PowerFleet demonstrates a long reinvestment runway, a major recent contract win, and a strong recurring revenue mix, but some elements (unit economics, self-reinforcing model, customer value deepening, and cash flow acceleration) are present but not yet exceptional. The business is in a growth phase but not a hypergrowth or disruptive outlier.
NICE (NICE) Q1 2026: AI ARR Soars 66% as Strategic Renewals Prioritize Long-Term CXAI Growth
NICE demonstrates a strong reinvestment runway and recent significant backlog growth, with an AI-driven business model that is transitioning to higher-value, long-term contracts. However, some elements such as unit economics, self-reinforcing model, and customer value are improving but not yet at the highest level. Revenue and EPS growth are solid but not hyper-growth, and the business is more a transitioning growth story than a breakout disruptor at this stage.
BKV (BKV) Q1 2026: Power Platform CapEx Rises 21% as Data Center Demand Accelerates
BKV is showing strong reinvestment opportunity, a significant inflection in power platform growth, and a transition to a growth business. However, while the business model is partially self-reinforcing and disruptive, the evidence for compounding customer value and unit economics is not overwhelming. Growth is strong but not at the very highest tier, and while the outlook is positive, it is not exceptional across all dimensions.
Hyperfine (HYPR) Q1 2026: Gross Margin Expands 940bps as Next-Gen Subsystem Drives Adoption
Hyperfine is at a commercial inflection with strong growth and margin expansion, but as a small-cap medical device company, its reinvestment runway and business model self-reinforcement are moderate, not exceptional. Growth is accelerating, but not at a scale or pace to merit the highest marks for disruptive potential or cash flow machine status. The business is transitioning to growth, but not yet a proven compounding giant.
Electrovaya (ELVA) Q2 2026: Gross Margin Expands 230bps as Energy Storage Push Accelerates
ELVA shows a long reinvestment runway and strong margin expansion, but the business is not yet at giant scale and some compounding dynamics are emerging rather than fully realized. Growth is solid (20% YoY) but not explosive, and while vertical diversification is promising, the scale and competitive moat are not yet proven. The business is transitioning with potential for growth but lacks the exceptional signal of a breakout compounder.
FIP Q1 2026: $1.52B Long Ridge Sale Unlocks $300M Deleveraging, Refocuses on Rail M&A
FIP is undergoing a strategic transformation with a long reinvestment runway in rail, a major asset sale, and visible deleveraging. While the business is becoming more focused and growth-oriented, some elements (unit economics, self-reinforcing model, customer value) are still developing, and the business is not yet at the level of a disruptive, high-growth compounder. Signal is solid but not exceptional.
CBRE (CBRE) Q4 2025: Data Center Solutions Surges 20%, Shaping Next-Phase Growth
CBRE is a large, well-followed company, and while the data center business is growing rapidly, the overall business is diversified and mature, limiting the runway for outsized returns. The data center segment is a strong growth engine, but the rest of the business is not disruptive or likely to deliver 20%+ annual EPS/revenue growth. The article reflects important business evolution and secular tailwinds, but the overall signal for dramatic valuation upside is moderate rather than exceptional.
Knightscope (KSCP) Q1 2026: Revenue Doubles to $6M as Managed Service Model Takes Hold
While Knightscope is showing strong growth and a major business model shift, the business is still early in proving sustainable high returns on capital, margin expansion, and cash flow generation. The acquisition and managed service pivot are disruptive and offer optionality, but execution risk and capital needs are high. The runway is long, but evidence of compounding economics and customer value is still emerging rather than proven at scale.
Dragonfly (DPRO) Q1 2026: Cash Surges to $147M as Defense Orders Drive 49% Growth
Dragonfly demonstrates a strong growth trajectory with a clear runway in defense, but some elements (unit economics, customer value, self-reinforcement) are improving but not yet exceptional. There is significant recent growth and cash position, but the business is still in transition. While the growth and platform potential are clear, the company is not yet at the stage of a compounding, disruptive giant.
Broadstone Net Lease (BNL) Q2 2026: Build-to-Suit Pipeline Swells to $645M, Unlocking 10% Forward Rent Growth
BNL exhibits a strong forward growth profile and a large build-to-suit pipeline, but as a REIT, its reinvestment runway is moderate and not truly exceptional. There is a significant development (data center), but the business model, while evolving, is not highly disruptive and is still exposed to execution and concentration risk. The company is transitioning to higher growth, but not at a level that would justify a top decile signal score.
Creative Realities (CREX) Q1 2026: $10M Synergy Target Drives Margin Expansion Amid Retail Media Surge
CREX shows a solid reinvestment runway and a potentially transformational contract win, with clear cost synergy realization and recurring revenue growth. However, while the business is transitioning toward higher-margin SaaS, evidence of compounding network effects, exceptional customer value expansion, and disruptive business model characteristics is emerging but not yet dominant. Growth is improving but not at hyper-growth levels, and execution risk remains high. The signal is above average but not exceptional.
Crescendo (CXDO) Q1 2026: $46M Backlog Anchors Double-Digit Organic Growth and AI Upsell Momentum
Crescendo demonstrates a solid growth trajectory with a large backlog, double-digit organic growth, and early AI monetization. However, while the business is showing improvement, it is not yet a clear outlier in terms of disruptive potential or runaway economics. Margins and unit economics are improving but not exceptional, and while the company is transitioning into a growth platform, it is not yet a category-defining business. Signal is above average but not at the highest tier.
Star Equity Holdings (STRR) Q2 2025: Backlog Soars 84% as Building Solutions Drives Margin Expansion
While the business shows strong recent momentum (backlog up 84%, margin expansion, and a major M&A catalyst), it is still a diversified holding company with some mature and cyclical elements. The reinvestment runway and disruptive potential are moderate but not exceptional; investments division adds optionality but also volatility. The business is transitioning to growth, but not at a scale or pace to warrant the highest signal scores.
Immucell (ICCC) Q1 2026: Tri-Shield Drives 38% Growth, Capturing 80% of Market Expansion
Immucell demonstrates strong growth, margin expansion, and a focused premium product with market share gains. However, the reinvestment runway is moderate rather than exceptional, and while recent growth is strong, the business model—though differentiated—is not fully disruptive or network-driven. International opportunity is promising but unproven, and the company is still reliant on a narrow product set. Signal is solid but not at the highest level of structural upside.
Lens Therapeutics (LENZ) Q1 2026: Three-Month Rx Share Hits 66%, Signaling Early Patient Persistence
LENZ demonstrates a strong reinvestment runway and recent significant growth, with a disruptive product and early evidence of stickiness. However, while growth is solid, it is not yet at an exceptional pace, and some elements (unit economics, self-reinforcement, customer value) are promising but not yet fully proven or compounding at scale. The business is transitioning to growth, but broader adoption and execution are still gating factors. Overall, signal is above average but not yet at the level of a breakout, high-conviction compounder.
Enova International (ENVA) Q4 2025: Originations Up 32% as Grasshopper Bank Deal Promises $125M+ Synergy
Enova is showing strong growth in SMB lending and a major strategic shift with the pending bank acquisition, but its business model is not exceptionally disruptive and the reinvestment runway, while solid, is not extraordinary. There are clear improvements in unit economics and profitability, but growth is not hyper-scaling. The outlook is strong but not at the highest possible signal level for massive upside.
Crane (CR) Q2 2026: Acquisitions Add 20% to Sales, Accelerating Margin and Backlog Growth
Crane demonstrates strong growth and margin acceleration due to acquisitions, with some evidence of improving unit economics and backlog. However, as a well-established industrial, its reinvestment runway and disruptive potential are moderate, and while growth is robust, it is not at a truly exceptional or transformative level. The business is transitioning to higher growth and margin, but remains within the bounds of a mature industrial acquirer, limiting upside relative to the highest-signal opportunities.
Colliers (CIGI) Q2 2026: Engineering Revenue Jumps 30% as Platform Integration Deepens
Colliers is showing solid growth and a strategic shift toward recurring revenue, with clear signals of business model evolution and margin expansion. However, while there is a long runway and some disruptive elements, the business is not a pure high-growth or highly disruptive story, and some metrics (unit economics, self-reinforcement, customer value) are improving but not at a breakout pace. The business is attractive and thesis-relevant, but not at the highest level of signal for transformative upside.
Perma-Fix (PESI) Q1 2026: Hanford Waste Ramp Targets $4M Quarterly Run-Rate Amid Transition
There is clear evidence of a long runway (Hanford contracts, PFAS, services), recent significant backlog growth, and a business at inflection. However, unit economics and model self-reinforcement are not yet proven at scale, and growth—while strong—is not yet exceptional or disruptive enough for top marks.
FLOCO (FLOC) Q1 2026: Rental Revenue Climbs to 60% of Mix, Valiant Integration Unlocks New Lift Synergies
FLOCO shows a strong recurring revenue shift and high margin profile with a long reinvestment runway, but the business is not in a hyper-growth phase and lacks truly disruptive characteristics. While there are positive signals—like the Valiant integration, rental mix expansion, and robust capital allocation—the growth and optionality are moderate rather than exceptional. Unit economics are stable to improving, but not at a transformative scale. The signal is good but not outstanding.
Talon Energy (TLN) Q1 2026: Spark Spread Expansion Drives 30% Free Cash Flow Per Share Upside
Talon Energy demonstrates strong recent growth, a differentiated hybrid contracting model, and visible free cash flow upside. However, while the spark spread expansion and M&A integration are material positives, the business is not exceptionally disruptive or unique, and the reinvestment runway is good but not extraordinary. The signal is solid for an IPP, but not at the level of a truly exceptional, high-multiple compounder.
Lantronics (LTRX) Q2 2026: Drone Revenue Outlook Raised 60% as Edge AI Platform Gains Traction
Lantronics is showing a clear inflection in growth, with a sizable upward revision in drone revenue and strengthening recurring revenue. However, while the business is transitioning to higher-value segments, its overall scale and the degree of compounding self-reinforcement are not yet at the level of a truly exceptional or dominant platform. Unit economics and cash flow are improving but not at a hyper-scaling trajectory. The business is moving from legacy to growth, but the upside is moderate rather than explosive.
NVT Q4 2025: Data Center Backlog Triples, Infrastructure Exposure Hits 45%
NVT has a strong reinvestment runway and is experiencing a major business inflection with backlog tripling and infrastructure now 45% of sales. However, while growth is robust, unit economics and business model self-reinforcement are still developing, and the business is not yet at the level of a giant or highly disruptive platform. The growth outlook is strong but does not reach the highest signal thresholds for explosive, sustained upside.
Snap (SNAP) Q4 2025: Subscription Revenue Jumps 62% as Profitability Pivot Accelerates
Snap is transitioning toward a more diversified, margin-accretive model with strong subscription momentum and positive inflections in margin and cash flow. However, the business is not yet a clear outlier in terms of reinvestment runway or disruptive potential. While growth is robust, particularly in subscriptions, the core ad business is maturing and faces competitive/regulatory headwinds. The signal is solid but not exceptional for a well-followed company.
QuickLogic (QUIK) Q4 2025: Q1 Revenue Set to Jump 50% as Storefront and Defense Contracts Accelerate
QuickLogic has a defensible niche and is pivoting to higher-value markets with runway, but the business is not yet at massive scale and faces execution risk. Revenue is inflecting and guidance is strong, but unit economics and business model compounding are still developing. The business is transitioning rapidly, but remains vulnerable to contract lumpiness and competitive threats.
CareDx (CDNA) Q2 2026: Revenue Soars 52% as NavDx and Transplant Volumes Expand Core Platform
CareDx is showing strong growth and transformation, with a significant recent uptick in revenue and volumes (Q2 revenue up 52%), and the NavDx acquisition adds a new growth vector. However, the reinvestment runway, while solid, is not yet proven to be exceptionally long or at extremely high ROICs. Some business model self-reinforcement is present, but not at the level of a true compounding platform. Customer value is improving, but not deeply evidenced as consistently accelerating. The business is clearly a growth business, but not at the very highest levels of disruption or acceleration.
Powell Industries (POWL) Q1 2026: Backlog Jumps 14%, Data Center and LNG Orders Reshape Growth Visibility
While Powell Industries demonstrates strong backlog growth, margin improvement, and a strategic pivot to secular growth markets, its business model—though evolving—is not yet highly disruptive or self-reinforcing. The reinvestment runway is moderate rather than exceptional, and while backlog and order growth are impressive, the durability and scalability of these gains remain to be proven. The business is transitioning into a growth phase, but some metrics (cash flow, customer value, disruptive potential) are not at the highest tier. Signal is strong but not best-in-class.
Littlefuse (LFUS) Q1 2026: Bassler Acquisition Drives 39% Industrial Growth, Margin Expansion Accelerates
LFUS demonstrates strong recent growth, margin expansion, and backlog momentum, but is not a disruptive or truly exceptional growth story. The business is showing high-quality execution and above-market growth, but its reinvestment runway and self-reinforcing model are moderate rather than extraordinary. The signal is strong for an industrial, but not at the level of a platform or hypergrowth disruptor.
ASM Q1 2026: Silver Revenue Share Hits 60% as La Preciosa Drives Multi-Asset Growth
ASM is demonstrating a credible multi-asset growth strategy, with a newly declared reserve base and ramping production at La Preciosa. The reinvestment runway is present, and there are significant recent developments (reserve declaration, ramp-up). However, some elements such as unit economics, business model self-reinforcement, and customer value are improving but not at a compounding or exceptional rate. The business is transitioning to growth with moderate disruption and cash flow improvement, but not at a level that would warrant a top decile signal score.
Roblox (RBLX) Q2 2026: DAUs Up 10% as Algorithm Shift Drives Monetization Reset
Roblox demonstrates a long reinvestment runway, international growth, and a disruptive business model with AI-driven content expansion. However, current monetization and unit economics are under pressure, and while future potential is significant, near-term growth and cash flow are not accelerating at a level to warrant a top score. The business is a growth platform in transition, with signal moderated by execution risk and the need for evidence of successful monetization crossover.
F5 (FFIV) Q3 2026: Product Revenue Jumps 19% as AI Security and Hybrid Cloud Drive Expansion
F5 shows solid growth and secular tailwinds, but its reinvestment runway and business model, while improving, are not at the level of a truly disruptive or compounding platform. Growth is strong but not hyper-scaling, and some drivers (hardware) remain cyclical. The signal is above average but not exceptional.
CI&T (CINT) Q1 2026: Value-Based Contracts Hit 20% of New Sales, Margin Expansion in Sight
CI&T is showing strong organic growth, a meaningful business model transition, and early evidence of margin expansion. The move to value-based pricing and AI-driven productivity are positive signals, but the business is not yet at the scale or disruptive trajectory of a category-defining compounder. The reinvestment of margin gains and gradual contract renewal cycle temper near-term upside. The company is transitioning toward growth, but the signal is not yet exceptional or unique enough to warrant a top score.
Dragonfly Energy (DFLI) Q2 2025: OEM Sales Surge 50%, Margin Expansion Signals Manufacturing Leverage
Dragonfly Energy shows a long reinvestment runway via OEM expansion and innovation. There is a significant OEM growth uptick, but not a massive backlog increase. Unit economics are improving, but not yet giant-scale. The business model is moving toward self-reinforcement, but is not yet deeply entrenched. Customer value is improving with OEM wins, but not consistently deepening across all channels. Future growth is good but not exceptional (guidance at ~25% YoY). The business is semi-disruptive with some lateral opportunities, and cash flow is improving but not yet accelerating. Revenue growth is in the 20-40% range, and this is a growth business moving out of transition.
Contango (CTGO) Q1 2026: Hedge Book Slashed to 22K Ounces, Paving Way for $200M+ Free Cash Flow in 2027
Contango demonstrates a long reinvestment runway with a reset capital structure, significant upcoming FCF, and clear operational inflections, but does not yet show compounding network effects or consistently improving unit economics across the board. Exploration provides optionality, but the business is not yet a proven compounding machine or a top-tier growth story. Signal is strong but not exceptional.
MEC (MEC) Q1 2026: Data Center Revenue Jumps 71%, Unlocking Multi-Year Growth Path
MEC is pivoting to a secular growth market with a long runway and recent acceleration in a high-value segment (data center/critical power, +71% YoY). However, unit economics and self-reinforcing advantages are still developing, not yet at the level of a compounding giant. Customer value is improving, but legacy drag and margin headwinds temper the near-term. While growth is solid, it's not yet at the exceptional level for several signal criteria. The business has transitioned from legacy to growth, but not all signal levers are fully mature.
Novavax (NVAX) Q1 2026: Partner Revenue Surges 116% as MatrixM Adoption Accelerates
Novavax is transitioning to a platform model with long runway and major pharma partners, but realization of upside depends on external execution and conversion of MTAs to licenses. Growth is improving but not yet exceptional; model is semi-disruptive and cash flow potential exists, but near-term results depend on partner progress.
BioHarvest Sciences (BHST) Q1 2026: CDMO Pipeline Adds 3–4 New Projects, Deepening Royalty and Margin Leverage
BioHarvest has a long reinvestment runway and is moving into a royalty-driven, high-margin model with new CDMO projects. Significant developments are present, but growth is not yet explosive. Unit economics and business model advantages are emerging but not fully proven. Customer value is improving, and the business is transitioning toward growth, but not yet at the level of a top-tier disruptor or hyper-growth story. The overall signal is strong but not exceptional.
Shift4 (FOUR) Q1 2026: International Payments Up 51%, Global Playbook Scales Beyond U.S. Core
Shift4 demonstrates a long reinvestment runway and significant international growth, but some signal questions are scored conservatively due to the early-stage nature of international economics, non-exceptional acceleration, and the business not being a category-creating disruptor. The business is a clear growth story, but not at the highest level of signal for all questions.
Corneet Digital (KRNT) Q4 2025: AIC Revenue Surges 104% as Recurring Model Reshapes Core
KRNT is undergoing a strategic business model transition with a long reinvestment runway and a disruptive recurring revenue model, supported by clear growth in AIC contracts and new verticals. However, near-term growth is muted, and while there are strong signals of future margin and cash flow improvement, the business is not yet at a scale or growth rate to warrant a higher signal score. The addressable market is expanding, but execution and adoption risks remain.
LiveOne (LVO) Q4 2025: Podcast Revenue Jumps 37% as B2B Pipeline Expands Tenfold
While LiveOne shows strong growth in podcasting and B2B, the business is not yet at the scale or defensibility of a giant, and much of the upside is contingent on execution. There are clear signs of a strategic pivot and accelerating revenues, but the business model, while improving, is not fundamentally disruptive at scale, and some optionality (Web3, AI) remains unproven. Still, there is meaningful signal for investors tracking inflection points in digital audio.
Vertex Pharmaceuticals (VRTX) Q4 2025: Non-CF Portfolio Set to Exceed $500M, Anchoring Multi-Vertical Expansion
Vertex shows a long reinvestment runway and recent material developments with the non-CF portfolio tripling, but the business model is only semi-disruptive and unit economics, while improving, are not yet at the level of a giant. Customer value is deepening, but not at an exceptional rate. The future is positive but not accelerating at an extraordinary pace, and cash flow is growing but not dramatically. Revenue and EPS growth are solid but not hypergrowth. The company is a growth business, but upside may be somewhat capped by its size and mature CF franchise.
Amkor Technology (AMKR) Q4 2025: CapEx Jumps 40% to Fuel Advanced Packaging Ramp
Amkor is positioned for strong growth with a long reinvestment runway and secular AI/auto tailwinds. There are clear recent developments (CapEx surge, customer commitments), but some metrics (unit economics, self-reinforcement, customer value) are improving but not exceptional. The business is growth-oriented but not disruptive or high-growth enough for a top signal score.
Enova (ENVA) Q1 2026: SMB Originations Surge 42%, Sharpening Portfolio Mix and Margin Leverage
Enova demonstrates strong growth, particularly in SMB originations, and is executing a notable strategic pivot with the Grasshopper Bank acquisition. While unit economics and credit metrics are improving, the company's long-term reinvestment runway and self-reinforcing business model are solid but not exceptional. Revenue and EPS growth are strong but not at hypergrowth levels, and the business is more of a transitioning/growth story than a disruptive outlier.
KKR (KKR) Q4 2025: $19B Embedded Gains Signal Monetization Pipeline Strength
KKR is a leading alternative asset manager with a long reinvestment runway and strong embedded gains, but as a well-known, mature, large-cap business, the upside is meaningful but not explosive. Recent developments (Arctos, record fundraising, and monetization) are significant, but the business is not in hypergrowth or disruption mode. Unit economics and customer value are improving, but not at a transformative pace. The business model is robust and diversified but not uniquely disruptive. Cash flow is strong, growth is solid, and the business is clearly a growth platform, but the signal is somewhat capped by the company's size and profile.
Cactus (WHD) Q2 2026: Spoolable Technologies Orders Jump $80M, Triggering Capacity Expansion
Cactus shows a strong growth inflection with the $80M order and capacity expansion, indicating a long reinvestment runway and growth business profile. However, while there are signs of improving unit economics and business model evolution, the evidence for deepening self-reinforcement and customer value is moderate, and some risks (backlog volatility, tariffs) temper the signal. Growth is strong but not at the very highest tier, and the business, while attractive, is not uniquely disruptive.
Integris (ENTG) Q4 2025: Free Cash Flow Margin Jumps 300 Basis Points as Node Transition Tailwinds Build
Integris demonstrates a long reinvestment runway (node transitions, local-for-local supply), and there are significant developments in margin and free cash flow. Unit economics are improving but not dramatically, and the business model shows some self-reinforcing elements but is not a pure compounding platform. Customer value is modestly improving, and guidance implies growth but not exceptional acceleration. The business is semi-disruptive given its position in advanced materials but not a true disruptor. Cash flow is improving but not accelerating at a dramatic rate. Revenue and EPS growth are likely in the 4-20% range, and the company is a growth business, not legacy or merely transitioning.
GigaCloud (GCT) Q1 2026: Europe Drives 80% Product Revenue Surge, Offsetting U.S. Headwinds
GigaCloud has a long reinvestment runway and is showing rapid growth in Europe (80%+ product revenue, 83% GMV), but the business is not yet at the level of a clear giant and some unit economics (service margins) are pressured. Model is semi-disruptive, with some self-reinforcing elements. Growth is strong but not consistently above 40% at the consolidated level, and while the company is a growth business, some metrics (operating cash flow, U.S. headwinds) temper the signal.
Cheniere Energy (LNG) Q1 2026: Guidance Raised $500M as LNG Supply Disruption Drives Margin Upside
Cheniere is a well-established, scale LNG exporter with strong growth and capital allocation but is not a new or underappreciated growth story. The supply disruption and guidance raise are significant, but the company is already widely followed and the business model, while robust, is not deeply disruptive. Growth is strong but not at hyper-growth levels, and much of the upside is already recognized.
Baozun (BZUN) Q1 2026: BBM Revenue Jumps 39% as Margin Expansion Accelerates
Baozun is showing clear business evolution with BBM's 39% growth and strong margin expansion, but the business is not a truly disruptive model and reinvestment runway is moderate, not exceptional. Unit economics and cash flow are improving, but future growth is more solid than explosive. The business is transitioning into growth, but not at a pace or scale that would warrant a higher signal score.
American Integrity Insurance (AII) Q1 2025: Policy Count Surges 43% as Florida Reforms Reset Loss Ratios
While AII shows strong growth and a clear inflection from legislative reform, it remains a traditional insurance business with moderate reinvestment runway and no true disruptive model. The step change in loss ratios and policy growth are notable, but future growth rates are likely to normalize below hyper-growth levels as Citizens takeout fades. The business is transitioning to organic growth, and while margins are improved, the overall signal is solid but not exceptional or unique.
Blaze (BZAI) Q1 2026: NeoTensor Contract Expands to $70M as Hybrid AI Drives Recurring Revenue Shift
Blaze is at a key inflection with a long reinvestment runway and a shift to recurring revenue, but it is not yet a clear outlier in terms of disruptive compounding or unit economics. Growth is strong but not at the extreme end, and while the model is improving, it is not yet a cash flow machine. The signal is solid for a mid-cap AI infrastructure player but not extraordinary.
EONR Q3 2025: $41M Debt Extinguished, Unlocks 92-Well Growth Pipeline
Eon Resources demonstrates a significant inflection with a clean balance sheet and a multi-year growth pipeline, suggesting a long reinvestment runway and a strong pivot to growth. However, while the business model is improving and the company is transitioning to a growth phase, there is not yet evidence of disruptive, compounding network effects, or exceptional acceleration in financial metrics. The signal is strong for an emerging small-cap growth story, but not yet at the highest level of transformative, high-velocity compounding.
Booted Juice (BUDA) Q1 2026: Walmart Rollout Expands Store Count 75%, Marking Nationwide Growth Inflection
BUDA is at a genuine inflection point with a major distribution expansion and a strong balance sheet, but the business is not yet proven as a high-ROIC compounder and is not (yet) showing exceptional acceleration in growth or economics. The business model is semi-disruptive, and while the Walmart rollout is a strong signal, execution and category creation risks remain.
Agnico Eagle (AEM) Q2 2026: Shareholder Returns Surge 48% of Free Cash Flow as Growth Pipeline Accelerates
Agnico Eagle is a sector leader with a credible multi-year growth pipeline, strong capital returns, and operational resilience. However, the business is relatively mature within the gold mining sector and faces execution and inflation risks. While there is growth and optionality, the business model is not highly disruptive, and unit economics are improving but not at a transformative pace. Revenue and EPS growth are solid but not exceptional, and the company is transitioning toward greater scale rather than being a hyper-growth story.
Enova (ENVA) Q3 2025: SMB Originations Jump 31% as Credit Quality Drives Expansion
Enova is demonstrating strong growth, especially in SMB originations, and improving operating leverage. However, while growth is robust, the business is not fundamentally disruptive or showing the kind of exceptional acceleration (over 40%) that would warrant the highest scores. There is some optionality and cash flow improvement, but the reinvestment runway and uniqueness are moderate, not extraordinary. The business is a growth story but not one with truly outsized signal or upside relative to the most compelling opportunities.
Acadia Pharmaceuticals (ACAD) Q1 2026: Debut Sticks Drives 20% Growth, Pipeline Readouts Set $11B Opportunity in Motion
Acadia shows a credible reinvestment runway and recent growth inflection in a rare disease market, supported by a strong balance sheet and pipeline catalysts. However, unit economics and business model compounding are not fully proven, and customer value improvement is only modest. While the business is growth-oriented and has disruptive elements, the risk of binary pipeline outcomes and the lack of clear 40%+ growth cap the signal score.
Shimmick (SHIM) Q1 2026: Book-to-Burn Ratio Surges to 2.6, Backlog Hits Multi-Year High
Shimmick is transitioning toward growth with strong backlog and margin inflection, but it remains a mid-cap contractor with moderate reinvestment runway and some legacy business model elements. The signal is solid but not exceptional for a widely followed sector.
MoneyHero Group (MNY) Q1 2026: Wealth & Insurance Revenue Jumps 31% as AI Reshapes Margin Profile
MoneyHero exhibits strong growth in core segments, a clear pivot to high-margin products, and AI-driven cost advantages, but does not demonstrate explosive, outsized growth or a disruptive business model with a massive reinvestment runway. The business is transitioning successfully to profitable scaling, but the signal is moderate rather than exceptional, especially given the competitive landscape and execution risks.
HERE (HERE) Q1 2026: Wacoku Drives 71% of Revenue, Cementing IP-Led Growth Strategy
HERE has a long reinvestment runway and is showing high growth, but unit economics, self-reinforcing model, and customer value deepening are still emerging and not yet fully proven. The business is transitioning to growth, but concentration risk and execution complexity temper the signal. The outlook is strong but not yet exceptional or fully derisked.
Monday.com (MNDY) Q4 2025: Enterprise ARR Above $500K Jumps 74% as AI Drives Upmarket Shift
Monday.com shows strong enterprise growth and early AI monetization, but the business is not a breakout disruptor and faces ongoing SMB headwinds. While the upmarket shift and AI products are promising, the company remains in a transition phase, with growth moderating and some uncertainty around long-term upside. The business model is improving but not yet exceptional in terms of compounding advantages or explosive growth.
Gemini (GEMI) Q4 2025: Services Revenue Jumps 33% as Platform Diversifies Beyond Crypto Trading
Gemini is executing a notable business model pivot and showing strong services revenue growth, but the business is not yet a clear high-growth outlier or compounding machine. Some metrics are improving, but the overall signal is moderate given execution and regulatory risks.
BKV (BKV) Q4 2025: PowerJV EBITDA Jumps 15%, Carbon Capture Target Raised to 1.5M Tons
BKV demonstrates a solid growth profile with some disruptive elements and strong capital discipline. The reinvestment runway and growth optionality are good, but not exceptional; unit economics and customer value are improving but not at a breakneck pace. The outlook is positive but not transformative, and the business, while differentiated, is not yet a clear outlier in terms of signal versus broader energy peers.
LTH Q2 2026: In-Center Revenue Jumps 2.9% as DPT and CTR Fuel Member Spend
LTH demonstrates a long reinvestment runway, strong recent developments (notably in-center growth), and robust growth signals. However, while the business is transitioning to higher-value memberships and in-center monetization, the model is not fully disruptive, and some metrics (unit economics, customer value, cash flow) are improving but not yet exceptional. The business is in a strong growth phase, but not at the highest level of signal for every dimension.
Elutia (ELUT) Q3 2025: $88M Divestiture Fuels NXT41X Launch Path and Margin Reset
Elutia demonstrates a strong reinvestment runway and major business evolution with the divestiture and refocus on NXT41X. However, while the growth opportunity is significant, evidence for compounding self-reinforcement, rapidly improving unit economics, and disruptive business model is present but not overwhelming. The business is moving into a growth phase, but scale and exceptional acceleration are not yet fully proven.
Alibaba (BABA) Q2 2026: Cloud Revenue Jumps 34% as AI Demand Outpaces Supply Chain Capacity
Alibaba demonstrates a long reinvestment runway and disruptive business model with strong cloud/AI growth and QuickCommerce momentum. However, margin and cash flow volatility, continued investment drag, and supply chain constraints temper the signal. Unit economics are improving but not yet exceptional, and while growth is strong, it is not at hypergrowth levels. The business is transitioning toward growth but not at the highest signal threshold.
Elastic (ESTC) Q4 2026: RPO Accelerates 28% as AI, Security, and Cloud Commitments Reshape Growth Trajectory
Elastic demonstrates strong growth signals: a surge in RPO/CRPO, large deal momentum, and AI-driven expansion. However, while the business is transitioning to multi-year commitments and cloud, overall revenue/EPS growth is forecasted in the mid-teens, not at hypergrowth levels. The business model is semi-disruptive but not category-defining, and while margins are improving, cash flow acceleration is moderate. The signal is solid but not exceptional.
Knightscope (KSCP) Q3 2025: Product Revenue Jumps 82% as K7 Launch Resets Growth Narrative
While Knightscope has a disruptive business model and is launching a major new product, the business remains in transition with some optionality and growth potential but not yet clear evidence of accelerating cash flow or consistent improvement in unit economics. The K7 launch and product revenue surge are notable, but recurring revenue and margin recovery are still unproven. The company is not yet a giant, but may be on the path if execution improves.
LifeZone Metals (LZM) Q2 2026: $850M Construction Packages Out for Tender as Strategic Equity Close Nears
The business has a long reinvestment runway and is at a major inflection, but some elements (unit economics, self-reinforcement, customer value) are not yet proven at scale. The growth is strong but not yet exceptional, and while the model is semi-disruptive with optionality, it is still transitioning to full-scale operations. The outlook is promising but not yet at the level of a clear, compounding, high-growth platform.
Biodesix (BDSX) Q2 2025: Development Services Revenue Jumps 53% as Primary Care Push Gains Traction
Biodesix demonstrates a solid growth trajectory with a long reinvestment runway and recent significant developments, particularly in development services. However, while there are clear improvements and high growth in select segments, some elements (unit economics, business model defensibility, customer value deepening, and cash flow acceleration) are still emerging or not yet exceptional. The business is transitioning toward profitability and growth, but not all metrics suggest a giant or disruptive model yet.
Avino (ASM) Q2 2025: Revenue Climbs 47% as La Preciosa Development Shifts Growth Trajectory
While the business is showing strong growth and a clear step-change in scale and margin, it is not yet a giant or highly disruptive model, and some elements like reinvestment runway and customer value expansion are moderate rather than exceptional. The growth is solid but not explosive, and the business, while transitioning, is not at the frontier of sector transformation.
QT Imaging (QTI) Q1 2026: 133% Revenue Growth Anchored by 13-System Shipments and SaaS Platform Expansion
QTI demonstrates a long reinvestment runway and is at an inflection point with significant revenue growth and a SaaS transition. However, while growth is strong, margins are compressed and SaaS is early, so compounding effects and unit economics are not yet fully proven. The business is moving toward recurring revenue but is not yet a cash flow machine or at a level of disruptive dominance.
Ultragenyx (RARE) Q3 2025: $400M Royalty Monetization Extends Runway Ahead of Transformative Readouts
Ultragenyx has a credible reinvestment runway and is approaching pivotal clinical readouts that could transform its profile, but most commercial metrics are strong yet not explosive. The business model is robust but not uniquely self-reinforcing, and while growth is solid, it is not at the highest acceleration tier. The signal is good but not exceptional—more upside depends on successful execution of late-stage assets.
Dario Health (DRIO) Q3 2025: 31% Operating Expense Cut Accelerates Shift to High-Margin Recurring Revenue
Dario Health is in transition to a potentially high-growth, high-margin model, but near-term fundamentals are not yet exceptional. There is a long runway and disruptive potential, but execution and onboarding risks remain, and clear evidence of accelerating cash flow and compounding network effects is still developing. The business is growth-oriented, but not yet at the level of a transformative compounder.
Census Healthcare (SRTS) Q1 2026: CPT Code Change Drives 300% Payment Uplift, Accelerates Recurring Revenue Shift
The CPT code change provides a strong catalyst and the business is transitioning to a recurring revenue model with growth potential. However, the company is not yet at scale, the business model is only semi-disruptive, and growth rates are improving but not exceptional. Margins are under pressure and the transition carries execution risk. The business is moving in the right direction but is not yet a clear, high-multiple growth story.
Texas Instruments (TXN) Q2 2026: Industrial Revenue Jumps 30%, Broad-Based Demand Cycle Takes Hold
While the article describes a clear inflection and broad-based demand upcycle, Texas Instruments is a large, well-followed company and the business model, while strong, is not highly disruptive. The runway is solid but not exceptional, and growth is robust but not at hyper-growth levels. Some elements (pricing, margin, data center) are improving, but not all signal a transformational step change.
UDAO (DAO) Q1 2026: Online Marketing Surges 21% as AI Drives Segment to 43% of Revenue
UDAO is undergoing a notable business model shift toward AI-driven, high-margin segments, with strong growth in online marketing and clear strategic intent. However, while the reinvestment runway and disruption potential are present, some elements (such as unit economics, customer value deepening, and cash flow acceleration) are still developing rather than fully proven. The business is growth-oriented but not yet demonstrating exceptional acceleration across all vectors.
Dragonfly Energy (DFLI) Q3 2025: $90M Capital Raise Reshapes Balance Sheet, Unlocks Growth Levers
The business shows a long reinvestment runway, recent significant developments, and a pivot to growth. However, unit economics and business model self-reinforcement are only partially evident, with DTC segment under pressure and margin improvement still in early stages. The business is moving toward growth, but most metrics are not yet at the exceptional or compounding level required for a higher signal score.
Arrow (AIRO) Q1 2026: $150M Drone Backlog Anchors Strategic Pivot to Pure-Play UAV
Arrow's business shows a strong backlog and clear strategic pivot, with a long runway and high growth potential, but not all areas are exceptional or fully proven yet. Unit economics and business model self-reinforcement are emerging but not yet compounding at scale, and while growth is strong, it is not yet at hypergrowth levels. The business is transitioning to a growth model, but some risks and uncertainties remain.
Central Puerto (CEPU) Q1 2026: EBITDA Surges 42% as Contracted Revenue Hits 44% of Mix
While the business is showing strong growth, improved mix, and operational leverage, it is not a highly disruptive model and the reinvestment runway is solid but not exceptional. Recent developments are significant, but future growth is likely to moderate as the business matures. The company is transitioning toward a more stable, contracted model, with some optionality from oil, but not a clear path to outsized compounding or disruption.
NetSol Technologies (NTWK) Q2 2026: Service Revenues Jump 41% as AI-Driven Platform Expands
NetSol is transitioning to a higher-margin, recurring revenue model with AI-driven products, which increases its reinvestment runway and growth opportunity. However, some metrics (unit economics, customer value, disruptive potential) are improving but not yet exceptional, and the business, while promising, is not yet at the scale or velocity of a truly outsized growth story.
Coherus Oncology (CHRS) Q2 2025: Lactorzy Revenue Jumps 36% as Pipeline Readouts Near
Coherus has a strong reinvestment runway and recent high growth (Lactorzy up 36%), but the business is still transitioning from a single-product focus and faces execution risk in community adoption. Unit economics and self-reinforcing advantages are present but not yet at full scale. Pipeline catalysts are material but not guaranteed, and while the business is moving toward growth, it is not yet a clear high-growth compounding story.
Cognizant (CTSH) Q4 2025: Large Deal TCV Surges 60%, Cementing AI-Led Growth Trajectory
Cognizant is showing clear business momentum with large deal TCV growth, margin expansion, and AI-driven productivity, but as a mature, well-followed IT services leader, its reinvestment runway and disruptive potential are somewhat capped compared to earlier-stage or more transformative names. The signal is strong for ongoing growth and margin improvement, but not at a level likely to deliver outsized valuation upside for investors seeking breakthrough opportunities.
Edwards Lifesciences (EW) Q4 2025: TMTT Grows 40% as Guideline Shifts Fuel Durable Share Gains
While Edwards shows strong growth in TMTT (40%+), a robust pipeline, and guideline-driven tailwinds, the business is not a disruptive new entrant and faces tougher comps and execution risks. The reinvestment runway is solid but not exceptional, and growth is likely to moderate. There are competitive moats and deepening customer value, but the business is not on track to become a hyper-growth giant.
CCEC (CCEC) Q2 2026: Contracted Revenue Backlog Surges to $4.3B, Locking in Multi-Year Cash Flow Visibility
CCEC has a long reinvestment runway, recent surge in backlog, and is positioned for growth in emerging segments (LCO2, ammonia). However, the business is not a breakthrough disruptor, and while backlog is strong, unit economics and customer value deepening are only moderately improving. Model is somewhat self-reinforcing but not at tech platform levels. Growth is solid but not hyper-scaling. Overall, signal is above average but not extraordinary.
NMM Q1 2026: Backlog Climbs 16% to $4.1B as Fleet Modernization Drives Margin Visibility
NMM demonstrates strong growth in backlog, margin expansion, and capital flexibility, with significant fleet modernization and some disruptive elements in asset rotation and charter strategy. However, it is not a truly disruptive business model, and the reinvestment runway is not as long or high-ROIC as the most exceptional compounders. Growth is robust but not hyper-scaling, and while the business is clearly not legacy or stalling, the upside is more incremental than transformative.
AMG (AMG) Q4 2025: Alternatives AUM Jumps 35% as Strategic Pivot Accelerates Earnings Power
AMG is showing strong growth in alternatives and capital allocation, but as an asset manager, its reinvestment runway is moderate (not a compounding platform business), and some signals (network effects, customer value expansion) are present but not world-class. The business is transitioning to growth, but not at a disruptive or hypergrowth pace. While recent AUM and earnings growth are impressive, the industry context and potential cyclicality temper the signal score.
Tego Energy (TYGO) Q1 2026: EMEA Climbs to 69% of Sales as Utility Pipeline Fuels Upside
Tego Energy demonstrates a strong reinvestment runway, a recent significant revenue uptick, and a credible pipeline for utility-scale growth. However, while the business is transitioning and showing growth potential, some elements (unit economics, self-reinforcement, customer value deepening) are still emerging rather than fully proven. The business is not yet at the level of a clear, compounding disruptor, but it is positioned for above-average growth with multiple levers in play.
Veru (VERU) Q3 2025: Phase IIb Data Drives 46% Reduction in Post-GLP-1 Weight Regain, FDA Clarity Looms
Veru has a disruptive late-stage asset with clear strategic inflection and a strong competitive/IP moat, but its financial runway is short and the business is not yet generating high returns or cash flow. The recent Phase IIb data is a major development, but the business is still transitioning and faces significant regulatory and capital risks. There is high growth potential, but not all the hallmarks of a compounding, self-reinforcing business are yet in place.
Tsakos Energy Navigation (TEN) Q1 2026: Profit-Sharing Revenues Surpass $40M, Amplifying Earnings Leverage
TEN is showing strong earnings leverage and growth, but the business is not highly disruptive or unique, and the sector is cyclical with limited long-term reinvestment optionality. Profit-sharing and fleet renewal are positive, but the underlying model is not exceptional in terms of compounding or network effects. Growth and cash flow are strong but not at the highest levels for signal.
Health in Tech (HIT) Q1 2026: Platform-Driven $82M Plan Value Signals Early Distribution Leverage
HIT demonstrates a long reinvestment runway, recent significant developments (platform-placed plan value and contracted revenue), and strong growth guidance. However, some elements such as improving unit economics, business model self-reinforcement, and customer value deepening are present but not yet at a compounding or exceptional level. The business is in transition with strong growth potential but not yet in the 'giant' category.
Gemini (GEMI) Q1 2026: Services Revenue Hits 49% of Total, Accelerating Diversification Beyond Crypto
Gemini demonstrates a credible pivot toward a more durable, recurring revenue model, with clear regulatory moats and new product traction. The reinvestment runway is long and the business is transitioning into a growth phase, but unit economics, self-reinforcing model elements, and customer value deepening are not yet fully proven. Growth is strong but not exceptional, and while the business is not legacy or stalling, it is still in the early innings of its transformation. Signal is solid but not extraordinary, especially given the company’s risk profile and the need for further execution.
ILPT Q2 2026: 5.4M SF Leased at 35% Spreads Drives Occupancy to 99%
ILPT demonstrates strong operational momentum and recent inflections (record leasing, 35% spreads, occupancy to 99%). However, as a REIT in a mature asset class with high leverage and some cash flow timing risks, its reinvestment runway and self-reinforcing business model are only moderate. The business is high-performing but not exceptional or disruptive, and growth is solid but not at hypergrowth levels.
ARQQ Q2 2026: Revenue Jumps 829% as Quantum Security Adoption Accelerates
ARQQ shows a disruptive business model with a long reinvestment runway and clear inflection in demand, supported by strong contract and revenue growth. However, unit economics and customer value deepening are still emerging, and the business is not yet at a scale where cash flow or revenue growth exceeds 20% annually. Signal is strong for a small-cap, high-optional business, but not yet at the level of a giant or established hypergrowth company.
Agnico Eagle (AEM) Q4 2025: $1.4B Returned, 20% Production Growth Path Unveiled
Agnico Eagle shows strong organic growth, high returns on capital, and robust capital allocation. However, while the growth path is notable, the business is a well-known large-cap gold miner and not a disruptive or unknown compounder, capping the signal score. Unit economics and business model are solid but not exceptional or rapidly improving. The company is a high-quality growth business, but the upside is moderate given sector maturity.
Clean Harbors (CLH) Q2 2026: SKSS EBITDA Doubles to $275M, Unlocking Margin Upside
Clean Harbors demonstrates strong growth, margin expansion, and new vertical entry, but its core markets are industrial and somewhat cyclical, with some limitations to reinvestment runway and self-reinforcing advantages. The company is a growth business with some disruptive elements, but not a category-defining compounder. Signal is solid but not at the level of a transformative, high-optional business.
Werner Enterprises (WERN) Q2 2026: One-Way Truckload Margin Expands 700bps, Supply Contraction Accelerates Upcycle
Werner is benefiting from a strong cyclical upturn, with clear margin expansion and operational leverage, but as a well-followed, mature trucking/logistics provider, the reinvestment runway and disruptive potential are moderate rather than exceptional. The business is transitioning to higher quality and profitability, but the underlying business model is not highly disruptive and growth, while strong, is not in the hypergrowth category.
Quinn Street (QNST) Q2 2026: HomeBuddy Adds $140M Media Scale, Unlocking Home Services Expansion
The HomeBuddy acquisition and ongoing margin expansion provide notable signal, as does the shift to AI-driven, data-centric operations. However, while there is growth and optionality, the business is not a clear-cut, massive reinvestment compounder with a long, uncapped runway. Growth is solid but not hyper-scaling, and while the business is well-positioned, it is not disruptive at the highest level. The signal is above average but not exceptional.
Modine (MOD) Q1 2027: Data Center Revenue Jumps 90% as Supply Chain Bottlenecks Delay Margin Recovery
Modine demonstrates a strong reinvestment runway and recent explosive growth (90% YoY in data center), but margin compression and supply chain bottlenecks limit the near-term signal. Unit economics are not clearly improving yet, and while the business model is shifting toward self-reinforcement, it is not fully compounding. Customer value is improving, but not exceptionally, and backlog/guidance is strong but not at an exceptional acceleration. The business is transitioning toward growth, but risks and execution challenges temper the overall signal.
Ralph Lauren (RL) Q4 2026: Asia Sales Surge 28%, Fueling Global Brand Elevation and Margin Expansion
RL is showing strong growth in Asia and DTC, with evidence of improving unit economics and margin expansion. However, the business is not disruptive or a new growth story, and while the growth is robust, it is not at a level that would warrant a top signal score. The company is mature, with some reinvestment runway but not at the level of a high-growth or highly disruptive business. Risks and macro headwinds temper the signal.
AMBR Q1 2026: Agentic Revenue Model Launches as AMM Debuts, Targeting Recurring Fee Scale
AMBER shows strong signal on reinvestment runway, business model disruption, and recent product launches. However, the business is still in transition with recurring revenue and margin expansion yet to be proven at scale. While growth potential is evident, current financials and adoption rates warrant caution, keeping the signal score conservative.
Jerash Holdings (JRSH) Q4 2026: Capacity Booked Through December as Orders Climb 47%
While Jerash is showing strong growth, order acceleration, and a fully booked pipeline, it is not an exceptional business with a long reinvestment runway or disruptive model. The business is transitioning from legacy to growth, with some improvement in unit economics and customer value, but still faces concentration and execution risks. The growth rate is strong but not at a hypergrowth level, and the business model, while improving, is not highly self-reinforcing or disruptive. The signal is solid for a small-cap manufacturer, but not exceptional.
Tamborin Resources (TBN) Q3 2026: $198M Equity Raise and Daily Waters Farm-Out Sharpen Beetaloo Basin Trajectory
Tamborin Resources shows a long reinvestment runway and a clear capital inflection, with recent transactions validating asset value and supporting future optionality. However, while the business is transitioning to scalable production and has positive growth signals, it is not yet a high-growth or disruptive business with compounding network effects. Unit economics and customer value are improving but not exceptional, and execution risk remains. Signal is solid but not extraordinary.
POSCO Holdings (PKX) Q4 2025: Lithium Sales Set to Double as Asset Ramp Drives 2026 Inflection
POSCO Holdings is at an inflection point with a substantial lithium ramp and portfolio shift, suggesting a long reinvestment runway and growth potential. However, some elements (unit economics, self-reinforcing model, customer value) are only moderately improving or not fully proven yet, and the business is not a pure high-growth disruptor. The overall signal is solid but not exceptional due to ongoing execution and market risks.
Be Light Bio (BLTE) Q3 2025: $140M Capital Infusion Extends Runway for Global Tinlaraban Launch
BLTE is not yet commercial, so some signal levers (unit economics, customer value, cash flow acceleration) are not fully proven—hence lower scores on those. However, the capital raise, coordinated regulatory momentum, and pipeline progress are strong signals of a high-upside, growth-stage biotech. The business is not yet at the inflection of a massive growth ramp, but the setup is strong for a rare disease asset approaching launch.
TPG (TPG) Q4 2025: Fundraising Surges 71% as Deployment and Fee Power Scale
TPG shows strong growth and diversification, with record fundraising and margin expansion, but as a large, well-followed asset manager, the business is not highly disruptive and much of the growth is already reflected in its scale and investor interest. While there are clear growth levers, the opportunity is not unique or underappreciated enough to warrant a higher signal score.
Sight Sciences (SGHT) Q1 2026: Dry Eye Revenue Triples, Early Adoption Signals Scaling Path
Sight Sciences displays a solid growth profile with a long reinvestment runway and recent significant developments, particularly in the dry eye segment (revenue nearly tripled). Some elements, such as improving unit economics and self-reinforcing business model, are present but not yet at the highest level of compounding or scale. Customer value and future growth are improving but not exceptional. The business is transitioning toward a growth phase but is not yet a clear breakout. The signal is strong for a medtech small-cap, but not at the highest level of disruptive upside.
Warrior Met Coal (HCC) Q4 2025: Blue Creek Drives 61% Production Surge, Reshaping Cost Curve
Blue Creek’s ramp and cost reset are significant, but Warrior Met Coal remains a cyclical, commodity business with moderate reinvestment optionality and limited structural disruption. The growth is strong but not exceptional, and while unit economics and margins are improving, the business is not transitioning to a high-multiple, compounding model. Signal is above average due to the scale/cost reset, but not at the highest level due to sector and business model limitations.
LaFrost (LFS) Q1 2025: Social Business Revenue Climbs to 28% of Mix, Powered by Club Support Expansion
LaFrost is at a strategic inflection with policy-driven growth and a long runway for reinvestment, as evidenced by rapid social business expansion and strong guidance. However, while growth is robust, the business is not yet on track for truly exceptional (40%+) growth, and some aspects of the model (unit economics, self-reinforcement, ARPU) are promising but not yet clearly compounding at scale. The business is transitioning to a growth platform, but international optionality and disruptive potential are still emerging, warranting a conservative signal score.
Opendoor (OPEN) Q1 2026: Inventory Over 120 Days Plunges 41 Points, Validating Velocity Model Shift
Opendoor's business model shift and recent results provide clear evidence of operational improvement and a credible path to profitability, but the business remains exposed to execution and macro risks. While growth is improving and there are strong signals of a turnaround, the company is not yet demonstrating the kind of exceptional, high-compounding dynamics or disruptive dominance that would warrant a higher signal score. The reinvestment runway and self-reinforcing model are emerging but not fully proven at scale.
Verica (VRCA) Q1 2026: YCANTH Applicator Units Jump 51% as Prescriber Base Expands
Verica shows strong commercial momentum and pipeline progress, with a 51% increase in dispensed units and expanding prescriber base. However, the reinvestment runway is moderate and not yet proven to deliver sustained 20%+ ROIC. There is a significant recent uptick in growth and backlog, but the business is not yet a clear category leader with deeply compounding self-reinforcing advantages. Unit economics are strong and improving, but customer value expansion is modest. The business is transitioning to growth, but future exceptional growth is not yet certain. The model is somewhat disruptive, but not fully proven as such. Cash flow is improving but not yet accelerating dramatically. Growth rates are above 20% but not yet at hypergrowth levels. Overall, the signal is solid for a specialty pharma in scaling mode, but not yet exceptional.
Ross Stores (ROST) Q1 2026: Customer Count Surges Double Digits, Fueling 17% Comp Growth
Ross delivered record growth and customer acquisition, but as a mature off-price retailer, its reinvestment runway and disruptive potential are more limited than a true high-growth or platform business. The inflection is material and recent, but the business model is not fundamentally disruptive and future growth is guided to normalize. Signal is strong for retail, but not exceptional or unique enough for a higher score.
American Integrity Insurance (AII) Q1 2026: Voluntary Policies Surge 18% as Southeast Expansion Gains Traction
The signal is solid: the business is in a growth phase, voluntary policy growth is strong, and legislative/reinsurance tailwinds are material. However, the business model—while improving—is not deeply disruptive, and the reinvestment runway, while long, is still subject to market/regulatory risks. Unit economics are improving but not yet compounding at a giant scale, and the business is not likely to deliver >40% annual growth. The upside is clear but not exceptional versus the highest-signal growth stories.
Harmonic (HLIT) Q1 2026: Rest of Market Revenue Jumps 78%, Fueling Diversification and Visibility
Harmonic demonstrates a solid reinvestment runway and recent significant growth in rest of market revenue. However, while the business is transitioning to a pure broadband model and shows growth, it is not yet a disruptive platform nor exhibiting network effects or clear compounding advantages. Unit economics and customer value are improving, but not at a giant scale. Guidance is positive but not exceptional, and growth rates, while robust, do not consistently exceed 40%. The business is growth-oriented but not a breakout compounder at this stage.
Atlas Clear (ATCH) Q1 2026: Equity Swings Positive by $13M as Platform Build Accelerates
Atlas Clear is in a transitional phase with improved capital position, visible growth initiatives, and a recurring revenue base, but the business is still early in proving out self-reinforcing economics, deepening customer value, and exceptional growth. There are positive signals, but the platform's upside is not yet at the level of a clear, high-multiple compounding business.